Clinical Trials

• P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
  ClinicalTrials.gov Identifier: NCT00393315 - Active, not recruiting
  In-Stent Restenosis
  
• P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00011414 - Recruiting
  Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
  
• P-Glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
  ClinicalTrials.gov Identifier: NCT00524134 - Not yet recruiting
  Epilepsy
  
• P210-B3A2 Derived Peptide Vaccine in CML
  ClinicalTrials.gov Identifier: NCT00452933 - Recruiting
  Chronic Myeloid Leukemia
  
• P3: Pacemaker Patient Profiling Study
  ClinicalTrials.gov Identifier: NCT00294060 - Active, not recruiting
  Bradycardia
  
• P4 (Pregabalin for Peripheral Posttraumatic Pain)
  ClinicalTrials.gov Identifier: NCT00292188 - Recruiting
  Neuralgia
  
• p450 Mediated Lung Toxicity
  ClinicalTrials.gov Identifier: NCT00023114 - Completed
  Pulmonary Disease
  
• p53 Peptide vaccination for Breast or Ovary Cancer
  ClinicalTrials.gov Identifier: NCT00001828 - Recruiting
  Breast Cancer; Breast Neoplasm
  
• p53 Peptide Vaccination to Treat Lung Cancer
  ClinicalTrials.gov Identifier: NCT00001829 - No longer recruiting
  Non-Small-Cell Lung Carcinoma
  
• p53 Vaccine for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00001827 - No longer recruiting
  Ovarian Neoplasm
  
• p53 Vaccine in Treating Patients With Adenocarcinoma of the Ovary Who Have Either No Evidence of Disease or Elevated Biomarkers
  ClinicalTrials.gov Identifier: NCT00019903 - Active, not recruiting
  Ovarian Cancer
  
• p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Oesophageal Cancer
  ClinicalTrials.gov Identifier: NCT00525200 - Recruiting
  Oesophageal Cancer
  
• PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis
  ClinicalTrials.gov Identifier: NCT00567840 - Completed
  Pulmonary Tuberculosis
  
• PACAP38´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
  ClinicalTrials.gov Identifier: NCT00380263 - Recruiting
  Migraine Without Aura
  
• PACE-iDP: An Intervention for Youth at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00412165 - Recruiting
  Obesity; Overweight; Diabetes
  
• PACE-PC: Primary Care Management of Adolescent Obesity
  ClinicalTrials.gov Identifier: NCT00415974 - Not yet recruiting
  Obesity; Overweight; Weight Loss; Weight Maintenance
  
• Pacemaker Therapy in Adults With Congenital Heart Defects
  ClinicalTrials.gov Identifier: NCT00303511 - Terminated
  Congenital Disorder
  
• PACEPro - Mood Management Pilot
  ClinicalTrials.gov Identifier: NCT00416221 - Active, not recruiting
  Depression
  
• Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00161538 - Completed
  Sick Sinus Syndrom
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00521313 - Recruiting
  Lung Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00307255 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00470548 - Recruiting
  Breast Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00499291 - Not yet recruiting
  Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00499252 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00503906 - Recruiting
  Breast Cancer
  
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Radiation Therapy in Treating Patients With Stage III Non-Small-Cell Lung Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00544648 - Recruiting
  Lung Cancer
  
• Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00095914 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006018 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005028 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
  
• Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00453323 - Recruiting
  Esophageal Cancer
  
• Paclitaxel and Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005649 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00004887 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00462397 - Recruiting
  Cervical Cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00077129 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00049257 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or IV Uterine Cancer
  ClinicalTrials.gov Identifier: NCT00112489 - Recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine carcinosarcoma
  
• Paclitaxel and Carboplatin in Treating Women Who are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096343 - Active, not recruiting
  invasive ductal breast carcinoma; invasive lobular breast carcinoma; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; ...
  
• Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00568451 - Recruiting
  Melanoma (Skin)
  
• Paclitaxel and Carboplatin With or Without AZD2171 in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00245154 - Recruiting
  Lung Cancer
  
• Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006229 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062179 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004934 - Completed
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00390611 - Recruiting
  Ovarian Cancer
  
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00084448 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00002717 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00021372 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004863 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00278122 - Recruiting
  Melanoma (Skin)
  
• Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00020007 - Completed
  Lung Cancer; Metastatic Cancer
  
• Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004924 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004126 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003193 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00238420 - Recruiting
  Bladder Cancer
  
• Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries
  ClinicalTrials.gov Identifier: NCT00472472 - Active, not recruiting
  Peripheral Arterial Disease
  
• Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009828 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003350 - Active, not recruiting
  epidemic Kaposi's sarcoma
  
• Paclitaxel Eluting Covered Metalic Stent for Uresectable Malignant Bile Duct Obstruction
  ClinicalTrials.gov Identifier: NCT00453076 - Recruiting
  Bile Duct Obstruction
  
• Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel from Baker Norton Pharmaceuticals
  ClinicalTrials.gov Identifier: NCT00002189 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Paclitaxel in Treating Older Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003092 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002922 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
  ClinicalTrials.gov Identifier: NCT00003120 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00002562 - Completed
  recurrent vaginal cancer; recurrent cervical cancer; cervical adenocarcinoma; vaginal clear cell adenocarcinoma
  
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003008 - Active, not recruiting
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002917 - Completed
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
  
• Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005646 - Completed
  extensive stage small cell lung cancer
  
• Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00217607 - Recruiting
  Sarcoma
  
• Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
  ClinicalTrials.gov Identifier: NCT00014599 - Active, not recruiting
  stage III vulvar cancer; stage IV vulvar cancer; recurrent vulvar cancer; squamous cell carcinoma of the vulva
  
• Paclitaxel in Treating Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002972 - Active, not recruiting
  stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung
  
• Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00002632 - Completed
  stage IV salivary gland cancer; recurrent salivary gland cancer; high-grade salivary gland mucoepidermoid carcinoma; salivary gland adenocarcinoma
  
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003326 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; squamous cell carcinoma of the esophagus
  
• Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00023907 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel in Treating Patients With Ovarian Stromal Cancer
  ClinicalTrials.gov Identifier: NCT00006227 - Recruiting
  ovarian stromal cancer
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003054 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005046 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002928 - Completed
  recurrent ovarian epithelial cancer
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004265 - Active, not recruiting
  recurrent non-small cell lung cancer
  
• Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003230 - Active, not recruiting
  untreated adult acute myeloid leukemia; untreated adult acute lymphocytic leukemia; recurrent adult acute myeloid leukemia; ...
  
• Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00022620 - Active, not recruiting
  recurrent endometrial cancer; endometrial papillary carcinoma
  
• Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002969 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00111904 - Recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Paclitaxel in Treating Women With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003130 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002662 - Completed
  stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Paclitaxel or Polyglutamate Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00108745 - Recruiting
  ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003880 - Completed
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00006454 - Active, not recruiting
  stage II ovarian epithelial cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003555 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003614 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003717 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003518 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; stage IV ovarian germ cell tumor; stage III testicular cancer
  
• Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00004057 - Active, not recruiting
  Cancer
  
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003539 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00031577 - Active, not recruiting
  untreated childhood brain stem glioma
  
• Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002519 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006256 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002587 - Completed
  unspecified adult solid tumor, protocol specific
  
• Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00265733 - Active, not recruiting
  Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
  
• Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00459810 - Recruiting
  Prostate Cancer
  
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028990 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003117 - Active, not recruiting
  stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenosquamous Cell Lung Cancer; ...
  
• Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00025688 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006459 - Completed
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With Or Without GW572016 As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00075270 - Active, not recruiting
  Metastatic breast cancer
  
• Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002937 - Active, not recruiting
  recurrent breast cancer
  
• Paclitaxel With or Without Sorafenib in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499525 - Recruiting
  Breast Cancer
  
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004013 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With or Without Trastuzumab in Treating Patients With Inoperable, Recurrent, or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003440 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer
  
• Paclitaxel(Phyxol) and Cisplatin as First-Line Chemotherapy for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00154882 - Recruiting
  Breast Cancer
  
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00136175 - Active, not recruiting
  Bladder Cancer
  
• Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176267 - Active, not recruiting
  Squamous Cell Carcinoma
  
• Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176254 - Active, not recruiting
  Squamous Cell Carcinoma
  
• Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00085501 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
  
• Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00193531 - Active, not recruiting
  Neuroendocrine Carcinoma
  
• Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00096226 - Recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00077220 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel, Carboplatin, and Topotecan in Patients with Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102375 - Completed
  Ovarian Cancer
  
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005087 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Oropharyngeal Cancer; ...
  
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002913 - Completed
  Ovarian Cancer
  
• Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00493025 - Recruiting
  Esophageal Cancer
  
• Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499083 - Recruiting
  Breast Cancer
  
• Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024310 - Active, not recruiting
  Drug Toxicity; unspecified adult solid tumor, protocol specific
  
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
  ClinicalTrials.gov Identifier: NCT00423852 - Recruiting
  Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Ovarian Cancer; Teratoma; Testicular Germ Cell Tumor
  
• Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
  ClinicalTrials.gov Identifier: NCT00004077 - Active, not recruiting
  Testicular Cancer; Reproductive Cancer
  
• Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00276796 - Not yet recruiting
  Cervical Cancer
  
• Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00084565 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions
  ClinicalTrials.gov Identifier: NCT00540813 - Recruiting
  Ischemia; Stenosis
  
• Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
  ClinicalTrials.gov Identifier: NCT00154726 - Completed
  Locally Advanced and Recurrent/Metastatic Gastric Cancer
  
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00360360 - Recruiting
  Neoplasm, Unknown Primary
  
• Paclitaxel/Cyclophosphamide and High-Dose Melphalan/Etoposide Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IIIB Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00019162 - Recruiting
  Breast Cancer
  
• PACMAN
  ClinicalTrials.gov Identifier: NCT00180596 - Completed
  Heart Failure
  
• PACT: Providers and Alzheimer's Caregivers Together
  ClinicalTrials.gov Identifier: NCT00182897 - Completed
  Alzheimer's Disease; Dementia
  
• PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00319865 - Recruiting
  Multiple Myeloma
  
• PADRE - Preventing Antibiotic-Associated DiarRhea Using Erceflora
  ClinicalTrials.gov Identifier: NCT00447161 - Recruiting
  Diarrhea, Infantile
  
• Pain and Sensory Changes Assessment in HIV+ Patients
  ClinicalTrials.gov Identifier: NCT00422695 - Recruiting
  HIV Infections
  
• Pain and Stress Management for People with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00088764 - Active, not recruiting
  Rheumatoid Arthritis
  
• Pain Assessment, Incidence & Nature in Heart Failure
  ClinicalTrials.gov Identifier: NCT00444301 - Recruiting
  Heart Diseases
  
• Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002668 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IV prostate cancer; recurrent prostate cancer; Pain
  
• Pain Detection and Interception in Neonates
  ClinicalTrials.gov Identifier: NCT00447824 - Recruiting
  Pain Detection; Pain Intervention
  
• Pain Evaluation and Treatment
  ClinicalTrials.gov Identifier: NCT00362167 - Completed
  Pain
  
• Pain in Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00581724 - Recruiting
  Breast Cancer; Colorectal Cancer; Prostate Cancer; Head and Neck Cancer; Lung Cancer
  
• Pain in Sickle Cell Epidemiologic Study
  ClinicalTrials.gov Identifier: NCT00035763 - Active, not recruiting
  Blood Disease; Anemia, Sickle Cell
  
• Pain Management and Behavioral Outcomes in Patients with Dementia
  ClinicalTrials.gov Identifier: NCT00012857 - Completed
  Dementia; Alzheimer Disease; Pain
  
• Pain Management Following TRAM Flap for Breast Reconstruction
  ClinicalTrials.gov Identifier: NCT00500565 - Recruiting
  Breast Cancer
  
• Pain Management for Pectus Excavatum Repair
  ClinicalTrials.gov Identifier: NCT00413582 - Recruiting
  Postoperative Pain
  
• Pain Management Protocol for Pediatric Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00386048 - Recruiting
  Sickle Cell Disease
  
• Pain Management Techniques for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00086060 - Recruiting
  Fibromyalgia
  
• Pain Measurement
  ClinicalTrials.gov Identifier: NCT00001597 - Completed
  Healthy; Pain
  
• Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years
  ClinicalTrials.gov Identifier: NCT00232895 - Completed
  ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
  
• Pain Pathways in the Brain
  ClinicalTrials.gov Identifier: NCT00078364 - Completed
  Healthy; Tooth Extraction
  
• Pain Perception in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00192816 - Recruiting
  Dementia Alzheimer Type
  
• Pain Perception is Attenuated in Patients With Painless Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00192790 - Completed
  Myocardial Infarction; Myocardial Ischemia
  
• Pain Post Abdominal Laparoscopy Prevention With Arcoxia
  ClinicalTrials.gov Identifier: NCT00565682 - Completed
  Laparoscopic Surgery for Appendicitis; Laparoscopic Surgery for Cholecystitis; Laparoscopic Surgery for Ovarian Cysts
  
• Pain Prevalence in the Trauma Population
  ClinicalTrials.gov Identifier: NCT00552968 - Recruiting
  Trauma
  
• Pain Processing in Anxiety and Depression
  ClinicalTrials.gov Identifier: NCT00560196 - Recruiting
  Pain; Anxiety; Depression
  
• Pain Quantification and Pain Management in Interventional Radiology
  ClinicalTrials.gov Identifier: NCT00500942 - Recruiting
  Pain
  
• Pain Reducing Effect of Transcutaneous Electrical Nerve Stimulation in Patients With Chronic Low Back Pain or Lumbo-Radiculalgia
  ClinicalTrials.gov Identifier: NCT00452010 - Recruiting
  Chronic Low Back Pain; Chronic Lumbo-Radiculalgia
  
• Pain Relief - Tramadol versus Ibuprofen
  ClinicalTrials.gov Identifier: NCT00111046 - Active, not recruiting
  Choroidal melanoma; Melanoma; Eye Neoplasms
  
• Pain Relief by Applying TENS on Acupuncture Points During the First Stage of Labour
  ClinicalTrials.gov Identifier: NCT00148577 - Active, not recruiting
  Pain relief at first stage
  
• Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
  ClinicalTrials.gov Identifier: NCT00433316 - Recruiting
  Laparoscopic Surgical Procedures
  
• Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy
  ClinicalTrials.gov Identifier: NCT00468052 - Recruiting
  Obstructive Sleep Apnea
  
• Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
  ClinicalTrials.gov Identifier: NCT00253032 - Terminated
  Chronic Musculoskeletal Pain
  
• Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population
  ClinicalTrials.gov Identifier: NCT00450905 - Recruiting
  Fibromyalgia; Pain
  
• Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
  ClinicalTrials.gov Identifier: NCT00022854 - Completed
  Anterior Cruciate Ligament Rupture
  
• Pain Study of Rectus Muscle Closure at Cesarean Delivery
  ClinicalTrials.gov Identifier: NCT00505362 - Recruiting
  Pain; Complications; Adhesions
  
• Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
  ClinicalTrials.gov Identifier: NCT00505531 - Recruiting
  Chronic Pain
  
• Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine
  ClinicalTrials.gov Identifier: NCT00270322 - Terminated
  Total Knee Replacement; Orthopedic Surgery; Pain, Postoperative; Osteoarthritis
  
• Pain Treatment for Sciatica
  ClinicalTrials.gov Identifier: NCT00009672 - Completed
  Radiculopathy; Sciatica
  
• Painful HIV Neuropathy and Alpha-Lipoic Acid
  ClinicalTrials.gov Identifier: NCT00079807 - Active, not recruiting
  HIV; Peripheral Neuropathy
  
• Painful Procedures in the Emergency Department: A Distraction Intervention
  ClinicalTrials.gov Identifier: NCT00338364 - Recruiting
  Pediatric Pain and Anxiety
  
• Painful Procedures in the Emergency Department: A Distraction Intervention (3-5 Year Olds)
  ClinicalTrials.gov Identifier: NCT00337870 - Recruiting
  Anxiety; Pain
  
• Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00539929 - Not yet recruiting
  Chronic Plaque Psoriasis
  
• Paleolithic Diet and Exercise Study
  ClinicalTrials.gov Identifier: NCT00360516 - Recruiting
  Healthy
  
• Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care
  ClinicalTrials.gov Identifier: NCT00435240 - Recruiting
  Diabetes Mellitus, Type 2
  
• Paleolithic Diet in the Treatment of Glucose Intolerance
  ClinicalTrials.gov Identifier: NCT00419497 - Completed
  Hyperglycemia; Coronary Heart Disease
  
• Paleolithic Diets and T2D
  ClinicalTrials.gov Identifier: NCT00548782 - Recruiting
  Type 2 Diabetes Mellitus
  
• Palifermin After Haploidentical PBSCT
  ClinicalTrials.gov Identifier: NCT00570999 - Not yet recruiting
  Non-Hodgkin's Lymphoma or Hodgkin's Disease; Acute Leukaemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia; Osteomyelofibrosis
  
• Palifermin DDI (Drug Drug Interaction)
  ClinicalTrials.gov Identifier: NCT00361348 - Completed
  Healthy Volunteers
  
• Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
  ClinicalTrials.gov Identifier: NCT00109031 - Active, not recruiting
  Cancer; Lymphoma; Leukemia
  
• Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00360971 - Recruiting
  Head and Neck Cancer; Mucositis; Pain; Radiation Toxicity
  
• Palifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00126529 - Recruiting
  Drug Toxicity; Leukemia; Lymphoma; oral complications of cancer and cancer therapy; plasma cell neoplasm; radiation toxicity
  
• Paliperidone ER Study of Economic, Functional, and Clinical Outcomes.
  ClinicalTrials.gov Identifier: NCT00488891 - Recruiting
  Schizophrenia
  
• Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis
  ClinicalTrials.gov Identifier: NCT00264017 - Completed
  Prostate Cancer Patients Undergoing External Radiation and Seed Implantation
  
• Palliative Care Efficacy Study in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00127517 - Recruiting
  Palliative Cancer Care; Advanced Cancer
  
• Palliative Care of Children With End-Stage Heart Failure
  ClinicalTrials.gov Identifier: NCT00327782 - Terminated
  Congenital Disorders
  
• Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002893 - Active, not recruiting
  recurrent colon cancer; stage III rectal cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Palliative Oxygen for the Relief of Breathlessness
  ClinicalTrials.gov Identifier: NCT00327873 - Recruiting
  Dyspnea
  
• Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00030459 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Pallidal Stimulation and Gilles de la Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00478842 - Not yet recruiting
  Gilles de la Tourette Syndrome
  
• Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia
  ClinicalTrials.gov Identifier: NCT00169403 - Recruiting
  Dystonia
  
• Pallidal Stimulation in Patients With Post-Anoxic and Idiopathic Dystonia
  ClinicalTrials.gov Identifier: NCT00169338 - Recruiting
  Dystonia
  
• Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
  ClinicalTrials.gov Identifier: NCT00553059 - Recruiting
  Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific
  
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00412425 - Recruiting
  Melanoma
  
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
  ClinicalTrials.gov Identifier: NCT00410488 - Recruiting
  Sarcoma; Nausea; Vomiting
  
• PALUREA: Severe Imported Malaria in Adults
  ClinicalTrials.gov Identifier: NCT00372684 - Recruiting
  Malaria
  
• Pamidronate Administration in Breast Cancer Patients with Bone Metastases.
  ClinicalTrials.gov Identifier: NCT00128297 - Completed
  Breast cancer patients with symptomatic bone metastases.
  
• Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
  ClinicalTrials.gov Identifier: NCT00376883 - Completed
  Multiple Myeloma
  
• Pamidronate to Treat Osteogenesis Imperfecta in Children
  ClinicalTrials.gov Identifier: NCT00005901 - Recruiting
  Osteogenesis Imperfecta
  
• Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00302627 - Active, not recruiting
  Transplant Bone Disease
  
• Pan-European Survey on the Under Treatment of Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00542867 - Completed
  Hypercholesterolemia
  
• Pancreas Transplantation in Man
  ClinicalTrials.gov Identifier: NCT00156364 - Recruiting
  Diabetes Mellitus
  
• Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
  ClinicalTrials.gov Identifier: NCT00526578 - Recruiting
  Pancreatic Cancer
  
• Pancreatic Cancer Serum and DNA Repository
  ClinicalTrials.gov Identifier: NCT00296114 - Recruiting
  Pancreas Cancer
  
• Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
  ClinicalTrials.gov Identifier: NCT00510744 - Not yet recruiting
  Obesity
  
• Pancreatic Islet Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00214786 - Recruiting
  Islet Cell Transplantation
  
• Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression
  ClinicalTrials.gov Identifier: NCT00530686 - Recruiting
  Islet Cell Transplantation; Type 1 Diabetes
  
• Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes
  ClinicalTrials.gov Identifier: NCT00172796 - Recruiting
  Prediabetic State; Obesity; Metabolic Syndrome X
  
• Pancreatic Islet Mass in Pregnancy
  ClinicalTrials.gov Identifier: NCT00548522 - Recruiting
  Type 1 Diabetes; Pregnancy
  
• Panic Disorder and Cardiac Risk
  ClinicalTrials.gov Identifier: NCT00168506 - Recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00038896 - Active, not recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00044772 - Active, not recruiting
  Panic Disorder
  
• Panitumumab DDI Irinotecan
  ClinicalTrials.gov Identifier: NCT00563316 - Not yet recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-Line Therapy in Subjects With mCRC
  ClinicalTrials.gov Identifier: NCT00475293 - Recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00112944 - Recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; ...
  
• Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00513383 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• Panitumumab Plus FOLFIRI in First-Line Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00508404 - Recruiting
  Metastatic Colorectal Cancer
  
• Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
  ClinicalTrials.gov Identifier: NCT00411450 - Recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer; Cancer; Metastatic Cancer; Metastatic Colorectal Cancer; Oncology
  
• PANORAMA Observational Study
  ClinicalTrials.gov Identifier: NCT00382525 - Recruiting
  Arrhythmia; Cardiac Pacemaker, Artificial; Defibrillators, Implantable
  
• PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer after Failing a Gemcitabine-Containing Regimen
  ClinicalTrials.gov Identifier: NCT00088660 - Active, not recruiting
  Pancreatic Cancer
  
• Papillary Serous Carcinoma of the Endometrium
  ClinicalTrials.gov Identifier: NCT00515073 - Recruiting
  Endometrial Cancer
  
• Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx
  ClinicalTrials.gov Identifier: NCT00002454 - Active, not recruiting
  respiratory papillomas
  
• Papua New Guinean Duffy Negativity And Vivax Malar
  ClinicalTrials.gov Identifier: NCT00138489 - Suspended
  Malaria
  
• PAR Family Polymorphisms and Placental Invasion Disorders
  ClinicalTrials.gov Identifier: NCT00425867 - Not yet recruiting
  Miscarriage, Recurrent; Premature Labor
  
• PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
  ClinicalTrials.gov Identifier: NCT00314951 - Recruiting
  Clostridium Infections; Diarrhea
  
• PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
  ClinicalTrials.gov Identifier: NCT00468728 - Recruiting
  Clostridium Infections; Diarrhea
  
• Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix
  ClinicalTrials.gov Identifier: NCT00193752 - Recruiting
  Cancer of Cervix; Cervical Cancer; Cancer of the Cervix; Cervix Cancer
  
• Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00534651 - Recruiting
  Coronary Arteriosclerosis; Endothelial Function
  
• Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
  ClinicalTrials.gov Identifier: NCT00434681 - Completed
  Fever; Pain
  
• Paracor Ventricular Support System (PVSS) for Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00291551 - Completed
  Heart Failure, Congestive
  
• Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism
  ClinicalTrials.gov Identifier: NCT00196027 - Active, not recruiting
  Patent Foramen Ovale
  
• Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
  ClinicalTrials.gov Identifier: NCT00002148 - Completed
  Cognitive Disorders; HIV Infections
  
• Parallel-Group Comparative Study of GONAL-F (SJ-0021) and Purified Pituitary Gonadotropin in Subjects With Amenorrhea 1 or Anovulatory Cycles
  ClinicalTrials.gov Identifier: NCT00467480 - Recruiting
  Infertility
  
• Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora
  ClinicalTrials.gov Identifier: NCT00190151 - Terminated
  Healthy Volunteers
  
• Paraoxonase and LDL Oxidation in Carotid Artery Disease
  ClinicalTrials.gov Identifier: NCT00011258 - Completed
  Carotid Stenosis
  
• Paraplegic Cycling: Improving Health After Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00204100 - Active, not recruiting
  Spinal Cord Injury
  
• Parasitic Infections of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00001162 - Recruiting
  Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease
  
• Parathyroid and Thymus Transplantation in DiGeorge
  ClinicalTrials.gov Identifier: NCT00566488 - Active, not recruiting
  DiGeorge Syndrome; Hypoparathyroidism
  
• Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00086619 - Active, not recruiting
  Postmenopausal Osteoporosis; Osteoporosis
  
• Parathyroid Hormone (PTH) with Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005006 - Active, not recruiting
  Osteoporosis
  
• Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
  ClinicalTrials.gov Identifier: NCT00018135 - Completed
  Renal Failure
  
• Paravertebral Block for Breast Surgery
  ClinicalTrials.gov Identifier: NCT00131170 - Completed
  Breast Cancer
  
• Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?
  ClinicalTrials.gov Identifier: NCT00547989 - Recruiting
  Breast Cancer
  
• Parecoxib In Post Surgery (Hemicolectomy) Pain
  ClinicalTrials.gov Identifier: NCT00139607 - Terminated
  colectomy
  
• Parecoxib in Renal Colic
  ClinicalTrials.gov Identifier: NCT00139646 - Terminated
  Colic
  
• Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents with Depression
  ClinicalTrials.gov Identifier: NCT00118469 - Recruiting
  Depression
  
• Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders
  ClinicalTrials.gov Identifier: NCT00402857 - Recruiting
  Attention Deficit Disorder With Hyperactivity; Attention Deficit and Disruptive Behavior Disorders
  
• Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias
  ClinicalTrials.gov Identifier: NCT00509951 - Recruiting
  Anxiety Disorders; Specific Phobia
  
• Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00429221 - Not yet recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Parent-Youth Teamwork in Pediatric Asthma Management
  ClinicalTrials.gov Identifier: NCT00166582 - Completed
  Asthma
  
• Parental Bereavement Study Among Couples Coping Traumatic Loss of a Child
  ClinicalTrials.gov Identifier: NCT00447174 - Recruiting
  Bereaved Parents
  
• Parental Involvement and Children's Extra-Familial Contexts
  ClinicalTrials.gov Identifier: NCT00538252 - Recruiting
  Prevention of Drug Abuse Risk
  
• Parental knowledge and beliefs about infant sleep position
  ClinicalTrials.gov Identifier: NCT00005567 - Completed
  Sudden Infant Death Syndrome
  
• Parental Permission and Adolescent Assent and Decision Making in Clinical Research
  ClinicalTrials.gov Identifier: NCT00571311 - Recruiting
  Adolescents
  
• Parenteral Hydration in Advanced Cancer Patients-A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00423722 - Recruiting
  Advanced Cancer; Dehydration
  
• Parenting Matters: Helping Parents with Young Children
  ClinicalTrials.gov Identifier: NCT00133055 - Recruiting
  Sleep Problems; Behavior Problems; Psychosocial
  
• Parenting Videos In Primary Care
  ClinicalTrials.gov Identifier: NCT00558987 - Not yet recruiting
  Discipline Attitudes; Discipline Practices
  
• ParentLink: Better and Safer Emergency Care for Children
  ClinicalTrials.gov Identifier: NCT00457600 - Completed
  Otitis Media; Urinary Tract Infection; Asthma; Head Injury
  
• Parents at the Center: Information Management in ADHD - Clinical Trial
  ClinicalTrials.gov Identifier: NCT00543257 - Recruiting
  Health Literacy; Attention Deficit Disorder With Hyperactivity; Computer Literacy; Information Management; Parents
  
• Parents Helping Infants Study: Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying
  ClinicalTrials.gov Identifier: NCT00175422 - Recruiting
  Shaken Baby Syndrome
  
• Parents Matter!: Interventions to Promote Effective Parent-Child Communication
  ClinicalTrials.gov Identifier: NCT00137943 - Active, not recruiting
  HIV; Sexually Transmitted Disease; Pregnancy
  
• Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00217477 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
  ClinicalTrials.gov Identifier: NCT00258258 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Paricalcitol in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00064376 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
  ClinicalTrials.gov Identifier: NCT00269620 - Completed
  Contraception
  
• Parity and Serum Lipids in White and Hispanic Women
  ClinicalTrials.gov Identifier: NCT00005405 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Parkin Mutations
  ClinicalTrials.gov Identifier: NCT00136721 - Active, not recruiting
  Parkinson''s Disease
  
• Parkinson's Disease Evaluated by PET and the Effect of Memantine
  ClinicalTrials.gov Identifier: NCT00375778 - Completed
  Parkinson's Disease
  
• Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
  ClinicalTrials.gov Identifier: NCT00460148 - Completed
  Parkinson's Disease
  
• Parkinson's Disease Registry of the Muhammad Ali Parkinson Center
  ClinicalTrials.gov Identifier: NCT00217321 - Recruiting
  Parkinson's Disease
  
• Parkinson's disease treatment with coenzyme Q10
  ClinicalTrials.gov Identifier: NCT00004731 - Completed
  Parkinson's Disease
  
• Parkinson's Diseases Susceptibility Genes and Pesticides
  ClinicalTrials.gov Identifier: NCT00044590 - Recruiting
  Parkinson's Disease
  
• Parkinson's Genes and Environment Study
  ClinicalTrials.gov Identifier: NCT00367900 - Recruiting
  Parkinson's Disease (PD)
  
• Parkinson's Research: The Organized Genetics Initiative (PROGENI)
  ClinicalTrials.gov Identifier: NCT00086073 - Recruiting
  Parkinson Disease
  
• Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
  ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
  Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
  
• Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-Being in Elderly Individuals With Depression
  ClinicalTrials.gov Identifier: NCT00178100 - Completed
  Unipolar Depression
  
• Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
  ClinicalTrials.gov Identifier: NCT00246441 - Active, not recruiting
  Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
  
• Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00209118 - Active, not recruiting
  Hepatitis C; Depression; Interferon-Alpha Associated Side Effects
  
• Paroxetine in the Treatment of Chronic Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00178048 - Completed
  Primary Insomnia; Depression
  
• Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
  ClinicalTrials.gov Identifier: NCT00330239 - Completed
  PTSD
  
• Paroxetine Versus Bupropion for Treating People With High-Risk Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00429169 - Recruiting
  Depression
  
• Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
  ClinicalTrials.gov Identifier: NCT00540098 - Completed
  Panic Disorder
  
• Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
  ClinicalTrials.gov Identifier: NCT00215163 - Completed
  Stress Disorders, Post-Traumatic
  
• Paroxetine-Referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
  ClinicalTrials.gov Identifier: NCT00445679 - Recruiting
  Depressive Disorder, Major
  
• Paroxysmal Atrial Fibrillation: Role of Inflammation and Effect of Statins
  ClinicalTrials.gov Identifier: NCT00321802 - Recruiting
  Atrial Fibrillation
  
• Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling
  ClinicalTrials.gov Identifier: NCT00556244 - Recruiting
  Patients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation
  
• Part A: Radiolabel Study With GSK786034 Part B: Single Dose of GSK786034
  ClinicalTrials.gov Identifier: NCT00478725 - Recruiting
  Cancer
  
• Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00325598 - Recruiting
  Breast Neoplasms
  
• Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy in Early Stage Breast Cancer After Breast-Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00581529 - Active, not recruiting
  Breast Cancer
  
• Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy
  ClinicalTrials.gov Identifier: NCT00499057 - Recruiting
  Breast Cancer
  
• Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00392184 - Active, not recruiting
  Breast Cancer
  
• Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00527293 - Recruiting
  Breast Cancer
  
• Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
  ClinicalTrials.gov Identifier: NCT00337064 - Recruiting
  Stage I Breast Cancer
  
• Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00467493 - Recruiting
  Menstruation Disorders
  
• Partial Word Knowledge Growth in Children With LLD
  ClinicalTrials.gov Identifier: NCT00547833 - Recruiting
  Language Disorders
  
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bios' HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
  ClinicalTrials.gov Identifier: NCT00541970 - Recruiting
  Papillomavirus Infections; Cervical Cancer
  
• Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
  ClinicalTrials.gov Identifier: NCT00244010 - Recruiting
  Anemia, Aplastic; Neutropenia; Diamond-Blackfan Anemia; Thrombocytopenia
  
• Partially-Blind (Observer-Blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children
  ClinicalTrials.gov Identifier: NCT00360230 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Participant Database for Autism Research Studies
  ClinicalTrials.gov Identifier: NCT00549731 - Recruiting
  Autism Spectrum Disorder; Developmental Language Disorders
  
• Participant Features Affecting Depression Treatment
  ClinicalTrials.gov Identifier: NCT00073697 - Completed
  Depression
  
• Particulate Reduction Education in City Homes
  ClinicalTrials.gov Identifier: NCT00466024 - Recruiting
  Asthma
  
• Partner Notification in Primary Care
  ClinicalTrials.gov Identifier: NCT00112255 - Completed
  Chlamydia Infections
  
• Partner Notification Intervention for STD Clinics.
  ClinicalTrials.gov Identifier: NCT00207571 - Active, not recruiting
  Contact Tracing
  
• PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
  ClinicalTrials.gov Identifier: NCT00454779 - Recruiting
  Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
  
• PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00279955 - Active, not recruiting
  Heart Failure, Congestive
  
• Partners in Dementia Care
  ClinicalTrials.gov Identifier: NCT00291161 - Recruiting
  Dementia; Alzheimer Disease
  
• Partnership for Healthy Seniors
  ClinicalTrials.gov Identifier: NCT00379743 - Recruiting
  Breast Cancer; Colon Cancer; Rectum Cancer; Cervix Cancer; Prostate Cancer
  
• Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection
  ClinicalTrials.gov Identifier: NCT00197561 - Active, not recruiting
  HIV Infections; Pregnancy Complications
  
• Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership
  ClinicalTrials.gov Identifier: NCT00101478 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Hypertension
  
• Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
  ClinicalTrials.gov Identifier: NCT00101491 - Recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians
  ClinicalTrials.gov Identifier: NCT00101465 - Recruiting
  Cardiovascular Diseases; Heart Failure; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Hypertension Education and Treatment (HEAT)
  ClinicalTrials.gov Identifier: NCT00101504 - Not yet recruiting
  Cardiovascular Diseases; Hypertension; Heart Diseases
  
• Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
  ClinicalTrials.gov Identifier: NCT00101530 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Diabetes Mellitus
  
• Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership
  ClinicalTrials.gov Identifier: NCT00101517 - Not yet recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Metabolic Syndrome X
  
• Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership
  ClinicalTrials.gov Identifier: NCT00336869 - Recruiting
  Metabolic Symdrome
  
• PASTA 4: Physical Activity and Self-Management Trial for HF and COPD
  ClinicalTrials.gov Identifier: NCT00467298 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease (COPD); Heart Failure
  
• Patch Contraception Study
  ClinicalTrials.gov Identifier: NCT00185354 - Completed
  Contraception
  
• Patching for Lazy Eye: Trial to Evaluate Daily Patching Amounts
  ClinicalTrials.gov Identifier: NCT00274664 - Completed
  Amblyopia
  
• Patellar Resurfacing in Total Knee Arthroplasty. A Prospective, Randomised and Double Blind Study.
  ClinicalTrials.gov Identifier: NCT00553982 - Recruiting
  Arthroplasty,Replacement,Knee; Osteoarthritis,Knee; Pain; Patella
  
• Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
  ClinicalTrials.gov Identifier: NCT00562289 - Not yet recruiting
  Ischemic Stroke; Patent Foramen Ovale; Atrial Septal Aneurysm; Migraine
  
• Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke
  ClinicalTrials.gov Identifier: NCT00557479 - Recruiting
  Paradoxical Embolic Stroke; Patent Foramen Ovale
  
• PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005005 - Active, not recruiting
  Osteoporosis
  
• Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
  ClinicalTrials.gov Identifier: NCT00005679 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Heart Diseases; Coronary Disease; Coronary Arteriosclerosis
  
• Pathogen Identification of Bacterial Pneumonia Via DNA Detection
  ClinicalTrials.gov Identifier: NCT00567827 - Not yet recruiting
  Pneumonia
  
• Pathogen Specific Immunity in Patients With Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00217789 - Recruiting
  Sarcoidosis
  
• Pathogenesis and Cerebrovascular Manifestations of Septic Encephalopathy
  ClinicalTrials.gov Identifier: NCT00410111 - Completed
  Sepsis
  
• Pathogenesis and Genetics of Environmental Asthma Ozone Study
  ClinicalTrials.gov Identifier: NCT00574158 - Recruiting
  No Disease Being Studied. Evaluating Response in Healthy Subjects to an Exposure to Air Pollutant.
  
• Pathogenesis of Adverse Drug Reactions
  ClinicalTrials.gov Identifier: NCT00224952 - Recruiting
  Seizures
  
• Pathogenesis of Liver Fluke Induced Cancer in Thailand
  ClinicalTrials.gov Identifier: NCT00472602 - Recruiting
  Opisthorchis Viverrini
  
• Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation
  ClinicalTrials.gov Identifier: NCT00263406 - Completed
  Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation
  
• Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
  ClinicalTrials.gov Identifier: NCT00518479 - Completed
  Hypertension; Left Ventricular Hypertrophy
  
• Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation
  ClinicalTrials.gov Identifier: NCT00445029 - Recruiting
  Allergic Contact Dermatitis
  
• Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
  ClinicalTrials.gov Identifier: NCT00015275 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans
  ClinicalTrials.gov Identifier: NCT00246714 - Recruiting
  Endotoxemia
  
• Pathophysiology of Chronic Wounds
  ClinicalTrials.gov Identifier: NCT00006437 - Completed
  Healthy; Skin Ulcer
  
• Pathways
  ClinicalTrials.gov Identifier: NCT00000545 - Completed
  Cardiovascular Diseases; Sedentary Behaviors; Obesity
  
• Pathways to Vocational Rehabilitation: Enhancing Entry and Retention
  ClinicalTrials.gov Identifier: NCT00223834 - Recruiting
  Unemployment; Poverty
  
• Patient Acceptance of Whole Body Magnetic Resonance Angiography.
  ClinicalTrials.gov Identifier: NCT00556101 - Recruiting
  Atherosclerosis; Intermittent Claudication; MRI
  
• Patient and Provider Attitudes in the Healthcare Context
  ClinicalTrials.gov Identifier: NCT00404027 - Recruiting
  Diabetes Mellitus; Hypertension
  
• Patient Based Strategy to Reduce Errors in Diabetes Care
  ClinicalTrials.gov Identifier: NCT00262197 - Completed
  Diabetes Mellitus
  
• Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract Infections
  ClinicalTrials.gov Identifier: NCT00105248 - Completed
  Respiratory Tract Infections
  
• Patient Centered Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00233077 - Recruiting
  Early-Stage Breast Cancer
  
• Patient Computer Dialog in Primary Care
  ClinicalTrials.gov Identifier: NCT00386776 - Not yet recruiting
  Medical History Taking
  
• Patient Controlled Oral Analgesia for Postoperative Pain Management After Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00221936 - Recruiting
  Self-Administered Versus Nurse Administered Pain Medication.
  
• Patient Education in NorthTrondelag Hospital Trust
  ClinicalTrials.gov Identifier: NCT00326222 - Recruiting
  Diabetes
  
• Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00005994 - Active, not recruiting
  nausea and vomiting
  
• Patient Education in Rheumatoid Arthritis and Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00000414 - Completed
  Rheumatoid Arthritis; Osteoarthritis
  
• Patient Evaluation for Head and Neck Surgery Branch Studies
  ClinicalTrials.gov Identifier: NCT00011492 - Recruiting
  Head and Neck Cancer
  
• Patient Experiences in Rheumatology
  ClinicalTrials.gov Identifier: NCT00346710 - Active, not recruiting
  Rheumatic Disease
  
• Patient Navigator Research Program
  ClinicalTrials.gov Identifier: NCT00375024 - Recruiting
  Breast Cancer; Colon Cancer
  
• PAtient NOtifier Feature for Reduction of Anxiety
  ClinicalTrials.gov Identifier: NCT00559559 - Not yet recruiting
  Tachycardia, Ventricular
  
• Patient Plasma Response and Outcome in Septic Shock with Thrombocytopenia Associated Multiple Organ Failure in Children
  ClinicalTrials.gov Identifier: NCT00118664 - Recruiting
  Septic Shock; Thrombocytopenia; Multiple Organ Failure
  
• Patient Position and Impact on Colonoscopy Time
  ClinicalTrials.gov Identifier: NCT00314418 - Completed
  Colonoscopy
  
• Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
  ClinicalTrials.gov Identifier: NCT00453934 - Terminated
  Type 1 Diabetes; Type 2 Diabetes
  
• Patient Preference Study
  ClinicalTrials.gov Identifier: NCT00576342 - Recruiting
  Glaucoma; Ocular Hypertension
  
• Patient Preference With Visicol Tablet Preparation for Colonoscopy
  ClinicalTrials.gov Identifier: NCT00318305 - Completed
  Preparation for Colonoscopy
  
• Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
  ClinicalTrials.gov Identifier: NCT00013143 - Completed
  Adverse Drug Reaction Reporting Systems
  
• Patient Provider Partnership: Improving Diabetes Care in the Community
  ClinicalTrials.gov Identifier: NCT00167284 - Completed
  Diabetes
  
• Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
  ClinicalTrials.gov Identifier: NCT00225966 - Active, not recruiting
  Urge Incontinence; Urinary Retention
  
• Patient Research In Self-Management of Asthma (PRISMA)
  ClinicalTrials.gov Identifier: NCT00411346 - Completed
  Asthma
  
• Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00473798 - Recruiting
  Cervical Cancer
  
• Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas
  ClinicalTrials.gov Identifier: NCT00160095 - Recruiting
  Larynx Cancer
  
• Patient Sleep Position Questionnaire
  ClinicalTrials.gov Identifier: NCT00338013 - Recruiting
  Sleep
  
• Patient Tolerability Study of GSK163090
  ClinicalTrials.gov Identifier: NCT00559299 - Recruiting
  Major Depressive Disorder
  
• Patient's Anastrozole Compliance to Therapy Programme
  ClinicalTrials.gov Identifier: NCT00555867 - Recruiting
  Breast Cancer
  
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00366002 - Completed
  Overactive Bladder (OAB)
  
• Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
  ClinicalTrials.gov Identifier: NCT00324051 - Active, not recruiting
  Schizophrenia
  
• Patient, Provider, and Healthcare System Factors Associated with in Suboptimal Prescribing for Older Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00144001 - Active, not recruiting
  Epilepsy
  
• Patient- and Physician-Based Osteoporosis Education
  ClinicalTrials.gov Identifier: NCT00073190 - Active, not recruiting
  Osteoporosis; Osteoporosis, Postmenopausal
  
• Patient-Centered Advance Care Planning
  ClinicalTrials.gov Identifier: NCT00204802 - Recruiting
  Heart Failure; Renal Failure
  
• Patient-Centered Alternative to Psychiatric Hospitalization for Veterans
  ClinicalTrials.gov Identifier: NCT00013169 - Completed
  Mental Disorders
  
• Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
  ClinicalTrials.gov Identifier: NCT00270959 - Recruiting
  Post-Traumatic Stress Disorder
  
• Patient-Centered Depression Care for African Americans
  ClinicalTrials.gov Identifier: NCT00243425 - Recruiting
  Major Depressive Disorder
  
• Patient-Centered Heart Failure Trial
  ClinicalTrials.gov Identifier: NCT00461513 - Not yet recruiting
  Heart Failure, Congestive
  
• Patient-Centered Implementation Trial for Single Embryo Transfer
  ClinicalTrials.gov Identifier: NCT00315029 - Active, not recruiting
  Male Infertility; Female Infertility; Pregnancy
  
• Patient-Centered Medication Adherence Intervention for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00144027 - Recruiting
  Schizophrenia
  
• Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery
  ClinicalTrials.gov Identifier: NCT00136682 - Completed
  Postoperative Pain
  
• Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, California
  ClinicalTrials.gov Identifier: NCT00521209 - Not yet recruiting
  Health Status Unknown
  
• Patient-Initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
  ClinicalTrials.gov Identifier: NCT00477334 - Recruiting
  Genital Herpes
  
• Patient-Physician Partnership to Improve High Blood Pressure Adherence
  ClinicalTrials.gov Identifier: NCT00123045 - Active, not recruiting
  Cardiovascular Diseases; Hypertension
  
• Patient-Provider Trust Among Individuals with End-Stage Kidney Disease
  ClinicalTrials.gov Identifier: NCT00075036 - Active, not recruiting
  Kidney Failure, Chronic
  
• Patient-Reported Outcomes in Long-Term Survivors of Colon Cancer Cancer
  ClinicalTrials.gov Identifier: NCT00410579 - Recruiting
  Colorectal Cancer; Fatigue; Long-Term Effects Secondary to Cancer Therapy in Adults; Pain; Psychosocial Effects/Treatment
  
• Patient-Reported Outcomes in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00230828 - Completed
  Schizophrenia
  
• Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib
  ClinicalTrials.gov Identifier: NCT00441155 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life
  ClinicalTrials.gov Identifier: NCT00362401 - Active, not recruiting
  Heart Valve Diseases
  
• Patients Preference for Oral or i.v. Therapy
  ClinicalTrials.gov Identifier: NCT00212589 - Completed
  Colorectal Cancer
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Patients with Advanced and/or Symptomatic Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00107614 - Active, not recruiting
  Waldenstrom Macroglobulinemia
  
• Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00540514 - Recruiting
  Non-Small Cell Lung Carcinoma
  
• Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
  ClinicalTrials.gov Identifier: NCT00264615 - Completed
  Epilepsy
  
• Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study
  ClinicalTrials.gov Identifier: NCT00325910 - Active, not recruiting
  Diabetes Mellitus, Type 2; Heart Failure, Congestive
  
• Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
  ClinicalTrials.gov Identifier: NCT00240578 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
  ClinicalTrials.gov Identifier: NCT00240591 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Patients with Metastatic Renal Cell Cancer Using Cultured, Tumor-Reactive Lymphocytes and Interleukin-2
  ClinicalTrials.gov Identifier: NCT00091611 - Recruiting
  Kidney Neoplasms
  
• Patients With Neck Pain Likely to Benefit From Thoracic Spine Thrust Manipulation
  ClinicalTrials.gov Identifier: NCT00504686 - Recruiting
  Neck Pain
  
• Patients With NMDA Biomarker Data Following Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00366886 - Terminated
  Congenital Disorders
  
• Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
  ClinicalTrials.gov Identifier: NCT00289614 - Completed
  Kidney Diseases
  
• Patients With Renal Impairment Undergoing CT
  ClinicalTrials.gov Identifier: NCT00292487 - Completed
  Contrast Induced Nephropathy
  
• Patients' Perspectives on Identity, Ancestry and Genetics
  ClinicalTrials.gov Identifier: NCT00359710 - Active, not recruiting
  Family History
  
• Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00414492 - Recruiting
  Metastatic Colorectal Cancer
  
• Patterns and natural history of insulin secretion in islet cell transplant recipients and controls
  ClinicalTrials.gov Identifier: NCT00018122 - Active, not recruiting
  Diabetes Mellitus
  
• Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine
  ClinicalTrials.gov Identifier: NCT00392964 - Completed
  Ischemic Heart Disease
  
• Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography
  ClinicalTrials.gov Identifier: NCT00167011 - Recruiting
  Heart Diseases
  
• Patterns of Fatty Acids in Framingham Offspring
  ClinicalTrials.gov Identifier: NCT00005233 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Atherosclerosis
  
• Patupilone Activity in Advanced/Metastatic Hepatocelluar Carcinoma
  ClinicalTrials.gov Identifier: NCT00273312 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00262990 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
  
• Paucibacillary TB Natural History and Resistance Diagnostic
  ClinicalTrials.gov Identifier: NCT00421798 - Recruiting
  Mycobacterium Tuberculosis
  
• Pawtucket Heart Health Program
  ClinicalTrials.gov Identifier: NCT00005151 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia; Hypertension; Obesity; Cerebrovascular Accident; Coronary Disease; Atherosclerosis
  
• Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00256880 - Active, not recruiting
  Multiple Myeloma
  
• Pazopanib After Leuprolide or Goserelin in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00454571 - Suspended
  Prostate Cancer
  
• Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00367679 - Recruiting
  Non-Small-Cell Lung Cancer
  
• Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00350727 - Recruiting
  Glioma, Malignant
  
• Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
  ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
  
• Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00459862 - Recruiting
  Malignant Mesothelioma
  
• Pazopanib in Treating Patients With Metastatic Urothelial Cancer
  ClinicalTrials.gov Identifier: NCT00471536 - Not yet recruiting
  Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
  
• Pazopanib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00450879 - Recruiting
  Breast Cancer
  
• Pazopanib in Treating Patients With Recurrent Glioblastoma
  ClinicalTrials.gov Identifier: NCT00459381 - Recruiting
  Brain and Central Nervous System Tumors
  
• Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00509587 - Recruiting
  Breast Cancer
  
• Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00454142 - Recruiting
  Head and Neck Cancer
  
• Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00430781 - Recruiting
  Metastatic Cervical Cancer
  
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00347919 - Recruiting
  Metastatic Breast Cancer
  
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00558103 - Recruiting
  Inflammatory Breast Cancer
  
• Pazopanib Plus Paclitaxel (TAXOL) And Pazopanib Plus Paclitaxel(TAXOL) Plus Carboplatin (PARAPLATIN)
  ClinicalTrials.gov Identifier: NCT00388076 - Recruiting
  Solid Tumors
  
• Pazopanib With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00486642 - Recruiting
  Prostate Cancer
  
• PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training after Sub-acute Stroke
  ClinicalTrials.gov Identifier: NCT00108030 - Recruiting
  Stroke
  
• PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism
  ClinicalTrials.gov Identifier: NCT00166257 - Recruiting
  Embolism, Paradoxical; Heart Septal Defects, Atrial
  
• PCI plus intensive medical therapy will be superior to intensive medical therapy alone in reducing all cause mortality or nonfatal MI
  ClinicalTrials.gov Identifier: NCT00007657 - Completed
  Myocardial Ischemia
  
• PCMRI - an MRI/TRUS System for the Evaluation of the Prostate
  ClinicalTrials.gov Identifier: NCT00542100 - Not yet recruiting
  Prostate Cancer
  
• PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2
  ClinicalTrials.gov Identifier: NCT00444288 - Recruiting
  Polycystic Ovary Syndrome
  
• PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood
  ClinicalTrials.gov Identifier: NCT00482339 - Not yet recruiting
  Healthy
  
• PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
  ClinicalTrials.gov Identifier: NCT00308867 - Completed
  Actinic Keratosis
  
• Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
  ClinicalTrials.gov Identifier: NCT00247312 - Recruiting
  Prostatic Neoplasm
  
• PDA+: A Personal Digital Assistant for Obesity Treatment
  ClinicalTrials.gov Identifier: NCT00371462 - Not yet recruiting
  Obesity; Pain
  
• PDE5-Inhibition With Sildenafil in Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00407446 - Completed
  Heart Failure
  
• PDS vs Polyamide for Midline Abdominal Closure
  ClinicalTrials.gov Identifier: NCT00514566 - Terminated
  Laparotomy
  
• PDT Study for Exudative AMD With PCV
  ClinicalTrials.gov Identifier: NCT00331435 - Recruiting
  Age-Related Macular Degeneration
  
• PDT Vs TTT in Occult CNV in AMD
  ClinicalTrials.gov Identifier: NCT00347906 - Active, not recruiting
  Age-Related Macular Degeneration
  
• PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma
  ClinicalTrials.gov Identifier: NCT00472043 - Completed
  Basal Cell Carcinoma
  
• PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-Melanoma Skin Cancer
  ClinicalTrials.gov Identifier: NCT00472459 - Completed
  Actinic Keratosis; Warts; Basal Cell Carcinoma; Bowens Disease; Squamous Cell Carcinoma
  
• PE Treatment for PTSD 20 Minutes vs. 40 Minutes
  ClinicalTrials.gov Identifier: NCT00229307 - Recruiting
  Posttraumatic Stress Disoder
  
• Peak Flow Monitoring in Older Adults with Asthma
  ClinicalTrials.gov Identifier: NCT00149474 - Completed
  Asthma
  
• PEAK Study (Physical Exercise and Activity in Kids)
  ClinicalTrials.gov Identifier: NCT00213187 - Completed
  Juvenile Idiopathic Arthritis
  
• Peanut Sublingual Immunotherapy
  ClinicalTrials.gov Identifier: NCT00580606 - Not yet recruiting
  Food Hypersensitivity; Hypersensitivity; Immediate Hypersensitivity; Peanut Hypersensitivity
  
• PEARL - Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)
  ClinicalTrials.gov Identifier: NCT00424710 - Recruiting
  Polypoidal Choroidal Vasculopathy
  
• Pearl Index Study With Low Dose Combined Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00220324 - Completed
  Contraception
  
• PEARL Intervention to Reduce Depression Among Adults With Epilepsy
  ClinicalTrials.gov Identifier: NCT00459329 - Recruiting
  Depression; Epilepsy
  
• Pedestrian Behavior Following Implementation of a Walking School Bus
  ClinicalTrials.gov Identifier: NCT00402701 - Completed
  Obesity
  
• Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial
  ClinicalTrials.gov Identifier: NCT00257374 - Completed
  Gastroenteritis
  
• Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
  ClinicalTrials.gov Identifier: NCT00328718 - Completed
  Asthma
  
• Pediatric Allergic Asthma Study
  ClinicalTrials.gov Identifier: NCT00289874 - Active, not recruiting
  Asthma
  
• Pediatric Asthma Controller Trial (PACT)
  ClinicalTrials.gov Identifier: NCT00272506 - Completed
  Asthma; Lung Diseases
  
• Pediatric Asthma Study Using Stepwise Treatment With Two FDA Approved Asthma Medications
  ClinicalTrials.gov Identifier: NCT00158834 - Completed
  Children aged 6-16 year, with moderate/ severe asthma using inhaled steroids.
  
• Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
  ClinicalTrials.gov Identifier: NCT00130481 - Completed
  Type 1 Diabetes; Type 2 Diabetes
  
• Pediatric Cardiomyopathy Registry
  ClinicalTrials.gov Identifier: NCT00005391 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Myocardial Diseases
  
• Pediatric Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00034736 - Completed
  Pneumonia
  
• Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)
  ClinicalTrials.gov Identifier: NCT00005264 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis
  
• Pediatric Epilepsy Database
  ClinicalTrials.gov Identifier: NCT00204360 - Completed
  Epilepsy
  
• Pediatric Epilepsy Study
  ClinicalTrials.gov Identifier: NCT00050934 - Completed
  Epilepsy; Epilepsies, Partial
  
• Pediatric Epilepsy Study
  ClinicalTrials.gov Identifier: NCT00050947 - Completed
  Epilepsy
  
• Pediatric Epilepsy Study
  ClinicalTrials.gov Identifier: NCT00044278 - Completed
  Epilepsy
  
• Pediatric Epilepsy Trial
  ClinicalTrials.gov Identifier: NCT00043875 - Completed
  Epilepsy
  
• Pediatric Exercise With Congenital Heart Defects (Kinderturnen Mit Angeborenem Herzfehler)
  ClinicalTrials.gov Identifier: NCT00436098 - Recruiting
  Heart Defects, Congenital
  
• Pediatric Expanded Access Program-Oral Solution
  ClinicalTrials.gov Identifier: NCT00543530 - Completed
  HIV Infections
  
• Pediatric Fingertip Injuries:Are Antibiotics Required?
  ClinicalTrials.gov Identifier: NCT00300092 - Completed
  1) Pediatric Patients and; 2) Injury to the Distal Fingertip
  
• Pediatric Headache Trial
  ClinicalTrials.gov Identifier: NCT00389038 - Recruiting
  Headache
  
• Pediatric Heart Disease Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00023517 - Recruiting
  Kawasaki Disease (KD); Pediatric Heart Disease; Heart Failure; Defect, Congenital Heart
  
• Pediatric Hydroxyurea in Sickle Cell Anemia (BABY HUG)
  ClinicalTrials.gov Identifier: NCT00006400 - Recruiting
  Blood Disease; Anemia, Sickle Cell
  
• Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
  ClinicalTrials.gov Identifier: NCT00000602 - Completed
  Anemia, Sickle Cell; Hematologic Diseases; Hemoglobinopathies
  
• Pediatric Hypothalamic Obesity
  ClinicalTrials.gov Identifier: NCT00076362 - Completed
  Obesity
  
• Pediatric Impact: Promoting Adherence to Medications Among HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00134602 - Active, not recruiting
  HIV Infection
  
• Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
  ClinicalTrials.gov Identifier: NCT00555373 - Not yet recruiting
  Renal Transplant
  
• Pediatric Kidney Transplant without Calcineurin Inhibitors
  ClinicalTrials.gov Identifier: NCT00023231 - Active, not recruiting
  End-Stage Renal Disease
  
• Pediatric Lead Extractability and Survival Evaluation (PLEASE)
  ClinicalTrials.gov Identifier: NCT00335036 - Recruiting
  Ventricular Tachycardia; Ventricular Fibrillation; Cardiomyopathy; Long QT Syndrome; Congenital Heart Disease
  
• Pediatric Multicenter Study of REPEL-CV
  ClinicalTrials.gov Identifier: NCT00116233 - Recruiting
  Adhesions
  
• Pediatric Nevirapine Resistance Study
  ClinicalTrials.gov Identifier: NCT00117728 - Recruiting
  AIDS; HIV Infections
  
• Pediatric Open-Label Extension Study
  ClinicalTrials.gov Identifier: NCT00141921 - Active, not recruiting
  Pediatric plaque psoriasis
  
• Pediatric Phase 1 Trial of LMB-2 for Leukemia and Lymphoma
  ClinicalTrials.gov Identifier: NCT00082004 - Recruiting
  Leukemia; Lymphoma
  
• Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
  ClinicalTrials.gov Identifier: NCT00005274 - Completed
  Acquired Immunodeficiency Syndrome; Lung Diseases; Cardiovascular Diseases; Heart Diseases; Heart Failure; HIV Infections; Cytomegalovirus Infections; ...
  
• Pediatric Residency Training On Tobacco
  ClinicalTrials.gov Identifier: NCT00098215 - Recruiting
  Tobacco Use Disorder
  
• Pediatric Sleep Questionnaire: Normalization and Validation Study
  ClinicalTrials.gov Identifier: NCT00203840 - Active, not recruiting
  Sleep Disorders
  
• Pediatric Sleep Questionnaire: Use for Collection of Clinical Data
  ClinicalTrials.gov Identifier: NCT00203827 - Active, not recruiting
  Sleep Disorders
  
• Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery
  ClinicalTrials.gov Identifier: NCT00035139 - Completed
  Brain Injuries
  
• Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
  ClinicalTrials.gov Identifier: NCT00272948 - Recruiting
  Hepatic Veno-Occlusive Disease
  
• Pediatric Zylet Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00420628 - Recruiting
  Chalazion; Hordeolum
  
• Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis (BATT)]
  ClinicalTrials.gov Identifier: NCT00094328 - Active, not recruiting
  Puberty, Precocious
  
• Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II
  ClinicalTrials.gov Identifier: NCT00037388 - Active, not recruiting
  Blood Disease; Anemia, Sickle Cell; Chlamydia Infections; Cerebrovascular Accident
  
• Pedobarographic Assessments of Clubfoot Treated Patients
  ClinicalTrials.gov Identifier: NCT00175708 - Recruiting
  Clubfoot
  
• PEDS-C: Pegylated Interferon +/- Ribavirin for Children with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00100659 - Active, not recruiting
  Chronic Hepatitis C
  
• PEEP Test and Gas Exchange in ALI/ARDS Patients
  ClinicalTrials.gov Identifier: NCT00284102 - Recruiting
  Acute Respiratory Distress Syndrome
  
• Peer Counseling for Weight Loss
  ClinicalTrials.gov Identifier: NCT00120029 - Recruiting
  Breast Cancer
  
• Peer Mentoring for Persons With Spinal Cord Injury (SCI)
  ClinicalTrials.gov Identifier: NCT00205205 - Completed
  Spinal Cord Injury
  
• Peer Mentors for Adolescents in HIV Affected Families
  ClinicalTrials.gov Identifier: NCT00056953 - Completed
  Adolescent behavior; Health behavior; HIV Seronegativity
  
• Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
  ClinicalTrials.gov Identifier: NCT00458094 - Not yet recruiting
  Mental Disorders
  
• Peer-Based Skills Training to Enhance Teen Weight Loss
  ClinicalTrials.gov Identifier: NCT00024830 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Peer-Enhanced Intervention to Support Teen Weight Loss
  ClinicalTrials.gov Identifier: NCT00285558 - Completed
  Obesity
  
• PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
  ClinicalTrials.gov Identifier: NCT00303290 - Active, not recruiting
  Chronic Myeloid Leukemia
  
• PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
  ClinicalTrials.gov Identifier: NCT00390598 - Active, not recruiting
  Colonoscopy
  
• PEG-Asparaginase During Two Treatment Courses
  ClinicalTrials.gov Identifier: NCT00192673 - Recruiting
  Acute Lymphoblastic Leukemia
  
• PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00001410 - Completed
  Gaucher's Disease
  
• Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
  ClinicalTrials.gov Identifier: NCT00081770 - Active, not recruiting
  Chronic Hepatitis C
  
• PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
  ClinicalTrials.gov Identifier: NCT00215891 - Completed
  Chronic Hepatitis C Infection in HIV-Infected Persons; HIV Infections
  
• PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
  ClinicalTrials.gov Identifier: NCT00215865 - Completed
  Chronic Hepatitis C Virus Infection
  
• PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00238329 - Active, not recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• PEG-Interferon alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00085384 - Suspended
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• PEG-Interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00276523 - Completed
  Head and Neck Cancer
  
• PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
  ClinicalTrials.gov Identifier: NCT00253474 - Active, not recruiting
  Neoplasm of Uncertain Malignant Potential; Unspecified Childhood Solid Tumor, Protocol Specific
  
• PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00052650 - Recruiting
  adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain stem glioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)
  ClinicalTrials.gov Identifier: NCT00255008 - Active, not recruiting
  Hepatitis C, Chronic
  
• PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron
  ClinicalTrials.gov Identifier: NCT00037882 - Terminated
  Leukemia, Myeloid, Philadelphia-Positive
  
• Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis
  ClinicalTrials.gov Identifier: NCT00048724 - Active, not recruiting
  Chronic Hepatitis C; Cirrhosis
  
• PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to alpha-Interferon Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00039871 - Completed
  Chronic Hepatitis C; Liver Fibrosis; Cirrhosis
  
• Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)
  ClinicalTrials.gov Identifier: NCT00371761 - Recruiting
  Hepatitis B, Chronic
  
• Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
  ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
  Hepatitis C, Chronic
  
• Pegaptanib Sodium (Macugen) Compared to Sham Injection in Patients with Diabetic Macular Edema (DME) Involving the Center of the Macula
  ClinicalTrials.gov Identifier: NCT00148811 - Active, not recruiting
  Diabetic Macular Edema
  
• Pegaptanib Sodium Compared to Sham Injection in Patients with Recent Vision Loss due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
  ClinicalTrials.gov Identifier: NCT00088283 - Completed
  Macular Degeneration
  
• Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00087763 - Completed
  Macular Degeneration
  
• Pegasparaginase or Asparaginase and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00400946 - Recruiting
  Drug Toxicity; Leukemia
  
• PEGASUS CRT Study
  ClinicalTrials.gov Identifier: NCT00146848 - Recruiting
  Heart Failure
  
• Pegasys and Copegus for Asian Patiens With Treatment-Naive Hepatitis C Genotypes 6, 7, 8, 9
  ClinicalTrials.gov Identifier: NCT00575224 - Active, not recruiting
  Chronic Hepatitis C; Asian Americans; Novel Genotypes; Treatment
  
• Pegasys in Combination with Copegus in Previously Untreated Patients with Chronic Hepatitis C Genotype 1
  ClinicalTrials.gov Identifier: NCT00077649 - Completed
  Chronic Hepatitis C
  
• Pegasys in Combination with Copegus in Previously Untreated Patients with Chronic Hepatitis C virus Genotype 2 or 3
  ClinicalTrials.gov Identifier: NCT00077636 - Completed
  Chronic Hepatitis C
  
• Pegasys® in Patients With Myeloproliferative Diseases
  ClinicalTrials.gov Identifier: NCT00452023 - Recruiting
  Myeloproliferative Disorders
  
• Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00067639 - Completed
  Multiple Myeloma
  
• Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00115193 - Active, not recruiting
  Non-Hodgkin''s Lymphoma
  
• Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00146562 - Active, not recruiting
  Breast Cancer; stage I breast cancer; Stage II breast cancer
  
• Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00035594 - Completed
  Neutropenia
  
• Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00035620 - Active, not recruiting
  Sarcoma; Neutropenia
  
• Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
  
• Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00094822 - Active, not recruiting
  Lung Cancer; Carcinoma, Non-Small-Cell Lung
  
• Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00066833 - Recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; Mantle Cell Lymphoma; Neutropenia
  
• Pegfilgrastim PBPC Mobilization Study
  ClinicalTrials.gov Identifier: NCT00066092 - Completed
  Lymphoma; Hodgkin Disease; Lymphoma, Non-Hodgkin; Hematology; Oncology
  
• Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy
  ClinicalTrials.gov Identifier: NCT00410696 - Recruiting
  Hematological Neoplasms; Tumors
  
• Pegfilgrastim Vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-Lymphoma
  ClinicalTrials.gov Identifier: NCT00306111 - Recruiting
  Non-Hodgkin Lymphoma
  
• Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
  ClinicalTrials.gov Identifier: NCT00532701 - Recruiting
  Chronic Hepatitis C; Genotype 2; Peginterferon; Ribavirin
  
• Peginterferon Alfa-2a Plus Ribavirin and Epoetin β in HIV-Infected Patients Coinfected With Hepatitis C Virus Not Responding to Previous Treatment Regimens
  ClinicalTrials.gov Identifier: NCT00470210 - Recruiting
  Hepatitis C; HIV Infections
  
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00154869 - Recruiting
  Patients with dual chronic hepatitis B and C
  
• Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
  ClinicalTrials.gov Identifier: NCT00221624 - Completed
  HCV Infection; Hepatitis C, Chronic
  
• Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in HCV-Genotype-1-Infection (PRAMA)
  ClinicalTrials.gov Identifier: NCT00127777 - Active, not recruiting
  Hepatitis C, Chronic
  
• Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
  ClinicalTrials.gov Identifier: NCT00085917 - Active, not recruiting
  Hepatitis C; HIV Infections
  
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
  ClinicalTrials.gov Identifier: NCT00252642 - Completed
  Hepatitis C; Cirrhosis; Fibrosis
  
• Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
  Hepatitis C; HIV Infections
  
• Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)
  ClinicalTrials.gov Identifier: NCT00150904 - Recruiting
  hepatitis C, HIV
  
• Pegintron Induction Therapy in HCV Non-Responders
  ClinicalTrials.gov Identifier: NCT00363259 - Completed
  Hepatitis C
  
• PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (Study P05170)
  ClinicalTrials.gov Identifier: NCT00536263 - Not yet recruiting
  Hepatitis B, Chronic
  
• PegIntron vs IntronA in CMAJCC Stage II (EADO 2001/CMII Trial).
  ClinicalTrials.gov Identifier: NCT00221702 - Recruiting
  Melanoma; Neoplasm Metastasis
  
• Pegvisomant and Sandostatin LAR Combination Study
  ClinicalTrials.gov Identifier: NCT00068029 - Completed
  Acromegaly
  
• Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00450372 - Suspended
  Melanoma (Skin)
  
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
  ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
  HIV Infections; Hepatitis C; Liver Disease
  
• Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-naïve Dialysis Patients With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00491244 - Recruiting
  Chronic Hepatitis C; Hemodialysis
  
• Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
  ClinicalTrials.gov Identifier: NCT00117533 - Recruiting
  Chronic Hepatitis B; Chronic Hepatitis D
  
• Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00383864 - Completed
  Hepatitis C
  
• Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
  ClinicalTrials.gov Identifier: NCT00277862 - Active, not recruiting
  Hepatitis C
  
• Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
  ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
  Hepatitis C
  
• Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
  ClinicalTrials.gov Identifier: NCT00203606 - Active, not recruiting
  Hepatitis C
  
• Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00132210 - Recruiting
  Hepatitis C
  
• Pegylated Interferon to Treat Chronic Hepatitis D
  ClinicalTrials.gov Identifier: NCT00023322 - Recruiting
  Hepatitis D
  
• Pegylated Interferon-Alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
  ClinicalTrials.gov Identifier: NCT00204529 - Active, not recruiting
  Melanoma
  
• Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00183976 - Terminated
  Non-Hodgkin's Lymphoma; Burkitt Lymphoma; Primary Effusion Lymphomas
  
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00524459 - Recruiting
  Breast Cancer
  
• Pegylated Liposomal Doxorubicin Compared to Capecitabine in Treating Women 60 Years and Older with Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082095 - Terminated
  Breast Cancer
  
• Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin''s Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00120198 - Terminated
  Non-Hodgkin''s Lymphoma
  
• Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
  ClinicalTrials.gov Identifier: NCT00111657 - Recruiting
  Gout
  
• Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
  ClinicalTrials.gov Identifier: NCT00575627 - Recruiting
  Chronic Hepatitis C
  
• Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00370617 - Recruiting
  Chronic Hepatitis C; Insulin Resistance
  
• PEKASYS- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
  ClinicalTrials.gov Identifier: NCT00332904 - Recruiting
  Liver Cirrhosis; Portal Hypertension
  
• Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)
  ClinicalTrials.gov Identifier: NCT00574184 - Active, not recruiting
  Erectile Dysfunction
  
• Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00003267 - Active, not recruiting
  perioperative/postoperative complications; stage II cervical cancer; stage I cervical cancer; stage I endometrial cancer; stage II endometrial cancer; ...
  
• Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00217633 - Recruiting
  cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical small cell carcinoma; cervical squamous cell carcinoma; ...
  
• Pelvic Floor Disorders Network
  ClinicalTrials.gov Identifier: NCT00065845 - Active, not recruiting
  Urinary Incontinence, Stress; Uterine Prolapse; Vaginal Prolapse
  
• Pelvic Floor Muscle Training for Incontinence in Older Women.
  ClinicalTrials.gov Identifier: NCT00222248 - Active, not recruiting
  Stress Urinary Incontinence
  
• Pelvic Floor Muscle Training to Treat Urinary Incontinence After Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00239824 - Active, not recruiting
  Urinary Incontinence
  
• Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
  ClinicalTrials.gov Identifier: NCT00334321 - Recruiting
  Endometrial Cancer
  
• Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
  ClinicalTrials.gov Identifier: NCT00359866 - Recruiting
  Uterine Cervical Neoplasms
  
• Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence
  ClinicalTrials.gov Identifier: NCT00576004 - Completed
  Pelvic Organ Prolapse; Urinary Incontinence
  
• Pelvic Pain in Women with Endometriosis
  ClinicalTrials.gov Identifier: NCT00073801 - Recruiting
  Endometriosis; Pelvic Pain
  
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00475657 - Recruiting
  Small Cell Lung Cancer
  
• Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00259285 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Pemetrexed and Gemcitabine Every 14 Days vs Every 21 Days in Advanced Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00383331 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00394147 - Recruiting
  Head and Neck Cancer
  
• Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193414 - Active, not recruiting
  Lung Cancer
  
• Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00503997 - Recruiting
  Head and Neck Cancer
  
• Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00470405 - Recruiting
  Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00216099 - Completed
  Prostate Cancer
  
• Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00293579 - Recruiting
  Head and Neck Cancer
  
• Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00268489 - Active, not recruiting
  Recurrent Non-Small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer
  
• Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00227565 - Recruiting
  Extensive Stage Small Cell Lung Cancer
  
• Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00389688 - Recruiting
  Lung Cancer
  
• Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00227630 - Active, not recruiting
  Malignant Mesothelioma
  
• Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00334594 - Recruiting
  Malignant Mesothelioma
  
• Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00248495 - Recruiting
  Lung Cancer
  
• Pemetrexed Disodium and Either Cisplatin or Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062088 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00101283 - Recruiting
  advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00387322 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00053209 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00060190 - Active, not recruiting
  advanced malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
  
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00407550 - Active, not recruiting
  Lung Cancer
  
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
  ClinicalTrials.gov Identifier: NCT00424242 - Recruiting
  Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Secondary Myelofibrosis; Unspecified Adult Solid Tumor, Protocol Specific
  
• Pemetrexed Disodium in Treating Patients With Locally Advanced or Metastatic Recurrent Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00039260 - No longer recruiting
  recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
  
• Pemetrexed Disodium in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00265785 - Recruiting
  Bronchoalveolar Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Adenocarcinoma of the Lung; ...
  
• Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00087087 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00087100 - Suspended
  recurrent endometrial cancer; endometrial adenocarcinoma; stage III endometrial cancer; stage IV endometrial cancer
  
• Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
  ClinicalTrials.gov Identifier: NCT00107419 - Active, not recruiting
  Chondrosarcoma
  
• Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00087113 - Active, not recruiting
  cervical squamous cell carcinoma; recurrent cervical cancer; stage III cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer
  
• Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
  ClinicalTrials.gov Identifier: NCT00276783 - Recruiting
  Adult Astrocytic Tumors; Adult Brain Tumor; Adult Oligodendroglial Tumors; Adult Tumors Metastatic to Brain; Mixed Gliomas; ...
  
• Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
  ClinicalTrials.gov Identifier: NCT00096187 - Completed
  good prognosis metastatic gestational trophoblastic tumor; recurrent gestational trophoblastic tumor; nonmetastatic gestational trophoblastic tumor
  
• Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00070473 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Pemetrexed Disodium in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
  ClinicalTrials.gov Identifier: NCT00459147 - Recruiting
  Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma
  
• Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00022646 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00454194 - Recruiting
  Lung Cancer
  
• Pemetrexed Disodium, Carboplatin, and Radiation Therapy with Or Without Cetuximab in Treating Patients with Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00117962 - Recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00438204 - Recruiting
  Lung Cancer
  
• Pemetrexed in Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00424723 - Active, not recruiting
  Neuroendocrine Tumors
  
• Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00216216 - Terminated
  Small Cell Lung Cancer
  
• Pemetrexed in Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00427466 - Recruiting
  Sarcoma
  
• Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00216203 - Completed
  Non-Small Cell Lung Cancer
  
• Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00415168 - Recruiting
  Gastric Cancer
  
• Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)
  ClinicalTrials.gov Identifier: NCT00374868 - Active, not recruiting
  Urologic Neoplasms
  
• Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma
  ClinicalTrials.gov Identifier: NCT00192010 - Recruiting
  Mesothelioma
  
• Pemetrexed Plus Gemcitabine in Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00491075 - Recruiting
  Renal Cell Carcinoma
  
• Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00541073 - Recruiting
  Malignant Mesothelioma
  
• Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00310050 - Recruiting
  Pancreatic Cancer
  
• Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00325234 - Recruiting
  Breast Neoplasms
  
• Pemetrexed/Carboplatin NSCLC Elderly Patients
  ClinicalTrials.gov Identifier: NCT00350792 - Recruiting
  Non Small Cell Lung Cancer
  
• PEMF Stimulation for Tibia Fractures
  ClinicalTrials.gov Identifier: NCT00127725 - Recruiting
  Diaphyseal fractures of the tibia
  
• PEMF Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression
  ClinicalTrials.gov Identifier: NCT00287703 - Recruiting
  Depression
  
• Pemoline for Cocaine Abuse - 7
  ClinicalTrials.gov Identifier: NCT00000282 - Completed
  Cocaine-Related Disorders
  
• Pemoline in the Treatment of Stimulant Dependence - 5
  ClinicalTrials.gov Identifier: NCT00000340 - Active, not recruiting
  Cocaine-Related Disorders
  
• Penclomedine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002915 - Completed
  unspecified adult solid tumor, protocol specific
  
• Penclomedine in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002946 - Completed
  Cancer
  
• Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV
  ClinicalTrials.gov Identifier: NCT00247884 - Recruiting
  Hepatitis C Virus Infection
  
• Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs
  ClinicalTrials.gov Identifier: NCT00392275 - Completed
  Cataract
  
• Penicillamine Chelation for Children With Lead Poisoning
  ClinicalTrials.gov Identifier: NCT00552630 - Active, not recruiting
  Lead Poisoning; Vitamin D Deficiency
  
• Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
  ClinicalTrials.gov Identifier: NCT00003751 - Active, not recruiting
  adult glioblastoma multiforme
  
• Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
  ClinicalTrials.gov Identifier: NCT00000585 - Completed
  Anemia, Sickle Cell; Hematologic Diseases; Hemoglobinopathies; Infection (S. pneumoniae); Pneumonia
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Pennsylvania Adolescent Intervention Research Study (PAIRStudy)
  ClinicalTrials.gov Identifier: NCT00329199 - Terminated
  Depression
  
• Pennsylvania Adolescent Smoking Study (PASStudy)
  ClinicalTrials.gov Identifier: NCT00381329 - Not yet recruiting
  Smoking Cessation
  
• Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
  ClinicalTrials.gov Identifier: NCT00540475 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
  ClinicalTrials.gov Identifier: NCT00209300 - Completed
  Ulcerative Colitis
  
• Pentastarch Use in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00182377 - Recruiting
  Cardiac Surgery; Cardiopulmonary Bypass
  
• Pentavalent DTaP-Hep B-IPV
  ClinicalTrials.gov Identifier: NCT00133445 - Active, not recruiting
  Pertussis; Hepatitis B; Polio
  
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003825 - Completed
  Diarrhea; Quality of Life; radiation enteritis
  
• Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00543283 - Recruiting
  Leukemia; Lymphoma; Hodgkin's Disease; Hematologic Neoplasms; Multiple Myeloma; Carcinoma, Renal Cell
  
• Pentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00096161 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00026351 - Completed
  Leukemia; Lymphoma
  
• Pentostatin and Rituximab With or Without Cyclophosphamide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00423423 - Recruiting
  Leukemia
  
• Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00006968 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children
  ClinicalTrials.gov Identifier: NCT00144430 - Recruiting
  Graft vs Host Disease
  
• Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00074035 - Suspended
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00201721 - Active, not recruiting
  B-Chronic Lymphocytic Leukemia
  
• Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00074282 - Recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
  ClinicalTrials.gov Identifier: NCT00003658 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00541034 - Recruiting
  Leukemia; Lymphoma
  
• Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
  ClinicalTrials.gov Identifier: NCT00546377 - Recruiting
  Leukemia; Lymphoma
  
• Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00000646 - Completed
  HIV Infections
  
• Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-High Risk Patients
  ClinicalTrials.gov Identifier: NCT00285298 - Active, not recruiting
  Kidney Failure, Chronic
  
• Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
  ClinicalTrials.gov Identifier: NCT00205049 - Recruiting
  Hepatitis, Alcoholic
  
• Pentoxifylline in Children with Malaria
  ClinicalTrials.gov Identifier: NCT00133393 - Terminated
  Plasmodium falciparum Malaria
  
• Pentoxifylline in Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00102453 - Active, not recruiting
  Muscular Dystrophy, Duchenne
  
• Pentoxifylline in the Treatment of NEC in Premature Neonates
  ClinicalTrials.gov Identifier: NCT00271336 - Recruiting
  Necrotizing Enterocolitis
  
• Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
  ClinicalTrials.gov Identifier: NCT00267670 - Recruiting
  Nonalcoholic Steatohepatitis; Liver Diseases
  
• PEPAF: Evaluation of Family Physician''s Effectiveness for Physical Activity Promotion
  ClinicalTrials.gov Identifier: NCT00131079 - Completed
  Exercise; Physical Fitness; Quality of Life
  
• PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel
  ClinicalTrials.gov Identifier: NCT00404144 - Active, not recruiting
  Coronary Stenosis
  
• PEPCAD III Substudy: Stem Cell Mobilization
  ClinicalTrials.gov Identifier: NCT00473499 - Recruiting
  Coronary Artery Disease
  
• PEPCAD IV, Drug Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00462631 - Recruiting
  Coronary Stenosis; Diabetes Mellitus
  
• Pepsinogens as the Early Marker of H. Pylori Eradication
  ClinicalTrials.gov Identifier: NCT00197457 - Completed
  H. Pylori Infection; Gastric Ulcer; Duodnal Ulcer
  
• Peptic Ulcer Hemorrhage Study
  ClinicalTrials.gov Identifier: NCT00037570 - Completed
  Peptic Ulcer Hemorrhage
  
• Peptic Ulcer Hemorrhage Study
  ClinicalTrials.gov Identifier: NCT00040495 - Active, not recruiting
  Peptic Ulcer Hemorrhage
  
• Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
  ClinicalTrials.gov Identifier: NCT00059475 - Active, not recruiting
  Melanoma
  
• Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
  ClinicalTrials.gov Identifier: NCT00488592 - Recruiting
  Myelodysplastic Syndrome (MDS); Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML)
  
• Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00078494 - Completed
  Nasopharyngeal Neoplasms
  
• Peptide Vaccine, Montanide ISA 51, and CpG 7909 in Treating Patients With Resected Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085189 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
  
• Peptide-Pulsed vs. RNA-Transfected Dendritic Cell Vaccines in Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00243529 - Recruiting
  Melanoma Stage III or IV
  
• Peptide-Sensitized Lymphocytes plus melanoma peptide immunization followed by IL-2 to Treat Patients with Melanoma
  ClinicalTrials.gov Identifier: NCT00076661 - Completed
  Melanoma; Neoplasm Metastasis
  
• Per Oral Levosimendan in Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00130884 - Completed
  Chronic Heart Failure
  
• Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00006290 - Completed
  HIV Infections; Lipodystrophy
  
• Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
  ClinicalTrials.gov Identifier: NCT00536796 - Recruiting
  Hyperlipidemias; Atherosclerosis; Coronary Heart Disease; Carotid Stenosis; Peripheral Vascular Diseases; Diabetes Mellitus
  
• Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
  ClinicalTrials.gov Identifier: NCT00536965 - Recruiting
  Hyperlipidemias; Atherosclerosis; Coronary Heart Disease; Carotid Stenosis; Peripheral Vascular Diseases; Diabetes Mellitus
  
• Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
  ClinicalTrials.gov Identifier: NCT00173550 - Recruiting
  Menopause, Premature; Hysterectomy; Ovariectomy; Estrogen Replacement Therapy; Attitude; Perception
  
• Perception of Musculoskeletal Injury in Professional Dancers
  ClinicalTrials.gov Identifier: NCT00554957 - Recruiting
  Musculoskeletal System; Disability Evaluation; Wounds and Injuries
  
• Perceptions of Cervical Cancer Among Asian Americans
  ClinicalTrials.gov Identifier: NCT00518388 - Recruiting
  Epidemiology
  
• Percutaneous Autologous Bone-Marrow Grafting for Open Tibial Shaft Fracture
  ClinicalTrials.gov Identifier: NCT00512434 - Not yet recruiting
  Tibial Fractures; Fractures, Open; Bone Marrow Transplantation
  
• Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00176358 - Recruiting
  CAD; Stable Angina Pectoris
  
• Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis
  ClinicalTrials.gov Identifier: NCT00176397 - Recruiting
  Coronary Stenosis; Coronary Artery Disease
  
• Percutaneous Interventions in Adults With CHD
  ClinicalTrials.gov Identifier: NCT00266916 - Terminated
  Congenital Disorders
  
• Percutaneous Nephrolithotomy: A Registry and Database
  ClinicalTrials.gov Identifier: NCT00159393 - Recruiting
  nephrolithiasis
  
• Percutaneous Removal and Margin Ablation for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00574301 - Recruiting
  Breast Cancer
  
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry
  ClinicalTrials.gov Identifier: NCT00005677 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Percutaneous Vertebroplasty Versus Conservative Treatment of Pain
  ClinicalTrials.gov Identifier: NCT00203554 - Recruiting
  Pain; Osteoporosis; Fracture
  
• Perennial Allergic Rhinitis In Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00257595 - Completed
  Perennial Allergic Rhinitis
  
• Perennial Allergic Rhinitis Study In Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00108914 - Active, not recruiting
  Rhinitis, Allergic, Perennial
  
• Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00407108 - Recruiting
  Diabetic Retinopathy
  
• Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures
  ClinicalTrials.gov Identifier: NCT00163605 - Completed
  Sinus Implant Reconstruction
  
• Performance Evaluation and Research for Older Adults Requiring Major Surgery
  ClinicalTrials.gov Identifier: NCT00487890 - Recruiting
  Healthy
  
• Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
  ClinicalTrials.gov Identifier: NCT00555737 - Completed
  Celiac Disease
  
• Performance of Acceleromyography With and Without Preload
  ClinicalTrials.gov Identifier: NCT00226018 - Completed
  Neuromuscular Blockade
  
• Performance of Cimetidine-Corrected MDRD Equation in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00475059 - Recruiting
  Kidney Transplantation
  
• Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.
  ClinicalTrials.gov Identifier: NCT00372190 - Recruiting
  Pelvic Organ Prolapse
  
• Performance of the Water-Enema Computed Tomography (WE-CT)
  ClinicalTrials.gov Identifier: NCT00188110 - Recruiting
  Colon Cancer
  
• Performance Status During Treatment With Pemetrexed in Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00540241 - Recruiting
  Non Small Cell Lung Cancer
  
• Perfusion Imaging and CT –Understanding Relative Efficacy
  ClinicalTrials.gov Identifier: NCT00486447 - Recruiting
  Coronary Artery Disease
  
• Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00005790 - Active, not recruiting
  genetic condition; Cancer; adult brain tumor; Brain Tumor; stage/type, adult brain tumor; body system/site cancer; central nervous system cancer; ...
  
• Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder
  ClinicalTrials.gov Identifier: NCT00252044 - Recruiting
  Schizotypal Personality Disorder; Other Personality Disorders
  
• Pergolide Treatment and Valvular Heart Disease
  ClinicalTrials.gov Identifier: NCT00234364 - Completed
  Heart Valve Diseases; Parkinson's Disease; Pergolide; Fibrosis
  
• Pergolide Treatment for Substance Abusers - 4
  ClinicalTrials.gov Identifier: NCT00000269 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00500552 - Recruiting
  Hypertrophic Cardiomyopathy
  
• Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00336401 - Recruiting
  Non Cardiac Surgery
  
• Peri-Operative Morbidity and Quality of Life After CABG
  ClinicalTrials.gov Identifier: NCT00248885 - Completed
  Coronary Artery Bypass Graft Surgery
  
• Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
  ClinicalTrials.gov Identifier: NCT00370045 - Recruiting
  Coronary Artery Disease
  
• Periacetabular Osteotomy
  ClinicalTrials.gov Identifier: NCT00119977 - Active, not recruiting
  Osteoarthritis
  
• Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling
  ClinicalTrials.gov Identifier: NCT00228280 - Active, not recruiting
  Stomatognathic Disease; Mouth Disease; Periapical Disease; Alveolar Bone Loss
  
• Peridural Analgesia Versus Patient Controlled Analgesia in Laparoscopic Colonic Surgery
  ClinicalTrials.gov Identifier: NCT00508300 - Not yet recruiting
  Colectomy
  
• Perifollicular Vascularity Assessment in in-Vitro Fertilization
  ClinicalTrials.gov Identifier: NCT00458380 - Completed
  Infertility
  
• Perifosine + Sunitinib Malate for Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00399152 - Recruiting
  Renal Cancer; GIST
  
• Perifosine and Docetaxel Pharmacodynamic Study
  ClinicalTrials.gov Identifier: NCT00431054 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer
  
• Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00422656 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Perifosine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00053924 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas; ...
  
• Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00064324 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma
  
• Perifosine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005794 - Completed
  unspecified adult solid tumor, protocol specific
  
• Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00059982 - Completed
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00053794 - Completed
  adult soft tissue sarcoma; uterine sarcoma
  
• Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00053781 - Completed
  Recurrent Melanoma; Stage IV Melanoma
  
• Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060437 - Completed
  Prostate Cancer
  
• Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00062387 - Active, not recruiting
  Head and Neck Cancer
  
• Perifosine in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058214 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054145 - Completed
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00019656 - Completed
  Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unspecified Adult Solid Tumor, Protocol Specific
  
• Perifosine to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058708 - Completed
  Prostate Cancer
  
• Periinterventional Abciximab + Heparin vs. Bivalirudin in Acute Coronary Syndrome (ISAR-REACT-4)
  ClinicalTrials.gov Identifier: NCT00373451 - Recruiting
  Myocardial Infarction; Coronary Disease
  
• Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003769 - Completed
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
  ClinicalTrials.gov Identifier: NCT00022425 - Active, not recruiting
  recurrent breast cancer
  
• Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003219 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00003238 - Completed
  recurrent prostate cancer
  
• Perillyl Alcohol in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00002862 - Completed
  Leukemia; Lymphoma
  
• Perimenopause-Related Mood and Behavioral Disorders
  ClinicalTrials.gov Identifier: NCT00001231 - Recruiting
  Depressive Disorder; Healthy
  
• Perinatal Hypothermia, Risk Factors and Long-Term Consequences in Guinea-Bissau, Westafrica
  ClinicalTrials.gov Identifier: NCT00429000 - Not yet recruiting
  Hypothermia; Morbidity; Mortality
  
• Perinatal Infections in Pakistan
  ClinicalTrials.gov Identifier: NCT00070746 - Completed
  Bacterial Vaginosis; Fetal Membranes, Premature Rupture; Chorioamnionitis; Pregnancy
  
• Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis
  ClinicalTrials.gov Identifier: NCT00529555 - Recruiting
  Adult Periodontitis
  
• Periodontal and Periapical Inflammation and Pregnancy
  ClinicalTrials.gov Identifier: NCT00490165 - Recruiting
  Periodontal Disease; Periapical Disease; Pregnancy; Diabetes; Cardiovascular Disease; Dental Caries
  
• Periodontal Care and Glycemic Control in Diabetes
  ClinicalTrials.gov Identifier: NCT00012688 - Completed
  Diabetes Mellitus; Poor glycemic control; Periodontal Disease
  
• Periodontal Disease and Preterm Birth
  ClinicalTrials.gov Identifier: NCT00582374 - Recruiting
  Periodontal Disease; Preterm Birth; Low Birth Weight
  
• Periodontal Infection and Prematurity Study
  ClinicalTrials.gov Identifier: NCT00116974 - Active, not recruiting
  Periodontal Diseases; Premature Birth
  
• Periodontal Ligament Stress Level and Tooth Movement
  ClinicalTrials.gov Identifier: NCT00099814 - Active, not recruiting
  Malocclusion, Angle Class III
  
• Periodontitis and Cardiovascular Events or "PAVE"
  ClinicalTrials.gov Identifier: NCT00066053 - Active, not recruiting
  Cardiovascular Disease; Coronary Heart Disease; Myocardial Infarction; Cerebrovascular Accident
  
• PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
  ClinicalTrials.gov Identifier: NCT00432796 - Recruiting
  Stroke
  
• Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery: an Intervention to Decrease Immune Suppression, Metastatic Potential and Cancer Recurrence
  ClinicalTrials.gov Identifier: NCT00502684 - Not yet recruiting
  Primary Operable Breast Cancer
  
• Perioperative Analgesia Reduces the Intensity of Phantom and Stump Pain in Lower Limb Amputation
  ClinicalTrials.gov Identifier: NCT00443404 - Recruiting
  Phantom Limb; Pain
  
• Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00495924 - Recruiting
  Pancreatic Neoplasms; Adenocarcinoma; Neoplasm Circulating Cells; Tumor Markers, Biological; Monitoring, Immunologic
  
• Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00420394 - Recruiting
  Stomach Neoplasms
  
• Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00301548 - Completed
  Breast Neoplasms; Carcinoma
  
• Perioperative Effect of Atenolol on Cytokine Profiles
  ClinicalTrials.gov Identifier: NCT00202358 - Recruiting
  Surgery
  
• Perioperative Epidural Trial (POET) Pilot Study
  ClinicalTrials.gov Identifier: NCT00221260 - Recruiting
  Post Operative Pain Control
  
• Perioperative Hemodynamic Optimization in High-Risk Patients Using Less-Invasive Monitoring Methods
  ClinicalTrials.gov Identifier: NCT00375271 - Recruiting
  Postoperative Care
  
• Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
  ClinicalTrials.gov Identifier: NCT00122096 - Active, not recruiting
  Neurosurgery; Pain
  
• Perioperative Insulin Glargine Dosing Study
  ClinicalTrials.gov Identifier: NCT00309465 - Recruiting
  Diabetes; Surgery
  
• PeriOperative Interventional Neuroprotection Trial (POINT)
  ClinicalTrials.gov Identifier: NCT00041392 - Recruiting
  Coronary Disease; Heart Diseases; Cardiovascular Diseases; Neurologic Manifestations
  
• Perioperative Nutrition in Gastric Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00549237 - Not yet recruiting
  Body Composition; Postoperative Complications; Length of Stay
  
• Perioperative Nutrition in Upper GI Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00560846 - Recruiting
  Stomach Neoplasms; Esophageal Neoplasms; Surgical Complications
  
• Perioperative Protective Effects of Lidocaine
  ClinicalTrials.gov Identifier: NCT00413127 - Recruiting
  Elective Surgical Procedure; Colorectal Surgery
  
• Perioperative Treatment of Patients Undergoing Coronary Artery Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00090792 - Completed
  
  
• PerioWave Re-Treatment Protocol Compared to Scaling and Root Planing (SRP) and a Single Treatment With PerioWave
  ClinicalTrials.gov Identifier: NCT00336661 - Completed
  Periodontitis
  
• Peripartum Bacteruria and UTI
  ClinicalTrials.gov Identifier: NCT00121797 - Recruiting
  Urinary Tract Infection; Postpartum Period
  
• Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin
  ClinicalTrials.gov Identifier: NCT00169624 - Terminated
  Coronary and peripheral endothelial dysfunction
  
• Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation
  ClinicalTrials.gov Identifier: NCT00005606 - Completed
  childhood Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
  
• Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)
  ClinicalTrials.gov Identifier: NCT00200993 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Hyperlipidemia; Insulin Resistance; Metabolic Syndrome X
  
• Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003839 - Recruiting
  Cancer
  
• Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
  ClinicalTrials.gov Identifier: NCT00066417 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases
  
• Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003553 - Recruiting
  Kidney Cancer
  
• Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00024128 - Completed
  AIDS-related peripheral/systemic lymphoma; HIV-associated Hodgkin's disease
  
• Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004171 - Active, not recruiting
  recurrent adult diffuse small cleaved cell lymphoma; recurrent grade III follicular large cell lymphoma; ...
  
• Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00045435 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006225 - Active, not recruiting
  Breast Cancer; Leukemia; Lymphoma; Male Breast Cancer; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003396 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00008216 - Recruiting
  Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00053989 - Recruiting
  childhood Hodgkin's lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00006126 - Completed
  recurrent testicular cancer; extensive stage small cell lung cancer; Stage IV Melanoma; Stage IV Renal Cell Cancer; stage II testicular cancer; ...
  
• Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00025519 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00028600 - Recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
  ClinicalTrials.gov Identifier: NCT00003163 - Active, not recruiting
  Lymphoma; Multiple Myeloma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005613 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006241 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007813 - Active, not recruiting
  childhood liver cancer; Bone Cancer; Testicular Cancer; Brain Tumor
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
  Lymphoma
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003402 - Active, not recruiting
  Lymphocytic Lymphoma
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003399 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003401 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
  Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
  
• Peripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
  ClinicalTrials.gov Identifier: NCT00004143 - Active, not recruiting
  Breast Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; skin tumor
  
• Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005787 - Active, not recruiting
  Lymphocytic Lymphoma; Myeloid Lymphoma; Neutropenia
  
• Peripheral Stem Cell Transplantation With Donor White Blood Cells in Treating Older Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00003196 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003877 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005998 - Active, not recruiting
  Hodgkin's Disease; Lymphocytic Lymphoma
  
• Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00005941 - Active, not recruiting
  Cervical Cancer; Vaginal Cancer
  
• Peripheral Stem Transplantation in Treating Patients With Refractory or Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00005803 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; Lymphoma
  
• Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change
  ClinicalTrials.gov Identifier: NCT00103636 - Active, not recruiting
  Phlebitis
  
• Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight
  ClinicalTrials.gov Identifier: NCT00226213 - Completed
  Catheterization
  
• Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight
  ClinicalTrials.gov Identifier: NCT00226226 - Not yet recruiting
  Catheterization
  
• Peristomal Mesh for Prophylaxis of Parastomal Hernia
  ClinicalTrials.gov Identifier: NCT00496418 - Recruiting
  Hernia
  
• Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection (LAR) for Recto-Sigmoid Cancer.
  ClinicalTrials.gov Identifier: NCT00271986 - Recruiting
  Rectal Neoplasms [C04.588.274.476.411.307.790]
  
• Peritransplant Cyclosporine in Treating Patients With Hematologic Malignancies Undergoing T-Cell Depleted Allogeneic Stem Cell Transplant Followed By T-Cell Add-Back
  ClinicalTrials.gov Identifier: NCT00079391 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00434850 - Recruiting
  Diabetes Mellitus, Type 1
  
• Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors
  ClinicalTrials.gov Identifier: NCT00278018 - Recruiting
  Cancer of Skin; Solid Tumors
  
• Permeability Factor Protein in Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00007475 - Recruiting
  Focal Glomerulosclerosis
  
• Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission
  ClinicalTrials.gov Identifier: NCT00526019 - Recruiting
  Remission of Asthma; Asthma
  
• Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine
  ClinicalTrials.gov Identifier: NCT00310713 - Completed
  Prevention of Meningococcal Infection
  
• Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00269477 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00258856 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• Persistence of Antibody Response to N. Meningitidis Group C in Children
  ClinicalTrials.gov Identifier: NCT00316654 - Completed
  Prevention of Meningococcal Infection
  
• Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
  ClinicalTrials.gov Identifier: NCT00411697 - Active, not recruiting
  Hepatitis B
  
• Persistence of Immune Response After Vaccination With MCC
  ClinicalTrials.gov Identifier: NCT00310687 - Completed
  Prevention of Meningococcal Infection
  
• Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
  ClinicalTrials.gov Identifier: NCT00335881 - Completed
  Hepatitis B
  
• Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
  ClinicalTrials.gov Identifier: NCT00356564 - Completed
  Hepatitis B
  
• Persistence Study of GSK Bio's Tdap Vaccine 1, 3, 5 and 10 Years After Administration as a Single Dose in 106316 Study
  ClinicalTrials.gov Identifier: NCT00489970 - Completed
  Diphtheria; Tetanus; Pertussis
  
• Personality Characteristics and Compliance With Antiglaucoma Medication
  ClinicalTrials.gov Identifier: NCT00481494 - Recruiting
  Glaucoma
  
• Personality-Targeted Interventions for Adolescent Alcohol Misuse
  ClinicalTrials.gov Identifier: NCT00344474 - Active, not recruiting
  Alcohol Abuse; Drug Abuse; Depression; Panic Disorder; Conduct Disorder
  
• Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
  ClinicalTrials.gov Identifier: NCT00510471 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet
  ClinicalTrials.gov Identifier: NCT00301678 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Personalized Risk Evaluation and Diagnosis In the Coronary Tree
  ClinicalTrials.gov Identifier: NCT00500617 - Recruiting
  Coronary Artery Disease
  
• PERSPECTIVE: Clinical Study to Compare the Effects of Telithromycin, Azithromycin and Cefuroxime Axetil on the Penicillin or Macrolide Resistance of Streptococcus Pneumoniae in Patients with Acute Exacerbation of Chronic Bronchitis
  ClinicalTrials.gov Identifier: NCT00132938 - Completed
  Chronic Bronchitis
  
• Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study
  ClinicalTrials.gov Identifier: NCT00300820 - Active, not recruiting
  Bipolar Disorder (BD); Bipolar
  
• Pertussis Maternal Immunization Study
  ClinicalTrials.gov Identifier: NCT00553228 - Recruiting
  Pregnant Women
  
• Pertuzumab, Cetuximab, and Irinotecan in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00551421 - Not yet recruiting
  Colorectal Cancer
  
• Pesticide Exposure and Health Status in North Carolina African American Male Farmers and Farm Workers
  ClinicalTrials.gov Identifier: NCT00341965 - Active, not recruiting
  Pesticide Exposure
  
• Pesticide Exposure Pathways for Farmworker Children
  ClinicalTrials.gov Identifier: NCT00013754 - Recruiting
  Poisoning
  
• Pesticides in the Households of Healthy Volunteers and Young Patients With Leukemia
  ClinicalTrials.gov Identifier: NCT00556985 - Recruiting
  Leukemia
  
• Pesticides, industrial chemicals and semen quality
  ClinicalTrials.gov Identifier: NCT00011713 - Recruiting
  Infertility
  
• Pesticides--Health Fertility and Reproductive Risk
  ClinicalTrials.gov Identifier: NCT00015561 - Completed
  Birth Defects; Miscarriages; Cancer
  
• PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
  ClinicalTrials.gov Identifier: NCT00343707 - Active, not recruiting
  Social Anxiety Disorder
  
• PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00004891 - Active, not recruiting
  stage II rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00004152 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00236275 - Active, not recruiting
  Advanced Breast Cancer
  
• PET and Recovery Following Revascularization (PARR 2)
  ClinicalTrials.gov Identifier: NCT00385242 - Completed
  Coronary Artery Disease; Ventricular Dysfunction, Left
  
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
  ClinicalTrials.gov Identifier: NCT00019565 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• PET Changes in Alzheimer's Disease (AD)
  ClinicalTrials.gov Identifier: NCT00094913 - Active, not recruiting
  Alzheimer Disease
  
• PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00275301 - Recruiting
  Borderline Personality Disorder
  
• PET Imaging in Post Radiation Evaluation of Head and Neck Tumours "PET PREVENT"
  ClinicalTrials.gov Identifier: NCT00147472 - Recruiting
  Cancer of the Head and Neck
  
• PET Imaging in Potentially Surgically Resectable Non-Small Cell Lung Cancers (ELPET Trial)
  ClinicalTrials.gov Identifier: NCT00136890 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma
  
• PET Imaging in Stage III Non-Small Cell Lung Cancer (PET START Trial)
  ClinicalTrials.gov Identifier: NCT00136864 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY
  ClinicalTrials.gov Identifier: NCT00263523 - Completed
  Healthy Volunteers
  
• PET Imaging of Brain mGluR5 Receptors Using [18F]SP203
  ClinicalTrials.gov Identifier: NCT00538798 - Recruiting
  Glutamate Receptor; mGlur5 Protein; Excitatory Amino Acid Receptors; Drug Kinetics; PET Scan
  
• PET Imaging of Brain Peripheral Benzodiazepine Receptors
  ClinicalTrials.gov Identifier: NCT00283920 - Completed
  Healthy Volunteer
  
• PET Imaging of Brain Peripheral Benzodiazepine Receptors in Healthy People and in HIV-Infected People
  ClinicalTrials.gov Identifier: NCT00459693 - Recruiting
  HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections
  
• PET Imaging of DHA Metabolism
  ClinicalTrials.gov Identifier: NCT00074503 - Recruiting
  Healthy
  
• PET Imaging of Dopamine in Healthy Study Participants
  ClinicalTrials.gov Identifier: NCT00062946 - Completed
  Healthy
  
• PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency
  ClinicalTrials.gov Identifier: NCT00246870 - Recruiting
  Succinic Semialdehyde Dehydrogenase Deficiency; SSADH Deficiency
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00547976 - Recruiting
  Atherosclerosis; Healthy
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [11C]PBR28
  ClinicalTrials.gov Identifier: NCT00526916 - Recruiting
  Neurocysticercosis; Epilepsy
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [18F]FBR
  ClinicalTrials.gov Identifier: NCT00527579 - Recruiting
  Neurocysticercosis; Epilepsy
  
• PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans
  ClinicalTrials.gov Identifier: NCT00222768 - Active, not recruiting
  Diabetes; Obesity
  
• PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
  ClinicalTrials.gov Identifier: NCT00201942 - Completed
  Breast Cancer
  
• PET Neuroimaging of [11C]Mirtazapine
  ClinicalTrials.gov Identifier: NCT00288782 - Completed
  Mental Disorders; Mood Disorders; Affective Disorders; Depressive Disorders
  
• PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases
  ClinicalTrials.gov Identifier: NCT00382252 - Recruiting
  Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00335751 - Recruiting
  Sarcoma
  
• PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00346125 - Recruiting
  Sarcoma
  
• PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00002930 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage III esophageal cancer; stage II non-small cell lung cancer; ...
  
• PET Scan in Patients with Neurocardiologic Disorders
  ClinicalTrials.gov Identifier: NCT00001418 - Completed
  
  
• PET Scan in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• PET Scan of Brain Metabolism in Relation to Age and Disease
  ClinicalTrials.gov Identifier: NCT00001972 - Completed
  Alzheimer's Disease; Brain Neoplasm; Niemann Pick Disease
  
• PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients with Heart Disease Taking Beta-Blockers
  ClinicalTrials.gov Identifier: NCT00001402 - Completed
  
  
• PET Scan to Map the Areas of the Brain Involved in Planning
  ClinicalTrials.gov Identifier: NCT00001363 - Completed
  Cognition Disorders
  
• PET Scan to Study Brain Control of Human Movement
  ClinicalTrials.gov Identifier: NCT00001324 - Completed
  Ataxia; Cerebrovascular Accident; Healthy; Movement Disorder; Tremor@@
  
• PET Scanning and [11C]MeS-IMPY to Measure Amyloid in Brain
  ClinicalTrials.gov Identifier: NCT00407576 - Recruiting
  Alzheimer's Disease; Neurodegenerative Disease; Dementia
  
• PET Scanning in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00024622 - Recruiting
  Parkinson Disease
  
• PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00397748 - Recruiting
  Volunteer; Attention Deficit Hyperactivity Disorder
  
• PET Scans and CT Scans in Treating Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00388024 - Recruiting
  Head and Neck Cancer; Unclassified and Other Cancer
  
• PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00362973 - Recruiting
  Breast Cancer
  
• PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00003429 - Completed
  stage I cervical cancer; stage II cervical cancer; recurrent cervical cancer
  
• PET Scans in Normal Volunteers and Patients with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00005111 - Completed
  Fabry disease; Healthy
  
• PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  ClinicalTrials.gov Identifier: NCT00544219 - Recruiting
  Lymphoma
  
• PET Scans in Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00109785 - Recruiting
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• PET Study in Panic Disorder According to Paroxetine Treatment
  ClinicalTrials.gov Identifier: NCT00515749 - Recruiting
  Panic Disorder
  
• PET Study of the Nicotinic Receptors in Human
  ClinicalTrials.gov Identifier: NCT00543322 - Terminated
  Healthy; Parkinson Disease; Alzheimer Disease; Epilepsy
  
• PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28
  ClinicalTrials.gov Identifier: NCT00407693 - Recruiting
  Healthy Subjects
  
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
  ClinicalTrials.gov Identifier: NCT00530283 - Recruiting
  Squamous Cell Cancer
  
• PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
  ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
  Unknown Primary Tumor
  
• PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
  ClinicalTrials.gov Identifier: NCT00562198 - Not yet recruiting
  Parkinson´s Disease
  
• PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
  ClinicalTrials.gov Identifier: NCT00375830 - Recruiting
  Neoplasm Metastasis; Neoplasms, Connective and Soft Tissue; Soft Tissue Neoplasms; Bone Neoplasms
  
• PET/CT to Identify "Vulnerable" Arterial Plaque
  ClinicalTrials.gov Identifier: NCT00416065 - Recruiting
  Cancer
  
• PET/CT to Image Hypoxia in Head and Neck Tumours
  ClinicalTrials.gov Identifier: NCT00395109 - Recruiting
  Head and Neck Cancer.
  
• PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00494897 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Pethema Multiple Myeloma 2000
  ClinicalTrials.gov Identifier: NCT00560053 - Completed
  Multiple Myeloma
  
• Pexelizumab in Conjunction with Angioplasty in Acute Myocardial Infarction (APEX-AMI)
  ClinicalTrials.gov Identifier: NCT00091637 - Active, not recruiting
  Acute Myocardial Infarction
  
• Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass (PRIMO-CABG II)
  ClinicalTrials.gov Identifier: NCT00088179 - Active, not recruiting
  Coronary Artery Disease
  
• PF-00299804 as a Single Agent, in Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy.
  ClinicalTrials.gov Identifier: NCT00548093 - Not yet recruiting
  Carcinoma, Non Small Cell Lung
  
• PF-00477736 is Being Studied in Advanced Solid Tumors in Combination With Chemotherapy of Gemcitabine
  ClinicalTrials.gov Identifier: NCT00437203 - Recruiting
  Neoplasms
  
• Pfizer/IVGTT/Ziprasidone/Olanzapine
  ClinicalTrials.gov Identifier: NCT00205725 - Active, not recruiting
  Schizophrenia; Type 2 Diabetes Mellitus
  
• PFMT in Treatment and Prevention of POP (POP Study)
  ClinicalTrials.gov Identifier: NCT00271297 - Recruiting
  Uterine Prolapse; Bladder Diseases; Cystocele; Rectocele
  
• PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness
  ClinicalTrials.gov Identifier: NCT00529945 - Suspended
  PFO; Stroke; Transient Ischemic Attack; Migraine; Decompression Illness
  
• PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)
  ClinicalTrials.gov Identifier: NCT00335296 - Suspended
  Patent Foramen Ovale
  
• PG2 Treatment for Improving Quality of Life Among Advanced Cancer Patients Under Standard Palliative Care
  ClinicalTrials.gov Identifier: NCT00523107 - Recruiting
  Fatigue
  
• PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00291395 - Terminated
  Headache; Migraine
  
• PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients
  ClinicalTrials.gov Identifier: NCT00174356 - Completed
  Carcinoma, Non-Small Cell Lung
  
• Ph 2 Bortezomib + Doxorubicin for Previously Treated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00581919 - Recruiting
  Multiple Myeloma
  
• Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00350948 - Suspended
  Ovarian Neoplasms
  
• Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
  ClinicalTrials.gov Identifier: NCT00546793 - Not yet recruiting
  NHL; Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Intermediate-Grade; Lymphoma, Large-Cell; Lymphoma, Low-Grade; Lymphoma, Mixed-Cell; Lymphoma, Small-Cell; Leukemia, Lymphocytic, Chronic; Leukemia, B-Cell, Chronic; Leukemia, Prolymphocytic; Leukemia, Small Lymphocytic; Lymphoma, Small Lymphocytic; Lymphoma, Lymphoplasmacytoid, CLL; Lymphoplasmacytoid Lymphoma, CLL; CLL; SLL
  
• Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC
  ClinicalTrials.gov Identifier: NCT00250978 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• PH II Advanced CML - Follow On
  ClinicalTrials.gov Identifier: NCT00123487 - Active, not recruiting
  - Accelerated Phase Chronic Myeloid Leukemia; - Lymphoid Blast Phase Chronic Myeloid Leukemia; - Myeloid Blast Phase Chronic Myeloid Leukemia; ...
  
• Ph II CHOP+Velcade in Mediastinal LBCL
  ClinicalTrials.gov Identifier: NCT00361621 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Ph II Study of Azacitidine in Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00569660 - Active, not recruiting
  Myelofibrosis
  
• Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
  ClinicalTrials.gov Identifier: NCT00498966 - Recruiting
  Kidney Cancer
  
• Ph II Study of Perifosine Plus Gleevec for Patients With GIST
  ClinicalTrials.gov Identifier: NCT00455559 - Recruiting
  Gastrointestinal Stromal Tumors
  
• PH III Chronic CML - Follow On
  ClinicalTrials.gov Identifier: NCT00123474 - Active, not recruiting
  Chronic Phase Chronic Myelogenous Leukemia
  
• Ph1 Lobeline Interaction Study - 1
  ClinicalTrials.gov Identifier: NCT00439504 - Recruiting
  Methamphetamine Dependence
  
• Ph1 Marinol Interaction Study - Part 1 - 1
  ClinicalTrials.gov Identifier: NCT00438139 - Active, not recruiting
  Marijuana Dependence
  
• Ph1 Marinol INteraction Study - Part 2 - 1
  ClinicalTrials.gov Identifier: NCT00490269 - Recruiting
  Marijuana Dependence
  
• PH2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00581854 - Completed
  Mantle Cell Lymphoma
  
• Ph2 Modafinil Meth - 1
  ClinicalTrials.gov Identifier: NCT00520286 - Not yet recruiting
  Methamphetamine Dependence
  
• Ph3 FCR vs PCR Untx'd & tx'd CLL
  ClinicalTrials.gov Identifier: NCT00254163 - Recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
  ClinicalTrials.gov Identifier: NCT00335868 - Recruiting
  Leukemia
  
• Phacoemulsification Sleeves
  ClinicalTrials.gov Identifier: NCT00289068 - Recruiting
  Cataract
  
• Phacotrabeculotomy vs. CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
  ClinicalTrials.gov Identifier: NCT00346931 - Recruiting
  Primary Open Angle Glaucoma; Pseudoexfoliative Glaucoma
  
• PHARES Study: Management of Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00224549 - Recruiting
  Hypertension
  
• Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
  ClinicalTrials.gov Identifier: NCT00335855 - Not yet recruiting
  Influenza
  
• Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
  ClinicalTrials.gov Identifier: NCT00263159 - Completed
  Asthma
  
• Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00277732 - Completed
  Diabetes Mellitus
  
• Pharmacist Assisted Medication Program Empowering Regulation of Diabetes
  ClinicalTrials.gov Identifier: NCT00541606 - Completed
  Diabetes Mellitus, Type 2
  
• Pharmacist-Initiated Intervention Trial in OsteoArthritis (PhIT-OA)
  ClinicalTrials.gov Identifier: NCT00391859 - Not yet recruiting
  Knee Osteoarthritis
  
• Pharmaco-Economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00284778 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
  ClinicalTrials.gov Identifier: NCT00330525 - Completed
  Obesity; Overweight
  
• Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
  ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
  Hypertension
  
• Pharmacodynamic Parameters of Two Different Doses of Cefepime
  ClinicalTrials.gov Identifier: NCT00177736 - Completed
  Infection; Bacteremia; Pneumonia
  
• Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
  ClinicalTrials.gov Identifier: NCT00478322 - Recruiting
  Diabetes Mellitus Type 2;; Obesity
  
• Pharmacodynamic Trial on Rocuronium in Obese Patients
  ClinicalTrials.gov Identifier: NCT00540085 - Recruiting
  Bariatric Surgery
  
• Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
  ClinicalTrials.gov Identifier: NCT00501254 - Completed
  Cardiovascular Disease
  
• Pharmacodynamic-Pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
  ClinicalTrials.gov Identifier: NCT00425074 - Completed
  Cardiovascular Disease
  
• Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients
  ClinicalTrials.gov Identifier: NCT00001474 - Completed
  HIV Infection
  
• Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.
  ClinicalTrials.gov Identifier: NCT00318552 - Active, not recruiting
  Sepsis
  
• PharmacoEconomic Assessment IRESSA® in the Treatment of Non–Small-Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00173524 - Recruiting
  Non-Small Cell Lung Cancer
  
• Pharmacoeconomics Consequences Of Analgesia In Intensive Care Unit ICU
  ClinicalTrials.gov Identifier: NCT00436345 - Recruiting
  Post-Surgical ICU Subjects Requiring Mechanical Ventilation for at Least 2 Days.
  
• Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
  ClinicalTrials.gov Identifier: NCT00241748 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
  ClinicalTrials.gov Identifier: NCT00201292 - Recruiting
  Metabolic Syndrome; Diabetes
  
• Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
  ClinicalTrials.gov Identifier: NCT00337493 - Recruiting
  Kidney Transplantation
  
• Pharmacogenetics and Cardiovascular Events
  ClinicalTrials.gov Identifier: NCT00094198 - Active, not recruiting
  Cardiovascular Diseases; Atrial Fibrillation; Cerebrovascular Accident; Heart Diseases; Myocardial Infarction
  
• Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00352872 - Recruiting
  Breast Cancer
  
• Pharmacogenetics of Antiretroviral Drugs
  ClinicalTrials.gov Identifier: NCT00435656 - Not yet recruiting
  HIV Infections
  
• Pharmacogenetics of Disulfiram for Cocaine - 2
  ClinicalTrials.gov Identifier: NCT00149630 - Recruiting
  Cocaine Dependence; Opioid Dependence
  
• Pharmacogenetics of Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00190255 - Active, not recruiting
  Gastrointestinal Hemorrhage; Stomach Ulcer; Anti-Inflammatory Agents, Non-Steroidal
  
• Pharmacogenetics of Hypertriglyceridemia in Hispanics
  ClinicalTrials.gov Identifier: NCT00086437 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertriglyceridemia
  
• Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
  ClinicalTrials.gov Identifier: NCT00166595 - Completed
  Child Development Disorders, Pervasive
  
• Pharmacogenetics Study in Taiwan's Ethnic Groups
  ClinicalTrials.gov Identifier: NCT00459251 - Completed
  Healthy
  
• Pharmacogenetics, Emotional Reactivity & Smoking
  ClinicalTrials.gov Identifier: NCT00507728 - Recruiting
  Pharmacogenetics
  
• Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00226577 - Active, not recruiting
  Non-Small-Cell Lung Cancer
  
• Pharmacogenomic Evaluation of Antihypertensive Responses
  ClinicalTrials.gov Identifier: NCT00246519 - Recruiting
  Hypertension
  
• Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00442520 - Recruiting
  Lung Cancer; Colorectal Cancer; Head and Neck Cancer
  
• Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.
  ClinicalTrials.gov Identifier: NCT00216008 - Terminated
  Esophageal Adenocarcinomas; Adenocarcinomas of the Gastroesophageal Junction
  
• Pharmacogenomic Study Realized on "Non-Small Cell Lung Carcinoma"
  ClinicalTrials.gov Identifier: NCT00222404 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Pharmacogenomically Selected Treatment for Gastric and GEJ Tumors
  ClinicalTrials.gov Identifier: NCT00515216 - Not yet recruiting
  Stomach Neoplasms; Esophageal Neoplasms
  
• Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
  ClinicalTrials.gov Identifier: NCT00140036 - Completed
  Colorectal Neoplasms
  
• Pharmacogenomics of Anti-TNF Treatment in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00321217 - Recruiting
  Rheumatoid Arthritis
  
• Pharmacogenomics of Antidepressant Response in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00516932 - Recruiting
  Anxiety Disorders; Depression; Eating Disorders; Obsessive-Compulsive Disorder; Suicide Prevention
  
• Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
  ClinicalTrials.gov Identifier: NCT00164073 - Recruiting
  Hepatitis C
  
• Pharmacogenomics of Paclitaxel in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00415181 - Recruiting
  Ovarian Neoplasms; Fallopian Tube Neoplasms
  
• Pharmacogenomics of Paclitaxel in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00415207 - Not yet recruiting
  Ovarian Neoplasms; Fallopian Tube Neoplasms
  
• Pharmacokinetic (PK) and Safety Study of Plasma-Derived Human Butyrylcholinesterase Administered Intravenously
  ClinicalTrials.gov Identifier: NCT00333515 - Recruiting
  Chemical Terrorism; Chemical Warfare
  
• Pharmacokinetic (PK) Study of Single-Dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00344123 - Active, not recruiting
  HIV Infections
  
• Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg
  ClinicalTrials.gov Identifier: NCT00476983 - Not yet recruiting
  Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
  
• Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00490815 - Recruiting
  Diabetic Macular Edema
  
• Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-Gene
  ClinicalTrials.gov Identifier: NCT00550485 - Not yet recruiting
  Pharmacokinetics
  
• Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
  ClinicalTrials.gov Identifier: NCT00448071 - Recruiting
  Hypotension; End Stage Renal Disease; Intra Dialytic Hypotension
  
• Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
  ClinicalTrials.gov Identifier: NCT00006330 - Completed
  Heart Diseases
  
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00424541 - Completed
  Hypertension
  
• Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
  ClinicalTrials.gov Identifier: NCT00197431 - Recruiting
  Gastric Cancer; Esophageal Cancer; Pancreatic Cancer; Colon Cancer
  
• Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
  ClinicalTrials.gov Identifier: NCT00493220 - Completed
  Healthy
  
• Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
  ClinicalTrials.gov Identifier: NCT00094640 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
  ClinicalTrials.gov Identifier: NCT00518466 - Active, not recruiting
  Obesity
  
• Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
  Hypertension
  
• Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00562250 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-Lowering Agents
  ClinicalTrials.gov Identifier: NCT00359281 - Completed
  Healthy
  
• Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients
  ClinicalTrials.gov Identifier: NCT00458900 - Recruiting
  Pneumonia
  
• Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS
  ClinicalTrials.gov Identifier: NCT00360438 - Completed
  Leukemia; Lymphoma; Tumor Lysis Syndrome
  
• Pharmacokinetic Evaluation of Testosterone Gel (1%)
  ClinicalTrials.gov Identifier: NCT00193700 - Completed
  Primary or Secondary Hypogonadism; Constitutional Delay in Growth and Puberty (CDGP)
  
• Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00338910 - Completed
  Healthy
  
• Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia
  ClinicalTrials.gov Identifier: NCT00306319 - Completed
  Tuberculosis
  
• Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
  ClinicalTrials.gov Identifier: NCT00571961 - Recruiting
  HIV Infections
  
• Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
  ClinicalTrials.gov Identifier: NCT00486330 - Completed
  HIV Infections
  
• Pharmacokinetic Investigation of UDCA in Bile and Serum
  ClinicalTrials.gov Identifier: NCT00529009 - Recruiting
  Healthy
  
• Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine
  ClinicalTrials.gov Identifier: NCT00460759 - Recruiting
  Mycobacterium Tuberculosis
  
• Pharmacokinetic of Ceftriaxone in Septic ICU Patients
  ClinicalTrials.gov Identifier: NCT00449800 - Recruiting
  Sepsis; Severe Sepsis; Septic Shock
  
• Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
  ClinicalTrials.gov Identifier: NCT00177710 - Completed
  Lung Transplantation; Fungal Infections
  
• Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
  ClinicalTrials.gov Identifier: NCT00354965 - Completed
  Sinusitis, Acute Bacterial
  
• Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
  ClinicalTrials.gov Identifier: NCT00177684 - Completed
  Lung Transplantation; Fungal Infections
  
• Pharmacokinetic Response to BPI in Burns
  ClinicalTrials.gov Identifier: NCT00462904 - Recruiting
  Burns
  
• Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
  ClinicalTrials.gov Identifier: NCT00387283 - Completed
  West Nile Virus
  
• Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00411957 - Recruiting
  HIV Infections
  
• Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid
  ClinicalTrials.gov Identifier: NCT00381433 - Completed
  Encephalitis
  
• Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid
  ClinicalTrials.gov Identifier: NCT00343148 - Completed
  Neoplasms
  
• Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00545259 - Recruiting
  de Novo Liver Transplantation
  
• Pharmacokinetic Study of Aralast (Human Alpha1- PI)
  ClinicalTrials.gov Identifier: NCT00242385 - Completed
  Alpha 1-Antitrypsin Deficiency
  
• Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer
  ClinicalTrials.gov Identifier: NCT00405210 - Recruiting
  Primary Disease; Prostate Cancer
  
• Pharmacokinetic Study Of EPZICOM Tablet
  ClinicalTrials.gov Identifier: NCT00337922 - Completed
  HIV Infection
  
• Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
  ClinicalTrials.gov Identifier: NCT00483600 - Recruiting
  Kidney Diseases
  
• Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand
  ClinicalTrials.gov Identifier: NCT00197639 - Recruiting
  HIV Infection
  
• Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-Dependent Adults
  ClinicalTrials.gov Identifier: NCT00273988 - Completed
  Acquired Immunodeficiency Syndrome
  
• Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin
  ClinicalTrials.gov Identifier: NCT00239616 - Completed
  Anemia
  
• Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
  ClinicalTrials.gov Identifier: NCT00572650 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00458614 - Active, not recruiting
  Cystic Fibrosis
  
• Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old
  ClinicalTrials.gov Identifier: NCT00544050 - Completed
  Epilepsy
  
• Pharmacokinetic Study of Liposomal Vincristine in Patients with Malignant Melanoma & Hepatic Dysfunction
  ClinicalTrials.gov Identifier: NCT00145041 - Completed
  Malignant Melanoma
  
• Pharmacokinetic Study of Marine Active in Health Men
  ClinicalTrials.gov Identifier: NCT00207974 - Active, not recruiting
  Hyperuricemia, Anserine, Pharmacokinetic
  
• Pharmacokinetic Study of Paclitaxel (Taxol) and ABI-0007
  ClinicalTrials.gov Identifier: NCT00092261 - Recruiting
  
  
• Pharmacokinetic study of palifermin in subjects receiving radiation therapy and chemotherapy followed by blood stem cell support
  ClinicalTrials.gov Identifier: NCT00070616 - Completed
  Leukemia; Lymphoma; Myeloma
  
• Pharmacokinetic Study of Previously Untreated, Relapsed, or Transformed Follicular Non-Hodgkin's Lymphoma with Fission-Derived Iodine I 131 Tositumomab
  ClinicalTrials.gov Identifier: NCT00062894 - Completed
  Non-Hodgkin's Lymphoma
  
• Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
  ClinicalTrials.gov Identifier: NCT00184951 - Completed
  HIV Infections; Hyperlipidemia
  
• Pharmacokinetic Study of Single Dose Daptomycin in Pediatric Patients with Gram Positive Infection for Which They Are Receiving Standard Antibiotics.
  ClinicalTrials.gov Identifier: NCT00136292 - Completed
  Gram positive infection
  
• Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00364754 - Active, not recruiting
  Metastatic/Recurrent Breast Cancer
  
• Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
  ClinicalTrials.gov Identifier: NCT00561496 - Recruiting
  HIV Infections
  
• Pharmacokinetic Study of Tigecycline in Adult Subjects With Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00406237 - Recruiting
  Healthy
  
• Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
  ClinicalTrials.gov Identifier: NCT00420355 - Recruiting
  HIV Infection
  
• Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets
  ClinicalTrials.gov Identifier: NCT00343278 - Terminated
  Renal Impairment
  
• Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment
  ClinicalTrials.gov Identifier: NCT00567047 - Recruiting
  Type-2 Diabetes
  
• Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
  ClinicalTrials.gov Identifier: NCT00325325 - Recruiting
  Kidney Diseases
  
• Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
  ClinicalTrials.gov Identifier: NCT00544258 - Active, not recruiting
  Actinic Keratoses
  
• Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00535951 - Recruiting
  Carcinoma, Non-Small-Cell Lung; Mesothelioma
  
• Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT®) in Critically Ill Patients.
  ClinicalTrials.gov Identifier: NCT00210756 - Completed
  Critical Illness; Anemia
  
• Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects
  ClinicalTrials.gov Identifier: NCT00578916 - Not yet recruiting
  Cancer
  
• Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00244257 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy
  ClinicalTrials.gov Identifier: NCT00214331 - Recruiting
  Pregnancy
  
• Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00347815 - Recruiting
  Healthy Volunteers
  
• Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Neonates
  ClinicalTrials.gov Identifier: NCT00516529 - Not yet recruiting
  Thoracic Surgery; Intubation, Intratracheal; Respiration, Artificial
  
• Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00239564 - Recruiting
  Idiopathic Parkinson's Disease
  
• Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-Naive Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00359190 - Recruiting
  Breast Cancer
  
• Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients
  ClinicalTrials.gov Identifier: NCT00482287 - Recruiting
  Hypotension; Cardiopulmonary Bypass
  
• Pharmacokinetics and Pharmacodynamics of Pentobarbital in Neonates, Infants, and Children Following Open Heart Surgery
  ClinicalTrials.gov Identifier: NCT00577434 - Recruiting
  Cardiac Surgical Procedures
  
• Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00411125 - Completed
  Postmenopausal Osteoporosis
  
• Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)
  ClinicalTrials.gov Identifier: NCT00528255 - Not yet recruiting
  Cervical Ripening; Induction of Labor
  
• Pharmacokinetics and Safety of Transdermal Megestrol Acetate
  ClinicalTrials.gov Identifier: NCT00163072 - Recruiting
  Cachexia
  
• Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
  ClinicalTrials.gov Identifier: NCT00418847 - Active, not recruiting
  Gangliosidoses GM2
  
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00471653 - Recruiting
  Brain and Central Nervous System Tumors; Thrombocytopenia
  
• Pharmacokinetics of 1-Octanol in Adults with Essential Tremor
  ClinicalTrials.gov Identifier: NCT00102596 - Recruiting
  
  
• Pharmacokinetics of a Single 14C-Labeled Dose of Risedronate or Alendronate Followed by Once-a-Week Unlabeled Oral Dose
  ClinicalTrials.gov Identifier: NCT00577850 - Completed
  Osteopenia; Osteoporosis
  
• Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
  ClinicalTrials.gov Identifier: NCT00006320 - Completed
  HIV Infection
  
• Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together
  ClinicalTrials.gov Identifier: NCT00352066 - Completed
  HIV Infection
  
• Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
  ClinicalTrials.gov Identifier: NCT00326716 - Recruiting
  HIV Infections
  
• Pharmacokinetics of C1 Esterase Inhibitor (C1INH-nf) in Hereditary Angioedema Subjects
  ClinicalTrials.gov Identifier: NCT00432510 - Completed
  Hereditary Angioedema
  
• Pharmacokinetics of Curcumin in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00181662 - Completed
  Healthy
  
• Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function
  ClinicalTrials.gov Identifier: NCT00264693 - Recruiting
  Renal Insufficiency
  
• Pharmacokinetics of Efavirenz in HIV-1 Invected Subjects with Hepatic Impairment
  ClinicalTrials.gov Identifier: NCT00162097 - Recruiting
  HIV Infections; Hepatic Impairment
  
• Pharmacokinetics of Emtricitabine/Tenofovir + Efavirenz in HIV-Infected Patients With Tuberculosis
  ClinicalTrials.gov Identifier: NCT00474435 - Not yet recruiting
  Tuberculosis; HIV Infections
  
• Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
  ClinicalTrials.gov Identifier: NCT00426595 - Recruiting
  Gastreoesophageal Reflux Disease
  
• Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00443937 - Completed
  Renal Transplantation
  
• Pharmacokinetics of Ghrelin
  ClinicalTrials.gov Identifier: NCT00116025 - Completed
  Healthy subjects
  
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
  ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
  Gastroparesis; Gastroesophageal Reflux Disease
  
• Pharmacokinetics of Intermittent Isoniazid
  ClinicalTrials.gov Identifier: NCT00023348 - Completed
  HIV Infections; Tuberculosis
  
• Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz
  ClinicalTrials.gov Identifier: NCT00023413 - Completed
  HIV Infections; Tuberculosis
  
• Pharmacokinetics of Ketamine in Infants and Children
  ClinicalTrials.gov Identifier: NCT00553839 - Recruiting
  General Anesthesia; Sedation; Pain Management
  
• Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00496483 - Recruiting
  Kidney Transplantation; Immunosuppressive Therapy
  
• Pharmacokinetics of Leptin Administration During Fasting
  ClinicalTrials.gov Identifier: NCT00140205 - Active, not recruiting
  energy deficiency due to short-term fasting
  
• Pharmacokinetics of Mmf and Valganciclovir
  ClinicalTrials.gov Identifier: NCT00189150 - Recruiting
  Kidney Transplant Recipient; Heart Transplant Recipient
  
• Pharmacokinetics of Mycophenolic Acid and Mycophenolate 7-O-Phenolic Glucuronide in Healthy Subjects With or Without Two Common Genetic Polymorphisms in the Promoter Region of Uridine Diphosphate Glucuronosyltransferase 1A9
  ClinicalTrials.gov Identifier: NCT00128947 - Completed
  
  
• Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function
  ClinicalTrials.gov Identifier: NCT00418626 - Recruiting
  Healthy
  
• Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)
  ClinicalTrials.gov Identifier: NCT00001998 - Completed
  HIV Infections
  
• Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.
  ClinicalTrials.gov Identifier: NCT00426140 - Active, not recruiting
  Advanced Malignancies; Solid Tumors
  
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
  ClinicalTrials.gov Identifier: NCT00555061 - Recruiting
  Skin Diseases, Infectious; Skin Abnormalities; Dermatoses; Impetigo
  
• Pharmacokinetics of tacrolimus in kidney transplant recipients: Once daily versus twice daily dosing
  ClinicalTrials.gov Identifier: NCT00028171 - Completed
  Kidney Transplantation
  
• Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
  ClinicalTrials.gov Identifier: NCT00372008 - Not yet recruiting
  Hypogonadism
  
• Pharmacokinetics of THCCOOH and Its Acyl-Glucuronide After Intravenous Administration of THCCOOH
  ClinicalTrials.gov Identifier: NCT00176085 - Completed
  THCCOOH; Pharmacokinetics; Metabolism; Cannabis
  
• Pharmacokinetics of Vancomycin in Adults Receiving ECMO
  ClinicalTrials.gov Identifier: NCT00281281 - Recruiting
  Extracorporeal Membrane Oxygenation
  
• Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00113971 - Terminated
  Lupus Erythematosus, Systemic
  
• Pharmacokinetics Study on Nevirapine Resistance in Tanzania
  ClinicalTrials.gov Identifier: NCT00294892 - Recruiting
  HIV Infections
  
• Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
  ClinicalTrials.gov Identifier: NCT00448227 - Recruiting
  Herpes Simplex Infection
  
• Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients
  ClinicalTrials.gov Identifier: NCT00162019 - Completed
  Hemophilia A
  
• Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-Pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
  ClinicalTrials.gov Identifier: NCT00380146 - Active, not recruiting
  Malaria
  
• Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor
  ClinicalTrials.gov Identifier: NCT00102674 - Completed
  Healthy
  
• Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
  ClinicalTrials.gov Identifier: NCT00035178 - Completed
  Kidney Failure, Chronic; Renal Disease, End-Stage
  
• Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00486317 - Completed
  Osteoarthritis
  
• Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00413790 - Completed
  Healthy
  
• Pharmacologic Intervention for Postcessation Weight Gain
  ClinicalTrials.gov Identifier: NCT00005704 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Pharmacologic Relapse Prevention for Alcoholic Smokers
  ClinicalTrials.gov Identifier: NCT00000457 - Completed
  Alcoholism; Smoking
  
• Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00463008 - Completed
  Brain and Central Nervous System Tumors
  
• Pharmacologic Study of Oseltamivir in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00439530 - Recruiting
  Avian Influenza A Virus
  
• Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
  ClinicalTrials.gov Identifier: NCT00478335 - Recruiting
  Nephrogenic Diabetes Insipidus
  
• Pharmacologic Treatment of PTSD in Sexually Abused Children
  ClinicalTrials.gov Identifier: NCT00078767 - Active, not recruiting
  Posttraumatic Stress Disorder; Major Depressive Disorder; Anxiety Disorders
  
• Pharmacological and Behavioral Treatment of Insomnia
  ClinicalTrials.gov Identifier: NCT00005753 - Completed
  Lung Diseases; Sleep; Sleep Initiation and Maintenance Disorders
  
• Pharmacological Augmentation Strategies for OCD Patients: A Double-Blind Placebo Controlled Study.
  ClinicalTrials.gov Identifier: NCT00466609 - Recruiting
  Obsessive Compulsive Disorder
  
• Pharmacological Intervention in Depression After Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00205491 - Completed
  TBI (Traumatic Brain Injury)
  
• Pharmacological Intervention Project (fluoxetine)
  ClinicalTrials.gov Identifier: NCT00027378 - Recruiting
  Alcoholism
  
• Pharmacological Modulation of Cocaine Effects - 1
  ClinicalTrials.gov Identifier: NCT00000201 - Completed
  Cocaine-Related Disorders
  
• Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract
  ClinicalTrials.gov Identifier: NCT00428428 - Completed
  Kidney Stone; Unexplained Haematuria; Benignant Tumour Mass in the Upper Urinary Tract
  
• Pharmacological Treatment for Alcoholism
  ClinicalTrials.gov Identifier: NCT00382642 - Recruiting
  Alcohol Dependence
  
• Pharmacological vs Surgical Treatment for Mixed Incontinence
  ClinicalTrials.gov Identifier: NCT00523068 - Not yet recruiting
  Mixed Urinary Incontinence; Urinary Incontinence, Stress; Urinary Incontinence, Urge
  
• Pharmacology Study of Aerosolized Liposomal
  ClinicalTrials.gov Identifier: NCT00250120 - Active, not recruiting
  Lung Diseases; Cancer
  
• Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
  ClinicalTrials.gov Identifier: NCT00250016 - Recruiting
  Corpus Uteri; Endometrial Cancer
  
• Pharmacosurveillance and Pharmacogenetics of First-Line Diuretics in Hypertension: The StayOnDiur Study
  ClinicalTrials.gov Identifier: NCT00408512 - Recruiting
  Essential Hypertension
  
• PHARMACOTHERAPIES: EFFICACY, MECHANISMS, AND ALGORITHMS - 1
  ClinicalTrials.gov Identifier: NCT00109447 - Recruiting
  nicotine
  
• Pharmacotherapy and Intensive Treatment - 2
  ClinicalTrials.gov Identifier: NCT00000218 - Active, not recruiting
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
  ClinicalTrials.gov Identifier: NCT00000217 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
  ClinicalTrials.gov Identifier: NCT00218036 - Recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Pharmacotherapy Dosing Regimen in Cocaine Dependent Individuals - 12
  ClinicalTrials.gov Identifier: NCT00218062 - Recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Pharmacotherapy for Schizophrenic Drug Users - 6
  ClinicalTrials.gov Identifier: NCT00000281 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Pharmacotherapy in Depression With Panic Spectrum
  ClinicalTrials.gov Identifier: NCT00177996 - Completed
  Major Depression
  
• Pharmacotherapy of Body Dysmorphic Disorder in Adolescents
  ClinicalTrials.gov Identifier: NCT00029471 - Suspended
  Body Dysmorphic Disorder
  
• Pharmacotherapy of Treatment-Resistant Mania
  ClinicalTrials.gov Identifier: NCT00518947 - Completed
  Mania
  
• Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy
  ClinicalTrials.gov Identifier: NCT00460343 - Recruiting
  Hypertension
  
• Pharmacy Interventions to Improve Chronic Disease Medication Refill
  ClinicalTrials.gov Identifier: NCT00469365 - Completed
  Diabetes; Hypertension; Hyperlipidemia; Heart Diseases; Depression; Psychoses
  
• Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00149565 - Completed
  Hepatocellular Carcinoma
  
• Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00387153 - Recruiting
  Cancer
  
• Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma
  ClinicalTrials.gov Identifier: NCT00396864 - Recruiting
  Cancer; Solid Tumors; Lymphomas
  
• Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00461045 - Recruiting
  Multiple Myeloma
  
• Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers
  ClinicalTrials.gov Identifier: NCT00452894 - Completed
  Smoking
  
• Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00385177 - Recruiting
  Breast Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms; Pelvic Neoplasms; Lung Neoplasms
  
• Phase 1 meCS6 + LT(R192G) vaccine study
  ClinicalTrials.gov Identifier: NCT00090688 - Completed
  Diarrhea
  
• Phase 1 Open-Label Study of E7974 Administered During a 28-Day Cycle in Patients With Solid Malignancies
  ClinicalTrials.gov Identifier: NCT00130169 - Recruiting
  Cancer
  
• Phase 1 Pediatric FMP2.1/AS02A Trial in Mali
  ClinicalTrials.gov Identifier: NCT00358332 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
  ClinicalTrials.gov Identifier: NCT00346853 - Completed
  Stargardt Macular Dystrophy
  
• Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression
  ClinicalTrials.gov Identifier: NCT00336778 - Completed
  HIV Infections
  
• Phase 1 Safety and Plasma Kinetic Study of AI-700 in Patients with Diminished DLCO and COPD and/or CHF
  ClinicalTrials.gov Identifier: NCT00156780 - Completed
  Congestive Heart Failure; Chronic Obstructive Pulmonary Disease
  
• Phase 1 Safety Study of Two Experimental HIV Vaccines
  ClinicalTrials.gov Identifier: NCT00479999 - Recruiting
  AIDS Vaccines; HIV Infections; HIV-1
  
• Phase 1 Single Ascending Dose Trial of MLN2704 in Subjects with Metastatic Androgen Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00052000 - Completed
  Prostate Cancer
  
• Phase 1 Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine
  ClinicalTrials.gov Identifier: NCT00323375 - Completed
  Malaria
  
• Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00517855 - Active, not recruiting
  Healthy Volunteers
  
• Phase 1 Study of Anti-Glycation Agent GLY-230 in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00544921 - Completed
  Diabetes
  
• Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00424632 - Recruiting
  Solid Tumors
  
• Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00453375 - Recruiting
  Diabetes; Hypoglycemia
  
• Phase 1 Study of BIIB022 in Relapsed/Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00555724 - Not yet recruiting
  Solid Tumors
  
• Phase 1 Study of BL22 to Treat Acute Lymphocytic Leukemia or Non-Hodgkin's Lymphoma in Children and Young Adults
  ClinicalTrials.gov Identifier: NCT00075309 - Recruiting
  Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Acute
  
• Phase 1 Study OF CDC-501 in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00046735 - Active, not recruiting
  Neoplasms
  
• Phase 1 Study of Continuous OSI-906 Dosing
  ClinicalTrials.gov Identifier: NCT00514007 - Recruiting
  Advanced Solid Tumors
  
• Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00466583 - Recruiting
  Carcinoma; Lymphoma
  
• Phase 1 Study of Imatinab (STI571) in Patients with Advanced Cancer and Kidney Dysfunction
  ClinicalTrials.gov Identifier: NCT00028392 - Completed
  Neoplasm; Kidney Failure
  
• Phase 1 Study of Imatinab (STI571) in Patients with Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00025948 - Completed
  Liver Dysfunction; Neoplasm
  
• Phase 1 Study of Intermittent OSI-906 Dosing
  ClinicalTrials.gov Identifier: NCT00514306 - Recruiting
  Advanced Solid Tumors
  
• Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
  ClinicalTrials.gov Identifier: NCT00344916 - Completed
  Liver Cirrhosis
  
• Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00511082 - Not yet recruiting
  Non-Hodgkin's Lymphoma; Multiple Myeloma
  
• Phase 1 Study of OSI-930 in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00513851 - Recruiting
  Advanced Solid Tumors
  
• Phase 1 Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00540943 - Recruiting
  Colorectal Cancer
  
• Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
  ClinicalTrials.gov Identifier: NCT00209144 - Recruiting
  Acute Myocardial Infarction
  
• Phase 1 Study of Radiosensitization Using Bortezomib in Patients With Relapsed Mantle Cell or Aggressive Lymphoma Receiving Radioimmunotherapy
  ClinicalTrials.gov Identifier: NCT00398762 - Recruiting
  Lymphoma
  
• Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn’s Disease
  ClinicalTrials.gov Identifier: NCT00353756 - Recruiting
  Crohn's Disease
  
• Phase 1 Study of SK3530 to Investigate of the Effect of Food
  ClinicalTrials.gov Identifier: NCT00443625 - Active, not recruiting
  Erectile Dysfunction
  
• Phase 1 Study of TG01 and Erlotinib in Non-Small Cell Lung Cancer (NCSLC) Patients
  ClinicalTrials.gov Identifier: NCT00569114 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum
  ClinicalTrials.gov Identifier: NCT00487916 - Recruiting
  Malaria
  
• Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00320814 - Active, not recruiting
  Diabetic Macular Edema
  
• Phase 1 Study With Sorafenib and Sirolimus
  ClinicalTrials.gov Identifier: NCT00509613 - Recruiting
  Advanced Solid Tumor; Refractory to Standard Therapies
  
• Phase 1 Thorough QT Study in Young Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00485667 - Completed
  Postoperative Pain
  
• Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children
  ClinicalTrials.gov Identifier: NCT00317473 - Completed
  Plasmodium Falciparum Malaria
  
• Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
  ClinicalTrials.gov Identifier: NCT00370006 - Completed
  Cytomegalovirus Infection
  
• Phase 1 Trial of Idebenone to Treat Patients with Friedreich's Ataxia
  ClinicalTrials.gov Identifier: NCT00078481 - Completed
  Friedreich Ataxia
  
• Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
  ClinicalTrials.gov Identifier: NCT00473967 - Recruiting
  Hookworm Infection
  
• Phase 1 Trial of New Dietary Treatment of Diabetes
  ClinicalTrials.gov Identifier: NCT00128089 - Terminated
  Diabetes Mellitus, Type 2
  
• Phase 1, Dose-Escalation Study of Oral CNF2024 in CLL
  ClinicalTrials.gov Identifier: NCT00344786 - Recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL
  ClinicalTrials.gov Identifier: NCT00319930 - Terminated
  Chronic Lymphocytic Leukemia
  
• Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00394446 - Active, not recruiting
  Refractory Solid Tumors
  
• Phase 1, Open-Label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00492830 - Recruiting
  Cancer; Neoplasm Metastasis
  
• Phase 1, Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00137865 - Completed
  Ovarian Neoplasms
  
• Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
  ClinicalTrials.gov Identifier: NCT00458952 - Recruiting
  Pheochromocytoma; Paraganglioma
  
• Phase 1-2a Dose-Ranging Study of TLK286 in Combination with Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00047801 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase 1/2 Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV NSCLC
  ClinicalTrials.gov Identifier: NCT00431015 - Recruiting
  Lung Cancer
  
• Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
  ClinicalTrials.gov Identifier: NCT00402116 - Recruiting
  Glioblastoma; Glioblastoma Multiforme; Gliosarcoma
  
• Phase 1/2 Study of AMG 531 in Patients with Advanced Malignancy Receiving Treatment with Carboplatin
  ClinicalTrials.gov Identifier: NCT00147225 - Recruiting
  Gastrointestinal Cancer; Genitourinary Cancer; Gynecologic Cancer; Head and Neck Cancer
  
• Phase 1/2 study of S-1 and cisplatin in advanced gastric cancer
  ClinicalTrials.gov Identifier: NCT00072787 - Active, not recruiting
  Gastric Cancer
  
• Phase 1/2 Study of VELCADE®, Dexamethasone, and Revlimid® Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid in Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00507442 - Recruiting
  Multiple Myeloma
  
• Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
  ClinicalTrials.gov Identifier: NCT00519792 - Recruiting
  Chronic Hepatitis C
  
• Phase 1b Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00401778 - Recruiting
  Lung Cancer
  
• Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors
  ClinicalTrials.gov Identifier: NCT00531284 - Recruiting
  Non-Small Cell Lung Carcinoma; Small-Cell Lung Carcinoma; Ovarian Cancer; Renal Cancer; Other Solid Tumors
  
• Phase 2 AMG 714 in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00433875 - Completed
  Rheumatoid Arthritis
  
• Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765
  ClinicalTrials.gov Identifier: NCT00205465 - Completed
  Psoriasis
  
• Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
  ClinicalTrials.gov Identifier: NCT00205478 - Completed
  Rheumatoid Arthritis
  
• Phase 2 Dose-Finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00542425 - Recruiting
  Osteoporosis
  
• Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy
  ClinicalTrials.gov Identifier: NCT00529126 - Recruiting
  Postoperative Pain
  
• Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
  ClinicalTrials.gov Identifier: NCT00030225 - Recruiting
  Fulminant Hepatic Failure
  
• Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00424021 - Active, not recruiting
  Pulmonary Hypertension
  
• Phase 2 FMP2.1 Trial in Mali
  ClinicalTrials.gov Identifier: NCT00460525 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
  ClinicalTrials.gov Identifier: NCT00499902 - Recruiting
  Acute Ischemic Stroke
  
• Phase 2 Randomized Study of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy for NSCLC
  ClinicalTrials.gov Identifier: NCT00312975 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00286780 - Completed
  Chronic Lymphocytic Leukemia
  
• Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
  ClinicalTrials.gov Identifier: NCT00511368 - Recruiting
  HIV Infections
  
• Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00426933 - Completed
  Soft Tissue Infections
  
• Phase 2 Study - Erdosteine in Patients With CB/COPD
  ClinicalTrials.gov Identifier: NCT00338507 - Completed
  Chronic Bronchitis; Chronic Obstructive Pulmonary Disease
  
• Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
  ClinicalTrials.gov Identifier: NCT00043186 - Completed
  Osteopenia; Osteoporosis
  
• Phase 2 Study for Patients with Poor Prognosis Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00071006 - Completed
  Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome
  
• Phase 2 Study in Patients With MiT Tumors
  ClinicalTrials.gov Identifier: NCT00557609 - Recruiting
  Microphthalmia Transcription (MiT) Factor Associated Tumors; Alveolar Soft Part Sarcoma (ASPS); Clear Cell Sarcoma (CCS); Renal Cell Carcinoma (RCC)
  
• Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event
  ClinicalTrials.gov Identifier: NCT00552188 - Recruiting
  Acute Coronary Syndrome
  
• Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)
  ClinicalTrials.gov Identifier: NCT00517920 - Recruiting
  Advanced Hepatocellular Carcinoma
  
• Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With m-Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00327119 - Completed
  Metastatic Colorectal Cancer
  
• Phase 2 Study Of AG-013736 In Patients With Doxorubicin-Refractory Or Intolerant Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00389441 - Recruiting
  Thyroid Neoplasms; Carcinoma, Papillary, Follicular; Oxyphil Cells
  
• Phase 2 Study of AG-013736 in Patients With Refractory Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00282048 - Recruiting
  Carcinoma, Renal Cell; Kidney Neoplasms
  
• Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00423592 - Active, not recruiting
  Pulmonary Hypertension
  
• Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00583674 - Recruiting
  Gastrointestinal Cancer
  
• Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00511459 - Recruiting
  Locally Recurrent and Metastatic Breast Cancer
  
• Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00131053 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma
  ClinicalTrials.gov Identifier: NCT00210041 - Recruiting
  Genital Neoplasms, Male
  
• Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00511238 - Recruiting
  Multiple Myeloma
  
• Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00530816 - Recruiting
  Multiple Myeloma
  
• Phase 2 Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
  ClinicalTrials.gov Identifier: NCT00570921 - Not yet recruiting
  Breast Cancer
  
• Phase 2 Study of CP-751,871 in Combination With Docetaxel and Prednisone in HRPC
  ClinicalTrials.gov Identifier: NCT00313781 - Recruiting
  Prostatic Neoplasms
  
• Phase 2 Study of Darbepoetin Alfa Extended Dosing
  ClinicalTrials.gov Identifier: NCT00527215 - Completed
  Pre-Dialysis
  
• Phase 2 study of ET-743 in persistent or recurrent endometrial carcinoma
  ClinicalTrials.gov Identifier: NCT00050440 - Completed
  Endometrial Neoplasms
  
• Phase 2 study of ET-743 in subjects with advanced ovarian cancer
  ClinicalTrials.gov Identifier: NCT00050414 - Completed
  Ovarian Cancer
  
• Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Patients With Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00267020 - Active, not recruiting
  Pancreatic Neoplasm
  
• Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
  ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00521053 - Recruiting
  Melanoma
  
• Phase 2 Study of Irofulven Plus Capecitabine in Patients with Advanced Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00124527 - Completed
  Thyroid Cancer
  
• Phase 2 Study of LY2140023 in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00149292 - Completed
  Schizophrenia
  
• Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00306748 - Completed
  Constipation
  
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
  ClinicalTrials.gov Identifier: NCT00258193 - Completed
  Irritable Bowel Syndrome
  
• Phase 2 Study of MM-093 to Treat Patients With Uveitis
  ClinicalTrials.gov Identifier: NCT00444743 - Recruiting
  Uveitis
  
• Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC
  ClinicalTrials.gov Identifier: NCT00188617 - Recruiting
  Lung Cancer
  
• Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00568646 - Recruiting
  Pancreatic Cancer
  
• Phase 2 Study of Panzem NCD in Combination With Fixed-Dose Temozolomide to Patients With Recurrent GBM
  ClinicalTrials.gov Identifier: NCT00481455 - Recruiting
  Recurrent Glioblastoma Multiforme
  
• Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00444314 - Recruiting
  Metastatic Renal Cell Carcinoma
  
• Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273)
  ClinicalTrials.gov Identifier: NCT00423150 - Recruiting
  Colorectal Neoplasm; Head and Neck Neoplasm; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasm
  
• Phase 2 Study of the Activity and Safety of Fludarabine, Cyclophosphamide, and Mitoxantrone Plus Rituximab (FCM-R) With Pegfilgrastim (Neulasta) as Frontline Therapy for Patients < 70 Years With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00254410 - Suspended
  Chronic Lymphocytic Leukemia
  
• Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD
  ClinicalTrials.gov Identifier: NCT00263874 - Terminated
  Pulmonary Disease, Chronic Obstructive
  
• Phase 2 Study of Ticilimumab in Refractory Melanoma
  ClinicalTrials.gov Identifier: NCT00254579 - Recruiting
  Malignant Melanoma
  
• Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040638 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase 2 Study of TLK286 in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00035841 - Active, not recruiting
  Breast Neoplasms
  
• Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00038428 - Active, not recruiting
  Ovarian Neoplasms
  
• Phase 2 Study of VELCADE Alone or VELCADE® plus Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00051974 - Active, not recruiting
  Non-small cell lung cancer
  
• Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
  ClinicalTrials.gov Identifier: NCT00213278 - Active, not recruiting
  Glioma
  
• Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00262483 - Completed
  Hepatitis C
  
• Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00372385 - Active, not recruiting
  Chronic Hepatitis C
  
• Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00336479 - Active, not recruiting
  Chronic Hepatitis C
  
• Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma
  ClinicalTrials.gov Identifier: NCT00190801 - Completed
  Gastrointestinal Neoplasms
  
• Phase 2 Study With AG-013736 Combined With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00460603 - Recruiting
  Colorectal Neoplasms
  
• Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00428714 - Recruiting
  Prostate Cancer
  
• Phase 2 Trial of TD 6424 Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00061633 - Completed
  Infections, Gram-Positive Bacterial; Abscess; Burns; Cellulitis; Ulcer; Wound Infections
  
• Phase 2 Trial of TD-6424 Versus Standard Therapy for Complicated Gram Positive Infections of the Skin and Soft Tissue
  ClinicalTrials.gov Identifier: NCT00077675 - Completed
  Infections, Gram-Positive Bacterial
  
• Phase 2 trial using Talampanel in patients with recurrent high grade gliomas
  ClinicalTrials.gov Identifier: NCT00062504 - Terminated
  Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Oligoastrocytoma
  
• Phase 2, AMG 386 (20060342) in Combination With Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00479817 - Recruiting
  Ovarian Cancer
  
• Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
  ClinicalTrials.gov Identifier: NCT00226460 - Completed
  Parkinson's Disease
  
• Phase 2, OPEN-LABEL Study TO EVALUATE CC-10004 RECALCITRANT (NOT RESPONDED TO THERAPY)PLAQUE-TYPE PSORIASIS
  ClinicalTrials.gov Identifier: NCT00521339 - Recruiting
  Recalcitrant Psoriasis; Refractory Psoriasis
  
• Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
  ClinicalTrials.gov Identifier: NCT00467610 - Recruiting
  Myelodysplastic Syndrome
  
• Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)
  ClinicalTrials.gov Identifier: NCT00449202 - Active, not recruiting
  Obesity
  
• Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults
  ClinicalTrials.gov Identifier: NCT00449254 - Active, not recruiting
  Obesity
  
• Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities
  ClinicalTrials.gov Identifier: NCT00493051 - Recruiting
  Diabetic Foot
  
• Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00051987 - Active, not recruiting
  Colorectal Carcinoma
  
• Phase 3 /Seroquel SR Acute Mania Monotherapy - US
  ClinicalTrials.gov Identifier: NCT00422123 - Completed
  Affective Psychosis, Bipolar; Manic Disorder; Manic-Depressive Psychosis; Mania; Manic State; Psychoses, Manic-Depressive
  
• Phase 3 Clinical Trial of Teriparatide in Japan
  ClinicalTrials.gov Identifier: NCT00433160 - Active, not recruiting
  Osteoporosis
  
• Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients
  ClinicalTrials.gov Identifier: NCT00146770 - Completed
  Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
  
• Phase 3 Imaging and Safety Study of AI-700 in Patients with Suspected Coronary Artery Disease Undergoing SPECT Imaging
  ClinicalTrials.gov Identifier: NCT00156793 - Completed
  Coronary Artery Disease
  
• Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
  ClinicalTrials.gov Identifier: NCT00462215 - Active, not recruiting
  Influenza
  
• Phase 3 Open-Label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
  ClinicalTrials.gov Identifier: NCT00498108 - Completed
  Idiopathic Restless Legs Syndrome
  
• Phase 3 Open-Label, Study of OPC-41061 in Subjects With Cardiac-Induced Edema (Congestive Heart Failure) — an Investigation of the Safety of Treatment Beyond 7 Days and the Effect of Dose Escalation to 30 mg
  ClinicalTrials.gov Identifier: NCT00544869 - Recruiting
  Cardiac Edema
  
• Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
  ClinicalTrials.gov Identifier: NCT00556296 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Phase 3 Randomized Study of Amonafide and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary AML
  ClinicalTrials.gov Identifier: NCT00509912 - Recruiting
  Secondary Acute Myeloid Leukemia
  
• Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)
  ClinicalTrials.gov Identifier: NCT00299520 - Active, not recruiting
  Complicated Skin and Skin Structure Infection
  
• Phase 3 Safety and Imaging Study of AI-700 in Patients with Suspected Coronary Artery Disease Undergoing Coronary Angiography
  ClinicalTrials.gov Identifier: NCT00156845 - Completed
  Coronary Artery Disease
  
• Phase 3 Study (Safety, Immunogenicity and Efficacy) of Improved Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
  ClinicalTrials.gov Identifier: NCT00368316 - Active, not recruiting
  Shigellosis@@@
  
• Phase 3 study comparing IOP lowering in OAG or OH in Japanese subjects C-01-98
  ClinicalTrials.gov Identifier: NCT00047593 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase 3 Study of Acupression''s Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy''s Sort.
  ClinicalTrials.gov Identifier: NCT00268125 - Recruiting
  Breast Neoplasms
  
• Phase 3 study of LY353381 vs tamoxifen in women with locally advanced or metastatic breast cancer.
  ClinicalTrials.gov Identifier: NCT00034125 - Completed
  Breast Neoplasms
  
• Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
  ClinicalTrials.gov Identifier: NCT00429377 - Completed
  Lupus Nephritis
  
• Phase 3 Study of YM060 in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
  ClinicalTrials.gov Identifier: NCT00189696 - Completed
  Irritable Bowel Syndrome
  
• Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular NHL
  ClinicalTrials.gov Identifier: NCT00384111 - Recruiting
  Follicular Lymphoma; Lymphoma, Follicular
  
• Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.
  ClinicalTrials.gov Identifier: NCT00041483 - Active, not recruiting
  Macular Degeneration
  
• Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-69
  ClinicalTrials.gov Identifier: NCT00047515 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-70
  ClinicalTrials.gov Identifier: NCT00047541 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-02-41
  ClinicalTrials.gov Identifier: NCT00047528 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
  ClinicalTrials.gov Identifier: NCT00440310 - Recruiting
  Liver Metastases; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local
  
• Phase 3 Trial of Ticilimumab Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
  ClinicalTrials.gov Identifier: NCT00257205 - Active, not recruiting
  Melanoma
  
• Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
  ClinicalTrials.gov Identifier: NCT00174915 - Completed
  Gout
  
• Phase 3/Safety & Efficacy of Esomeprazole in Infants
  ClinicalTrials.gov Identifier: NCT00468559 - Recruiting
  Gastroesophageal Reflux Disease (GERD)
  
• Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
  ClinicalTrials.gov Identifier: NCT00570492 - Recruiting
  Perennial Allergic Rhinitis
  
• Phase 4 Study – Mucinex D as Adjunct Therapy
  ClinicalTrials.gov Identifier: NCT00441246 - Recruiting
  Acute Respiratory Infection; Bronchitis; Rhinosinusitis
  
• Phase 4 study comparing IOP lowering in OAG or OH in Caucasian or Japanese subjects C-02-32
  ClinicalTrials.gov Identifier: NCT00047606 - Terminated
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
  ClinicalTrials.gov Identifier: NCT00360074 - Active, not recruiting
  Central Hypothyroidism; Hypopituitarism; Hyperlipidemias
  
• Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00467012 - Recruiting
  Metastatic Breast Cancer
  
• Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00201812 - Active, not recruiting
  Tumors
  
• Phase I & II Trial of Intravesicular Abraxane for Treatment-Refractory Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00583349 - Recruiting
  Bladder Cancer
  
• Phase I (PH I) Mad Refractory Solid Tumor Study
  ClinicalTrials.gov Identifier: NCT00099606 - Completed
  Neoplasms
  
• Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00403221 - Recruiting
  Prostatic Neoplasms
  
• Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209625 - Completed
  Colorectal Cancer
  
• Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
  ClinicalTrials.gov Identifier: NCT00246181 - Active, not recruiting
  Non-Small Cell Lung Cancer
  
• Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients with Refractory Malignancy
  ClinicalTrials.gov Identifier: NCT00001387 - Completed
  Neoplasms
  
• Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients with Refractory Malignancy
  ClinicalTrials.gov Identifier: NCT00001565 - Completed
  Brain Neoplasms; Neuroblastoma
  
• Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML
  ClinicalTrials.gov Identifier: NCT00502385 - Completed
  Leukaemia; Myelocytic; Acute
  
• Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention
  ClinicalTrials.gov Identifier: NCT00578396 - Not yet recruiting
  Colon Cancer
  
• Phase I Cetuximab and Concurrent Radio-Chemotherapy
  ClinicalTrials.gov Identifier: NCT00522886 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase I Chinese PK
  ClinicalTrials.gov Identifier: NCT00503711 - Active, not recruiting
  Advanced Solid, Malignant Tumors
  
• Phase I Clinical and PK Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00551512 - Recruiting
  Cancer; Solid Tumors
  
• Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women
  ClinicalTrials.gov Identifier: NCT00491595 - Completed
  Drug Toxicity
  
• Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT
  ClinicalTrials.gov Identifier: NCT00524953 - Not yet recruiting
  Allogeneic Transplantation (- Non-T-Cell Depleted)
  
• Phase I Combination w/ Epirubicin
  ClinicalTrials.gov Identifier: NCT00322374 - Recruiting
  Metastatic Breast Cancer
  
• Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
  ClinicalTrials.gov Identifier: NCT00496275 - Completed
  Non Small Cell Lung Cancer
  
• Phase I Dasatinib/Erlotinib in Recurrent NSCLC
  ClinicalTrials.gov Identifier: NCT00444015 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00368329 - Recruiting
  Esophageal Cancer; Esophageal Diseases; Carcinoma, Squamous Cell; Adenocarcinoma; Cancer of Digestive System
  
• Phase I Dose Escalation study of VELCADE plus Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00064636 - Terminated
  Advanced Non-Small Cell Lung Cancer; Other Solid Tumors
  
• Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00547261 - Recruiting
  Neoplasms
  
• Phase I Dose-finding Study of E7070 in Combination with Irinotecan
  ClinicalTrials.gov Identifier: NCT00060567 - Recruiting
  Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumors; Pulmonary Neoplasms; Pulmonary Cancer
  
• Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
  ClinicalTrials.gov Identifier: NCT00261391 - Active, not recruiting
  Vascular Anomalies
  
• Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00496509 - Completed
  Hepatocellular Carcinoma
  
• Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
  ClinicalTrials.gov Identifier: NCT00538876 - Recruiting
  Acute Myeloid Leukemia
  
• Phase I FOLFOX Combination
  ClinicalTrials.gov Identifier: NCT00499850 - Active, not recruiting
  Advanced Colorectal Carcinoma
  
• Phase I Hepatitis C Vaccine Trial of Virosome-Formulated Peptides
  ClinicalTrials.gov Identifier: NCT00445419 - Recruiting
  Chronic Hepatitis C
  
• Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
  ClinicalTrials.gov Identifier: NCT00185874 - Recruiting
  Liver Cancer
  
• Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
  ClinicalTrials.gov Identifier: NCT00507091 - Active, not recruiting
  Metastatic; Colorectal; Adenocarcinoma
  
• Phase I Multiple-Ascending Dose (Japan)
  ClinicalTrials.gov Identifier: NCT00538174 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00405405 - Recruiting
  Head and Neck Cancer.; Parotid Gland, Thyroid Gland and Melanoma Cases; Stage IV Head and Neck Caner
  
• Phase I Open-Label Dose Finding Study for CD30 Positive Hematologic Malignancies.
  ClinicalTrials.gov Identifier: NCT00430846 - Recruiting
  Hematologic Malignancies
  
• Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
  ClinicalTrials.gov Identifier: NCT00489931 - Active, not recruiting
  Influenza A Virus, H5N1 Subtype; Influenza A Virus; Influenzavirus A; Orthomyxovirdae; H5N1 Virus
  
• Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00179699 - Terminated
  Non-small cell lung cancer
  
• Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
  ClinicalTrials.gov Identifier: NCT00473005 - Recruiting
  Breast Cancer
  
• Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors
  ClinicalTrials.gov Identifier: NCT00503412 - Completed
  Advanced Solid Metastatic Tumor
  
• Phase I Perifosine and Gemcitabine Study
  ClinicalTrials.gov Identifier: NCT00398697 - Completed
  Neoplasms
  
• Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
  ClinicalTrials.gov Identifier: NCT00000733 - Completed
  HIV Infections
  
• Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004779 - Completed
  Cystic Fibrosis
  
• Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00005896 - Active, not recruiting
  Fanconi's Anemia
  
• Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
  ClinicalTrials.gov Identifier: NCT00004471 - Active, not recruiting
  Cystic Fibrosis
  
• Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
  ClinicalTrials.gov Identifier: NCT00004386 - Terminated
  Ornithine Transcarbamylase Deficiency Disease
  
• Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00014755 - Completed
  Multiple Sclerosis
  
• Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination with Synthetic HIV Envelope Peptides in Patients with Early Human Immunodeficiency Virus Infection
  ClinicalTrials.gov Identifier: NCT00001386 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection
  
• Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004533 - Active, not recruiting
  Cystic Fibrosis
  
• Phase I Randomized Study of CPX for the Treatment of Adult Patients with Mild Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004428 - Completed
  Cystic Fibrosis
  
• Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
  ClinicalTrials.gov Identifier: NCT00000692 - Completed
  HIV Infections
  
• Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
  ClinicalTrials.gov Identifier: NCT00529698 - Completed
  HIV Infections
  
• Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination with Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)
  ClinicalTrials.gov Identifier: NCT00000630 - Completed
  HIV Infections
  
• Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
  ClinicalTrials.gov Identifier: NCT00505401 - Completed
  HIV Infections
  
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children.
  ClinicalTrials.gov Identifier: NCT00000773 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• Phase I Safety Study of anti-HIV Immune Serum Globulin (Human)
  ClinicalTrials.gov Identifier: NCT00002036 - Completed
  HIV Infections
  
• Phase I Safety Study Of The Combination Of Lenalidomide And DTIC (Dacarbazine) In Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
  ClinicalTrials.gov Identifier: NCT00179608 - Active, not recruiting
  Malignant Melanoma
  
• Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
  ClinicalTrials.gov Identifier: NCT00473616 - Recruiting
  Advanced Solid Tumors; Cancer; Advanced Solid Malignancies
  
• PHASE I SINGLE DOSE TRIAL OF Sirna-027 IN PATIENT WITH AMD
  ClinicalTrials.gov Identifier: NCT00363714 - Completed
  Age-Related Macular Degeneration (AMD)
  
• Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)
  ClinicalTrials.gov Identifier: NCT00258778 - Completed
  Gaucher Disease
  
• Phase I Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With AICP
  ClinicalTrials.gov Identifier: NCT00424385 - Recruiting
  Prostate Cancer
  
• Phase I Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00415454 - Recruiting
  Pancreatic Cancer
  
• Phase I Study Comparing Pharmacokinetics and Safety Profile of Thyrogen Vs a Modified Release of Recombinant Human Thyroid Stimulating Hormone
  ClinicalTrials.gov Identifier: NCT00137891 - Completed
  Multinodular goiter
  
• Phase I Study in Patients with Metastatic Melanoma of Immunization with Dendritic Cells Presenting Epitopes Derived from the Melanoma Associated Antigen MART-1 and gp100
  ClinicalTrials.gov Identifier: NCT00001558 - Completed
  Melanoma; Neoplasm Metastasis
  
• Phase I Study in Patients With Solid Tumours
  ClinicalTrials.gov Identifier: NCT00496028 - Recruiting
  Neoplasms
  
• Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas
  ClinicalTrials.gov Identifier: NCT00051675 - Completed
  Adenocarcinoma
  
• Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
  ClinicalTrials.gov Identifier: NCT00099463 - Completed
  Healthy
  
• Phase I Study of Abiraterone Acetate in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00473746 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults with Partial Ornithine Transcarbamylase Deficiency
  ClinicalTrials.gov Identifier: NCT00004498 - Active, not recruiting
  Ornithine Transcarbamylase Deficiency Disease
  
• Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
  ClinicalTrials.gov Identifier: NCT00002078 - Completed
  HIV Infections
  
• Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients with Acute Renal Failure
  ClinicalTrials.gov Identifier: NCT00004496 - Recruiting
  Acute Renal Failure
  
• Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
  ClinicalTrials.gov Identifier: NCT00427167 - Active, not recruiting
  Malaria
  
• Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00006127 - Active, not recruiting
  Fanconi's Anemia
  
• Phase I Study of AMN107 with Imatinib in Gastrointestinal Stromal Tumors (GIST)
  ClinicalTrials.gov Identifier: NCT00135005 - Completed
  Gastrointestinal Stromal Tumors; GIST
  
• Phase I Study of Anakinra to Treat Advanced Cancers that Produce Interluekin-1
  ClinicalTrials.gov Identifier: NCT00068016 - Recruiting
  Neoplasms
  
• Phase I Study of Anti-Tac(Fv)-PE38 (LMB-2), a Recombinant Single-Chain Immunotoxin for Treatment of Tac-Expressing Malignancies
  ClinicalTrials.gov Identifier: NCT00001501 - Completed
  Chronic Lymphocytic Leukemia; Hodgkin's Disease; Leukemia; Non Hodgkin's Lymphoma; T Cell Leukemia
  
• Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers
  ClinicalTrials.gov Identifier: NCT00001538 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection
  
• Phase I Study of Aprotinin in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00354900 - Terminated
  Metastatic Breast Cancer
  
• Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00502060 - Completed
  Advanced Tumor
  
• Phase I Study of Bevacizumab to Treat Solid Tumors in Children
  ClinicalTrials.gov Identifier: NCT00080561 - Recruiting
  Neoplasms
  
• Phase I Study of BL22, A Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas
  ClinicalTrials.gov Identifier: NCT00021593 - Completed
  B Cell Leukemia; Lymphoma; Chronic Lymphocytic Leukemia
  
• Phase I Study of BL22, a Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas
  ClinicalTrials.gov Identifier: NCT00114751 - Recruiting
  
  
• Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas
  ClinicalTrials.gov Identifier: NCT00001792 - No longer recruiting
  Chronic Lymphocytic Leukemia; Hairy Cell Leukemia; Non Hodgkin's Lymphoma; Prolymphocytic Leukemia
  
• Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00306878 - Completed
  Psoriasis Vulgaris
  
• Phase I Study of BMS-663513 (Anti-CD137) Administered in Combination With Radiotherapy Alone or Radiotherapy Plus Chemotherapy to Subjects With Non Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00461110 - Recruiting
  Non Small Cell Lung Cancer
  
• Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00516451 - Recruiting
  Cancer
  
• Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
  ClinicalTrials.gov Identifier: NCT00249977 - Active, not recruiting
  Solid Tumors; Cancer
  
• Phase I Study of Carbendazim in Patients With Advanced Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00023816 - Active, not recruiting
  Leukemia; Lymphoma; Eye Cancer
  
• Phase I Study of Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00021346 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Phase I Study of CHOP + Campath for T-Cell, Null Cell, or NK Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00161590 - Active, not recruiting
  T-Cell Lymphoma; NK cell lymphoma; Null cell lymphoma
  
• Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00004368 - Active, not recruiting
  Cirrhosis; Liver Cirrhosis
  
• Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00001332 - Completed
  Peritoneal Neoplasms; Stomach Neoplasms
  
• Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00061620 - Terminated
  Hematologic Malignancies
  
• Phase I Study of Corticosteroid Treatment of Ill-defined Choroidal Neovascularization in Age-related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00001615 - Completed
  Choroidal Neovascularization; Macular Degeneration
  
• Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00452673 - Recruiting
  Advanced Breast Cancer
  
• Phase I Study of Depsipeptide in Children with Cancer
  ClinicalTrials.gov Identifier: NCT00069771 - Recruiting
  Neoplasms
  
• Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00004809 - Completed
  Familial Hypercholesterolemia
  
• Phase I Study of Gemcitabine to Treat Cancer Spread to the Meninges
  ClinicalTrials.gov Identifier: NCT00048243 - Recruiting
  Meningeal Neoplasms
  
• Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00375310 - Recruiting
  Pancreatic Cancer; Adenocarcinoma of the Pancreas
  
• Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00493571 - Recruiting
  Myelodysplastic Syndromes; MDS
  
• Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies
  ClinicalTrials.gov Identifier: NCT00295243 - Active, not recruiting
  Advanced Solid Malignancies
  
• Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00496171 - Not yet recruiting
  Healthy
  
• Phase I Study of HeFi-1 to Treat Cancers with CD30 Protein
  ClinicalTrials.gov Identifier: NCT00048880 - Recruiting
  Neoplasms
  
• Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
  ClinicalTrials.gov Identifier: NCT00004398 - Completed
  Porphyria
  
• Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00017628 - Completed
  Multiple Sclerosis
  
• Phase I Study of High-Dose Cyclophosphamide, Anti-Thymocyte Globulin, and Total Body Irradiation With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00017615 - Recruiting
  Rheumatoid Arthritis; Juvenile Rheumatoid Arthritis
  
• Phase I Study of Human von Willebrand Factor for von Willebrand's Disease
  ClinicalTrials.gov Identifier: NCT00004667 - Completed
  von Willebrand's Disease
  
• Phase I Study of Imatinib Mesylate and SU011248 (Sunitinib) for Patients With GIST
  ClinicalTrials.gov Identifier: NCT00495001 - Not yet recruiting
  Gastrointestinal Stromal Tumor; GIST
  
• Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00017641 - Active, not recruiting
  Systemic Lupus Erythematosus
  
• Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen
  ClinicalTrials.gov Identifier: NCT00354263 - Active, not recruiting
  Healthy
  
• Phase I Study of Interleukin-7 (CYT 99 007) in Patients with Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00059059 - Recruiting
  Non-Hematologic Neoplasms
  
• Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding
  ClinicalTrials.gov Identifier: NCT00539877 - Completed
  Stomach Neoplasms
  
• Phase I Study of Intrathecal Mafosfamide
  ClinicalTrials.gov Identifier: NCT00001251 - Completed
  Leukemia; Lymphoma; Meningeal Neoplasm
  
• Phase I Study of Intrathecal Topotecan
  ClinicalTrials.gov Identifier: NCT00001333 - Completed
  Leukemia; Lymphoma; Meningeal Neoplasms
  
• Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00497250 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
  ClinicalTrials.gov Identifier: NCT00014729 - Active, not recruiting
  Epidermolysis Bullosa
  
• Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00059605 - Recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00575562 - Recruiting
  Colorectal Cancer
  
• Phase I Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00536809 - Recruiting
  Advanced Colorectal Cancer; Metastatic Colorectal Cancer
  
• Phase I Study of Liposome-Mediated Gene Transfer in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004806 - Completed
  Cystic Fibrosis
  
• Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Immunotoxin for Advanced Carcinomas that Express Lewis Y Antigen
  ClinicalTrials.gov Identifier: NCT00001691 - Completed
  Breast Neoplasm; Colonic Neoplasm; Lung Neoplasm; Ovarian Neoplasm; Stomach Neoplasm
  
• Phase I Study of MEDI-507 to Treat Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00071825 - Recruiting
  Lymphoproliferative Disorders
  
• Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00284817 - Active, not recruiting
  Cancer
  
• Phase I Study of Nimotuzumab in Solid Tumours
  ClinicalTrials.gov Identifier: NCT00369252 - Completed
  Advanced and/or Metastatic Solid Tumours
  
• Phase I Study Of Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00158886 - Terminated
  Rectal Cancer
  
• Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms.
  ClinicalTrials.gov Identifier: NCT00408018 - Recruiting
  Neoplasm
  
• Phase I Study of Patupilone and RAD001
  ClinicalTrials.gov Identifier: NCT00496600 - Recruiting
  Refractory Malignancy
  
• Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors.
  ClinicalTrials.gov Identifier: NCT00516672 - Recruiting
  Solid Tumor
  
• Phase I Study of PEG-Paclitaxel In Patients with Advanced Solid Tumors & Lymphomas
  ClinicalTrials.gov Identifier: NCT00023166 - Terminated
  Neoplasm; Lymphomas; Neoplasm Metastasis
  
• Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00415064 - Recruiting
  Multiple Myeloma
  
• Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00398814 - Recruiting
  Renal Cancer; Tumors
  
• Phase I study of PN401, fluorouracil, leucovorin and CPT-11 in patients with solid tumors
  ClinicalTrials.gov Identifier: NCT00044785 - Terminated
  Solid Tumors
  
• Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
  ClinicalTrials.gov Identifier: NCT00483990 - Active, not recruiting
  Healthy
  
• Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene into Peripheral Blood Stem Cells for Autologous Transplantation in Patients with Type I Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00004294 - Completed
  Gaucher's Disease
  
• Phase I Study of Retrovirus-Mediated Transfer of cDNA for Human CD18 into Peripheral Blood Repopulating Cells of Patients With Leukocyte Adherence Deficiency
  ClinicalTrials.gov Identifier: NCT00004470 - Active, not recruiting
  Leukocyte Adhesion Deficiency Syndrome
  
• Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
  ClinicalTrials.gov Identifier: NCT00414336 - Recruiting
  Malaria
  
• Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
  ClinicalTrials.gov Identifier: NCT00441909 - Recruiting
  HIV Infections
  
• Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
  ClinicalTrials.gov Identifier: NCT00002164 - Completed
  HIV Infections
  
• Phase I Study of Satraplatin (JM-216) in Combination with Docetaxel
  ClinicalTrials.gov Identifier: NCT00125411 - Recruiting
  Advanced Solid Tumors
  
• Phase I Study of Sequential Cord Blood Transplants
  ClinicalTrials.gov Identifier: NCT00299767 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma; Myelodysplastic Syndrome
  
• Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
  ClinicalTrials.gov Identifier: NCT00562913 - Not yet recruiting
  Cancer
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Phase I Study of T-Cell Large Granular Lymphocytic Leukemia Using the MIK-Beta-1 Monoclonal Antibody Directed Toward the IL-2R-Beta Subunit
  ClinicalTrials.gov Identifier: NCT00001425 - Completed
  Agranulocytosis; Pure Red Cell Aplasia; T Cell Leukemia; Thrombocytopenia
  
• Phase I Study of Temazolomide, Valproic Acid and Radiation Therapy in Subjects With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00437957 - Recruiting
  Unresectable Brain Metastases
  
• Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
  ClinicalTrials.gov Identifier: NCT00002139 - Completed
  Bacterial Infections; HIV Infections
  
• Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00473720 - Recruiting
  Advanced Cancers
  
• Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00572637 - Recruiting
  Solid Tumors; Lymphoma, Non-Hodgkin
  
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)phosphonylmethoxyethyl]adenine (bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002128 - Completed
  HIV Infections
  
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children with Fever and Neutropenia
  ClinicalTrials.gov Identifier: NCT00001790 - Completed
  Fever; Mycoses; Neutropenia
  
• Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004287 - Completed
  Cystic Fibrosis
  
• Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
  ClinicalTrials.gov Identifier: NCT00004397 - Completed
  Porphyria
  
• Phase I Study of Tipifarnib with Radiation Therapy to Treat Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00060879 - Recruiting
  Glioblastoma Multiforme
  
• Phase I Study of Topical CRx-191 in Normal Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00544687 - Completed
  Healthy
  
• Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00363454 - Recruiting
  Cancer
  
• Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
  ClinicalTrials.gov Identifier: NCT00321061 - Active, not recruiting
  HIV Infections
  
• Phase I Study of Vaccination With MUC-1 Antigen and Immunologic Adjuvant SB AS-2 in Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00008099 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer
  
• Phase I Study of Vasoactive Intestinal Peptide in Patients with Acute Respiratory Distress Syndrome and Sepsis
  ClinicalTrials.gov Identifier: NCT00004494 - Recruiting
  Sepsis; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Adult
  
• Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
  ClinicalTrials.gov Identifier: NCT00565227 - Recruiting
  Non-Small Cell Lung, Prostate, Bladder/Urothelial Cancers.
  
• Phase I Study of Weekly Intravenous PS-341 Plus Mitoxantrone
  ClinicalTrials.gov Identifier: NCT00059631 - Active, not recruiting
  Prostate Cancer
  
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00000660 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00466232 - Recruiting
  Small Cell Carcinoma; Lung Cancer
  
• Phase I Study of West Nile Virus Vaccine
  ClinicalTrials.gov Identifier: NCT00300417 - Active, not recruiting
  West Nile Fever
  
• Phase I Study of ZD4054 and Docetaxel in Patients With Metastatic HRPC
  ClinicalTrials.gov Identifier: NCT00314782 - Active, not recruiting
  Prostate Cancer
  
• Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00504790 - Recruiting
  Refractory Cancer
  
• Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
  ClinicalTrials.gov Identifier: NCT00546650 - Recruiting
  Healthy
  
• Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
  ClinicalTrials.gov Identifier: NCT00453297 - Recruiting
  Healthy
  
• Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children with HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00001445 - Completed
  HIV Infection
  
• Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-Thalassemia Patients With Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00560820 - Recruiting
  β-Thalassemia; Transfusional Iron Overload
  
• Phase I Study to Investigate the Alcohol Interaction of SK3530
  ClinicalTrials.gov Identifier: NCT00489450 - Completed
  Erectile Dysfunction
  
• Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
  ClinicalTrials.gov Identifier: NCT00489606 - Completed
  Erectile Dysfunction
  
• Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
  ClinicalTrials.gov Identifier: NCT00513968 - Recruiting
  Chronic Hepatitis B
  
• Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
  ClinicalTrials.gov Identifier: NCT00437372 - Recruiting
  Cancer; Head and Neck Cancer; Pelvic Cancer; Nervous System Neoplasms; Thoracic Neoplasms
  
• Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
  ClinicalTrials.gov Identifier: NCT00501605 - Completed
  Advanced Solid Tumor; Liver Metastasis
  
• Phase I Thymus Transplantation With Immunosuppression
  ClinicalTrials.gov Identifier: NCT00579527 - Recruiting
  DiGeorge Syndrome
  
• Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector
  ClinicalTrials.gov Identifier: NCT00534378 - Completed
  Seizures
  
• Phase I Trial and Pharmacokinetic Study of TLC D-99 in Pediatric Patients with Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00001798 - Completed
  Glioma; Neoplasm; Nephroblastoma; Neuroblastoma; Rhabdomyosarcoma
  
• Phase I Trial From GRID 18F-FDG-PET Biological Imaging-Guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area
  ClinicalTrials.gov Identifier: NCT00528294 - Recruiting
  Head and Neck Tumors
  
• Phase I Trial in Patients with Metastatic Melanoma of Immunization with a Recombinant Fowlpox Virus Encoding the gp100 Melanoma Antigen
  ClinicalTrials.gov Identifier: NCT00001510 - Completed
  Melanoma; Neoplasm Metastasis
  
• Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC 630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients with Refractory Neoplasms
  ClinicalTrials.gov Identifier: NCT00001578 - Completed
  Neoplasm
  
• Phase I Trial of a PSA based Vaccine and an anti-CTLA-4 Antibody in Patients with Metastatic Androgen Independent Prostrate Cancer
  ClinicalTrials.gov Identifier: NCT00113984 - Recruiting
  
  
• Phase I Trial of ABT-751 in Children with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00032266 - Recruiting
  Neoplasms
  
• Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples
  ClinicalTrials.gov Identifier: NCT00000928 - Active, not recruiting
  HIV Infections
  
• Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
  ClinicalTrials.gov Identifier: NCT00504972 - Recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
  
• Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00185861 - Active, not recruiting
  Brain Tumor
  
• Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176241 - Recruiting
  Head and Neck Cancer
  
• Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas
  ClinicalTrials.gov Identifier: NCT00074646 - Completed
  Glioblastoma; Malignant Gliomas
  
• Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL
  ClinicalTrials.gov Identifier: NCT00477945 - Recruiting
  Non Hodgkin's Lymphoma
  
• Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00001569 - Completed
  Carcinoma; Peritoneal Neoplasm
  
• Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
  ClinicalTrials.gov Identifier: NCT00378404 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase I Trial of Docetaxel With Perifosine
  ClinicalTrials.gov Identifier: NCT00399087 - Active, not recruiting
  Neoplasms
  
• Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) with Escalating Doses of Docetaxel in Patients with Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00038194 - Terminated
  Prostate Cancer
  
• Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001269 - Completed
  Breast Neoplasms; Neoplasm Metastasis
  
• Phase I Trial of G3139 Plus Chemotherapy to Treat Relapsed Childhood Tumors
  ClinicalTrials.gov Identifier: NCT00061191 - Recruiting
  Tumors
  
• Phase I Trial of Gefitinib, Taxol, and Radiation Therapy to Treat Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00080249 - Recruiting
  Carcinoma, Squamous Cell; Head and Neck Neoplasms
  
• Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
  ClinicalTrials.gov Identifier: NCT00481546 - Recruiting
  Amaurosis of Leber; Retinal Diseases
  
• Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00199797 - Active, not recruiting
  Colorectal Cancer
  
• Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00038441 - Terminated
  Glioma; Brain Neoplasms
  
• Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00323206 - Recruiting
  Malignant Melanoma
  
• Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
  ClinicalTrials.gov Identifier: NCT00000689 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Phase I Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00123942 - Terminated
  CD2+ Lymphoproliferative disorder
  
• Phase I Trial of Paclitaxel With Perifosine
  ClinicalTrials.gov Identifier: NCT00399126 - Active, not recruiting
  Neoplasms
  
• Phase I Trial of Periocular Topotecan in Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00460876 - Recruiting
  Retinoblastoma
  
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients with Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001761 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Phase I Trial of S-1153 in Patients With HIV Infection
  ClinicalTrials.gov Identifier: NCT00002214 - Completed
  HIV Infections
  
• Phase I Trial of Smallpox Vaccine
  ClinicalTrials.gov Identifier: NCT00046397 - Completed
  Healthy
  
• Phase I Trial of Thalidomide Analog CC-5013 in Patients with Gliomas
  ClinicalTrials.gov Identifier: NCT00032214 - Completed
  Glioma
  
• Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients with Persistent Generalized Lymphadenopathy
  ClinicalTrials.gov Identifier: NCT00000728 - Completed
  HIV Infections
  
• Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00246103 - Recruiting
  Neoplams, Advanced
  
• Phase I Trial of Vorinostat in Combination With Decitabine in Patients With AML or MDS
  ClinicalTrials.gov Identifier: NCT00479232 - Recruiting
  Leukemia, Myelocytic; Myelodysplastic Syndromes
  
• Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00263783 - Active, not recruiting
  Cancer
  
• Phase I Trial of ZIO-101 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00509782 - Active, not recruiting
  Solid Tumors
  
• Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
  ClinicalTrials.gov Identifier: NCT00382954 - Recruiting
  Acute Myelogenous Leukemia
  
• Phase I Using ZD6474 Plus Chemoradiation Followed by Surgery for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00462033 - Not yet recruiting
  Cancer of the Esophagus and Gastroesophageal Junction
  
• Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00532909 - Recruiting
  Colorectal Cancer
  
• Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00425347 - Recruiting
  Multiple Myeloma
  
• Phase I, Multicentre, Open-Label, Dose-Escalating, Study of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS
  ClinicalTrials.gov Identifier: NCT00464321 - Recruiting
  Glomerulosclerosis, Focal Segmental
  
• Phase I, Open Label, Single Center Safety Study of [F-18]FLT
  ClinicalTrials.gov Identifier: NCT00553748 - Recruiting
  Brain Cancer
  
• Phase I, Open-Label, Dose Escalation of AZD4877 in Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00460460 - Terminated
  Lymphoma
  
• Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors
  ClinicalTrials.gov Identifier: NCT00389389 - Recruiting
  Neoplasms
  
• Phase I, Open-Label, Dose-Escalation, Safety and PK Study of AZD4877
  ClinicalTrials.gov Identifier: NCT00471367 - Recruiting
  Advanced Solid Tumors; Cancer; Advanced Solid Malignancies
  
• Phase I, Open-Label, Dose-Escalation, Safety and PK Study of AZD4877 in Patients With AML
  ClinicalTrials.gov Identifier: NCT00486265 - Recruiting
  Acute Myelogenous Leukemia
  
• Phase I, Open-Label, Multi-Center, SIngle-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic Study of GC1008 in Patients with IPF
  ClinicalTrials.gov Identifier: NCT00125385 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; IPF
  
• Phase I, Safety, PK and PD Study of KW-0761 in CCR4+ Peripheral T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00355472 - Recruiting
  Adult T-Cell Leukemia and Lymphoma (ATLL); Adult Peripheral T-Cell Lymphoma (PTCL)
  
• Phase I- Lapatinib and Epirubicin Study
  ClinicalTrials.gov Identifier: NCT00566748 - Recruiting
  Metastatic Breast Cancer
  
• Phase I-II for Patients With Recurrent or Refractory NSCLC
  ClinicalTrials.gov Identifier: NCT00411593 - Completed
  Lung Cancer
  
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
  ClinicalTrials.gov Identifier: NCT00001693 - Completed
  Colorectal Neoplasm; Hereditary Nonpolyposis
  
• Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00277069 - Completed
  Breast; Cancer
  
• Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
  ClinicalTrials.gov Identifier: NCT00542971 - Recruiting
  AML; High-Risk MDS; Acute Myeloid Leukemia; High-Risk Myelodysplastic Disorder
  
• Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00526045 - Recruiting
  Breast Cancer; Hematologic Neoplasms
  
• Phase I-II study to evaluate safety, efficacy and pharmacokinetic interactions between capecitabine (XELODA) and exisulind (APTOSYN) in patients with metastatic breast cancer.
  ClinicalTrials.gov Identifier: NCT00037609 - Terminated
  Breast Neoplasms; Metastases, Neoplasm
  
• Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00541840 - Recruiting
  Soft Tissue Sarcoma
  
• Phase I/II 5-Azacytidine Plus VPA Plus ATRA
  ClinicalTrials.gov Identifier: NCT00326170 - Active, not recruiting
  High-Risk Myelodysplastic Syndrome; Acute Myelogenous Leukemia
  
• Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
  ClinicalTrials.gov Identifier: NCT00185965 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291785 - Active, not recruiting
  Colorectal Cancer
  
• Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00064610 - Active, not recruiting
  Prostatic Neoplasms
  
• Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00050986 - Suspended
  Glioblastoma Multiforme
  
• Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00214097 - Recruiting
  Prostate Cancer
  
• Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CA
  ClinicalTrials.gov Identifier: NCT00547144 - Recruiting
  Pancreatic Cancer
  
• Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00568932 - Suspended
  Pancreatic Cancer
  
• Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00279760 - Completed
  Rheumatoid Arthritis
  
• Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
  ClinicalTrials.gov Identifier: NCT00503971 - Not yet recruiting
  Non-Small Cell Lung Cancer
  
• Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00179725 - Terminated
  Ovarian Cancer
  
• Phase I/II Pazopanib Plus Lapatinib for Relapsed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00412711 - Recruiting
  Brain Cancer; Glioma; Astrocytoma; Oligodendroglioma; Oligoastrocytoma; Glioblastoma; Gliosarcoma
  
• Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00185588 - Recruiting
  Pancreatic Cancer
  
• Phase I/II R788 in B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00446095 - Active, not recruiting
  Lymphoma
  
• Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00004492 - Recruiting
  Sickle Cell Anemia
  
• Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
  ClinicalTrials.gov Identifier: NCT00004316 - Active, not recruiting
  Interstitial Cystitis; Vulvar Diseases
  
• Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory AML or High Risk MDS
  ClinicalTrials.gov Identifier: NCT00569010 - Recruiting
  Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Leukemia
  
• Phase I/II Study of ADI-SS PEG 20,000mw in Patients With Advanced Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00520299 - Recruiting
  Metastatic Melanoma; Skin Cancer; Neoplasm
  
• Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00534664 - Completed
  Advanced Hepatocellular Carcinoma
  
• Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00539331 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase I/II Study of CAMPATH in Patients with Relapsing or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00051701 - Terminated
  Non-Hodgkins Lymphoma
  
• Phase I/II Study of Celebrex and EPO906 in Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00159484 - Recruiting
  Colon Cancer; Colorectal Cancer
  
• Phase I/II Study of Cetuximab, Gemcitabine, and Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00027755 - Active, not recruiting
  stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00559026 - Completed
  Melanoma
  
• Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor in Premalignant Lesions of Head and Neck of Former Smokers
  ClinicalTrials.gov Identifier: NCT00314262 - Recruiting
  Precancerous Conditions
  
• Phase I/II Study of Curdlan Sulfate
  ClinicalTrials.gov Identifier: NCT00002100 - Completed
  HIV Infections
  
• Phase I/II Study of Dasatinib in Combination With Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00566618 - Recruiting
  Breast Cancer
  
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00075010 - Terminated
  Leukemia; Myelodysplastic Syndromes
  
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours
  ClinicalTrials.gov Identifier: NCT00351962 - Not yet recruiting
  Lung Neoplasms; Metastatic Lung Cancer
  
• Phase I/II Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00276055 - Recruiting
  Sarcoma
  
• Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00021749 - Completed
  Chronic Lymphocytic Leukemia; CLL
  
• Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
  ClinicalTrials.gov Identifier: NCT00004789 - Completed
  Porphyria
  
• Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
  ClinicalTrials.gov Identifier: NCT00004644 - Completed
  Herpes Simplex
  
• Phase I/II Study of hLL1 in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00421525 - Recruiting
  Multiple Myeloma; Myeloma, Plasma-Cell; Plasmacytoma
  
• Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns with Symptomatic Congenital CMV Infection without Central Nervous System Disease
  ClinicalTrials.gov Identifier: NCT00004642 - Completed
  Cytomegalovirus Infections
  
• Phase I/II Study of Ig-gp96 Based Vaccine Against Lung Cancer
  ClinicalTrials.gov Identifier: NCT00247065 - Not yet recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
  ClinicalTrials.gov Identifier: NCT00226993 - Terminated
  Mycosis Fungoides
  
• Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
  ClinicalTrials.gov Identifier: NCT00004811 - Completed
  Histoplasmosis; Sporotrichosis; Blastomycosis
  
• Phase I/II Study of IV Estramustine Combined with Taxol in Patients with Hormone Refractory Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00038168 - Terminated
  Prostate Cancer
  
• Phase I/II Study of Lepirudin in Patients with Recurrent or Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003726 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; childhood thorax/respiratory cancer
  
• Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
  ClinicalTrials.gov Identifier: NCT00004801 - Completed
  Hemophilia B; Factor IX Deficiency
  
• Phase I/II Study of Neuroendocrine Dysfunction in Patients With Closed Head Injuries
  ClinicalTrials.gov Identifier: NCT00006271 - Active, not recruiting
  Brain Injury
  
• Phase I/II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation in Patients With High Risk Hemoglobinopathy
  ClinicalTrials.gov Identifier: NCT00005897 - Recruiting
  Graft Versus Host Disease; Sickle Cell Anemia; Thalassemia
  
• Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
  ClinicalTrials.gov Identifier: NCT00209729 - Recruiting
  Gastric Cancer
  
• Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00209677 - Suspended
  Pancreatic Cancer
  
• Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00209638 - Completed
  Gastric Cancer
  
• Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.
  ClinicalTrials.gov Identifier: NCT00209612 - Recruiting
  Gastric Cancer
  
• Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00578071 - Recruiting
  Cancer of the Esophagus; Locally Advanced; Unresectable
  
• Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
  ClinicalTrials.gov Identifier: NCT00506922 - Active, not recruiting
  Leukemia; Lymphoma
  
• Phase I/II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients with Advanced Stages Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00147875 - Active, not recruiting
  Hodgkin''s Disease
  
• Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure
  ClinicalTrials.gov Identifier: NCT00225901 - Recruiting
  Liver Failure, Acute
  
• Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000761 - Completed
  HIV Infections
  
• Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene into Lymphocytes of Patients with Mucopolysaccharidosis II (Mild Hunter Syndrome)
  ClinicalTrials.gov Identifier: NCT00004454 - Completed
  Mucopolysaccharidosis II
  
• Phase I/II Study of Safety & Efficacy of Perifosine & Bortezomib With or Without Dexamethasone for Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00401011 - Recruiting
  Multiple Myeloma; Relapsed or Refractory Multiple Myeloma
  
• Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00524706 - Recruiting
  Colorectal Cancer
  
• Phase I/II Study of Stem Cell Transplantation for Aggressive Acute Leukemias Using Clofarabine and Busulfan Regimen
  ClinicalTrials.gov Identifier: NCT00556452 - Recruiting
  Acute Leukemias; Chronic Myelogenous Leukemia
  
• Phase I/II Study of Tac-Expressing Adult T-Cell Leukemia (ATL) with Yttrium-90 (90Y)-Radiolabeled Humanized Anti-Tac Monoclonal Antibody and Calcium-DTPA
  ClinicalTrials.gov Identifier: NCT00001514 - Completed
  T Cell Leukemia
  
• Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
  ClinicalTrials.gov Identifier: NCT00001575 - Recruiting
  Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
  
• Phase I/II Study of Tamoxifen and Tipifarnib to Treat Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00048867 - Completed
  Breast Neoplasms
  
• Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-Treated Pts With Metastatic Esophageal Cancer.
  ClinicalTrials.gov Identifier: NCT00209716 - Recruiting
  Esophageal Cancer
  
• Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00002098 - Completed
  HIV Infections
  
• Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00005898 - Completed
  Fanconi's Anemia
  
• Phase I/II Study of TPF as First-Line Chemotherapy in Patients With Metastatic Esophageal Cancer.
  ClinicalTrials.gov Identifier: NCT00209690 - Recruiting
  Esophageal Cancer
  
• Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy.
  ClinicalTrials.gov Identifier: NCT00424840 - Recruiting
  Lung Cancer
  
• Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00154791 - Completed
  Pancreatic Adenocarcinoma
  
• Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America.
  ClinicalTrials.gov Identifier: NCT00312663 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America.
  ClinicalTrials.gov Identifier: NCT00312702 - Active, not recruiting
  Malaria; Plasmodium Falciparum Malaria
  
• Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00351039 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase I/II Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00477386 - Recruiting
  Ovarian Cancer
  
• Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients with Chest Wall Recurrence or Stage IV Disease with Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006433 - Recruiting
  Breast Cancer
  
• Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
  ClinicalTrials.gov Identifier: NCT00506857 - Active, not recruiting
  Hematologic Malignancies
  
• Phase I/II Trial of GS-9219 in Patients With NHL and CLL
  ClinicalTrials.gov Identifier: NCT00499239 - Recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
  
• Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-Small Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00212043 - Completed
  Non Small Cell Lung Cancer
  
• Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00378235 - Not yet recruiting
  Recurrent Malignant Glioma
  
• Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection
  ClinicalTrials.gov Identifier: NCT00352235 - Completed
  Chronic Hepatitis C
  
• Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine against Smallpox
  ClinicalTrials.gov Identifier: NCT00053742 - Completed
  Healthy
  
• Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
  ClinicalTrials.gov Identifier: NCT00281125 - Suspended
  Non-Small Cell Lung Cancer and Pleural Mesothelioma
  
• Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00406276 - Recruiting
  Lung Cancer
  
• Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00448149 - Recruiting
  Carcinoma, Renal Cell
  
• Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
  ClinicalTrials.gov Identifier: NCT00358319 - Recruiting
  Malignant Melanoma
  
• Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
  ClinicalTrials.gov Identifier: NCT00151320 - Active, not recruiting
  Non-Hodgkin''s Lymphoma
  
• Phase I/II trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
  ClinicalTrials.gov Identifier: NCT00038792 - Terminated
  Acute Graft Versus Host Disease
  
• Phase I/II Trials of Silymarin for Chronic Liver Diseases
  ClinicalTrials.gov Identifier: NCT00389376 - Recruiting
  Hepatitis C; Non-Alcoholic Fatty Liver Disease
  
• Phase I/II XP+Sorafenib in AGC
  ClinicalTrials.gov Identifier: NCT00565370 - Recruiting
  Advanced Gastric Cancer
  
• Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
  ClinicalTrials.gov Identifier: NCT00219986 - Completed
  HIV Infections
  
• Phase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone
  ClinicalTrials.gov Identifier: NCT00542529 - Completed
  Healthy
  
• Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
  ClinicalTrials.gov Identifier: NCT00563173 - Recruiting
  Chronic Hepatitis C Virus Infection
  
• Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00443495 - Completed
  Seasonal Allergic Rhinitis
  
• Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00522665 - Recruiting
  Colorectal Cancer
  
• Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection
  ClinicalTrials.gov Identifier: NCT00542217 - Completed
  Healthy
  
• Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
  ClinicalTrials.gov Identifier: NCT00400101 - Terminated
  Falciparum Malaria
  
• Phase Ia Study of a Pandemic Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00136331 - Completed
  Prevention of Pandemic Influenza
  
• Phase Ib Trial of MSP3 LSP in Children in Tanzania
  ClinicalTrials.gov Identifier: NCT00469651 - Recruiting
  Malaria
  
• Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
  ClinicalTrials.gov Identifier: NCT00513669 - Not yet recruiting
  Falciparum Malaria
  
• Phase IB, Multicenter, Randomized, Double-Blind Placebo-Controlled, Dose-Escalation Study w/Open-Label Extension to Evaluate Safety and Tolerability of Multiple IV Doses of MEDI-545; A Fully Human Anti-IFN-Alpha Monoclonal Antibody in Patients w/SLE
  ClinicalTrials.gov Identifier: NCT00566163 - Recruiting
  Systemic Lupus Erythematosus; Multiple Intravenous Doses; Pharmokinetics
  
• Phase Ib, Open-Label, Two-Arm, Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00268905 - Recruiting
  Cancer
  
• Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
  ClinicalTrials.gov Identifier: NCT00266279 - Recruiting
  Head & Neck Cancer
  
• Phase II - Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
  ClinicalTrials.gov Identifier: NCT00321100 - Recruiting
  Colorectal Neoplasms
  
• Phase II AMN107 with Newly Diagnosed Chronic Phase CML
  ClinicalTrials.gov Identifier: NCT00129740 - Recruiting
  Newly diagnosed chronic phase CML
  
• Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00481845 - Not yet recruiting
  Breast Cancer
  
• Phase II Artesunate Study in Severe Malaria
  ClinicalTrials.gov Identifier: NCT00522132 - Recruiting
  Malaria
  
• Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (Excluding Squamous Cell)
  ClinicalTrials.gov Identifier: NCT00323869 - Recruiting
  Non-Small Cell Lung Cancer (NSCLC)
  
• Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00398320 - Recruiting
  Neuroendocrine Tumors
  
• Phase II Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma
  ClinicalTrials.gov Identifier: NCT00172367 - Not yet recruiting
  Carcinoma, Transitional Cell
  
• Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00147160 - Recruiting
  Glioma
  
• Phase II Cladribine Add-on to Rebif New Formulation in MS Subjects With Active Disease (ONWARD)
  ClinicalTrials.gov Identifier: NCT00436826 - Recruiting
  Multiple Sclerosis
  
• Phase II Clinical Study of a Liposomal-Cisplatin Analogue (L-NDDP) Administered Intrapleurally in Patients with Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00004033 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
  
• Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
  ClinicalTrials.gov Identifier: NCT00237172 - Completed
  Gastrointestinal Stromal Tumors
  
• Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-Line or Later Therapy in Patients With Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Pl
  ClinicalTrials.gov Identifier: NCT00216645 - Completed
  Ovarian Neoplasms
  
• Phase II Clinical Trial in Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00081627 - Completed
  Colon Cancer; Rectal Cancer
  
• Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
  ClinicalTrials.gov Identifier: NCT00216658 - Completed
  Pain, Intractable
  
• Phase II Clinical Trial to Evaluate the Accuracy of 99m-Tc- ThromboView in the Detection of Deep Vein Thrombosis
  ClinicalTrials.gov Identifier: NCT00123734 - Completed
  Deep Vein Thrombosis
  
• Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.
  ClinicalTrials.gov Identifier: NCT00270556 - Completed
  HIV
  
• Phase II Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00495170 - Recruiting
  Lung Cancer
  
• Phase II CT-2103/Carboplatin in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00069901 - Active, not recruiting
  Ovarian Neoplasm
  
• Phase II Dasatinib Study in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00546104 - Not yet recruiting
  Advanced Breast Cancer
  
• Phase II DelCath Hepatic Perfusion (PHP)
  ClinicalTrials.gov Identifier: NCT00091455 - Recruiting
  
  
• Phase II Dendritic Cell - Idiotype Vaccination After Autologous Stem Cell Transplant for Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00490529 - Not yet recruiting
  Mantle-Cell Lymphoma
  
• Phase II Dose Ranging Study of Artesunate
  ClinicalTrials.gov Identifier: NCT00459615 - Recruiting
  Falciparum Malaria; Uncomplicated Malaria
  
• Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00532506 - Recruiting
  Type 2 Diabetes Mellitus
  
• Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476
  ClinicalTrials.gov Identifier: NCT00545389 - Completed
  Colitis, Ulcerative
  
• Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00447928 - Not yet recruiting
  Tendonitis
  
• Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00004387 - Completed
  Parkinson Disease
  
• Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00004393 - Completed
  Tourette Syndrome
  
• Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients with Anxiety
  ClinicalTrials.gov Identifier: NCT00004373 - Completed
  Anxiety Disorder; Panic Disorder
  
• Phase II Efficacy and Safety Study of GPX-100 in the Treatment of Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00123877 - Terminated
  Breast Cancer; Metastasis
  
• Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
  ClinicalTrials.gov Identifier: NCT00001909 - Completed
  Asthma; Hypersensitivity
  
• Phase II Efficacy Study of AZD6244 in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00514761 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
  ClinicalTrials.gov Identifier: NCT00000807 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00323115 - Recruiting
  Glioblastoma Multiforme
  
• Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00220155 - Active, not recruiting
  Colorectal Cancer
  
• Phase II Fludarabine, Cytoxan and FCCAM in Untreated B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00230282 - Recruiting
  B-Lymphocytic Leukemia, Chronic; Chronic Lymphocytic Leukemia
  
• Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054808 - Completed
  Non-Hodgkin's Lymphoma; Relapsed Lymphoma; Refractory Lymphoma; Low-Grade Lymphoma; Intermediate-Grade Lymphoma
  
• Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT
  ClinicalTrials.gov Identifier: NCT00246974 - Completed
  Bladder Cancer
  
• Phase II Gemcitabine, Paclitaxel and Bevacizumab Combination as First Line Treatment for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00403130 - Recruiting
  Breast Cancer
  
• Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00230334 - Active, not recruiting
  Eosinophilia; Hypereosinophilic Syndrome
  
• Phase II Gleevec Study for Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00510653 - Recruiting
  Ovarian Cancer
  
• Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00477087 - Recruiting
  Prostate Cancer
  
• Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00296205 - Recruiting
  Multiple Sclerosis
  
• Phase II IMRT Radiotherapy for Treating Prostate Pelvic Nodes
  ClinicalTrials.gov Identifier: NCT00214136 - Recruiting
  Prostate Cancer
  
• Phase II Iressa & Carbo/Gem in NSCLC
  ClinicalTrials.gov Identifier: NCT00264498 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Iressa + Irradiation Followed by Chemo in NSCLC
  ClinicalTrials.gov Identifier: NCT00333294 - Completed
  Non-Small Cell Lung Cancer
  
• Phase II Iressa Versus Vinorelbine (INVITE)
  ClinicalTrials.gov Identifier: NCT00256711 - Completed
  Non-Small-Cell Lung Carcinoma
  
• Phase II Letrozole + Herceptin in Her2neu Positive, ER and/or PR Receptor (+),Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00134680 - Active, not recruiting
  Metastatic breast cancer
  
• Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004700 - Active, not recruiting
  Hyperinsulinism
  
• Phase II Low-Dose Temozolomide for 2 Weeks on Brain Tumor (Study P04602)
  ClinicalTrials.gov Identifier: NCT00424554 - Recruiting
  Glioma
  
• Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
  ClinicalTrials.gov Identifier: NCT00229697 - Completed
  Breast Neoplasms
  
• Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176605 - Recruiting
  Prostate Cancer
  
• Phase II Multicatheter HDR Breast Brachytherapy
  ClinicalTrials.gov Identifier: NCT00214149 - Recruiting
  Breast Cancer
  
• Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
  ClinicalTrials.gov Identifier: NCT00404066 - Recruiting
  Breast Cancer
  
• Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
  ClinicalTrials.gov Identifier: NCT00255463 - Completed
  Breast Cancer
  
• Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00001499 - Completed
  Carcinoma, Non-Small-Cell Lung; Lung Neoplasms
  
• Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
  ClinicalTrials.gov Identifier: NCT00503750 - Not yet recruiting
  Breast Cancer
  
• Phase II of Bevacizumab in Advanced Hepatocellular
  ClinicalTrials.gov Identifier: NCT00162669 - Recruiting
  Advanced Hepatocellular Carcinoma
  
• Phase II Open Label Trial for Post-Menopausal Women with Newly Diagnosed Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00161291 - Recruiting
  Breast Cancer
  
• Phase II Pilot Controlled Study of Short vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00004652 - Completed
  Tourette Syndrome
  
• Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
  ClinicalTrials.gov Identifier: NCT00004493 - Recruiting
  Lactic Acidosis
  
• Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease
  ClinicalTrials.gov Identifier: NCT00004314 - Completed
  Lesch-Nyhan Syndrome
  
• Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis
  ClinicalTrials.gov Identifier: NCT00004762 - Completed
  Cholangitis, Sclerosing
  
• Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00016458 - Active, not recruiting
  Systemic Sclerosis
  
• Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004643 - Completed
  Lupus Erythematosus, Systemic
  
• Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
  ClinicalTrials.gov Identifier: NCT00004669 - Completed
  Bronchopulmonary Dysplasia
  
• Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
  ClinicalTrials.gov Identifier: NCT00004359 - Completed
  Epidermolysis Bullosa Acquisita
  
• Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
  ClinicalTrials.gov Identifier: NCT00004808 - Completed
  Histoplasmosis; Sporotrichosis; Blastomycosis
  
• Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00004787 - Completed
  Shwachman syndrome; Fanconi's Anemia; Dyskeratosis Congenita; Thrombocytopenia
  
• Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
  ClinicalTrials.gov Identifier: NCT00004327 - Completed
  Hereditary Hemorrhagic Telangiectasia; Ectasia
  
• Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00004288 - Completed
  Ankylosing Spondylitis
  
• Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00541411 - Active, not recruiting
  Ewing's Sarcoma
  
• Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.
  ClinicalTrials.gov Identifier: NCT00359164 - Not yet recruiting
  Macular Degeneration
  
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol with Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
  ClinicalTrials.gov Identifier: NCT00004315 - Active, not recruiting
  Cystic Fibrosis; Gastrointestinal Diseases; Cholestasis
  
• Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00233454 - Recruiting
  Aggressive Systemic Mastocytosis; Mast Cell Leukemia
  
• Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
  ClinicalTrials.gov Identifier: NCT00004276 - Completed
  HIV Infections; Mycobacterium Infections; Tuberculosis
  
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00004810 - Completed
  Ulcerative Colitis
  
• Phase II Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globlulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (
  ClinicalTrials.gov Identifier: NCT00482053 - Recruiting
  Lymphoma, B-Cell
  
• Phase II Protocol with Laboratory Correlates of 1-[(S)-3-hydroxy-2-(phosphomethoxy)propyl]cytosine dihydrate (Cidofovir) in Patients with Kaposi's Sarcoma (KS)
  ClinicalTrials.gov Identifier: NCT00001559 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection; Herpesviridae Infection; Kaposi's Sarcoma
  
• Phase II randomized bilateral comparison of topical targretin gel 1% in alopecia areata
  ClinicalTrials.gov Identifier: NCT00063076 - Completed
  Alopecia Areata
  
• Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
  ClinicalTrials.gov Identifier: NCT00004660 - Active, not recruiting
  Graves' Disease
  
• Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
  ClinicalTrials.gov Identifier: NCT00000794 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00004812 - Completed
  Spinal Cord Injury
  
• Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients with Gaucher's Disease
  ClinicalTrials.gov Identifier: NCT00004488 - Recruiting
  Gaucher's Disease; Osteopenia
  
• Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
  ClinicalTrials.gov Identifier: NCT00004794 - Completed
  Cytomegalovirus Retinitis; Acquired Immunodeficiency Syndrome
  
• Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
  ClinicalTrials.gov Identifier: NCT00004409 - Recruiting
  Dupuytren's Contracture
  
• Phase II Randomized Study of Cultured Skin Substitutes versus Split Thickness Skin Grafts in Patients with Severe Burn Injuries
  ClinicalTrials.gov Identifier: NCT00004413 - Recruiting
  Burns
  
• Phase II Randomized Study of Early Surgery vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
  ClinicalTrials.gov Identifier: NCT00004758 - Completed
  Spasms, Infantile; Epilepsy
  
• Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00004686 - Active, not recruiting
  Giant Cell Arteritis
  
• Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00004310 - Active, not recruiting
  Obsessive-Compulsive Disorder
  
• Phase II Randomized Study of Leuprolide vs Oral Contraceptive Therapy vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
  ClinicalTrials.gov Identifier: NCT00004763 - Completed
  Hyperandrogenism
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
  ClinicalTrials.gov Identifier: NCT00004400 - Recruiting
  HIV Infections; Cachexia
  
• Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy vs Physiotherapy Alone for Spastic Diplegia
  ClinicalTrials.gov Identifier: NCT00004751 - Active, not recruiting
  Spastic Diplegia
  
• Phase II Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00004285 - Completed
  End Stage Renal Disease
  
• Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
  ClinicalTrials.gov Identifier: NCT00004659 - Active, not recruiting
  Brain Neoplasms
  
• Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
  ClinicalTrials.gov Identifier: NCT00004340 - Completed
  Renal Osteodystrophy; End Stage Renal Disease
  
• Phase II Randomized Study of three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00067808 - Active, not recruiting
  Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
  
• Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
  ClinicalTrials.gov Identifier: NCT00004381 - Completed
  Glucosephosphate Dehydrogenase Deficiency; Hyperbilirubinemia; Hemolytic Disease of Newborn
  
• Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
  ClinicalTrials.gov Identifier: NCT00004412 - Recruiting
  Skin Ulcers; Sickle Cell Anemia
  
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00287547 - Completed
  Psoriasis Vulgaris
  
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004747 - Completed
  Cystic Fibrosis; Bacterial Infections
  
• Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00225992 - Terminated
  Myelodysplastic Syndrome (MDS)
  
• Phase II Safety and Efficacy Study of Single-Agent AT-101 in Patients With Relapsed or Refractory B-Cell Malignancies
  ClinicalTrials.gov Identifier: NCT00275431 - Completed
  Follicular Lymphoma; Diffuse Large Cell Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia
  
• Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients With Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00532259 - Recruiting
  Lymphoma, Large-Cell, Diffuse
  
• Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients
  ClinicalTrials.gov Identifier: NCT00069719 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients
  ClinicalTrials.gov Identifier: NCT00069706 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase II Safety, Efficacy and Tolerability Study of MCC135 in Subjects with Congestive Heart Failure, NYHA Class II/III
  ClinicalTrials.gov Identifier: NCT00050076 - Active, not recruiting
  Congestive Heart Failure
  
• Phase II Single Arm BIBW 2992 in NSCLC With EGFR Activating Mutations
  ClinicalTrials.gov Identifier: NCT00525148 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00518193 - Suspended
  Cervix Cancer
  
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
  ClinicalTrials.gov Identifier: NCT00517595 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
  ClinicalTrials.gov Identifier: NCT00516152 - Recruiting
  Chronic Myeloid Leukemia; Acute Myelogenous Leukemia; Myelodysplasia; Acute Lymphocytic Leukemia; Severe Aplastic Anemia; Non-Hodgkin's Lymphoma; Lymphoproliferative Disease; Multiple Myeloma; Advanced Myeloproliferative Disease
  
• Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00564876 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Study for Patients With Relapsed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00261651 - Recruiting
  Lymphoma
  
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
  ClinicalTrials.gov Identifier: NCT00527735 - Not yet recruiting
  Lung Cancer; Small Cell Lung Cancer; Carcinoma, Non-Small-Cell Lung
  
• Phase II Study in Patients with EGFR + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00063401 - Active, not recruiting
  Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
  
• Phase II Study in Patients With Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00518583 - Recruiting
  Breast Cancer
  
• Phase II Study in Patients with Recurrent Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00063388 - Active, not recruiting
  Non-Small-Cell Lung Cancer
  
• Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
  ClinicalTrials.gov Identifier: NCT00539591 - Recruiting
  Melanoma
  
• Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
  ClinicalTrials.gov Identifier: NCT00504751 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients With High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00539552 - Recruiting
  Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Oligoastrocytoma
  
• Phase II Study of a HER2/Neu Vaccine for Stage IV HER2/Neu Positive Breast Cancer Patients on Herceptin
  ClinicalTrials.gov Identifier: NCT00343109 - Recruiting
  Breast Cancer
  
• Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00583024 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
  ClinicalTrials.gov Identifier: NCT00583752 - Recruiting
  Recurrent Prostate Cancer
  
• Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
  ClinicalTrials.gov Identifier: NCT00249990 - Recruiting
  Corpus Uteri; Endometrial Cancer
  
• Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
  ClinicalTrials.gov Identifier: NCT00471419 - Active, not recruiting
  Dry Eye
  
• Phase II Study of Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients with Relapsed and Resistant Classical Hodgkin''s Disease
  ClinicalTrials.gov Identifier: NCT00129753 - Completed
  Hodgkin''s Disease
  
• Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
  ClinicalTrials.gov Identifier: NCT00010439 - Completed
  Osteoporosis
  
• Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
  ClinicalTrials.gov Identifier: NCT00198133 - Active, not recruiting
  Thymoma; Thymic Carcinoma
  
• Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Lysosomal or Peroxisomal Inborn Errors of Metabolism
  ClinicalTrials.gov Identifier: NCT00005894 - Recruiting
  Graft Versus Host Disease; Lysosomal Storage Diseases; Peroxisomal Disorders
  
• Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Mucopolysaccharidosis I (Hurler Disease)
  ClinicalTrials.gov Identifier: NCT00005899 - Recruiting
  Mucopolysaccharidosis I
  
• Phase II Study of Amithiozone (Thiacetazone) for Patients with Mycobacterium Avium Complex Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00004689 - Active, not recruiting
  Mycobacterium avium-intracellulare Infection
  
• Phase II Study of anti-VEGF in Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00040313 - Completed
  Diabetic Macular Edema
  
• Phase II Study of Arginine Butyrate With or Without Epoetin alfa in Patients With Thalassemia Intermedia
  ClinicalTrials.gov Identifier: NCT00006136 - Completed
  beta-Thalassemia
  
• Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00512083 - Recruiting
  Leukemia, Myeloid
  
• Phase II Study of ASP3550 in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00568516 - Recruiting
  Prostatic Neoplasms
  
• Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00185731 - Recruiting
  Non-Hodgkins Lymphoma
  
• Phase II Study of Azacitidine and Phenylbutyrate in Patients With Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00007072 - Terminated
  Thalassemia Major
  
• Phase II Study of Best Support Care (BSC) Plus ZD6474 in Patients With Inoperable Hepatocellular Carcinoma (HCC)
  ClinicalTrials.gov Identifier: NCT00508001 - Recruiting
  Carcinoma, Hepatocellular
  
• Phase II Study of Bevacizumab and Erlotinib
  ClinicalTrials.gov Identifier: NCT00553800 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
  ClinicalTrials.gov Identifier: NCT00378066 - Recruiting
  Advanced Colorectal Cancer
  
• Phase II Study of Bevacizumab, FDR Gemcitabine, & Rapid Fractionation Radiotherapy in Preoperative Treatment of Potentially Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00428324 - Recruiting
  Pancreatic Cancer
  
• Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00407459 - Not yet recruiting
  Mesothelioma
  
• Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00490009 - Recruiting
  Diffuse Large-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
  Multiple Myeloma
  
• Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients with Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00004323 - Completed
  Aplastic Anemia
  
• Phase II Study of Bortezomib (Velcade) in Combination with Dexamethasone to Treat Patients with Relapsed Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00148018 - Terminated
  Hodgkin Disease
  
• Phase II Study of Calcitonin for Tumoral Calcinosis
  ClinicalTrials.gov Identifier: NCT00004358 - Completed
  Calcinosis
  
• Phase II Study of Campath-1H Antibody to Treat Waldenstrom''s Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00142181 - Active, not recruiting
  Lymphoplasmacytic lymphoma; Waldenstrom''s Macroglobulinemia
  
• Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00422786 - Recruiting
  Carcinoma, Renal Cell
  
• Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
  ClinicalTrials.gov Identifier: NCT00225056 - Terminated
  Metastatic Breast Cancer
  
• Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00517361 - Recruiting
  Metastatic Breast Cancer
  
• Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
  ClinicalTrials.gov Identifier: NCT00004688 - Active, not recruiting
  Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Gliomas; Glioblastoma Multiforme; Recurrent Brain Tumor
  
• Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
  ClinicalTrials.gov Identifier: NCT00181532 - Active, not recruiting
  Non Small Cell Lung Carcinoma
  
• Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00251498 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
  ClinicalTrials.gov Identifier: NCT00530452 - Not yet recruiting
  Osteoarthritis, Knee; Osteoarthritis, Hip
  
• Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
  ClinicalTrials.gov Identifier: NCT00004346 - Recruiting
  Cerebrotendinous Xanthomatosis
  
• Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00198172 - Terminated
  Germ Cell Tumor
  
• Phase II Study of CLOFARABINE in Adult Patients with Refractory or Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00044889 - Completed
  Acute Myelogenous Leukemia
  
• Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00042341 - Completed
  Leukemia, Lymphoblastic, Acute
  
• Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
  ClinicalTrials.gov Identifier: NCT00042354 - Completed
  Leukemia, Myeloid
  
• Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00487669 - Recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin’s Lymphoma
  ClinicalTrials.gov Identifier: NCT00210379 - Recruiting
  Lymphoma, B Cell
  
• Phase II Study of Dasatinib (BMS-354825) for Androgen-Deprived Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00385580 - Recruiting
  Prostate Cancer
  
• Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00538824 - Not yet recruiting
  Multiple Myeloma
  
• Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00004347 - Recruiting
  Smith-Lemli-Opitz Syndrome
  
• Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00231465 - Completed
  Non-Small Cell Lung Cancer
  
• Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III
  ClinicalTrials.gov Identifier: NCT00172380 - Recruiting
  NSCLC
  
• Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00559455 - Recruiting
  Carcinoma, Hepatocellular
  
• Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00000626 - Completed
  HIV Infections; Hodgkin's Disease
  
• Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
  ClinicalTrials.gov Identifier: NCT00004938 - Completed
  Sporotrichosis
  
• Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab
  ClinicalTrials.gov Identifier: NCT00208975 - Recruiting
  Lymphoma
  
• Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00004293 - Recruiting
  Gaucher's Disease
  
• Phase II Study of Growth Hormone in Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00016445 - Active, not recruiting
  Cystic Fibrosis
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
  ClinicalTrials.gov Identifier: NCT00010413 - Active, not recruiting
  Pemphigus
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
  Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
  
• Phase II Study of Hyper-CVAD plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00038610 - Active, not recruiting
  Leukemia, Lymphocytic, Acute, L2
  
• Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
  ClinicalTrials.gov Identifier: NCT00151125 - Completed
  von Willebrand Disease
  
• Phase II Study of Imatinib Mesylate in Patients with Life Threatening Malignant Rare Diseases
  ClinicalTrials.gov Identifier: NCT00154388 - Completed
  Life threatening diseases
  
• Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-Differentiated Thyroid Cancer.
  ClinicalTrials.gov Identifier: NCT00279721 - Recruiting
  Thyroid Neoplasms
  
• Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
  ClinicalTrials.gov Identifier: NCT00400205 - Recruiting
  Squamous Cell Carcinoma; Oral Cancer
  
• Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00580372 - Active, not recruiting
  Multiple Myeloma
  
• Phase II Study of Intensive Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantion in Patients With Chronic Myelogenous Leukemia or High Risk Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00004905 - Completed
  adult acute myeloid leukemia in remission; chronic phase chronic myelogenous leukemia; recurrent adult acute myeloid leukemia; ...
  
• Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00299988 - Active, not recruiting
  Alzheimer's Disease
  
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002259 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Phase II Study of Intravenous Rexin-G in Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00572130 - Recruiting
  Osteosarcoma
  
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
  ClinicalTrials.gov Identifier: NCT00360828 - Recruiting
  Recurrent Anaplastic Astrocytoma; Mixed Malignant Glioma; Oligodendroglioma
  
• Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00506571 - Recruiting
  Colorecal Neoplasms; Secondary
  
• Phase II Study of Irofulven in Patients with Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124566 - Active, not recruiting
  Prostate Cancer
  
• Phase II Study of Ironotecan Plus Capecitabine in Patients With Antracycline and Taxane Pretreated Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00532714 - Recruiting
  Breast Cancer Metastatic
  
• Phase II Study of Lactulose and Circadian Rhythms in Patients with Cirrhosis
  ClinicalTrials.gov Identifier: NCT00004796 - Completed
  Portal Hypertension; Hepatic Encephalopathy; Cirrhosis
  
• Phase II Study of Lapatinib and Bevacizumab for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00444535 - Recruiting
  Metastatic Breast Cancer
  
• Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00478959 - Recruiting
  Hodgkin Disease
  
• Phase II Study of Leuprolide and Testosterone for Men with Kennedy's Disease or Other Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00004771 - Completed
  Spinal Muscular Atrophy; Amyotrophic Lateral Sclerosis; Spinobulbar Muscular Atrophy
  
• Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004665 - Completed
  Systemic Lupus Erythematosus
  
• Phase II Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma Patients at High Risk for Myelosuppression
  ClinicalTrials.gov Identifier: NCT00482261 - Not yet recruiting
  Multiple Myeloma
  
• Phase II Study of MDX-010 (BMS-734016) Extended-Treatment Monotherapy or Follow-Up for Patients Previously Enrolled in MDX-010 (BMS-734016) Protocols
  ClinicalTrials.gov Identifier: NCT00162123 - Recruiting
  unresectable melanoma
  
• Phase II Study of Methylprednisolone and Xylose Absorption in Children with Hypersensitivity Vasculitis Associated with Connective Tissue Disease
  ClinicalTrials.gov Identifier: NCT00004357 - Recruiting
  Vasculitis, Hypersensitivity; Connective Tissue Diseases; Dermatomyositis; Vasculitis
  
• Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
  ClinicalTrials.gov Identifier: NCT00004268 - Completed
  Orthostatic Hypotension
  
• Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) With Growth Factor Support in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00515411 - Recruiting
  Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
  
• Phase II Study of Modified Triple Doublet Therapy in Women with Newly Diagnosed Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00157560 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Phase II Study of Motexafin Gadolinium and Cranial Irradiation in Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00022256 - Active, not recruiting
  adult glioblastoma multiforme
  
• Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00538525 - Active, not recruiting
  Breast Cancer
  
• Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients with HIV Associated Large Cell and Immunoblastic Lymphomas
  ClinicalTrials.gov Identifier: NCT00002003 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Phase II study of ONTAK in previously treated patients with low-grade Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00051025 - Recruiting
  Non-Hodgkin's Lymphoma; Lymphoma, B-Cell; Lymphoma, Low-Grade
  
• Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209651 - Active, not recruiting
  Colorectal Cancer
  
• Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00209664 - Suspended
  Gastric Cancer
  
• Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.
  ClinicalTrials.gov Identifier: NCT00238849 - Not yet recruiting
  Previously Treated Metastatic Non-Small Cell Lung Cancer
  
• Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00186277 - Active, not recruiting
  Bladder Cancer
  
• Phase II Study of Pallidotomy for Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00004670 - Completed
  Parkinson Disease
  
• Phase II Study of Pandemic Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00320346 - Completed
  Influenza
  
• Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
  ClinicalTrials.gov Identifier: NCT00391560 - Recruiting
  Leukemia
  
• Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
  ClinicalTrials.gov Identifier: NCT00208936 - Terminated
  Esophageal Diseases
  
• Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
  ClinicalTrials.gov Identifier: NCT00532857 - Recruiting
  Breast Cancer
  
• Phase II Study of Proteasome Inhibitor PS-341 For Patients With Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00038571 - Terminated
  Lymphoma, B-Cell
  
• Phase II Study of PSA-3 Peptide Vaccine Emulsified in Montanide ISA-51 in Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00030602 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Phase II Study of PTK787 in the Treatment of Patients with Non-Metastatic Androgen Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00134355 - Active, not recruiting
  Prostate Cancer
  
• Phase II Study of R115777 in Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00012350 - Completed
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Phase II Study of Raloxifene in Patients With Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00004915 - Completed
  recurrent endometrial cancer
  
• Phase II Study of Range and Schedule of rPA Doses
  ClinicalTrials.gov Identifier: NCT00170456 - Active, not recruiting
  Bacillus Anthracis (Anthrax)
  
• Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00004380 - Completed
  Systemic Sclerosis
  
• Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00540644 - Recruiting
  Multiple Myeloma
  
• Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
  ClinicalTrials.gov Identifier: NCT00004658 - Completed
  5'-nucleotidase syndrome
  
• Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00005652 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00472225 - Recruiting
  Steroid-Refractory Chronic GVHD
  
• Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
  ClinicalTrials.gov Identifier: NCT00038376 - Terminated
  Lymphoma, T-Cell; Mycosis Fungoides; Hematologic Neoplasms
  
• Phase II Study of RR110 in Patients With Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00417391 - Recruiting
  Crohn’s Disease
  
• Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00151281 - Recruiting
  Non-Hodgkin''s Lymphoma
  
• Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
  ClinicalTrials.gov Identifier: NCT00038597 - Terminated
  Myelogenous Leukemia, Chronic
  
• Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
  ClinicalTrials.gov Identifier: NCT00313859 - Recruiting
  Colorectal Cancer; Metastasis
  
• Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00519077 - Recruiting
  Head and Neck Neoplasms
  
• Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
  ClinicalTrials.gov Identifier: NCT00004767 - Completed
  Amino Acid Metabolism, Inborn Errors
  
• Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
  ClinicalTrials.gov Identifier: NCT00004300 - Suspended
  stereotyped behavior; Mental Retardation
  
• Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
  ClinicalTrials.gov Identifier: NCT00434109 - Recruiting
  Neuroendocrine Tumor; Islet Cell Tumor
  
• Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00400569 - Recruiting
  Liposarcoma; Leiomyosarcoma; Fibrosarcoma
  
• Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148070 - Active, not recruiting
  Metastatic breast cancer
  
• Phase II Study of TALL-104 and Gleevec in CML
  ClinicalTrials.gov Identifier: NCT00415909 - Recruiting
  Chronic Myelogenous Leukemia
  
• Phase II Study of Taxotere in Combination with Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
  ClinicalTrials.gov Identifier: NCT00036010 - No longer recruiting
  Non-small cell lung cancer
  
• Phase II Study of Taxotere in Combination with Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
  ClinicalTrials.gov Identifier: NCT00072618 - Completed
  NSCLC
  
• Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
  ClinicalTrials.gov Identifier: NCT00365222 - Recruiting
  Glioblastoma; Gliosarcoma
  
• Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00195091 - Recruiting
  Breast Cancer
  
• Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00538733 - Recruiting
  Multiple Myeloma
  
• Phase II Study of the BiTE® MT103 in Patients With Minimal Residual Disease of B-Precursor Acute ALL
  ClinicalTrials.gov Identifier: NCT00560794 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women with Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
  ClinicalTrials.gov Identifier: NCT00004311 - Completed
  Acanthosis Nigricans; Polycystic Ovary Syndrome
  
• Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00117845 - Recruiting
  
  
• Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
  ClinicalTrials.gov Identifier: NCT00000392 - Active, not recruiting
  HIV Infections; Cognition Disorders
  
• Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
  ClinicalTrials.gov Identifier: NCT00004333 - Completed
  Tyrosinemia, Type I
  
• Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
  ClinicalTrials.gov Identifier: NCT00004437 - Completed
  Neurofibromatosis 2
  
• Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
  ClinicalTrials.gov Identifier: NCT00004328 - Completed
  Pseudohypoaldosteronism
  
• Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients with Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modali
  ClinicalTrials.gov Identifier: NCT00001568 - Completed
  Colorectal Neoplasm
  
• Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00499837 - Recruiting
  Cystic Fibrosis
  
• Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft
  ClinicalTrials.gov Identifier: NCT00435942 - Recruiting
  Thoracic Aortic Aneurysms
  
• Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients with 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
  ClinicalTrials.gov Identifier: NCT00002079 - Completed
  HIV Infections
  
• Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00563836 - Recruiting
  Ovarian Cancer; Epithelial Ovarian Cancer
  
• Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00200382 - Terminated
  Non-Small Cell Lung Cancer
  
• Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
  ClinicalTrials.gov Identifier: NCT00004382 - Active, not recruiting
  Hyperbilirubinemia
  
• Phase II Study of TLK286 in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00036920 - Active, not recruiting
  stage IV non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; ...
  
• Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma
  ClinicalTrials.gov Identifier: NCT00503321 - Recruiting
  Gastric Cancer
  
• Phase II Study of Valproic Acid With FEC100 for Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00437801 - Recruiting
  Breast Cancer
  
• Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00581776 - Recruiting
  Mantle Cell Lymphoma
  
• Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00148317 - Recruiting
  Multiple Myeloma
  
• Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00344552 - Recruiting
  Esophageal Cancer
  
• Phase II Study of Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
  ClinicalTrials.gov Identifier: NCT00343044 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Phase II Study of XELOX With Cetuximab in Advanced AGC
  ClinicalTrials.gov Identifier: NCT00398398 - Completed
  Gastric Cancer
  
• Phase II Study of ZD6474 in Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00290537 - Active, not recruiting
  Lung Cancer
  
• Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00000687 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
  ClinicalTrials.gov Identifier: NCT00421213 - Recruiting
  Hematologic Neoplasms; Bone Marrow Neoplasms
  
• Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00530075 - Completed
  Wegener's Granulomatosis
  
• Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-Treated Patients
  ClinicalTrials.gov Identifier: NCT00294372 - Terminated
  HIV Infections
  
• Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients with Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00135018 - Recruiting
  Breast Cancer
  
• Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
  ClinicalTrials.gov Identifier: NCT00322764 - Completed
  Bipolar Depression
  
• Phase II Study to Determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) Administered with or Without Prophylactic Oral Budesonide
  ClinicalTrials.gov Identifier: NCT00135408 - Completed
  Unresectable Stage III or IV Malignant Melanoma
  
• Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)
  ClinicalTrials.gov Identifier: NCT00261365 - Completed
  Unresectable Stage III or IV Malignant Melanoma
  
• Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
  ClinicalTrials.gov Identifier: NCT00550004 - Recruiting
  Pancreatic Cancer
  
• Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00531115 - Not yet recruiting
  Metastatic Colorectal Cancer
  
• Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00048633 - Completed
  Breast Neoplasms
  
• Phase II Study to Evaluate the Combination of Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients with B-CLL
  ClinicalTrials.gov Identifier: NCT00147901 - Recruiting
  B-cell Chronic Lymphocytic Leukemia
  
• Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-Cell Lymphoma With Neuromeninge
  ClinicalTrials.gov Identifier: NCT00553943 - Recruiting
  Lymphoma, Non-Hodgkin; Diffuse Large B-Cell Lymphoma
  
• Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
  ClinicalTrials.gov Identifier: NCT00295854 - Recruiting
  Interstitial Cystitis
  
• Phase II Study to Evaluate the Efficacy of AMG 317
  ClinicalTrials.gov Identifier: NCT00436670 - Recruiting
  Asthma
  
• Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
  ClinicalTrials.gov Identifier: NCT00038454 - Suspended
  Cardiovascular Disease
  
• Phase II Study Using Thalidomide for the Treatment of ALS
  ClinicalTrials.gov Identifier: NCT00140452 - Completed
  Amyotrophic Lateral Sclerosis; ALS
  
• Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00479674 - Recruiting
  Breast Cancer
  
• Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
  ClinicalTrials.gov Identifier: NCT00464893 - Recruiting
  Gastric Cancer; Gastric Adenocarcinoma
  
• Phase II Study With CC-10004 in Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00456092 - Recruiting
  Psoriatic Arthritis
  
• Phase II Study With Rituximab and CHOP in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma
  ClinicalTrials.gov Identifier: NCT00204659 - Recruiting
  Primary Gastric Diffuse-Large B-Cell Lymphoma
  
• Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
  ClinicalTrials.gov Identifier: NCT00522457 - Recruiting
  Metastatic Breast Cancer; Advanced Breast Cancer
  
• Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
  ClinicalTrials.gov Identifier: NCT00452140 - Recruiting
  Metastatic Breast Cancer; Advanced Breast Cancer
  
• Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
  ClinicalTrials.gov Identifier: NCT00285857 - Recruiting
  Breast Cancer
  
• Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00220116 - Recruiting
  Colorectal Cancer
  
• Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00274456 - Active, not recruiting
  Metastatic Breast Cancer
  
• Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
  ClinicalTrials.gov Identifier: NCT00220168 - Active, not recruiting
  Upper Gastrointestinal Tumours
  
• Phase II Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases
  ClinicalTrials.gov Identifier: NCT00542048 - Recruiting
  Metastases of the Liver
  
• Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00570531 - Recruiting
  Loco-Regional Esophageal Cancer
  
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients with Stage III/IV and Relapsed NSCLC
  ClinicalTrials.gov Identifier: NCT00001450 - Completed
  Carcinoma, Non-Small-Cell Lung; Lung Neoplasms
  
• Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Releated
  ClinicalTrials.gov Identifier: NCT00582933 - Recruiting
  Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
  
• Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00284752 - Recruiting
  Prostate Cancer
  
• Phase II Trial of Allovectin-7® for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00050388 - Completed
  Head and Neck Cancer; Squamous Cell Carcinoma of the Oral Cavity or Oropharynx; Head and Neck Neoplasms; Carcinoma of the Head and Neck
  
• Phase II Trial of Allovectin-7® for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00044356 - Completed
  Melanoma; Metastatic Melanoma; Malignant Melanoma; Skin Cancer
  
• Phase II Trial of Bevacizumab in Comb. w/Pemetrexed as 2nd Line Rx in Patients w/Stable Brain Metastases from NSCLC
  ClinicalTrials.gov Identifier: NCT00227019 - Recruiting
  Non-Small-Cell Lung Carcinoma; Neoplasm Metastasis
  
• Phase II Trial of BIBW 2992 in Patients With HER2-Positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
  ClinicalTrials.gov Identifier: NCT00431067 - Recruiting
  Breast Neoplasms
  
• Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00574236 - Recruiting
  Metastatic Breast Cancer
  
• Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
  ClinicalTrials.gov Identifier: NCT00464295 - Completed
  Carcinoma, Hepatocellular
  
• Phase II Trial of Capecitabine Plus Fulvestrant in First Line Treatment of Hormone Receptor Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00534417 - Recruiting
  Metastatic Breast Cancer
  
• Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancers (LCCC 0403)
  ClinicalTrials.gov Identifier: NCT00492375 - Recruiting
  Metastatic Breast Cancer
  
• Phase II Trial of Cetuximab in Patients with Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas
  ClinicalTrials.gov Identifier: NCT00148109 - Recruiting
  Unresectabale or metastatic high grade soft tissue or bony sarcoma
  
• Phase II Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse
  ClinicalTrials.gov Identifier: NCT00462865 - Recruiting
  Breast Cancer
  
• Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00177554 - Active, not recruiting
  Non-Hodgkin Lymphoma
  
• Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
  ClinicalTrials.gov Identifier: NCT00569699 - Recruiting
  Colorectal Cancer
  
• Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00569790 - Recruiting
  Colorectal Cancer
  
• Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00569335 - Recruiting
  Colorectal, Cancer
  
• Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00210314 - Recruiting
  Lymphoma, B Cell
  
• Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
  ClinicalTrials.gov Identifier: NCT00539773 - Active, not recruiting
  Transitional Carcinoma of Urinary Bladder
  
• Phase II trial of decitabine in patients with chronic myelogenous leukemia accelerated phase who are refractory to imatinib mesylate (Gleevec)
  ClinicalTrials.gov Identifier: NCT00041990 - Completed
  Chronic Myelogenous Leukemia
  
• Phase II trial of decitabine in patients with chronic myelogenous leukemia blast phase who are refractory to imatinib mesylate (Gleevec)
  ClinicalTrials.gov Identifier: NCT00042003 - Completed
  Chronic Myelogenous Leukemia
  
• Phase II trial of decitabine in patients with chronic myelogenous leukemia chronic phase who are refractory to imatinib mesylate (Gleevec)
  ClinicalTrials.gov Identifier: NCT00042016 - Completed
  Chronic Myelogenous Leukemia
  
• Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00494338 - Terminated
  Metastatic Prostate Cancer
  
• Phase II Trial of Dose-Dense Paclitaxel and Cisplatin as Neo-Adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
  ClinicalTrials.gov Identifier: NCT00291850 - Terminated
  Non-Small Cell Lung Cancer
  
• Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00581360 - Recruiting
  Adenoid Cystic Carcinoma
  
• Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00224393 - Suspended
  Primary Systemic Amyloidosis
  
• Phase II Trial of EOquin in High-Risk Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00141531 - Active, not recruiting
  Bladder Neoplasms
  
• Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-Small Cell Lung Cancer (PEARL)
  ClinicalTrials.gov Identifier: NCT00391248 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00497224 - Recruiting
  Cancer; Pancreas
  
• Phase II Trial of Gemcitabine and Carboplatin Followed by Paclitaxel and Carboplatin With Radiation for Stage IIIA/IIIB NSCLC.
  ClinicalTrials.gov Identifier: NCT00226590 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Phase II Trial of Gleevec (STI571) in Patients with Advanced Soft Tissue or Bone Cancer
  ClinicalTrials.gov Identifier: NCT00029094 - Completed
  Sarcoma
  
• Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00209079 - Terminated
  Gastric Adenocarcinoma
  
• Phase II Trial of Gleevec in Patients with Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00035646 - No longer recruiting
  Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
  
• Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment
  ClinicalTrials.gov Identifier: NCT00467883 - Not yet recruiting
  Zygomycosis
  
• Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00574171 - Recruiting
  Metastatic Colorectal Cancer
  
• Phase II Trial of Lenalidomide in Older Patients (> 60 Years) With Untreated Acute Myeloid Leukemia Without Chromosome 5q Abnormalities
  ClinicalTrials.gov Identifier: NCT00546897 - Active, not recruiting
  Acute Myeloid Leukemia
  
• Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST
  ClinicalTrials.gov Identifier: NCT00359333 - Recruiting
  Sarcoma; Malignant GIST
  
• Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
  ClinicalTrials.gov Identifier: NCT00425607 - Active, not recruiting
  Progeria; Hutchinson-Gilford Syndrome
  
• Phase II Trial of Monoclonal Antibody (J591) in Combination with Low-Dose Subcutaneous Interleukin-2
  ClinicalTrials.gov Identifier: NCT00040586 - Completed
  Prostatic Neoplasms
  
• Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
  ClinicalTrials.gov Identifier: NCT00580073 - Recruiting
  Rectal Cancer
  
• Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00542191 - Recruiting
  Breast Cancer
  
• Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00535509 - Active, not recruiting
  Breast Cancer
  
• Phase II Trial of Ontak With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00299689 - Recruiting
  Malignant Melanoma
  
• Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00527930 - Recruiting
  Breast Neoplasms
  
• Phase II Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer After First Line Chemotherapy
  ClinicalTrials.gov Identifier: NCT00531687 - Recruiting
  Testicular Cancer Relapse
  
• Phase II Trial of Peginterferon alpha-2b and Thalidomide in Adults with Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00047879 - Recruiting
  Glioma
  
• Phase II Trial of Pentostatin and Targeted Busulfan
  ClinicalTrials.gov Identifier: NCT00496340 - Not yet recruiting
  Hematologic Malignancies
  
• Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease
  ClinicalTrials.gov Identifier: NCT00201786 - Suspended
  Graft-Versus-Host Disease
  
• Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer
  ClinicalTrials.gov Identifier: NCT00239343 - Completed
  Breast Cancer
  
• Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
  ClinicalTrials.gov Identifier: NCT00186628 - Recruiting
  Mast Cell Leukemia; Chronic Lymphocytic Leukemia
  
• Phase II Trial of Pulsed Paclitaxel With Concurrent Thoracic Radiotherapy, and Adjuvant Gemcitabine and Carboplatin in Stage IIIA and IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00449657 - Recruiting
  Non Small Cell Lung Cancer
  
• Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00374140 - Recruiting
  Small Cell Lung Cancer
  
• Phase II Trial of RAD001 in Refractory Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00337545 - Completed
  Colorectal Cancer
  
• Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00365599 - Recruiting
  Breast Cancer
  
• Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00000801 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Phase II Trial of SK3530 in Erectile Dysfunction
  ClinicalTrials.gov Identifier: NCT00351065 - Terminated
  Male Erectile Dysfunction
  
• Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00430261 - Recruiting
  Lung Cancer; Adenocarcinoma
  
• Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00466284 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00209014 - Terminated
  B-Cell Lymphoma; Hodgkin's Disease
  
• Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176644 - Recruiting
  Prostate Cancer
  
• Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
  ClinicalTrials.gov Identifier: NCT00215202 - Active, not recruiting
  Nonresectable Adrenocortical Carcinoma
  
• Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients with Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00209989 - Recruiting
  Glioblastoma Multiforme
  
• Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-Positive Breast Cancer (Study P05048)
  ClinicalTrials.gov Identifier: NCT00550771 - Recruiting
  Breast Neoplasm
  
• Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00202800 - Recruiting
  Pancreatic Cancer
  
• Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis
  ClinicalTrials.gov Identifier: NCT00322296 - Terminated
  Parapsoriasis
  
• Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision Method
  ClinicalTrials.gov Identifier: NCT00572754 - Recruiting
  Circumcision; Male
  
• Phase II Trial to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccines.
  ClinicalTrials.gov Identifier: NCT00192309 - Completed
  Influenza
  
• Phase II Trial Using Aldesleukin (lL-2) Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00118599 - Recruiting
  
  
• Phase II Trial using Infliximab in Subjects with Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00076726 - Completed
  Giant Cell Arteritis; Granulomatous Arteritis
  
• Phase II Trial W/Chemo & Radiation Therapy for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00424827 - Recruiting
  Pancreatic Cancer
  
• Phase II Trial: Higher Dose Casodex in Hormone Refractory Prostate Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00260455 - Recruiting
  Prostate Cancer
  
• Phase II Two-Step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
  ClinicalTrials.gov Identifier: NCT00467506 - Recruiting
  Thyroid Neoplasms
  
• Phase II, Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-Valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated
  ClinicalTrials.gov Identifier: NCT00307567 - Completed
  Pneumococcal Disease
  
• Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)
  ClinicalTrials.gov Identifier: NCT00570661 - Recruiting
  Active Systemic; Onset Juvenile Idiopathic Arthritis
  
• Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
  ClinicalTrials.gov Identifier: NCT00501241 - Recruiting
  Chronic Constipation
  
• Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
  ClinicalTrials.gov Identifier: NCT00447915 - Recruiting
  Primary Osteoporosis
  
• Phase II/III Randomized Study of Transplantation With Unmodified Versus T-Cell Depleted, Unrelated Allogeneic Bone Marrow in Patients With Leukemia
  ClinicalTrials.gov Identifier: NCT00006451 - Active, not recruiting
  acute undifferentiated leukemia; accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; ...
  
• Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Mild to Moderate Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004795 - Completed
  Systemic Lupus Erythematosus
  
• Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients with CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Have Received Antiretroviral Treat
  ClinicalTrials.gov Identifier: NCT00071890 - Active, not recruiting
  HIV Infections
  
• Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00460096 - Completed
  Alpha 1-Antitrypsin Deficiency
  
• Phase II/III study of anti-VEGF in neovascular AMD
  ClinicalTrials.gov Identifier: NCT00021736 - Completed
  Macular Degeneration; Choroidal Neovascularization
  
• Phase II/III Study of CDX-110 in Patients With GBM
  ClinicalTrials.gov Identifier: NCT00458601 - Recruiting
  Glioblastoma
  
• Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00002099 - Active, not recruiting
  HIV Infections
  
• Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00312442 - Recruiting
  Prostate Cancer
  
• Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00284258 - Recruiting
  Colorectal Cancer
  
• Phase II: Imatinib & Gemcitabine for First-Line Tx of Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00161213 - Recruiting
  Pancreatic Cancer
  
• Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00376636 - Completed
  Hypertension
  
• Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
  ClinicalTrials.gov Identifier: NCT00409214 - Recruiting
  Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
  
• Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
  ClinicalTrials.gov Identifier: NCT00561171 - Not yet recruiting
  Hypertension; Type II Diabetes Mellitus
  
• Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
  ClinicalTrials.gov Identifier: NCT00541320 - Terminated
  Venous Thromboembolism
  
• Phase IIa Vorinostat Study in Lower Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00486720 - Recruiting
  Myelodysplastic Syndromes; Blood Disease; Bone Marrow Disease
  
• Phase IIA Window Study of Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00509600 - Recruiting
  Leukemia
  
• Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00431561 - Active, not recruiting
  Glioblastoma; Anaplastic Astrocytoma
  
• Phase IIb Randomized Controlled Study of BLP25 Liposome Vaccine for Immunotherapy of Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00157209 - Active, not recruiting
  Lung Neoplasms; Carcinoma, Non-Small-Cell Lung
  
• Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
  ClinicalTrials.gov Identifier: NCT00492960 - Recruiting
  Celiac Disease
  
• Phase III ALTU-135 CP Safety Trial
  ClinicalTrials.gov Identifier: NCT00500084 - Recruiting
  Pancreatic Insufficiency
  
• Phase III ALTU-135 Safety Trial
  ClinicalTrials.gov Identifier: NCT00449904 - Recruiting
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• Phase III Clinical Trial of Fentanyl Transdarmal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
  ClinicalTrials.gov Identifier: NCT00216684 - Completed
  Pain, Intractable
  
• Phase III Comparative Study(Double-Blind) of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144521 - Completed
  Rheumatoid Arthritis
  
• Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144508 - Completed
  Rheumatoid Arthritis
  
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
  ClinicalTrials.gov Identifier: NCT00004817 - Completed
  Post-Traumatic Seizure Disorder; Head Injuries
  
• Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00002070 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Phase III Hypothermia Clinical Trial
  ClinicalTrials.gov Identifier: NCT00222742 - Not yet recruiting
  Traumatic Brain Injury
  
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
  ClinicalTrials.gov Identifier: NCT00004286 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease
  ClinicalTrials.gov Identifier: NCT00002145 - Completed
  HIV Infections; Gastrointestinal Diseases
  
• Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00499109 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00206752 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck
  
• Phase III Open Label Atazanavir (BMS-232632) in Combination with Ritonavir or Saquinavir, and Lopinavir/Ritonavir, each with Tenofovir and a Nucleoside in Subjects with HIV
  ClinicalTrials.gov Identifier: NCT00035932 - Active, not recruiting
  HIV Infections
  
• Phase III PEG-Intron in HIV-infected patients
  ClinicalTrials.gov Identifier: NCT00035360 - Completed
  HIV Infections; AIDS
  
• Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia
  ClinicalTrials.gov Identifier: NCT00004390 - Completed
  Pain; Herpes Zoster
  
• Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
  ClinicalTrials.gov Identifier: NCT00002238 - Completed
  HIV Infections
  
• Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/day, and Placebo in AIDS Patients With Anorexia and Cachexia
  ClinicalTrials.gov Identifier: NCT00002067 - Completed
  Anorexia; Cachexia; HIV Infections
  
• Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00337389 - Active, not recruiting
  Metastatic Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients with Enterocutaneous Fistulae as a Complication of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00004941 - Completed
  Crohn's Disease
  
• Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
  ClinicalTrials.gov Identifier: NCT00014742 - Not yet recruiting
  Dupuytren's Contracture
  
• Phase III Randomized Study of Cyclophosphamide with or without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients with Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00004474 - Active, not recruiting
  Aplastic Anemia
  
• Phase III Randomized Study of Diazepam vs Lorazepam vs Placebo for Prehospital Treatment of Status Epilepticus
  ClinicalTrials.gov Identifier: NCT00004297 - Completed
  Status Epilepticus
  
• Phase III Randomized Study of High vs Standard Dose of Interferon alfa for Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00004804 - Completed
  Hepatitis C
  
• Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis
  ClinicalTrials.gov Identifier: NCT00004402 - Completed
  Osteopetrosis
  
• Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
  ClinicalTrials.gov Identifier: NCT00004500 - Recruiting
  Meconium Aspiration
  
• Phase III Randomized Study of Melphalan With or Without Holmium Ho 166 DOTMP Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00008229 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Phase III Randomized Study of Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion for Smoking Cessation and Prevention of Relapse in Participants Who Currently Smoke
  ClinicalTrials.gov Identifier: NCT00033592 - Completed
  Small Cell Lung Cancer; prevention of lung cancer; Non-small cell lung cancer
  
• Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
  ClinicalTrials.gov Identifier: NCT00006132 - Recruiting
  Herpes Simplex
  
• Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
  ClinicalTrials.gov Identifier: NCT00006135 - Completed
  Herpes Simplex
  
• Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00004408 - Active, not recruiting
  Sickle Cell Anemia
  
• Phase III Randomized Study of Sodium Dichloroacetate in Children with Congenital Lactic Acidosis
  ClinicalTrials.gov Identifier: NCT00004490 - Active, not recruiting
  Lactic Acidosis
  
• Phase III Randomized Study of SYNSORB Pk in Children with E. coli-Associated Hemolytic Uremic Syndrome
  ClinicalTrials.gov Identifier: NCT00004465 - Completed
  Hemolytic Uremic Syndrome
  
• Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
  ClinicalTrials.gov Identifier: NCT00004650 - Completed
  Osteoporosis
  
• Phase III Randomized Study of the Inhalation of Tobramycin in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004829 - Completed
  Cystic Fibrosis; Bacterial Infection
  
• Phase III Randomized Study of Ursodiol with vs without Methotrexate for Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00004784 - Completed
  Liver Cirrhosis, Biliary
  
• Phase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00004497 - Completed
  Pulmonary Hypertension
  
• Phase III Randomized Study of Vapreotide in Patients Undergoing Elective Pancreatic Resection
  ClinicalTrials.gov Identifier: NCT00014651 - Active, not recruiting
  perioperative/postoperative complications; stage I pancreatic cancer
  
• Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00323830 - Recruiting
  Gastric Cancer; Surgery
  
• Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD.
  ClinicalTrials.gov Identifier: NCT00215943 - Suspended
  Multiple Myeloma
  
• Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
  ClinicalTrials.gov Identifier: NCT00004278 - Completed
  Cytomegalovirus Infections
  
• Phase III Randomized, Double-Blind Study of Dexamethasone vs Dexamethasone/Methylprednisolone vs Placebo for Bronchopulmonary Dysplasia
  ClinicalTrials.gov Identifier: NCT00004785 - Completed
  Bronchopulmonary Dysplasia
  
• Phase III Randomized, Double-Blind Study of Potassium Phosphate vs Potassium Citrate for Absorptive Hypercalciuria
  ClinicalTrials.gov Identifier: NCT00004284 - Completed
  Hypercalciuria; Kidney Calculi
  
• Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00004646 - Completed
  Duchenne Muscular Dystrophy
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00004939 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
  ClinicalTrials.gov Identifier: NCT00004799 - Completed
  Pertussis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
  ClinicalTrials.gov Identifier: NCT00004800 - Completed
  Pertussis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women with Threatened Premature Delivery
  ClinicalTrials.gov Identifier: NCT00004778 - Completed
  Respiratory Distress Syndrome
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004814 - Completed
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Active Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004662 - Completed
  Systemic Lupus Erythematosus
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00004313 - Completed
  Addison's Disease
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
  ClinicalTrials.gov Identifier: NCT00004802 - Completed
  Paralysis, Hyperkalemic Periodic; Hypokalemic Periodic Paralysis; Paramyotonia Congenita
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00004376 - Completed
  Tourette Syndrome
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00004772 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00004647 - Completed
  Pain; Diabetic Neuropathies; Paresthesia
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00004786 - Completed
  Systemic Sclerosis; Raynaud Disease
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
  ClinicalTrials.gov Identifier: NCT00004776 - Completed
  Lennox-Gastaut Syndrome
  
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
  ClinicalTrials.gov Identifier: NCT00004645 - Active, not recruiting
  Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ...
  
• Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
  ClinicalTrials.gov Identifier: NCT00004757 - Completed
  Herpes Simplex
  
• Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
  ClinicalTrials.gov Identifier: NCT00004654 - Completed
  Hereditary Hemorrhagic Telangiectasia
  
• Phase III RCT of UFT/LV Versus UFT/LV+PSK for Stage IIIa/IIIb Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00497107 - Recruiting
  Colorectal Cancer
  
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
  ClinicalTrials.gov Identifier: NCT00288951 - Active, not recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced NSCLC in Patients With Mutations in the TK Domain of EGFR
  ClinicalTrials.gov Identifier: NCT00446225 - Recruiting
  Non-Small Cell Lung Cancer
  
• Phase III Study evaluating immunogenicity and safety of GSK Fluarix Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00100399 - Active, not recruiting
  Influenza
  
• Phase III Study for Aggressive ATLL (JCOG9801, ATL98)
  ClinicalTrials.gov Identifier: NCT00145002 - Completed
  adult T-cell leukemia / lymphoma
  
• Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)
  ClinicalTrials.gov Identifier: NCT00437554 - Completed
  Diabetes Mellitus, Type 2
  
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567762 - Completed
  Keratoconjunctivitis; Conjunctivitis
  
• Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
  ClinicalTrials.gov Identifier: NCT00419419 - Completed
  Raynaud's Disease; Scleroderma; Autoimmune Diseases
  
• Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes
  ClinicalTrials.gov Identifier: NCT00579189 - Recruiting
  Acute Otitis Media With Tympanostomy Tubes
  
• Phase III Study of Atamestane Plus Toremifene versus Letrozole in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00044291 - Completed
  Breast Neoplasms; Neoplasms, Hormone-Dependent
  
• Phase III Study of BAY 43-9006 in Japanese Patients With Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00494299 - Recruiting
  Cancer; Liver Cancer; Hepatocellular Carcinoma
  
• Phase III Study of BMS-188667 (CTLA4Ig) in patients with rheumatoid arthritis who are currently failing anti-TNF therapy or who have failed anti-TNF therapy in the past.
  ClinicalTrials.gov Identifier: NCT00048581 - Completed
  Rheumatoid Arthritis
  
• Phase III Study of Cetuximab, Oxaliplatin, 5-FU/LV vs. Oxaliplatin, 5-FU/LV in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00061815 - Active, not recruiting
  Colorectal Cancer
  
• Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux
  ClinicalTrials.gov Identifier: NCT00004487 - Active, not recruiting
  Vesicoureteral Reflux
  
• Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00287768 - Recruiting
  Gastric Cancer
  
• Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients with Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00148291 - Completed
  Lung Cancer
  
• Phase III Study of Gemcitabine Compared with UFT in Patients with Completely Resected pStage IB-IIIa Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00139971 - Recruiting
  Lung Cancer
  
• Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents
  ClinicalTrials.gov Identifier: NCT00191438 - Completed
  Breast Neoplasms
  
• Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
  ClinicalTrials.gov Identifier: NCT00420277 - Recruiting
  Hypotension; Ischemia
  
• Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
  ClinicalTrials.gov Identifier: NCT00421200 - Recruiting
  Hypotension; Ischemia
  
• Phase III Study of Imatinib Mesylate in Combination with Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients with Temozolomide Resistant Progressive Glioblastoma
  ClinicalTrials.gov Identifier: NCT00154375 - Completed
  Glioblastoma multiforme, astrocytoma
  
• Phase III Study of Irinotecan and Cetuximab vs Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00063141 - Active, not recruiting
  Colorectal Cancer
  
• Phase III Study of L-Cysteine in Patients with Erythropoietic Protoporphyria
  ClinicalTrials.gov Identifier: NCT00004940 - Active, not recruiting
  Erythropoietic Protoporphyria
  
• Phase III Study of Monolaurin Cream Therapy for Patients with Congenital Ichthyosis
  ClinicalTrials.gov Identifier: NCT00004690 - Active, not recruiting
  Ichthyosis
  
• Phase III Study of MRA for Polyarticular Juvenile Idiopathic Arthritis(pJIA)
  ClinicalTrials.gov Identifier: NCT00144664 - Completed
  systemic juvenile idiopathic arthritis
  
• Phase III Study of MRA for Systemic Juvenile Idiopathic Arthritis(sJIA)
  ClinicalTrials.gov Identifier: NCT00144599 - Completed
  systemic juvenile idiopathic arthritis
  
• Phase III Study of PI-88 in Post-Resection Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00568308 - Recruiting
  Cancer; Liver Cancer; Primary Liver Cancer; Hepatocellular Carcinoma; Hepatoma
  
• Phase III Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00134563 - Recruiting
  Multiple Sclerosis with relapses
  
• Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00260884 - Completed
  Gastric Cancer
  
• Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
  ClinicalTrials.gov Identifier: NCT00266669 - Completed
  Raynaud's Disease
  
• Phase III Study of Two Different Schedules (Weekly and Tri-Weekly) of Combination of Gemcitabine and Two Taxanes in MBC
  ClinicalTrials.gov Identifier: NCT00236899 - Recruiting
  Metastatic Breast Cancer (MBC)
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy
  
• Phase III Study Treatment of CLL B and C
  ClinicalTrials.gov Identifier: NCT00535912 - Completed
  Leukemia, Lymphocytic, Chronic
  
• Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00468767 - Completed
  Atrial Fibrillation
  
• PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCIN
  ClinicalTrials.gov Identifier: NCT00180973 - Active, not recruiting
  LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT
  
• Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
  ClinicalTrials.gov Identifier: NCT00432744 - Recruiting
  Mitochondrial Diseases
  
• Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
  ClinicalTrials.gov Identifier: NCT00472901 - Recruiting
  Polymorphic Light Eruption (PLE)
  
• Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00313872 - Terminated
  Gastric Cancer; Metastases
  
• Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00486460 - Recruiting
  Pancreatic Cancer
  
• Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00295035 - Not yet recruiting
  Colon Neoplasm
  
• Phase III Trial of HSV-2 Suppression in Sero-Discordant Couples and Substudy on Role of TNF-a in HIV-1 Transmission
  ClinicalTrials.gov Identifier: NCT00197574 - Recruiting
  Risk for HIV Infection
  
• Phase III Trial of Neoadjuvant TS-1 and CDDP for Type 4 and Large Type 3 Gastric Cancer.JCOG0501
  ClinicalTrials.gov Identifier: NCT00252161 - Recruiting
  Gastric Neoplasm
  
• Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
  ClinicalTrials.gov Identifier: NCT00225290 - Recruiting
  Carcinoma, Hepatocellular
  
• Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With TCC of the Urothelial Tract
  ClinicalTrials.gov Identifier: NCT00315237 - Active, not recruiting
  Transitional Cell Carcinoma of the Urothelial Tract; Bladder Cancer; Bladder Neoplasms
  
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
  Keratoconjunctivitis; Conjunctivitis
  
• Phase III, Open, Comparative Study in Healthy Adults Aged 18-50 Years Administered With Hepatyrix or Havrix + Typherix or Tiphim Vi, to Compare Reactogenicity and Immunogenicity.
  ClinicalTrials.gov Identifier: NCT00197249 - Active, not recruiting
  Prophylaxis of Typhoid and Hepatitis A and B
  
• Phase III/Seroquel SR Bipolar Depression Monotherapy - US
  ClinicalTrials.gov Identifier: NCT00422214 - Completed
  Affective Psychosis, Bipolar; Depression, Bipolar; Manic-Depressive Psychosis; Psychoses, Manic-Depressive
  
• Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
  ClinicalTrials.gov Identifier: NCT00535795 - Active, not recruiting
  Nasopharyngeal CA
  
• Phase IIIB Subcutaneous Abatacept Monotherapy Study
  ClinicalTrials.gov Identifier: NCT00547521 - Not yet recruiting
  Rheumatoid Arthritis (RA)
  
• Phase IIIB Subcutaneous Missed Dose Study
  ClinicalTrials.gov Identifier: NCT00533897 - Recruiting
  Rheumatoid Arthritis
  
• Phase IV Capecitabine and Docetaxel Combination for Neoadjuvant Treatment of Patients with Recently Diagnosed Breast Cancer and with Trastuzumab for Patients That Are Positive for Her2-Neu.
  ClinicalTrials.gov Identifier: NCT00127933 - Active, not recruiting
  Breast Cancer
  
• Phase IV Clinical Trial of an Influenza Split Vaccine Anflu
  ClinicalTrials.gov Identifier: NCT00556062 - Completed
  Influenza
  
• Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00004754 - Completed
  Hypertension, Pulmonary
  
• Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
  ClinicalTrials.gov Identifier: NCT00047554 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
  ClinicalTrials.gov Identifier: NCT00526448 - Recruiting
  Chronic Hepatitis C
  
• Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency.
  ClinicalTrials.gov Identifier: NCT00243542 - Completed
  Acne Vulgaris
  
• Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone Vaccine
  ClinicalTrials.gov Identifier: NCT00561002 - Recruiting
  Influenza Vaccine
  
• Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine
  ClinicalTrials.gov Identifier: NCT00258817 - Active, not recruiting
  Influenza
  
• Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine
  ClinicalTrials.gov Identifier: NCT00389532 - Active, not recruiting
  Influenza Vaccines
  
• Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances
  ClinicalTrials.gov Identifier: NCT00356096 - Completed
  Restless Legs Syndrome; Depression
  
• Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
  ClinicalTrials.gov Identifier: NCT00242814 - Recruiting
  Hypertension; Metabolic Syndrome X
  
• Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium
  ClinicalTrials.gov Identifier: NCT00176592 - Active, not recruiting
  Multiple Sclerosis
  
• Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
  ClinicalTrials.gov Identifier: NCT00531947 - Recruiting
  Mental Health; Major Depressive Disorder
  
• Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®
  ClinicalTrials.gov Identifier: NCT00532012 - Completed
  Pharmacokinetics
  
• Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00371553 - Not yet recruiting
  Relapsed or Cisplatin-Refractory Germ Cell Cancer
  
• PhaseⅢOpen-Label Study of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00380601 - Recruiting
  Rheumatoid Arthritis
  
• Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
  ClinicalTrials.gov Identifier: NCT00005883 - Active, not recruiting
  Lung Cancer
  
• Phenotype and Etiology of Pallister-Hall Syndrome
  ClinicalTrials.gov Identifier: NCT00001404 - Recruiting
  Epilepsy; Hamartoma; Multiple Abnormalies; Syndactyly
  
• Phenotype/Genotype Correlations in Movement Disorders
  ClinicalTrials.gov Identifier: NCT00018889 - Recruiting
  Movement Disorder
  
• Phenotype/Genotype Correlations in Neuromuscular Disorders
  ClinicalTrials.gov Identifier: NCT00017745 - Completed
  Neuromuscular Disease
  
• Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-Centered US Study
  ClinicalTrials.gov Identifier: NCT00573846 - Active, not recruiting
  Inflammatory Bowel Diseases
  
• Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Treating Patients With Recurrent Late-Stage Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00091377 - Active, not recruiting
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Phenoxodiol in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00022295 - Completed
  unspecified adult solid tumor, protocol specific
  
• Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003241 - Completed
  recurrent childhood ependymoma; recurrent childhood medulloblastoma; recurrent childhood brain stem glioma; high-grade childhood cerebral astrocytoma; ...
  
• Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006239 - Completed
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
  ClinicalTrials.gov Identifier: NCT00387530 - Recruiting
  Gastric Cancer; Head and Neck Cancer; Lymphoma
  
• Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System
  ClinicalTrials.gov Identifier: NCT00006238 - Active, not recruiting
  Brain Cancer
  
• Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002909 - Completed
  Leukemia; Lymphoma
  
• Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006019 - Completed
  Lung Cancer; Leukemia; Lymphoma; Prostate Cancer
  
• Phenylbutyrate to Treat Children with Progressive or Recurrent Brain Tumors
  ClinicalTrials.gov Identifier: NCT00006450 - Completed
  Brain Tumor
  
• Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006240 - Completed
  recurrent adult acute myeloid leukemia
  
• Phenylephrine in Spinal Anesthesia in Preeclamptic Patients
  ClinicalTrials.gov Identifier: NCT00458003 - Recruiting
  Preeclampsia; Spinal Anesthesia; Hypotension; Cesarean Section
  
• Phenylephrine Versus Norepinephrine in Septic Shock
  ClinicalTrials.gov Identifier: NCT00481442 - Completed
  Septic Shock
  
• Phenytoin and Driving Safety
  ClinicalTrials.gov Identifier: NCT00581893 - Recruiting
  Cognitive Measures; Driving Simulator Performance
  
• Phenytoin as an Augmentation for SSRI Failures
  ClinicalTrials.gov Identifier: NCT00146237 - Recruiting
  Depression
  
• PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
  ClinicalTrials.gov Identifier: NCT00439673 - Active, not recruiting
  Myelodysplastic Syndromes
  
• PhII ICb With/Without Erbitux in MBC Pts
  ClinicalTrials.gov Identifier: NCT00248287 - Recruiting
  Metastatic Breast Cancer
  
• PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone
  ClinicalTrials.gov Identifier: NCT00291005 - Completed
  Prostatic Neoplasms
  
• phII Study of an HDAC Inhibitor in Very High-Risk Relapsed/Refractory Hodgkin's Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00496431 - Recruiting
  Hodgkin's Lymphoma
  
• PHIRST-1: Safety and Efficacy of Tadalafil in the Treatment of Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00125918 - Active, not recruiting
  Pulmonary Hypertension
  
• PHOENIX - Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00252330 - Completed
  Major Depressive Disorder
  
• Phosphate Intake's Effect on the Skeletal System - Pilot
  ClinicalTrials.gov Identifier: NCT00187629 - Recruiting
  Healthy; Kidney Failure, Chronic
  
• Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00004129 - Recruiting
  recurrent adult brain tumor; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006212 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Photodynamic and Pharmacologic Treatment of CNV
  ClinicalTrials.gov Identifier: NCT00570193 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• Photodynamic Lasertherapy (PDT) in Periodontal Treatment (in Vivo)
  ClinicalTrials.gov Identifier: NCT00196456 - Completed
  Periodontal Disease
  
• Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
  ClinicalTrials.gov Identifier: NCT00116571 - Terminated
  Prostatic Hyperplasia
  
• Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00472108 - Completed
  Basal Cell Carcinoma
  
• Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
  ClinicalTrials.gov Identifier: NCT00002167 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
  ClinicalTrials.gov Identifier: NCT00155337 - Recruiting
  Oral Leukoplakia
  
• Photodynamic Therapy for Permanent Hair Removal
  ClinicalTrials.gov Identifier: NCT00371930 - Not yet recruiting
  Hypertrichosis; Hirsutism
  
• Photodynamic Therapy in Occult-Only Lesions (POOL)
  ClinicalTrials.gov Identifier: NCT00135837 - Completed
  Age related Macula Degeneration (AMD)
  
• Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00017485 - Active, not recruiting
  basal cell carcinoma of the skin; recurrent skin cancer
  
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
  ClinicalTrials.gov Identifier: NCT00003923 - Active, not recruiting
  Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
  
• Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00002935 - Active, not recruiting
  stage 0 esophageal cancer
  
• Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00054171 - Completed
  B-cell Chronic Lymphocytic Leukemia; stage I cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00281736 - Suspended
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Photodynamic Therapy in Treating Patients With Skin Cancer
  ClinicalTrials.gov Identifier: NCT00002963 - Completed
  basal cell carcinoma of the skin; squamous cell carcinoma of the skin
  
• Photodynamic Therapy in Treating Patients With Skin Cancer
  ClinicalTrials.gov Identifier: NCT00002975 - Recruiting
  basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis
  
• Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
  ClinicalTrials.gov Identifier: NCT00023790 - Active, not recruiting
  adult solid tumor; Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; skin tumor
  
• Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00007969 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study
  ClinicalTrials.gov Identifier: NCT00206895 - Completed
  Acne Vulgaris
  
• Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00014066 - Completed
  recurrent non-small cell lung cancer; limited stage small cell lung cancer; Recurrent Small Cell Lung Cancer; stage I non-small cell lung cancer; ...
  
• Photodynamic Therapy System for Patients with Refractory/Unresponsive Solid Tumors
  ClinicalTrials.gov Identifier: NCT00028405 - Completed
  Liver Metastasis; Pelvic Cancer; Head and Neck Cancer; Sarcoma; Rectal Cancer; Breast Cancer; Colorectal Cancer; Mouth Cancer
  
• Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00571558 - Recruiting
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00470496 - Recruiting
  Head and Neck Cancer
  
• Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages
  ClinicalTrials.gov Identifier: NCT00528775 - Recruiting
  Lung Cancer
  
• Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
  ClinicalTrials.gov Identifier: NCT00060268 - Active, not recruiting
  recurrent esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer
  
• Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00526461 - Recruiting
  Lung Cancer
  
• Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00005808 - Completed
  Cervical Cancer
  
• Photodynamic Therapy Using Porfimer Sodium in Treating Patients Who Are Undergoing Surgery for Recurrent Malignant Astrocytoma
  ClinicalTrials.gov Identifier: NCT00118222 - Active, not recruiting
  Mixed Gliomas; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
  
• Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00530088 - Recruiting
  Head and Neck Cancer
  
• Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00103246 - Recruiting
  actinic keratosis; Cutaneous T-Cell Lymphoma; Skin Cancer
  
• Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00524485 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)
  ClinicalTrials.gov Identifier: NCT00211445 - Completed
  Chronic Central Serous Chorioretinopathy
  
• Photodynamic Therapy With HPPH in Treating Patients With Early Stage Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025571 - Active, not recruiting
  Squamous Cell Lung Cancer; stage 0 non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005067 - Completed
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
  
• Photodynamic Therapy With or Without Methyl-5-aminolevulinate in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00022503 - No longer recruiting
  basal cell carcinoma of the skin
  
• Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
  ClinicalTrials.gov Identifier: NCT00308854 - Completed
  Actinic Keratosis
  
• Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
  ClinicalTrials.gov Identifier: NCT00453336 - Recruiting
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
  ClinicalTrials.gov Identifier: NCT00002647 - Recruiting
  adult brain tumor; brain metastases; childhood brain stem glioma; childhood brain tumor; childhood cerebellar astrocytoma; ...
  
• Photodynamic Therapy with Talaporfin Sodium (LS11) in Treating Patients with Refractory Colorectal Liver Metastases
  ClinicalTrials.gov Identifier: NCT00068068 - Completed
  Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
  
• Photodynamic Therapy With Verteporfin for Corneal Neovascularization
  ClinicalTrials.gov Identifier: NCT00471406 - Completed
  Corneal Neovascularization
  
• Photodynamic Treatment of Endotracheal Tubes
  ClinicalTrials.gov Identifier: NCT00529685 - Not yet recruiting
  Hospital-Acquired Infections
  
• Photographic Assessment of Eyebrow Position and Range of Motion
  ClinicalTrials.gov Identifier: NCT00347308 - Not yet recruiting
  Brow Ptosis
  
• Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls
  ClinicalTrials.gov Identifier: NCT00430274 - Recruiting
  Glaucoma
  
• Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
  ClinicalTrials.gov Identifier: NCT00221039 - Recruiting
  Cutaneous T Cell Lymphoma; Mycosis Fungoides
  
• Photoselective Vaporization of the Prostate Compared to Transurethral Resection of the Prostate for the Treatment of Benign Hyperplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00527371 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00492895 - Recruiting
  Photosensitivity
  
• PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
  ClinicalTrials.gov Identifier: NCT00359008 - Completed
  Age Related Macular Degeneration
  
• PHS, Lichtenstein Mesh, and PerFixPlug for Primary Inguinal Hernia Repair - 3 Years Results
  ClinicalTrials.gov Identifier: NCT00580177 - Completed
  Hernia, Inguinal
  
• Phs. II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients W/Advanced Stage or Inoperable Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00200395 - Suspended
  Non-Small Cell Lung Cancer
  
• Physical Activities in Daily Life After Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00395889 - Recruiting
  Lung Transplantation
  
• Physical Activity After Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00501761 - Recruiting
  Endometrial Cancer
  
• Physical Activity After Stroke: How Does it Effect Chronical Inflammation and Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00376207 - Completed
  Cerebral Infarction
  
• Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study
  ClinicalTrials.gov Identifier: NCT00359060 - Completed
  Breast Cancer
  
• Physical Activity and Cardiovascular Disease Prevention
  ClinicalTrials.gov Identifier: NCT00005447 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction
  
• Physical Activity and Cardiovascular Risk in Black Girls
  ClinicalTrials.gov Identifier: NCT00005437 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Obesity
  
• Physical Activity and Childhood Obesity
  ClinicalTrials.gov Identifier: NCT00063544 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Physical Activity and Functioning in Palliative Cancer Patients - a Clinical Randomised Trial
  ClinicalTrials.gov Identifier: NCT00397774 - Recruiting
  Palliative Care; Cancer; Physical Exercise; Physical Function
  
• Physical Activity and Immigrant Health
  ClinicalTrials.gov Identifier: NCT00539903 - Not yet recruiting
  Activity Level
  
• Physical Activity and Inactivity in Lung Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00582348 - Recruiting
  Lung Cancer Survivors
  
• Physical Activity as an Aid for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00521391 - Terminated
  Tobacco Dependence; Cardiovascular Diseases; Physical Activity
  
• Physical Activity Effects on Health Care Utilization
  ClinicalTrials.gov Identifier: NCT00005415 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Physical Activity in Fontan Patients
  ClinicalTrials.gov Identifier: NCT00363363 - Active, not recruiting
  Heart Defects, Congenital
  
• Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00554489 - Recruiting
  Leukemia
  
• Physical Activity in Preventing Breast Cancer in Women With a History of Breast Cancer or at High Risk for Breast Cancer Who Are Not Physically Active
  ClinicalTrials.gov Identifier: NCT00095849 - Active, not recruiting
  Breast Cancer
  
• Physical Activity Management for Clients With Arthritis
  ClinicalTrials.gov Identifier: NCT00248105 - Recruiting
  Osteoarthritis, Knee; Rheumatoid Arthritis
  
• Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00509626 - Recruiting
  Breast Cancer; Depression; Fatigue; Psychosocial Effects/Treatment; Weight Changes
  
• Physical Activity Promotion in Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00221221 - Completed
  Breast Cancer
  
• Physical Activity Promotion in Cancer Follow-Up Care
  ClinicalTrials.gov Identifier: NCT00230711 - Recruiting
  Breast Cancer
  
• Physical Activity, Body Composition, and Prevalent Asthma
  ClinicalTrials.gov Identifier: NCT00037375 - Completed
  Asthma; Lung Diseases
  
• Physical Activity, Calcium, and Bone in Children
  ClinicalTrials.gov Identifier: NCT00000415 - Completed
  Physical activity; Nutrition
  
• Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005419 - Completed
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Coronary Disease; Hypertension; Diabetes Mellitus, non-insulin dependent
  
• Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00268541 - Completed
  Type 2 Diabetes Mellitus; Cardiovascular Diseases
  
• Physical and Behavioral Traits of Overweight and Obese Adults
  ClinicalTrials.gov Identifier: NCT00428987 - Recruiting
  Morbid Obesity; Diabetes Mellitus Type 2; Insulin Resistance; Obstructive Sleep Apnea; Mood Disorders
  
• Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00499785 - Recruiting
  Cognitive/Functional Effects; Depression; Leukemia
  
• Physical and Mental Load in the Surgeon Performing Laparoscopic Tasks
  ClinicalTrials.gov Identifier: NCT00311285 - Not yet recruiting
  Stress
  
• Physical CAM Therapies for Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00065975 - Completed
  Chronic Low Back Pain
  
• Physical Characteristics of Retrieved Massive Allografts
  ClinicalTrials.gov Identifier: NCT00160758 - Recruiting
  Bone Cancer
  
• Physical Conditioning in Management of Chronic Venous Insufficiency
  ClinicalTrials.gov Identifier: NCT00013273 - Completed
  Venous Insufficiency
  
• Physical Fitness and Cardiovascular Mortality in Firefighters
  ClinicalTrials.gov Identifier: NCT00005540 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Hypertension; Obesity
  
• Physical Inactivity and Insulin Resistance in Skeletal Muscle.
  ClinicalTrials.gov Identifier: NCT00536211 - Not yet recruiting
  Metabolic Syndrome X; Insulin Resistance; Hypertension; Hypercholesterolemia; Obesity
  
• Physical Performance Measures for Manual Wheelchair Users
  ClinicalTrials.gov Identifier: NCT00011544 - Completed
  Spinal Cord Injury
  
• Physical Therapy After Anti-Spastic Treatment in Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00552721 - Recruiting
  Cerebral Palsy
  
• Physical Therapy for Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00152555 - Terminated
  Lupus Erythematosus, Systemic; SLE
  
• Physical Therapy Trial for Pelvic Pain
  ClinicalTrials.gov Identifier: NCT00434343 - Recruiting
  Interstitial Cystitis; Painful Bladder Syndrome; Chronic Prostatitis; Chronic Pelvic Pain Syndrome
  
• Physical Training and Blood Pressure in High Risk Youths
  ClinicalTrials.gov Identifier: NCT00005695 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Obesity
  
• Physical,Histological,and Genetic Analyses of Lipid-Rich Atherosclerotic Plaques
  ClinicalTrials.gov Identifier: NCT00449306 - Recruiting
  Atherosclerosis; Aortic Aneurysm; Peripheral Vascular Diseases
  
• Physician Uncertainty Reduction for Hypertension
  ClinicalTrials.gov Identifier: NCT00201084 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Physician's Comfort Level and Satisfaction Study With The e2TM Collector Compared to the Spatula/CytoBrush Technique
  ClinicalTrials.gov Identifier: NCT00496314 - Recruiting
  Cervical Cell Collection
  
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
  ClinicalTrials.gov Identifier: NCT00002520 - Active, not recruiting
  Leukemia; Lymphoma; Head and Neck Cancer; Lung Cancer; Eye Cancer; Gastrointestinal Cancer; Oral Cancer; Reproductive Cancer
  
• Physicians Survey on Genetic Testing
  ClinicalTrials.gov Identifier: NCT00341107 - Completed
  Cancer
  
• Physicians' Health Study
  ClinicalTrials.gov Identifier: NCT00000500 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Physicians' Health Study II: Vitamin E, Ascorbic Acid, Beta Carotene, and/or Multivitamins in Preventing Cancer and Cardiovascular Disease in Older Healthy Male Doctors
  ClinicalTrials.gov Identifier: NCT00270647 - Active, not recruiting
  Colorectal Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Physicians' Health Study: Study of Low Cardiovascular Disease Mortality
  ClinicalTrials.gov Identifier: NCT00005252 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction
  
• Physicians' Understanding of Human Genetic Variation
  ClinicalTrials.gov Identifier: NCT00339924 - Recruiting
  Genetic Variation
  
• Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
  ClinicalTrials.gov Identifier: NCT00018356 - Completed
  Muscle Weakness; Muscular Atrophy
  
• Physiologic Growth Hormone Effects in HIV Lipodstrophy
  ClinicalTrials.gov Identifier: NCT00100698 - Active, not recruiting
  AIDS; HIV Infections
  
• Physiologic Regulation of FGF-23
  ClinicalTrials.gov Identifier: NCT00356512 - Recruiting
  Hypoparathyroidism
  
• Physiologic Studies of Spasticity
  ClinicalTrials.gov Identifier: NCT00014976 - Recruiting
  Muscle Spasticity; Healthy
  
• Physiological and Psychosocial Correlates of Type A Behavior
  ClinicalTrials.gov Identifier: NCT00005155 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00277004 - Completed
  Breast; Cancer
  
• Physiological Brain Atlas Development
  ClinicalTrials.gov Identifier: NCT00575081 - Recruiting
  Parkinson's Disease; Dystonia; Essential Tremor; OCD
  
• Physiological Effects of Androstadienone Exposure
  ClinicalTrials.gov Identifier: NCT00553384 - Not yet recruiting
  Healthy
  
• Physiological, Behavioral and Subjective Effects of Drugs (GHB)
  ClinicalTrials.gov Identifier: NCT00058955 - Recruiting
  Sedative abuse
  
• Physiology of Weakness in Movement Disorders
  ClinicalTrials.gov Identifier: NCT00307346 - Recruiting
  Movement Disorders
  
• Physiopathology of Sodium Retention in Acromegaly
  ClinicalTrials.gov Identifier: NCT00531908 - Recruiting
  Acromegaly
  
• Phytoestrogens and Memory Decline in Menopause
  ClinicalTrials.gov Identifier: NCT00051402 - Completed
  Memory Loss; Postmenopausal Period
  
• Phytosterol Supplementation and Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00153738 - Active, not recruiting
  Hypercholesteremia
  
• PI Vs. NNRTI Based Therapy for HIV Advanced Disease
  ClinicalTrials.gov Identifier: NCT00162643 - Recruiting
  Acquired Immunodeficiency Syndrome
  
• PI-88 and/or Dacarbazine in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00128648 - Recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• PI-88 in Hepatocellular Carcinoma After Hepatectomy
  ClinicalTrials.gov Identifier: NCT00247728 - Completed
  Carcinoma, Hepatocellular
  
• PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00073892 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; Stage IV Melanoma; Recurrent Melanoma
  
• PiCCO Guided Therapy in Liver Cirrhosis
  ClinicalTrials.gov Identifier: NCT00232427 - Completed
  Liver Cirrhosis
  
• Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
  ClinicalTrials.gov Identifier: NCT00380497 - Recruiting
  Colonoscopy
  
• Picoplatin or Topotecan as Second-Line Therapy for Subjects with Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00116610 - Active, not recruiting
  Small Cell Lung Cancer
  
• PIE II: Pharmacological Intervention in the Elderly II
  ClinicalTrials.gov Identifier: NCT00123955 - Active, not recruiting
  Diastolic Heart Failure
  
• Piedra Flumist & Herd Immunity
  ClinicalTrials.gov Identifier: NCT00138294 - Recruiting
  Influenza
  
• Pigment Dispersion Syndrome With and Without Glaucoma
  ClinicalTrials.gov Identifier: NCT00001152 - Completed
  Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
  ClinicalTrials.gov Identifier: NCT00003686 - Active, not recruiting
  oral complications of cancer and cancer therapy; Quality of Life
  
• Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00343382 - Recruiting
  Breast Cancer; Sexual Dysfunction and Infertility; Sexuality and Reproductive Issues
  
• Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population
  ClinicalTrials.gov Identifier: NCT00182117 - Recruiting
  Bleeding; End Stage Renal Disease
  
• Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients
  ClinicalTrials.gov Identifier: NCT00384319 - Recruiting
  Resuscitation
  
• Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients
  ClinicalTrials.gov Identifier: NCT00410969 - Recruiting
  Heart Arrest; Coma
  
• Pilot Clinical Trial of Computer-Based Motivational Intervention - 1
  ClinicalTrials.gov Identifier: NCT00230022 - Not yet recruiting
  Behavior Therapy; Substance-Related Disorders
  
• Pilot Community Clinical Study of Hypothermia in Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00329563 - Completed
  Cardiac Arrest
  
• Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients
  ClinicalTrials.gov Identifier: NCT00571714 - Not yet recruiting
  Chronic Hepatitis C
  
• Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
  ClinicalTrials.gov Identifier: NCT00004770 - Completed
  Mitochondrial Myopathy
  
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
  ClinicalTrials.gov Identifier: NCT00412464 - Recruiting
  Thrombosis; Heparin-Induced Thrombocytopenia
  
• Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00268593 - Active, not recruiting
  Prostate Cancer
  
• Pilot Efficacy Study of T2000 in Myoclonus Dystonia
  ClinicalTrials.gov Identifier: NCT00506012 - Recruiting
  Myoclonus
  
• Pilot Efficacy Study to Treat Gingivitis
  ClinicalTrials.gov Identifier: NCT00391547 - Completed
  Gingival Diseases
  
• Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
  ClinicalTrials.gov Identifier: NCT00255307 - Completed
  Upper Respiratory Infection
  
• Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
  ClinicalTrials.gov Identifier: NCT00483795 - Completed
  Corneal Staining
  
• Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
  ClinicalTrials.gov Identifier: NCT00541931 - Recruiting
  Skin Aging; Aging
  
• Pilot Investigation of Ultrasound Imaging and Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Locally-Advanced Breast Cancer Response to Neoadjuvant Treatment
  ClinicalTrials.gov Identifier: NCT00437879 - Recruiting
  Locally Advanced Breast Cancer
  
• Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00531882 - Recruiting
  Cystic Fibrosis; Anti Inflammatory Non-Steroidal; Neutrophils
  
• Pilot Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00579423 - Active, not recruiting
  Prostate; Cancer
  
• Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00558506 - Not yet recruiting
  Ankylosing Spondylitis
  
• Pilot Placebo-Controlled Trial of Early Noninvasive Ventilation for ALS
  ClinicalTrials.gov Identifier: NCT00580593 - Recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• Pilot Protocol for the Treatment of Patients with Small Non-Cleaved and Diffuse Large Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00001237 - Completed
  Burkitt Lymphoma; Lymphoma, Large-Cell, Diffuse; Lymphoma, Small Noncleaved-Cell
  
• Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis
  ClinicalTrials.gov Identifier: NCT00004444 - Completed
  Tuberculosis, Pulmonary
  
• Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination
  ClinicalTrials.gov Identifier: NCT00219453 - Completed
  Virus Diseases; Hepatitis B
  
• Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
  ClinicalTrials.gov Identifier: NCT00193648 - Completed
  Focal Glomerulosclerosis
  
• Pilot Study - Comparison of Upper Body Ergometer Vs. Robot in Upper Extremity Motor Recovery Post-Stroke
  ClinicalTrials.gov Identifier: NCT00343304 - Completed
  Stroke
  
• Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
  ClinicalTrials.gov Identifier: NCT00222443 - Suspended
  Lymphomas; Tumors
  
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in COPD
  ClinicalTrials.gov Identifier: NCT00239499 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance
  ClinicalTrials.gov Identifier: NCT00187551 - Active, not recruiting
  HIV Infections
  
• Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania
  ClinicalTrials.gov Identifier: NCT00194064 - Terminated
  Bipolar Disorder
  
• Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
  ClinicalTrials.gov Identifier: NCT00544310 - Recruiting
  Bilateral Ovarian Disease
  
• Pilot Study Evaluating The Safety Of Avastin And Pelvic Radiation In Women With Vaginal Recurrence Of Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00545792 - Not yet recruiting
  Endometrial Cancer
  
• Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
  ClinicalTrials.gov Identifier: NCT00469521 - Completed
  Tear Film Thickness
  
• Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00514202 - Recruiting
  Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders; Substance-Related Disorders
  
• Pilot Study for Combined Colon and Endometrial Cancer Screening in Women With HNPCC
  ClinicalTrials.gov Identifier: NCT00510796 - Recruiting
  Colon Cancer
  
• Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00457327 - Recruiting
  Rectal Cancer
  
• Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00352092 - Active, not recruiting
  Renal Transplant
  
• Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling
  ClinicalTrials.gov Identifier: NCT00161278 - Recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Pilot Study Freeze and Transport Immune Cells
  ClinicalTrials.gov Identifier: NCT00138268 - Active, not recruiting
  Diphtheria; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  
• Pilot Study in Patients with Symptomatic Steroid-Naive Asthma
  ClinicalTrials.gov Identifier: NCT00024544 - Completed
  Asthma
  
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia in Asian Men
  ClinicalTrials.gov Identifier: NCT00540124 - Recruiting
  Benign Prostatic Hyperplasia
  
• Pilot Study of 18F Fluoropaclitaxel (FPAC)
  ClinicalTrials.gov Identifier: NCT00572598 - Active, not recruiting
  Breast Cancer
  
• Pilot Study of a Dietary Intervention to Prevent Acne Recurrence
  ClinicalTrials.gov Identifier: NCT00132574 - Terminated
  Acne
  
• Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
  ClinicalTrials.gov Identifier: NCT00001577 - Completed
  Melanoma; Sarcoma
  
• Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00467831 - Recruiting
  Hermansky-Pudlak Syndrome (HPS); Pulmonary Fibrosis; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Metabolic Disease
  
• Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
  ClinicalTrials.gov Identifier: NCT00405899 - Recruiting
  Allergy; Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis
  
• Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00008450 - Recruiting
  Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ...
  
• Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
  ClinicalTrials.gov Identifier: NCT00265408 - Active, not recruiting
  Ischemic Stroke; Cervicocephalic Arterial Dissection
  
• Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00488163 - Completed
  Schizophrenia
  
• Pilot Study of Atorvastatin in Children with Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
  ClinicalTrials.gov Identifier: NCT00004466 - Completed
  Nephrotic Syndrome; Hyperlipidemia
  
• Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)
  ClinicalTrials.gov Identifier: NCT00308230 - Recruiting
  Congenital Heart Disease; Cardiovascular Disease
  
• Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00547534 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Pilot Study of Budesonide for Patients with Primary Sclerosing Cholangitis
  ClinicalTrials.gov Identifier: NCT00004842 - Active, not recruiting
  Cholangitis, Sclerosing; Liver Cirrhosis, Biliary
  
• Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-Breastfeeding Women
  ClinicalTrials.gov Identifier: NCT00119210 - Active, not recruiting
  Tobacco Use Disorder
  
• Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients
  ClinicalTrials.gov Identifier: NCT00227162 - Active, not recruiting
  Asthma
  
• Pilot Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
  ClinicalTrials.gov Identifier: NCT00557362 - Recruiting
  Fungal Keratitis
  
• Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00113841 - Recruiting
  Multiple Myeloma
  
• Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
  ClinicalTrials.gov Identifier: NCT00010400 - Completed
  Systemic Lupus Erythematosus; Antiphospholipid Antibody Syndrome
  
• Pilot Study of Docetaxel and Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00364611 - Recruiting
  Breast Cancer
  
• Pilot Study of Duloxetine in Psychological Resilience
  ClinicalTrials.gov Identifier: NCT00331799 - Recruiting
  Major Depressive Disorder
  
• Pilot Study of Edaravone to Treat Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00265239 - Completed
  Myocardial Infarction; Reperfusion Injury
  
• Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00006137 - Completed
  IGA Glomerulonephritis
  
• Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
  ClinicalTrials.gov Identifier: NCT00294203 - Recruiting
  Anemia
  
• Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
  ClinicalTrials.gov Identifier: NCT00572689 - Recruiting
  Gestational Diabetes
  
• Pilot Study of Familial Nonsyndromal Mondini Dysplasia
  ClinicalTrials.gov Identifier: NCT00004336 - Completed
  Mondini dysplasia
  
• Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
  ClinicalTrials.gov Identifier: NCT00563576 - Recruiting
  Metrorrhagia
  
• Pilot Study of Fructose for Sickle Cell Crisis
  ClinicalTrials.gov Identifier: NCT00004797 - Completed
  Sickle Cell Anemia
  
• Pilot Study of Genotypic Analysis
  ClinicalTrials.gov Identifier: NCT00421837 - Recruiting
  Influenza
  
• Pilot Study of Growth Hormon to Treat SMA Typ II and III
  ClinicalTrials.gov Identifier: NCT00533221 - Not yet recruiting
  Muscular Atrophy, Spinal
  
• Pilot Study of Haloperidol to Treat Critical Illness Delirium
  ClinicalTrials.gov Identifier: NCT00429676 - Recruiting
  Delirium; Critical Illness
  
• Pilot Study Of Haplo-Identical Natural Killer Cell Transplantation For Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00187096 - Recruiting
  Acute Myeloid Leukemia
  
• Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
  ClinicalTrials.gov Identifier: NCT00317512 - Completed
  Angina Pectoris; Unstable Angina; Myocardial Infarction
  
• Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy
  ClinicalTrials.gov Identifier: NCT00061152 - Active, not recruiting
  HIV Infections
  
• Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
  ClinicalTrials.gov Identifier: NCT00034710 - Completed
  Neuralgia; Pain; Peripheral Nervous System Diseases; Herpes Zoster
  
• Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
  ClinicalTrials.gov Identifier: NCT00314873 - Active, not recruiting
  Thymic Carcinoma
  
• Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
  ClinicalTrials.gov Identifier: NCT00344071 - Active, not recruiting
  Inflammatory Breast Cancer
  
• Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease
  ClinicalTrials.gov Identifier: NCT00543933 - Recruiting
  Pulmonary Insufficiency
  
• Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00069056 - Completed
  Diabetic Retinopathy
  
• Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
  ClinicalTrials.gov Identifier: NCT00015769 - Completed
  Bipolar Disorder
  
• Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00517010 - Recruiting
  Age-Related Macular Degeneration
  
• Pilot Study of Minocycline in Huntington''s Disease
  ClinicalTrials.gov Identifier: NCT00277355 - Active, not recruiting
  Huntington Disease
  
• Pilot Study of Monocyte Biology in Insulin Sensitive, Resistant and Diabetic Subjects
  ClinicalTrials.gov Identifier: NCT00570154 - Recruiting
  Diabetes
  
• Pilot Study of Mycophenolate Mofetil in Congenital Uropathies
  ClinicalTrials.gov Identifier: NCT00193635 - Completed
  Congenital Urological Abnormalities
  
• Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia
  ClinicalTrials.gov Identifier: NCT00348218 - Recruiting
  Myopia
  
• Pilot Study of ONO-1101 in Patients Scheduled for Multi-Slice CT
  ClinicalTrials.gov Identifier: NCT00311038 - Completed
  Coronary Artery Disease
  
• Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00335712 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00386594 - Recruiting
  Barrett Esophagus
  
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00002076 - Completed
  Meningitis, Cryptococcal; HIV Infections
  
• Pilot Study of Patients Chronic Hepatitis C in co-Infected HIV Patients Relapsers After Previous Therapies
  ClinicalTrials.gov Identifier: NCT00530972 - Recruiting
  Chronic Hepatitis C; HIV Infections
  
• Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00560937 - Active, not recruiting
  Schizophrenia
  
• Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00385996 - Recruiting
  Carcinoma, Non-Small Cell Lung
  
• Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation
  ClinicalTrials.gov Identifier: NCT00397436 - Recruiting
  Proteomics
  
• Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
  ClinicalTrials.gov Identifier: NCT00518154 - Not yet recruiting
  HIV Infections
  
• Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-Operation
  ClinicalTrials.gov Identifier: NCT00571987 - Recruiting
  Cancer of the Breast
  
• Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  ClinicalTrials.gov Identifier: NCT00286156 - Not yet recruiting
  Autosomal Dominant Polycystic Kidney Disease
  
• Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
  ClinicalTrials.gov Identifier: NCT00513318 - Recruiting
  Acute Myeloid Leukemia; Myelodysplasia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Lymphomas; Low-Grade NHL and Chronic Lymphocytic Leukemia
  
• Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
  ClinicalTrials.gov Identifier: NCT00275613 - Recruiting
  Membranoproliferative Glomerulnephritis
  
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00372892 - Recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
  ClinicalTrials.gov Identifier: NCT00293072 - Completed
  Systemic Lupus Erythematosus; ANCA Associated Vasculitis
  
• Pilot Study of Sentinel Lymph Node Biopsy for Conjunctival Melanoma and Sebaceous Cell Carcinoma of the Eyelid
  ClinicalTrials.gov Identifier: NCT00386906 - Recruiting
  Conjunctival Melanoma; Sebaceous Cell Carcinoma
  
• Pilot study of spinal manipulation for chronic neck pain
  ClinicalTrials.gov Identifier: NCT00030004 - Terminated
  Neck Pain
  
• Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00127920 - Active, not recruiting
  Ovarian Neoplasms
  
• Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
  ClinicalTrials.gov Identifier: NCT00237510 - Recruiting
  Antidepressant Induced Excessive Sweating
  
• Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00475865 - Recruiting
  Multiple Sclerosis
  
• Pilot Study of Teriflunomide as Adjunctive Therapy to Interferon-β in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00489489 - Recruiting
  Multiple Sclerosis
  
• Pilot Study of Thalidomide to Treat Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00001599 - Completed
  Sjogren's Syndrome; Xerostomia
  
• Pilot Study of the Correlation Between the Findings of Atypical/Malignant Cells in Sputum and Fluorescence Bronchoscopy in Patients at Risk for Lung Cancer of the LIFE Imaging System and White Light Bronchoscopy
  ClinicalTrials.gov Identifier: NCT00001511 - Completed
  Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Lung Neoplasms
  
• Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children
  ClinicalTrials.gov Identifier: NCT00004793 - Completed
  Growth Disorders
  
• Pilot Study of the Feasibility of Palm Pilots in Monitoring Smoking Behavior in Individuals With Chronic Mental Illness
  ClinicalTrials.gov Identifier: NCT00435903 - Active, not recruiting
  Smoking
  
• Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates
  ClinicalTrials.gov Identifier: NCT00503737 - Not yet recruiting
  Colorectal Cancer Screening
  
• Pilot Study of the Navigator Continuous Glucose Monitor
  ClinicalTrials.gov Identifier: NCT00166673 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Pilot Study of the Process of Prenatal Genetic Counseling
  ClinicalTrials.gov Identifier: NCT00047905 - Completed
  Genetic Counseling
  
• Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections
  ClinicalTrials.gov Identifier: NCT00516958 - Recruiting
  Foot Ulcer, Diabetic
  
• Pilot Study of the Safety and Efficacy of Three Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Patients With Node Positive or High Risk Node Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00446030 - Recruiting
  Breast Neoplasms
  
• Pilot Study of the Spiration IBV™ System
  ClinicalTrials.gov Identifier: NCT00145548 - Active, not recruiting
  Emphysema
  
• Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection
  ClinicalTrials.gov Identifier: NCT00438269 - Completed
  Nosocomial Infection; Pneumonia; Systemic Inflammatory Response Syndrome; Critical Illness; Pyrexia
  
• Pilot Study of Topiramate and Olanzapine in the Prevention of Weight Gain in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00394095 - Recruiting
  Bipolar Disorder; Weight Gain
  
• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
  ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
  Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
  
• Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
  ClinicalTrials.gov Identifier: NCT00514722 - Suspended
  Acute Myeloid Leukemia; Myelodysplasia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Lymphoma, Large-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Peripheral; T-NK Cell Lymphoma; Hodgkin Disease
  
• Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
  ClinicalTrials.gov Identifier: NCT00006056 - Active, not recruiting
  Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; ...
  
• Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00470171 - Recruiting
  Serum Levels of ALAT Transaminases; Serum Markers for Fibrosis and Hepatic Inflammation
  
• Pilot Study of Vedic Medicine for Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00065650 - Completed
  Diabetes Mellitus, Type 2
  
• Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction
  ClinicalTrials.gov Identifier: NCT00004366 - Completed
  Vestibular Diseases; Agoraphobia; Panic Disorder
  
• Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse
  ClinicalTrials.gov Identifier: NCT00573534 - Not yet recruiting
  Attention Deficit Hyperactivity Disorder
  
• Pilot Study of Wearable Artificial Kidney
  ClinicalTrials.gov Identifier: NCT00454974 - Completed
  Renal Failure
  
• Pilot Study of ZD1839 (Iressa, Gefitinib) in Patients with Advanced Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, or Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00046007 - No longer recruiting
  Ovarian Neoplasms; Cervix Neoplasms
  
• Pilot Study on MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery
  ClinicalTrials.gov Identifier: NCT00519155 - Recruiting
  Alveolar Bone Loss; Periodontal Bone Loss
  
• Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00196599 - Completed
  HIV Infections; Antiretroviral Naive
  
• Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
  ClinicalTrials.gov Identifier: NCT00520377 - Active, not recruiting
  Alveolar Ridge Augmentation
  
• Pilot Study on Shear-Induced Platelet Aggregation in Acute Coronary Syndromes
  ClinicalTrials.gov Identifier: NCT00299143 - Recruiting
  Angina, Unstable
  
• Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00187564 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00252122 - Terminated
  Sickle Cell Disease
  
• Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity
  ClinicalTrials.gov Identifier: NCT00240058 - Completed
  Blood Pressure
  
• Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00188955 - Active, not recruiting
  Kidney Transplantation
  
• Pilot Study to Asses the Function and Patency of Polyester-Coated Composite Bypasses From Autologous Varicose Veins
  ClinicalTrials.gov Identifier: NCT00460291 - Recruiting
  Peripheral Arterial Disease; Peripheral Bypass Surgery; Bypass From Autologous Varicose Vein; External Graft Support
  
• Pilot Study to Assess Safety and Feasibility of Resuscitation of Preterm Infants with Controlled Volume of Air/Oxygen
  ClinicalTrials.gov Identifier: NCT00157989 - Terminated
  Resuscitation
  
• Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00222963 - Recruiting
  Obesity; Obstructive Sleep Apnea Syndrome
  
• Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00316550 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• Pilot Study to Assess the Efficacy and Safety of the Lubo Cervical Collar
  ClinicalTrials.gov Identifier: NCT00355173 - Recruiting
  Elective Surgical Procedure
  
• Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain
  ClinicalTrials.gov Identifier: NCT00384371 - Not yet recruiting
  Low Back Pain
  
• Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain
  ClinicalTrials.gov Identifier: NCT00384579 - Not yet recruiting
  Low Back Pain
  
• Pilot Study to Assess the Efficacy of Short Exposure to Defocus to Slow the Progression of Myopia in Children
  ClinicalTrials.gov Identifier: NCT00400140 - Recruiting
  Myopia
  
• Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients with the Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00000627 - Completed
  HIV Infections; Histoplasmosis
  
• Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors
  ClinicalTrials.gov Identifier: NCT00507884 - Recruiting
  Kidney Neoplasms
  
• Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00240149 - Completed
  Hyperglycemia
  
• Pilot Study to Evaluate Escitalopram in Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00215137 - Completed
  OCD
  
• Pilot Study to Evaluate Nucleic Acid Amplification Methods in the Diagnosis and Management of Active TB
  ClinicalTrials.gov Identifier: NCT00023439 - Recruiting
  Tuberculosis
  
• Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System
  ClinicalTrials.gov Identifier: NCT00414596 - Completed
  Low Back Pain
  
• Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One treatment arm receives placebo)
  ClinicalTrials.gov Identifier: NCT00000765 - Completed
  HIV Infections
  
• Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered with an Opioid Agent for Cancer Pain
  ClinicalTrials.gov Identifier: NCT00101621 - Terminated
  Cancer; Pain
  
• Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System
  ClinicalTrials.gov Identifier: NCT00542646 - Recruiting
  Vascular Disease, Peripheral
  
• Pilot Study to Identify the Influence of Genetic Profile Aberrations on Patients With Recurrent Hernias
  ClinicalTrials.gov Identifier: NCT00527670 - Recruiting
  Pathological Processes
  
• Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00306397 - Recruiting
  Kidney Transplantation
  
• Pilot Study to Monitor Patients With Injections Site Reactions From Enfuvirtide to Raltegravir
  ClinicalTrials.gov Identifier: NCT00523237 - Not yet recruiting
  HIV Infections
  
• Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00243854 - Recruiting
  Pancreatic Cancer
  
• Pilot Study Using Neoadjuvant Chemo-Radiotherapy and Tarceva for Potentially Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00216307 - Not yet recruiting
  adenocarcinoma of the pancreas
  
• Pilot Study: Does Chiropractic Care Decrease Fall Risk in Older Adults
  ClinicalTrials.gov Identifier: NCT00497965 - Recruiting
  Musculoskeletal Equilibrium
  
• Pilot Study: Dynamic Light Scattering Device for Studying Early Changes in Cataract
  ClinicalTrials.gov Identifier: NCT00067483 - Completed
  Cataract
  
• Pilot Study: Effects of G-CSF on T Cell Function
  ClinicalTrials.gov Identifier: NCT00039650 - Completed
  Healthy
  
• Pilot Study: Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00512590 - Completed
  Fibromyalgia; Pain; Functional Status; Self-Efficacy; Distress
  
• Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
  ClinicalTrials.gov Identifier: NCT00242177 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Pilot Trial for Implementation of a MPA PK Monitoring Strategy
  ClinicalTrials.gov Identifier: NCT00187915 - Completed
  Kidney Transplant
  
• Pilot Trial of a Behavioral Treatment for Epilepsy
  ClinicalTrials.gov Identifier: NCT00212745 - Recruiting
  Epilepsies, Partial
  
• Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00385268 - Recruiting
  Cocaine Dependence
  
• Pilot Trial of Arsenic + Ara-C in Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00572065 - Recruiting
  Myelofibrosis
  
• Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332085 - Terminated
  Type 2 Diabetes
  
• Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression
  ClinicalTrials.gov Identifier: NCT00333931 - Recruiting
  Impulsive Aggression; Posttraumatic Stress Disorder
  
• Pilot Trial of Pre-Operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA
  ClinicalTrials.gov Identifier: NCT00535041 - Active, not recruiting
  Rectal Neoplasms
  
• Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
  ClinicalTrials.gov Identifier: NCT00208039 - Completed
  Respiratory Distress Syndrome; Bronchopulmonary Dysplasia
  
• Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation
  ClinicalTrials.gov Identifier: NCT00165074 - Completed
  Respiratory Distress Syndrome
  
• Pilot Trial of Treatment of Poor-Prognosis Iga Nephropathy With Low Exposure to Sirolimus.
  ClinicalTrials.gov Identifier: NCT00396721 - Recruiting
  Glomerulonephritis, IGA; Nephropathy, IGA; IGA Nephropathy
  
• Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00461721 - Recruiting
  Allergy
  
• Pilot, Multicenter and Prospective Study of the Natural Killer Index From Hematopoietic Stem Cell Graft at a Genotypic, Phenotypic and Functional Level
  ClinicalTrials.gov Identifier: NCT00435864 - Not yet recruiting
  Acute Lymphoblastic Leukemia; Acute Myeloblastic Leukemia; Chronic Myeloid Leukemia
  
• Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)
  ClinicalTrials.gov Identifier: NCT00287157 - Completed
  Traumatic Brain Injury
  
• Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00231140 - Terminated
  Amyotrophic Lateral Sclerosis (ALS)
  
• Pilots of Self-Collection for HPV DNA Detection
  ClinicalTrials.gov Identifier: NCT00342511 - Active, not recruiting
  HPV
  
• Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis
  ClinicalTrials.gov Identifier: NCT00232115 - Completed
  Perioral Dermatitis
  
• Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis
  ClinicalTrials.gov Identifier: NCT00226707 - Completed
  Chronic Hand Dermatitis
  
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) with Severe Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00121381 - Completed
  Dermatitis, Atopic
  
• Pimecrolimus Cream for Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00297037 - Recruiting
  Oral Lichen Planus
  
• Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs
  ClinicalTrials.gov Identifier: NCT00374517 - Not yet recruiting
  Refractory Pulmonary Tuberculosis
  
• Pindolol and Venlafaxine
  ClinicalTrials.gov Identifier: NCT00159146 - Terminated
  Major depression (DSM-IVR)
  
• Pioglitazone Add-on Study in Patients with Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00086502 - Completed
  Diabetes Mellitus, Type 2
  
• Pioglitazone and Losartan Provides Additional Renoprotection
  ClinicalTrials.gov Identifier: NCT00364988 - Completed
  Type 2 Diabetes; Diabetic Nephropathy
  
• Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00231894 - Recruiting
  Diabetes; Schizophrenia; Insulin Resistance; Cognitive Impairment
  
• Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE)
  ClinicalTrials.gov Identifier: NCT00225277 - Active, not recruiting
  Diabetes Mellitus, Type 2; Coronary Artery Disease
  
• PIoglitazone for PrEvention of Restenosis in Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00376870 - Not yet recruiting
  Coronary Atherosclerosis; Coronary Restenosis; Diabetes
  
• Pioglitazone in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00189163 - Recruiting
  Chronic Hepatitis C
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)
  ClinicalTrials.gov Identifier: NCT00485056 - Not yet recruiting
  Diabetes
  
• Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study)
  ClinicalTrials.gov Identifier: NCT00212004 - Recruiting
  Diabetes Mellitus; Myocardial Infarction
  
• Pioglitazone to Treat Fatty Liver in People With HIV Infection
  ClinicalTrials.gov Identifier: NCT00441272 - Recruiting
  HIV Infections; Hepatic Steatosis; Insulin Resistance
  
• Pioglitazone Treatment in Polycystic Ovary Syndrome
  ClinicalTrials.gov Identifier: NCT00145340 - Active, not recruiting
  Polycystic Ovary Syndrome
  
• Pioglitazone Versus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00331487 - Completed
  Type 2 Diabetes Mellitus; Dyslipidemia
  
• Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
  ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
  Metabolic Syndrome
  
• Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients with Nonalcoholic Steatohepatitis (PIVENS)
  ClinicalTrials.gov Identifier: NCT00063622 - Active, not recruiting
  Liver Diseases
  
• Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00177814 - Recruiting
  Gram-Negative Bacterial Infections
  
• Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
  ClinicalTrials.gov Identifier: NCT00414193 - Recruiting
  Bacteremia; AmpC Beta-Lactamase
  
• Piracetam for Treatment of Cocaine Addiction - 3
  ClinicalTrials.gov Identifier: NCT00000198 - Completed
  Cocaine-Related Disorders
  
• Piracetam for Treatment of Cocaine Addiction, Phase II - 4
  ClinicalTrials.gov Identifier: NCT00000199 - Completed
  Cocaine-Related Disorders
  
• Piracetam for Treatment Tardive Dyskinesia
  ClinicalTrials.gov Identifier: NCT00190008 - Completed
  Tardive Dyskinesia
  
• Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
  ClinicalTrials.gov Identifier: NCT00080223 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
  
• Pirfenidone in Children and Young Adults with Neurofibromatosis type I and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00076102 - Recruiting
  Neurofibromatosis 1; Neurofibroma, Plexiform
  
• Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00020631 - Completed
  Radiation Fibrosis
  
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00053937 - Completed
  childhood neurofibrosarcoma; childhood soft tissue sarcoma
  
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00078936 - Recruiting
  neurofibromatosis 1 and 2 (NF1 and NF2)
  
• Pirfenidone to Treat Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00050453 - No longer recruiting
  Neurofibromatosis 1; Plexiform Neurofibroma
  
• Pirfenidone to Treat Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00011076 - Completed
  Hypertrophic Cardiomyopathy
  
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
  ClinicalTrials.gov Identifier: NCT00001959 - Active, not recruiting
  Fibrosis; Focal Glomerulosclerosis; Kidney Failure; Nephrotic Syndrome; Proteinuria
  
• Pirfenidone to Treat Kidney Disease in Patients with Diabetes
  ClinicalTrials.gov Identifier: NCT00105391 - Active, not recruiting
  
  
• Pirfenidone to Treat Radiation-Induced Fibrosis
  ClinicalTrials.gov Identifier: NCT00014924 - Completed
  Fibrosis
  
• Pirfenidone: A New Drug to Treat Kidney Disease in Patients with Diabetes
  ClinicalTrials.gov Identifier: NCT00063583 - Recruiting
  Diabetes Mellitus; Diabetic Nephropathy
  
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00002914 - Active, not recruiting
  recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ...
  
• Pituitary Derived-Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure
  ClinicalTrials.gov Identifier: NCT00133783 - Recruiting
  1.Premenopausal and postmenopausal women; 2.Surgically-induced menopause women; 3.IVF treatment patients
  
• Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
  ClinicalTrials.gov Identifier: NCT00507104 - Recruiting
  Traumatic Brain Injury; Subarachnoid Hemorrhage; Hypopituitarism
  
• Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
  ClinicalTrials.gov Identifier: NCT00477230 - Recruiting
  Atrial Fibrillation
  
• Pivotal Study in Advanced Parkinson's Disease Patients
  ClinicalTrials.gov Identifier: NCT00466167 - Recruiting
  Parkinson Disease
  
• Pivotal Study of a Percutaneous Mitral Valve Repair System
  ClinicalTrials.gov Identifier: NCT00209274 - Recruiting
  Mitral Valve Insufficiency; Mitral Valve Regurgitation; Mitral Valve Incompetence; Mitral Regurgitation; Mitral Insufficiency
  
• Pivotal Study of the Sonablate® 500 HIFU Treatment of Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00485381 - Recruiting
  Prostate Cancer
  
• Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)
  ClinicalTrials.gov Identifier: NCT00533832 - Completed
  Major Depressive Disorder
  
• Pixantrone (BBR 2778) in Patients with Refractory Acute Myelogenous Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00106600 - Completed
  Acute Myelogenous Leukemia
  
• Pixantrone or Other Chemotherapy Drugs in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101049 - Recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma; ...
  
• Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
  ClinicalTrials.gov Identifier: NCT00069966 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• PK and PD of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00419666 - Recruiting
  Chronic Plaque Psoriasis
  
• PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00343954 - Not yet recruiting
  Sickle Cell Disease
  
• PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
  ClinicalTrials.gov Identifier: NCT00532116 - Completed
  Healthy
  
• PK Effects of Bifeprunox & Valproate in Bipolar I
  ClinicalTrials.gov Identifier: NCT00141505 - Completed
  Bipolar I Disorder
  
• PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00178425 - Completed
  Transplantation, Liver
  
• PK Study in 3- to 6- Month-Old Children
  ClinicalTrials.gov Identifier: NCT00394069 - Completed
  Bronchiolitis
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)
  ClinicalTrials.gov Identifier: NCT00574210 - Recruiting
  Seasonal Allergic Rhinitis; Hay Fever; Rhinoconjunctivitis
  
• PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034671 - Completed
  Mycoses
  
• PK/PD, Long-Term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder
  ClinicalTrials.gov Identifier: NCT00340704 - Recruiting
  Bladder, Neurogenic
  
• PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
  ClinicalTrials.gov Identifier: NCT00045942 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes
  
• PKC412 With or Without Itraconazole in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00045578 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093600 - Active, not recruiting
  adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
  
• Place of Low-Dose Naltrexone in Opiate Detoxification - 1
  ClinicalTrials.gov Identifier: NCT00135759 - Active, not recruiting
  Heroin Dependence; Opioid-Related Disorders; Substance-Related Disorders
  
• Placebo and Active Comparator Controlled Dose Reponse Study of Rivoglitazone in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00575874 - Recruiting
  Type 2 Diabetes
  
• Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00143520 - Completed
  Type 2 Diabetes
  
• Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia
  ClinicalTrials.gov Identifier: NCT00159640 - Terminated
  Pain
  
• Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00575471 - Recruiting
  Type 2 Diabetes
  
• Placebo Controlled Double-Blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (MAIA)
  ClinicalTrials.gov Identifier: NCT00233441 - Completed
  Atrial Fibrillation; Atrial Flutter
  
• Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00543751 - Completed
  Diabetes Mellitus, Type 2
  
• Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  ClinicalTrials.gov Identifier: NCT00484536 - Recruiting
  Multiple Sclerosis
  
• Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00528073 - Recruiting
  Crohn's Disease
  
• Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection
  ClinicalTrials.gov Identifier: NCT00187759 - Completed
  Soft Tissue Infections
  
• Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00403104 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients with Focal Hand Dystonia
  ClinicalTrials.gov Identifier: NCT00106782 - Recruiting
  
  
• Placebo Controlled Trial of a Titanium Dioxide Semiconductor Toothbrush on Mild-to-Moderate Gum Disease.
  ClinicalTrials.gov Identifier: NCT00167466 - Active, not recruiting
  mild-to-moderate periodontal disease; adult patients 18 to 70 years of age
  
• Placebo Controlled Trial of Bosentan in Scleroderma Patients
  ClinicalTrials.gov Identifier: NCT00377455 - Recruiting
  Systemic Scleroderma; Pulmonary Hypertension
  
• Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
  ClinicalTrials.gov Identifier: NCT00372970 - Recruiting
  Gastroparesis
  
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
  ClinicalTrials.gov Identifier: NCT00202514 - Active, not recruiting
  Alcoholism; Alcohol Related Disorders; Mood Disorders
  
• Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00221403 - Recruiting
  Bipolar Disorder
  
• Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
  ClinicalTrials.gov Identifier: NCT00455598 - Recruiting
  Type 2 Diabetes Mellitus
  
• Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
  ClinicalTrials.gov Identifier: NCT00378131 - Recruiting
  Cancer Cachexia
  
• Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
  ClinicalTrials.gov Identifier: NCT00267358 - Active, not recruiting
  Cancer Cachexia
  
• Placebo Effects on Blood Pressure
  ClinicalTrials.gov Identifier: NCT00570271 - Recruiting
  Blood Pressure
  
• Placebo Versus Antibiotics in Acute Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00170222 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Placebo-Controlled Assessment of the Effect of a Food Supplement on Skin Protection After Exposure to UV Radiation
  ClinicalTrials.gov Identifier: NCT00351689 - Completed
  Photobiology
  
• Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
  ClinicalTrials.gov Identifier: NCT00254878 - Completed
  ADHD
  
• Placebo-Controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00409071 - Recruiting
  Breast Cancer
  
• Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
  ClinicalTrials.gov Identifier: NCT00253214 - Completed
  Alzheimer Disease; Dementia
  
• Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy
  ClinicalTrials.gov Identifier: NCT00443690 - Recruiting
  Heart Failure, Congestive
  
• Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00190879 - Completed
  Attention Deficit Hyperactivity Disorder; Comorbid Social Anxiety Disorder
  
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 Mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00453063 - Completed
  Seasonal Allergic Rhinitis
  
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 Mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00468312 - Completed
  Seasonal Allergic Rhinitis
  
• Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00514865 - Recruiting
  Major Depressive Disorder
  
• Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
  ClinicalTrials.gov Identifier: NCT00398879 - Recruiting
  Soft Tissue Sarcoma
  
• Placebo-Controlled Study of the Combination of SYR-322 and Pioglitazone HCl in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00328627 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Placebo-Controlled Trial of Levofloxacin as Prophylaxis After Allogeneic SCT
  ClinicalTrials.gov Identifier: NCT00215007 - Recruiting
  Malignancy; Allogeneic Stem Cell Transplantation
  
• Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
  ClinicalTrials.gov Identifier: NCT00002104 - Completed
  Mycobacterium avium-intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection
  
• Placebo-Controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)
  ClinicalTrials.gov Identifier: NCT00553891 - Recruiting
  Nasal Obstruction; Adenoids Hypertrophy; Adenoidectomy
  
• Placebo-Controlled Trial, Testing the Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles Tendinopathy
  ClinicalTrials.gov Identifier: NCT00377910 - Recruiting
  Chronic Achilles Tendinopathy
  
• Placement of CS/LV Pacing Leads With EnSite NavX Guidance
  ClinicalTrials.gov Identifier: NCT00577187 - Enrolling by invitation
  Heart Failure
  
• Placement of Permanent Pacemaker Study
  ClinicalTrials.gov Identifier: NCT00512161 - Recruiting
  Cardiac Surgical Procedures
  
• Plant-Based Dietary Intervention in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00276939 - Completed
  Diabetes Mellitus, Type 2
  
• Plantar Fasciosis Treatment Using Coblation
  ClinicalTrials.gov Identifier: NCT00189592 - Recruiting
  Plantar Fasciosis; Plantar Fasciitis
  
• Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
  ClinicalTrials.gov Identifier: NCT00504088 - Recruiting
  Peripheral Vascular Diseases
  
• Plaquenil for Alopecia Areata, Alopecia Totalis
  ClinicalTrials.gov Identifier: NCT00176982 - Active, not recruiting
  Alopecia Areata
  
• PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00525954 - Not yet recruiting
  Coronary Artery Disease
  
• Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration
  ClinicalTrials.gov Identifier: NCT00280514 - Recruiting
  Abscess or Abdominal Cyst
  
• Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks
  ClinicalTrials.gov Identifier: NCT00528736 - Completed
  Infant, Premature; Ductus Arteriosus, Patent; Natriuretic Peptide Brain
  
• Plasma Brain Natriuretic Peptide Levels in Pregnancy
  ClinicalTrials.gov Identifier: NCT00324402 - Recruiting
  Cardiomyopathy; Pregnancy
  
• Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
  ClinicalTrials.gov Identifier: NCT00318604 - Not yet recruiting
  Head and Neck Cancer; Esophageal Cancer
  
• Plasma Citrulline Level in Relation to Absorptive Surface
  ClinicalTrials.gov Identifier: NCT00286039 - Recruiting
  Intestinal "Failure"
  
• Plasma Determination of Glucagon-Like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure
  ClinicalTrials.gov Identifier: NCT00180648 - Recruiting
  Short Bowel Syndrome
  
• Plasma Exchange for Autoimmune Autonomic Failure
  ClinicalTrials.gov Identifier: NCT00359346 - Recruiting
  Plasma Exchange; Autonomic Failure
  
• Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 Absorption
  ClinicalTrials.gov Identifier: NCT00306358 - Completed
  Vitamin B12 Absorption
  
• Plasma Homocysteine Distribution in the United States
  ClinicalTrials.gov Identifier: NCT00005483 - Completed
  Cardiovascular Diseases; Heart Diseases; Hyperhomocysteinemia
  
• Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma
  ClinicalTrials.gov Identifier: NCT00327613 - Recruiting
  Pseudoexfoliation Syndrome; Glaucoma
  
• Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00209755 - Terminated
  Chronic Hepatitis C
  
• Plasma Transfusion in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00235183 - Recruiting
  Bleeding in Liver Transplantation
  
• PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00455546 - Recruiting
  Coronary Artery Disease (CAD)
  
• Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
  ClinicalTrials.gov Identifier: NCT00031291 - Completed
  Anthrax
  
• Plasmodium Resistance in A. Gambiae
  ClinicalTrials.gov Identifier: NCT00466557 - Recruiting
  Malaria; Plasmodium Falciparum Malaria
  
• Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00372450 - Recruiting
  Esophageal Cancer; Gastrointestinal Complications
  
• Plasticity in Cervical Dystonia
  ClinicalTrials.gov Identifier: NCT00323765 - Recruiting
  Cervical Dystonia
  
• Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome
  ClinicalTrials.gov Identifier: NCT00456287 - Recruiting
  Sleep Apnea; Cardiovascular Diseases
  
• Platelet Activation Markers in Pediatric Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00450151 - Recruiting
  Coronary Disease
  
• Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
  ClinicalTrials.gov Identifier: NCT00115375 - Completed
  Congenital Heart Defects; Blood Platelet Disorders
  
• Platelet Concentrate in Achilles Tendon Repair
  ClinicalTrials.gov Identifier: NCT00537784 - Recruiting
  Achilles Tendon Rupture; Soft Tissue Injury; Tendon Imjury
  
• Platelet Drug Trial in Coronary Disease Progression
  ClinicalTrials.gov Identifier: NCT00000496 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis
  ClinicalTrials.gov Identifier: NCT00156520 - Recruiting
  Hemorrhage
  
• Platelet Function Assessment for Atherothrombotic Patients
  ClinicalTrials.gov Identifier: NCT00513149 - Recruiting
  Coronary Artery Disease
  
• Platelet Function in Patients Treated with SSRI and non-SSRI Antidepressants
  ClinicalTrials.gov Identifier: NCT00009568 - Completed
  Depression
  
• Platelet Gel in Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00463125 - Recruiting
  Scleroderma, Systemic
  
• Platelet Inhibition by Aspirin, Acetaminophen and NSAID
  ClinicalTrials.gov Identifier: NCT00536068 - Completed
  Hemostasis
  
• Platelet Rich Plasma Study in Lower Extremity Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00517452 - Active, not recruiting
  Atherosclerosis
  
• Platelet-Inhibitor Drug Trial in Coronary Angioplasty
  ClinicalTrials.gov Identifier: NCT00000510 - Completed
  Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Platelets for Acute Wound Healing
  ClinicalTrials.gov Identifier: NCT00125086 - Completed
  Acute wounds healing by secondary intention
  
• Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00407368 - Recruiting
  End Stage Renal Disease; Cardiovascular Disease
  
• Platelets in Acute Wounds: A Pilot Study (PAWS)
  ClinicalTrials.gov Identifier: NCT00199992 - Completed
  Wounds
  
• Platelets Induced Vasodilation, in Vitro and in Vivo Study
  ClinicalTrials.gov Identifier: NCT00152646 - Recruiting
  arteriopathy
  
• Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002894 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Pleural Abrasion Plus Minocycline Versus Apical Pleurectomy for Primary Spontaneous Pneumothorax
  ClinicalTrials.gov Identifier: NCT00270751 - Recruiting
  Pneumothorax
  
• Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00165555 - Active, not recruiting
  Pleural Mesothelioma; Malignant Pleural Mesothelioma
  
• Pleurectomy/Decortication With or Without Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
  ClinicalTrials.gov Identifier: NCT00165503 - Active, not recruiting
  Pleural Mesothelioma; Malignant Pleural Mesothelioma
  
• Plexus Anesthesia in Lateral, Head-Down Position for Elective Surgery of the Shoulder
  ClinicalTrials.gov Identifier: NCT00403013 - Recruiting
  Shoulder Surgery
  
• Plug Arterial Closure System (PACS, 7F)
  ClinicalTrials.gov Identifier: NCT00533156 - Completed
  Angioplasty, Transluminal, Percutaneous Coronary; Coronary Arteriosclerosis
  
• PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
  ClinicalTrials.gov Identifier: NCT00355615 - Active, not recruiting
  Familial Hypercholesterolemia
  
• Pneumatic Displacement of Subretinal Hemorrhage with Perfluorocarbon Gases
  ClinicalTrials.gov Identifier: NCT00161525 - Recruiting
  Subretinal Hemorrhage and exudative maculopathy
  
• Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
  ClinicalTrials.gov Identifier: NCT00485199 - Completed
  Retinal Detachment
  
• Pneumococcal Adult-Dose Ranging Immunization Study
  ClinicalTrials.gov Identifier: NCT00169234 - Active, not recruiting
  Pneumonia
  
• Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
  ClinicalTrials.gov Identifier: NCT00164411 - Active, not recruiting
  Pneumococcal Infections
  
• Pneumococcal Reference Standard
  ClinicalTrials.gov Identifier: NCT00479323 - Recruiting
  Pneumococcal Infections
  
• Pneumococcal Vaccination of Fiji Infants
  ClinicalTrials.gov Identifier: NCT00170612 - Active, not recruiting
  Pneumococcal Infections
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Mths Old Previously Primed With the Same Vaccines
  ClinicalTrials.gov Identifier: NCT00463437 - Recruiting
  Pneumococcal Disease
  
• Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
  ClinicalTrials.gov Identifier: NCT00547248 - Not yet recruiting
  Pneumococcal Diseases
  
• Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
  ClinicalTrials.gov Identifier: NCT00143780 - Active, not recruiting
  Bone Marrow Transplant
  
• Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00152802 - Active, not recruiting
  transplant
  
• Pneumoniae Epidemiology Study in China
  ClinicalTrials.gov Identifier: NCT00471770 - Recruiting
  Pneumococcal Disease
  
• Pneumothorax Post CT Lung Biopsy
  ClinicalTrials.gov Identifier: NCT00188409 - Completed
  Lung Nodules
  
• Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage
  ClinicalTrials.gov Identifier: NCT00556335 - Recruiting
  Pneumothorax
  
• PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See If It Protects Their Babies From Ear Disease
  ClinicalTrials.gov Identifier: NCT00310349 - Not yet recruiting
  Middle Ear Effusion; Tympanic Membrane Perforation; Acute Otitis Media; Streptococcus Pneumoniae
  
• PNT With Chronic Low Back Pain Patients
  ClinicalTrials.gov Identifier: NCT00290238 - Terminated
  Low Back Pain
  
• PNU 166148 in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004076 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00016900 - Active, not recruiting
  stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; ...
  
• POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson’s Disease
  ClinicalTrials.gov Identifier: NCT00234676 - Active, not recruiting
  Parkinson's Disease
  
• Point of Care Device Use in the Pediatric Emergency Department
  ClinicalTrials.gov Identifier: NCT00285285 - Completed
  Dehydration; Seizure; Gastroenteritis; Hyperglycemia
  
• POISE Trial: Perioperative Ischemic Evaluation Study
  ClinicalTrials.gov Identifier: NCT00182039 - Recruiting
  Cardiovascular Diseases
  
• Polarity Therapy for American Indian Caregivers of Dementia Patients
  ClinicalTrials.gov Identifier: NCT00100035 - Active, not recruiting
  Stress; Depression; Anxiety
  
• Policosanol for the Treatment of Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00255216 - Completed
  Hyperlipidemia
  
• Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
  ClinicalTrials.gov Identifier: NCT00399451 - Not yet recruiting
  Apnea; Snoring
  
• Polish-Italian-Hungarian RAndomized ThrombEctomy Trial
  ClinicalTrials.gov Identifier: NCT00377650 - Recruiting
  Myocardial Infarction
  
• Pollutant altered allergic responses
  ClinicalTrials.gov Identifier: NCT00011440 - Completed
  Allergic Rhinitis; Allergy
  
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
  ClinicalTrials.gov Identifier: NCT00058123 - Active, not recruiting
  adult anaplastic astrocytoma; Mixed Gliomas; adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult anaplastic ependymoma
  
• Polyamine-Free Diet to Prevent Post Surgery Hyperalgesia
  ClinicalTrials.gov Identifier: NCT00304850 - Recruiting
  Breast Cancer; Surgery
  
• PolyArginine Treated vEiN grafTs (PATENT)
  ClinicalTrials.gov Identifier: NCT00264706 - Active, not recruiting
  Saphenous Vein Graft Disease
  
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00190502 - Recruiting
  Diabetes Mellitus, Type 1
  
• Polycystic Ovary Syndrome (PCOS) and New Treatment Strategies - Effect of Physical Exercise and Electroacupuncture
  ClinicalTrials.gov Identifier: NCT00484705 - Recruiting
  Polycystic Ovary Syndrome
  
• Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00203996 - Recruiting
  Polycystic Ovary Syndrome; Obstructive Sleep Apnea
  
• Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy
  ClinicalTrials.gov Identifier: NCT00558376 - Not yet recruiting
  Colonoscopy
  
• PolyethyleneGlycol3350 Laxative Vs Placebo in Constipated Children
  ClinicalTrials.gov Identifier: NCT00153114 - Completed
  Constipation
  
• Polyethyleneglycol3350 Vs Tegaserod in Treatment of Patients with Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00153140 - Completed
  Constipation
  
• Polyglactin Sutures Versus Nylon Sutures for Suturing of Conjunctival Autograft in Pterygium Surgery: a Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00391573 - Completed
  Pterygium
  
• Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00059917 - Completed
  unspecified adult solid tumor, protocol specific
  
• Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00060359 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054184 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054197 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054210 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
  ClinicalTrials.gov Identifier: NCT00479193 - Recruiting
  Burns
  
• Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A
  ClinicalTrials.gov Identifier: NCT00223054 - Recruiting
  Renal Transplantation
  
• Polymorphisms in Inflammatory Cytokines Genes in Subjects With Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00395590 - Not yet recruiting
  Sleep Apnea
  
• Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
  ClinicalTrials.gov Identifier: NCT00312403 - Recruiting
  Interstitial Collagenase; Stromelysin 1; Gelatinase B; Glaucoma
  
• Polymyxin-B Protects From Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00490477 - Recruiting
  Gram-Negative Bacterial Infections; Sepsis
  
• Polyp Prevention Trial
  ClinicalTrials.gov Identifier: NCT00339625 - Active, not recruiting
  Polyp Prevention
  
• Polyphenol Bioavailability From Chocolate
  ClinicalTrials.gov Identifier: NCT00492713 - Recruiting
  Healthy
  
• Polypill For Prevention of Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00567307 - Not yet recruiting
  Cardiovascular Disease
  
• Polyunsaturated Fats and Risk of Primary Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00005259 - Active, not recruiting
  Heart Arrest; Cardiovascular Diseases; Heart Diseases
  
• Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)
  ClinicalTrials.gov Identifier: NCT00323414 - Recruiting
  Fatty Liver
  
• Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy
  ClinicalTrials.gov Identifier: NCT00299533 - Active, not recruiting
  Epilepsy
  
• Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery
  ClinicalTrials.gov Identifier: NCT00458549 - Recruiting
  Prostate Cancer
  
• Polyunsaturates and KCL to Control Mild Hypertension
  ClinicalTrials.gov Identifier: NCT00000511 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00349024 - Recruiting
  Brain and Central Nervous System Tumors; Kidney Cancer; Leukemia; Lymphoma; Mucositis; Pain; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Pomegranate Juice in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00336934 - Recruiting
  Prostate Cancer
  
• Pompe Disease Registry
  ClinicalTrials.gov Identifier: NCT00231400 - Recruiting
  Glycogen Storage Disease Type II; Pompe Disease
  
• Pompe Lactation Sub-Registry
  ClinicalTrials.gov Identifier: NCT00566878 - Not yet recruiting
  Glycogen Storage Diseae Type II; Pompe Disease
  
• Pompe Pregnancy Sub-Registry
  ClinicalTrials.gov Identifier: NCT00567073 - Not yet recruiting
  Glycogen Storage Disease Type II; Pompe Disease
  
• Pool-Based Exercise in Fibromyalgia Management
  ClinicalTrials.gov Identifier: NCT00550641 - Completed
  Fibromyalgia
  
• Pooled Analysis of NHANES I/II--Race, Gender, and CHD
  ClinicalTrials.gov Identifier: NCT00005492 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Pooling of Cohort Studies on Diet & Coronary Disease
  ClinicalTrials.gov Identifier: NCT00006309 - Completed
  Coronary Arteriosclerosis; Cardiovascular Diseases; Heart Diseases
  
• POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
  Multiple Sclerosis
  
• Popcorn Lung: the discovery of a new disease
  ClinicalTrials.gov Identifier: NCT00027235 - Completed
  Lung Diseases, Interstitial; Bronchiolitis Obliterans
  
• POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)
  ClinicalTrials.gov Identifier: NCT00160537 - Completed
  Seasonal Allergic Rhinitis
  
• Popular Diets, Metabolism, and CVD Risk
  ClinicalTrials.gov Identifier: NCT00315354 - Recruiting
  Obesity; Insulin Resistance
  
• Population Based Intervention to Prevent Obesity in Kindergartens (TigerKids)
  ClinicalTrials.gov Identifier: NCT00336128 - Active, not recruiting
  Infant
  
• Population Based Strategies for Effective Control of High Blood Pressure in Pakistan
  ClinicalTrials.gov Identifier: NCT00327574 - Active, not recruiting
  Hypertension; Cardiovascular Disease; Obesity; Diabetes; Kidney Disease
  
• Population Pharmacokinetic Study in Adolescent Patients with Schizophrenia or Bipolar I Disorder with Olanzapine
  ClinicalTrials.gov Identifier: NCT00113594 - Completed
  Schizophrenia; Bipolar Disorder
  
• Population PK/PD of Propofol in the Morbidly Obese Patient
  ClinicalTrials.gov Identifier: NCT00395681 - Not yet recruiting
  Morbid Obesity
  
• Population-Based Modeling of Cholesterol Lowering in the United States
  ClinicalTrials.gov Identifier: NCT00005463 - Completed
  Cardiovascular Diseases; Coronary Heart Disease Risk Reduction; Heart Diseases; Coronary Disease; Hypercholesterolemia
  
• Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease
  ClinicalTrials.gov Identifier: NCT00493493 - Recruiting
  Pilonidal Sinus
  
• Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002964 - Completed
  stage I oropharyngeal cancer; stage 0 lip and oral cavity cancer; stage 0 laryngeal cancer; stage I laryngeal cancer; stage 0 oropharyngeal cancer; ...
  
• Porous Coated Motion (PCM) Artificial Disc
  ClinicalTrials.gov Identifier: NCT00578812 - Active, not recruiting
  Radiculopathy; Myelopathy
  
• Porphozym in the Treatment of Acute Attacks in AIP
  ClinicalTrials.gov Identifier: NCT00418795 - Completed
  Acute Intermittent Porphyria
  
• Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00028626 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Portfolio 5 - Multicentre
  ClinicalTrials.gov Identifier: NCT00438425 - Recruiting
  Hyperlipidemia; Cardiovascular Disease
  
• POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558)
  ClinicalTrials.gov Identifier: NCT00423267 - Recruiting
  Coccidioidomycosis
  
• Posaconazole to Treat Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00033982 - Completed
  Granulomatous Disease, Chronic; Job's Syndrome; Infection
  
• Positional Cloning of the Gene(s) Responsible for Alagille Syndrome
  ClinicalTrials.gov Identifier: NCT00001642 - Completed
  Alagille Syndrome
  
• Positioning and Tracking the Prostate During External Beam Radiation
  ClinicalTrials.gov Identifier: NCT00123838 - Active, not recruiting
  Prostate Cancer; Cancer of Prostate; Neoplasms, Prostate
  
• Positive Choice: Prevention for Positive Health
  ClinicalTrials.gov Identifier: NCT00447707 - Completed
  HIV Infections; Sexual Risk Behavior; Substance Use Risks
  
• Positive Effect of Ischemic Postconditioning During Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00333320 - Recruiting
  Acute Myocardial Infarction
  
• Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences
  ClinicalTrials.gov Identifier: NCT00340964 - Recruiting
  Craniofacial Differences
  
• Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
  ClinicalTrials.gov Identifier: NCT00421694 - Completed
  Prostate Cancer
  
• Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
  ClinicalTrials.gov Identifier: NCT00302146 - Recruiting
  Glucocerebrosidase Mutations; Gaucher Disease
  
• Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III
  ClinicalTrials.gov Identifier: NCT00199654 - Recruiting
  Colorectal Cancer
  
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
  ClinicalTrials.gov Identifier: NCT00029926 - Completed
  Lupus Erythematosus; Systemic
  
• Positron Emission Tomography (PET) to Study Brain Signaling
  ClinicalTrials.gov Identifier: NCT00044200 - Recruiting
  Healthy
  
• Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
  ClinicalTrials.gov Identifier: NCT00205062 - Recruiting
  Inflammatory Bowel Diseases
  
• Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
  ClinicalTrials.gov Identifier: NCT00316901 - Recruiting
  Kidney Cancer; Melanoma (Skin)
  
• Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00014794 - Completed
  Rheumatoid Arthritis
  
• Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00039286 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer
  
• Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004138 - Completed
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00554164 - Not yet recruiting
  Lymphoma, High-Grade
  
• Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
  ClinicalTrials.gov Identifier: NCT00088517 - Completed
  Healthy
  
• Positron Emission Tomography Imaging Using Tariquidar and Technetium Tc 94m Sestamibi in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00086853 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Positron Emission Tomography in Detecting Testicle Cancer
  ClinicalTrials.gov Identifier: NCT00045045 - Active, not recruiting
  Testicular Cancer
  
• Positron Emission Tomography in Determining Stage of Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00004867 - Completed
  stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
  
• Positron Emission Tomography in Patients with Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001385 - Completed
  Breast Neoplasms
  
• Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00227539 - Recruiting
  Lung Cancer
  
• Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)
  ClinicalTrials.gov Identifier: NCT00497614 - Recruiting
  Rheumatoid Arthritis
  
• Positron Emission Tomography of Amyloid in Alzheimer''s Disease
  ClinicalTrials.gov Identifier: NCT00205621 - Suspended
  Alzheimer''s Disease
  
• Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00310219 - Recruiting
  Lung Cancer
  
• Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
  ClinicalTrials.gov Identifier: NCT00188253 - Recruiting
  Nasopharyngeal Carcinoma
  
• Positron Emission Tomography to Measure Pain and Pain Control
  ClinicalTrials.gov Identifier: NCT00001307 - Completed
  Healthy; Hyperalgesia; Pain; Peripheral Nervous System Disease
  
• Positron Emission Tomography Using 11C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer
  ClinicalTrials.gov Identifier: NCT00253461 - Recruiting
  Brain and Central Nervous System Tumors; Lung Cancer; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00534274 - Recruiting
  Breast Cancer
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Positron Emission Tomography Using Carbon-11 Acetate in Finding Metastasis and Predicting Recurrence in Patients with Newly Diagnosed Prostate Cancer Who Are At Risk for Recurrence After Treatment
  ClinicalTrials.gov Identifier: NCT00121212 - Recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00110006 - Recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• Positron Emission Tomography Using Fluorine F 18 EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00110032 - Completed
  adult brain tumor
  
• Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for Newly Diagnosed Stage III or Stage IV Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00559377 - Not yet recruiting
  Cervical Cancer
  
• Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
  ClinicalTrials.gov Identifier: NCT00276770 - Recruiting
  Adult Astrocytic Tumors; Adult Brain Stem Glioma; Adult Brain Tumor; Adult Ependymal Tumors; Adult Oligodendroglial Tumors; Mixed Gliomas
  
• Positron Emission Tomography Using [11C]Rolipram to Measure Phosphodiesterase in the Brain and Body
  ClinicalTrials.gov Identifier: NCT00250172 - Recruiting
  Dosimetry
  
• Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00547612 - Recruiting
  Pancreatic Cancer
  
• Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
  ClinicalTrials.gov Identifier: NCT00245167 - Active, not recruiting
  Lung Diseases
  
• Post Burn Pruritus Study
  ClinicalTrials.gov Identifier: NCT00137202 - Completed
  Itching
  
• Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00334373 - Recruiting
  Myocardial Infarction
  
• Post Coronary Artery Bypass Graft (CABG) Study
  ClinicalTrials.gov Identifier: NCT00000463 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Post Discharge Human Milk Fortifier in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00413985 - Active, not recruiting
  Infant, Low Birth Weight
  
• Post Enucleation Socket Syndrome Study
  ClinicalTrials.gov Identifier: NCT00347282 - Not yet recruiting
  Eye Enucleation; Orbit Surgery; Postoperative Complications
  
• Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
  ClinicalTrials.gov Identifier: NCT00237016 - Completed
  Relapsing Fever, Tick-Borne; Jarisch Herxheimer Reaction
  
• Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band
  ClinicalTrials.gov Identifier: NCT00543140 - Active, not recruiting
  Morbid Obesity
  
• Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
  ClinicalTrials.gov Identifier: NCT00139828 - Completed
  Hemophilia B
  
• Post marketing surveillance study of Actimmune in patients with severe, malignant osteopetrosis.
  ClinicalTrials.gov Identifier: NCT00043329 - Completed
  Osteopetrosis
  
• Post Marketing Surveillance Study of Dysport
  ClinicalTrials.gov Identifier: NCT00210431 - Completed
  Blepharospasm; Hemifacial Spasm; Cervical Dystonia; Spasmodic Torticollis; Cerebral Palsy; Muscle Spasticity; Cerebrovascular Accident; Equinus Deformity; Facial Hyperdynamic Lines
  
• Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
  ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
  Smoking Cessation
  
• Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutent
  ClinicalTrials.gov Identifier: NCT00444795 - Not yet recruiting
  Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell
  
• Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00538330 - Active, not recruiting
  Breast Cancer
  
• Post Operative Hemodynamic Function After Anesthetic Induction With Etomidate for Cardiac Surgery With ECC
  ClinicalTrials.gov Identifier: NCT00451776 - Recruiting
  Cardiac Surgery
  
• Post Partum Thyroiditis 2: Long Term Observations
  ClinicalTrials.gov Identifier: NCT00287144 - Active, not recruiting
  Hypothyroidism
  
• Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy
  ClinicalTrials.gov Identifier: NCT00385229 - Completed
  Newborn Diseases
  
• Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00578461 - Recruiting
  Leukemia; Cancer; Lymphoma
  
• Post Transplant Study
  ClinicalTrials.gov Identifier: NCT00395902 - Completed
  Kidney Tansplant; Secondary Hyperparathyroidism; Hyperparathyroidism
  
• Post Traumatic Stress Disorder Among VA Ambulatory Care Patients
  ClinicalTrials.gov Identifier: NCT00439322 - Completed
  PTSD
  
• Post-Approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System
  ClinicalTrials.gov Identifier: NCT00546598 - Recruiting
  Non-Inflammatory Joint Disease; Osteoarthritis; Avascular Necrosis; Congenital Hip Dysplasia; Post-Traumatic Arthritis
  
• Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE
  ClinicalTrials.gov Identifier: NCT00180492 - Active, not recruiting
  Atherosclerotic Disease, Carotid
  
• Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA
  ClinicalTrials.gov Identifier: NCT00478673 - Recruiting
  Extracranial Carotid Artery Stenosis
  
• Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
  ClinicalTrials.gov Identifier: NCT00332514 - Active, not recruiting
  Inpatients; Patient Readmission
  
• Post-Hospitalization Nursing Effectiveness (PHONE) Study
  ClinicalTrials.gov Identifier: NCT00314431 - Completed
  Bronchopulmonary Dysplasia; Prematurity
  
• Post-Licensure, Modified Double-Blind, Multi-Center Study Evaluating Safety and Immunogenicity of ADACEL and BOOSTRIX
  ClinicalTrials.gov Identifier: NCT00319553 - Active, not recruiting
  Pertussis; Tetanus; Diphtheria
  
• Post-Marketing Clinical Study of Alteplase for Acute Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00412867 - Recruiting
  Stroke
  
• Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
  ClinicalTrials.gov Identifier: NCT00171977 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Post-Marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
  ClinicalTrials.gov Identifier: NCT00233389 - Completed
  Stomach Ulcer
  
• Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
  ClinicalTrials.gov Identifier: NCT00248001 - Not yet recruiting
  Conscious Sedation
  
• Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
  ClinicalTrials.gov Identifier: NCT00318955 - Completed
  Conscious Sedation
  
• Post-Marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
  ClinicalTrials.gov Identifier: NCT00304265 - Active, not recruiting
  Pertussis; Diphtheria; Tetanus; Poliomyelitis
  
• Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults
  ClinicalTrials.gov Identifier: NCT00113880 - Active, not recruiting
  Healthy; Influenza
  
• Post-Marketing Observational Study in Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00234884 - Active, not recruiting
  Rheumatoid Arthritis
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• Post-Marketing Safety Study of GSK Biologicals' Boostrix® Vaccine.
  ClinicalTrials.gov Identifier: NCT00297856 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Post-Marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
  ClinicalTrials.gov Identifier: NCT00234065 - Active, not recruiting
  Cerebral Infarction
  
• Post-Marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00442234 - Recruiting
  Pulmonary Embolism
  
• Post-Marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus
  ClinicalTrials.gov Identifier: NCT00134940 - Active, not recruiting
  Coronary Heart Disease
  
• Post-Marketing Study to Evaluate the Efficacy of Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00197223 - Completed
  Influenza
  
• Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis
  ClinicalTrials.gov Identifier: NCT00163592 - Completed
  Femoral Vascular Anastomosis
  
• Post-Meal Insulin Dosing With Adjuvant Pre-Meal Pramlintide in Children With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00442767 - Recruiting
  Type 1 Diabetes Mellitus
  
• Post-Nasal Drainage as an Extraesophageal Manifestation of Reflux
  ClinicalTrials.gov Identifier: NCT00199953 - Active, not recruiting
  - Postnasal Drainage
  
• Post-Op Quality of Life After Colorectal Surgery
  ClinicalTrials.gov Identifier: NCT00468455 - Recruiting
  Colorectal Neoplasms; Colitis, Ulcerative; Diverticulitis; Colonic Polyps; Crohn Disease
  
• Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00201383 - Completed
  Oral Cavity; Squamous Cell Carcinoma
  
• Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00502411 - Recruiting
  Soft Tissue Sarcoma
  
• Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00193895 - Recruiting
  Skin Cancer
  
• Post-Operative Drainage Following Lymph Node Dissection
  ClinicalTrials.gov Identifier: NCT00324272 - Recruiting
  Malignant Melanoma; Carcinoma, Squamous Cell
  
• Post-Operative Haloperidol Versus Placebo for Prevention of Post-Operative Delirium After Acute Hip Surgery.
  ClinicalTrials.gov Identifier: NCT00250237 - Recruiting
  Post-Operative Delirium; Hip Fracture
  
• Post-Operative Mobilization for Carpal Tunnel
  ClinicalTrials.gov Identifier: NCT00435149 - Recruiting
  Carpal Tunnel
  
• Post-Operative Nausea And Vomiting Study In Female Patients
  ClinicalTrials.gov Identifier: NCT00274690 - Completed
  Postoperative Nausea and Vomiting
  
• Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata
  ClinicalTrials.gov Identifier: NCT00163930 - Recruiting
  Uterine Fibroids
  
• Post-Operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00508352 - Recruiting
  Breast Cancer
  
• Post-Operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas
  ClinicalTrials.gov Identifier: NCT00169221 - Recruiting
  Head and Neck Cancer
  
• Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery
  ClinicalTrials.gov Identifier: NCT00238563 - Recruiting
  Glaucoma
  
• Post-PCI:Cardiac Imaging in Patients with Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
  ClinicalTrials.gov Identifier: NCT00162357 - Active, not recruiting
  Diabetes Mellitus, Type 2; Coronary Restenosis
  
• Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
  ClinicalTrials.gov Identifier: NCT00231439 - Completed
  Post-Polio Syndrome
  
• Post-Pregnancy Research Study
  ClinicalTrials.gov Identifier: NCT00550979 - Recruiting
  Gestational Diabetes Mellitus; Cardiovascular Disease Risk
  
• Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
  ClinicalTrials.gov Identifier: NCT00198341 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• Post-TBI Fatigue and Its Treatment
  ClinicalTrials.gov Identifier: NCT00233090 - Recruiting
  Fatigue
  
• Post-Transplant Autologous Cytokine-Induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00477035 - Recruiting
  Leukemia; Multiple Myeloma
  
• Post-Traumatic Stress Disorder (PTSD) Symptom Study
  ClinicalTrials.gov Identifier: NCT00018798 - Completed
  PTSD
  
• Post-traumatic Stress Disorder (PTSD), Sleep Apnea, Apolipoprotein E (APOE), and Cognition
  ClinicalTrials.gov Identifier: NCT00108641 - Recruiting
  Post-Traumatic Stress Disorder; Sleep Apnea
  
• Post-Treatment Effects of Naltrexone
  ClinicalTrials.gov Identifier: NCT00006449 - Completed
  Alcoholism
  
• Postanesthesia Cognitive Recovery and Neuropsychologic Complications
  ClinicalTrials.gov Identifier: NCT00507195 - Recruiting
  Anesthesia Recovery Period; Delirium, Dementia, Cognitive Disorders; Neurobehavioural Manifestation; Mental Competency
  
• Postcesarean Section Pain: Possible Demographic and Medical Predictors
  ClinicalTrials.gov Identifier: NCT00416104 - Not yet recruiting
  Pain; Cesarean Section
  
• Postcoital Testing of the SILCS Diaphragm
  ClinicalTrials.gov Identifier: NCT00561613 - Completed
  Contraceptive Device
  
• Postconditioning in Primary PCI and Direct Stenting
  ClinicalTrials.gov Identifier: NCT00351247 - Not yet recruiting
  Myocardial Infarction
  
• Postconditioning in the Treatment of Acute ST-Segment Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00507156 - Recruiting
  ST-Segment Myocardial Infarction
  
• Posterior Capsule Opacification Study
  ClinicalTrials.gov Identifier: NCT00312299 - Completed
  Cataract
  
• Posterior Cingulate Function in Persons With Risk Factors for Alzheimer’s Disease
  ClinicalTrials.gov Identifier: NCT00478166 - Completed
  Magnetic Resonance Imaging; Alzheimer's Disease; Dementia; Adult Children; Risk
  
• Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair
  ClinicalTrials.gov Identifier: NCT00153231 - Recruiting
  Vaginal Prolapse
  
• Posterior Tibial Nerve Stimulation vs. Sham
  ClinicalTrials.gov Identifier: NCT00534521 - Completed
  Overactive Bladder
  
• Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks.
  ClinicalTrials.gov Identifier: NCT00331071 - Active, not recruiting
  Female Contraception; Contraception
  
• Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Using Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00377988 - Active, not recruiting
  Female Contraception; Contraception
  
• Postmenopausal Estrogen/Progestin Interventions (PEPI)
  ClinicalTrials.gov Identifier: NCT00000466 - Completed
  Bone Diseases; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Ischemia; ...
  
• Postmenopausal Evaluation and Risk-Reduction with Lasofoxifene (PEARL)
  ClinicalTrials.gov Identifier: NCT00141323 - Active, not recruiting
  Osteoporosis
  
• Postmenopausal Hormone Therapy in Unstable Angina
  ClinicalTrials.gov Identifier: NCT00000601 - Completed
  Angina, Unstable; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Postmenopause
  
• Postmenopausal Progestins, MI and Stroke
  ClinicalTrials.gov Identifier: NCT00005220 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Cerebrovascular Accident; Myocardial Infarction; Postmenopause
  
• Postmenopausal Women Estrogen and Progesterone Infusion
  ClinicalTrials.gov Identifier: NCT00455741 - Active, not recruiting
  Postmenopause; Aging
  
• Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
  ClinicalTrials.gov Identifier: NCT00234182 - Completed
  Hepatocellular Carcinoma
  
• Postoperative Analgesia After Total Hip Replacement
  ClinicalTrials.gov Identifier: NCT00219921 - Completed
  Total Hip replacement
  
• Postoperative Analgesia After Total Knee Arthroplasty
  ClinicalTrials.gov Identifier: NCT00421967 - Recruiting
  Arthroplasty, Replacement, Knee
  
• Postoperative Analgesia by Epidural vs IV Ketamine Concurrent With Caudal Anesthesia in Pediatric Orthopedic Surgery
  ClinicalTrials.gov Identifier: NCT00532662 - Not yet recruiting
  Analgesia
  
• Postoperative Analgesia With Local Infiltration After Hip Fracture
  ClinicalTrials.gov Identifier: NCT00529425 - Recruiting
  Hip Fracture
  
• Postoperative Analgesic Requirements for the ProSeal Laryngeal Mask Airway Versus the Tracheal Tube in Females Undergoing Gynecological Laparoscopic Surgery
  ClinicalTrials.gov Identifier: NCT00402870 - Completed
  Intubation
  
• Postoperative Cognitive Dysfunction in Geriatric Patients
  ClinicalTrials.gov Identifier: NCT00512200 - Recruiting
  Delirium, Dementia, Amnestic, Cognitive Disorders; Age; Postoperative Complications; Memory Disorders
  
• Postoperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
  ClinicalTrials.gov Identifier: NCT00561678 - Not yet recruiting
  Postoperative Delirium (PD); Postoperative Cognitive Dysfunction (POCD)
  
• Postoperative Delirium at Heidelberg's Intensive Care Unit -New Diagnostic Markers
  ClinicalTrials.gov Identifier: NCT00463333 - Completed
  Postoperative Delirium
  
• Postoperative Delirium in Hip Fracture Patients
  ClinicalTrials.gov Identifier: NCT00564434 - Completed
  Delirium
  
• Postoperative Dietary Counseling After Bariatric Surgery
  ClinicalTrials.gov Identifier: NCT00125073 - Recruiting
  Standard Care; Nutritional Counseling
  
• Postoperative Function Following Partial and Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00492219 - Recruiting
  Osteoarthritis; Post-Traumatic Arthritis
  
• Postoperative Oral Intake Trial
  ClinicalTrials.gov Identifier: NCT00134407 - Completed
  Surgery; Major; Abdominal; Adult; Postoperative
  
• Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen
  ClinicalTrials.gov Identifier: NCT00188071 - Completed
  Abortion, Induced
  
• Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil Based Anesthesia?
  ClinicalTrials.gov Identifier: NCT00241332 - Completed
  Pain, Postoperative
  
• Postoperative Pain Control After Kidney Surgery : a Comparison of Intrathecal Morphine Plus PCA and PCA Only
  ClinicalTrials.gov Identifier: NCT00199316 - Recruiting
  Postoperative Pain
  
• Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
  ClinicalTrials.gov Identifier: NCT00232960 - Recruiting
  Oral Cancer; Oropharynx Cancer
  
• Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.
  ClinicalTrials.gov Identifier: NCT00263107 - Completed
  Kidney Cancer; Ureteral Cancer; Prostate Cancer; Nephrolithiasis
  
• Postoperative Treatment After Endoscopic Sinus Surgery
  ClinicalTrials.gov Identifier: NCT00534768 - Completed
  Sinusitis
  
• Postoperative Urinary Retention and UTI After LAVH for Benign Disease
  ClinicalTrials.gov Identifier: NCT00564135 - Active, not recruiting
  Hysterectomy; Urinary Retention; Urinary Tract Infection
  
• Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy
  ClinicalTrials.gov Identifier: NCT00512993 - Recruiting
  Breast Cancer
  
• Postpartum Depression and Cesarean Section
  ClinicalTrials.gov Identifier: NCT00370903 - Completed
  Postpartum Depression
  
• Postpartum Maintenance of Abstinence from Tobacco
  ClinicalTrials.gov Identifier: NCT00139529 - Recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Postpartum Thyroid Measures and Mood
  ClinicalTrials.gov Identifier: NCT00565032 - Completed
  Postpartum Depression
  
• Postpartum Uterine Regression
  ClinicalTrials.gov Identifier: NCT00341848 - Recruiting
  Uterine Leiomyoma
  
• Postplacental or Delayed Insertion of the Levonorgestrel-IUD After Vaginal Delivery
  ClinicalTrials.gov Identifier: NCT00476021 - Recruiting
  Contraception; Postpartum Period; Intrauterine Devices
  
• Postprandial Insulin Secretion and Appetite Regulation After Moderate Alcohol Consumption
  ClinicalTrials.gov Identifier: NCT00524550 - Active, not recruiting
  Healthy
  
• Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD
  ClinicalTrials.gov Identifier: NCT00037401 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Heart Diseases
  
• Postprandial Lipoproteins and Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00005263 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Carotid Artery Diseases; Myocardial Ischemia
  
• Posttraumatic Symptoms Among Toddlers and Their Parents Following Exposure to Terrorism
  ClinicalTrials.gov Identifier: NCT00447538 - Completed
  Post-Traumatic Stress Disorder
  
• Postural Control in the Elderly
  ClinicalTrials.gov Identifier: NCT00059501 - Completed
  Musculoskeletal Physiology; Healthy
  
• Postural Orientation In The Use Of School Backpacks
  ClinicalTrials.gov Identifier: NCT00536354 - Completed
  Backpain; Prevention; Physical Therapy
  
• Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00170105 - Completed
  Healthy
  
• Potassium and Sodium to Control Blood Pressure in Hypertensives
  ClinicalTrials.gov Identifier: NCT00000509 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Potassium Citrate to Prevent Age Related Bone Loss
  ClinicalTrials.gov Identifier: NCT00282126 - Recruiting
  Osteoporosis
  
• Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
  ClinicalTrials.gov Identifier: NCT00028327 - Completed
  HIV Infections
  
• Potential Allergens in Wine: Double-Blind Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00163735 - Recruiting
  Food Allergy; Anaphylaxis
  
• Potential Association of a Common L-FABP Polymorphism With Lipid-Induced Hepatic Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00277342 - Completed
  Wildtype; Polymorphism Liver FABP
  
• Potential Impact (Benefit) of Preventative Treatment with Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
  ClinicalTrials.gov Identifier: NCT00210496 - Completed
  Migraine; Common Migraine; Classic Migraine
  
• Potential of Transplanted Stem Cells to Mature into Salivary Gland and Cheek Cells
  ClinicalTrials.gov Identifier: NCT00023491 - Completed
  Graft vs Host Disease; Sjogren's Syndrome
  
• Potential Risk Factors for Stroke
  ClinicalTrials.gov Identifier: NCT00001368 - Completed
  Carotid Atherosclerosis; Cerebrovascular Accident; Diabetes Mellitus; Hypercholesterolemia; Hypertension
  
• Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
  ClinicalTrials.gov Identifier: NCT00001531 - Completed
  Arterial Occlusive Diseases; Atherosclerosis; Coronary Disease; Cytomegalovirus Infections
  
• Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00294151 - Recruiting
  Breast Cancer; Prostate Cancer; Vertebral Metastasis; Pain
  
• Potentiation of Procedural Motor Learning in Health and Disease
  ClinicalTrials.gov Identifier: NCT00126087 - Recruiting
  Stroke; Aging
  
• Povidone-Iodine Antisepsis for Strabismus Surgery
  ClinicalTrials.gov Identifier: NCT00461656 - Not yet recruiting
  Strabismus; Surgery; Endophthalmitis
  
• POWER (Pulse Width Optimized Waveform Evaluation Trial)
  ClinicalTrials.gov Identifier: NCT00311181 - Completed
  Sudden Cardiac Death
  
• POWER Point of Care Effect on Satisfaction of Treatment
  ClinicalTrials.gov Identifier: NCT00549068 - Completed
  Osteoporosis, Postmenopausal
  
• Power Wheelchair Joystick Use in Spastic Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00337688 - Not yet recruiting
  Cerebral Palsy; Spasticity
  
• Powerlink Bifurcated Stent Graft Long-Term Follow-up Study
  ClinicalTrials.gov Identifier: NCT00543270 - Enrolling by invitation
  Abdominal Aortic Aneurysm
  
• PPAR - Combination With Metformin
  ClinicalTrials.gov Identifier: NCT00162240 - Completed
  Diabetes Mellitus
  
• PPAR-COMBO With Sulfonylurea
  ClinicalTrials.gov Identifier: NCT00162175 - Completed
  Metabolics Diabetes Nos
  
• PPAR-Gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00554853 - Recruiting
  Rheumatoid Arthritis
  
• Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
  ClinicalTrials.gov Identifier: NCT00465296 - Recruiting
  Metabolic Syndrome
  
• PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites
  ClinicalTrials.gov Identifier: NCT00561327 - Recruiting
  Hypertension
  
• PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period
  ClinicalTrials.gov Identifier: NCT00172783 - Recruiting
  Tuberculosis
  
• PPI Sequencing Study
  ClinicalTrials.gov Identifier: NCT00384592 - Active, not recruiting
  Gastro-Oesophageal Reflux Disease
  
• PPI Test in GP Patients
  ClinicalTrials.gov Identifier: NCT00318084 - Completed
  GERD
  
• PPI Versus Placebo in Severe Functional Heartburn
  ClinicalTrials.gov Identifier: NCT00222989 - Recruiting
  GERD
  
• PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena
  ClinicalTrials.gov Identifier: NCT00526006 - Recruiting
  Healthy
  
• PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria
  ClinicalTrials.gov Identifier: NCT00295581 - Active, not recruiting
  Plasmodium Falciparum; Plasmodium Vivax Malaria
  
• PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
  ClinicalTrials.gov Identifier: NCT00239694 - Recruiting
  Aging
  
• PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00459836 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• PR-104 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00349167 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• PR-104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00544674 - Recruiting
  Lung Cancer
  
• PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition
  ClinicalTrials.gov Identifier: NCT00228124 - Recruiting
  Prostate Cancer
  
• Practicability and Acceptability of Stylomax® in Children
  ClinicalTrials.gov Identifier: NCT00476385 - Completed
  Somatotrope Deficiency
  
• Practicing Self-Control Lowers the Risk of Smoking Lapse
  ClinicalTrials.gov Identifier: NCT00349687 - Recruiting
  Addictions; Cigarette Smoking
  
• Prader-Willi Syndrome and Appetite
  ClinicalTrials.gov Identifier: NCT00175305 - Terminated
  Hyperphagia; Prader-Willi Syndrome
  
• PRADO Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose
  ClinicalTrials.gov Identifier: NCT00405808 - Recruiting
  Obesity
  
• Pragmatic RCT of an Exercise Programme for Women With Depression
  ClinicalTrials.gov Identifier: NCT00546221 - Not yet recruiting
  Depression; Physical Health; Mental Health; Social Wellbeing
  
• Pramipexole and Escitalopram to Treat Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00086307 - Recruiting
  
  
• Pramipexole Conversion to Ropinirole CR
  ClinicalTrials.gov Identifier: NCT00275275 - Recruiting
  Parkinson Disease
  
• Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
  ClinicalTrials.gov Identifier: NCT00558467 - Not yet recruiting
  Tourette Syndrome
  
• Pramipexole Versus Placebo in PD Patients With Depressive Symptoms
  ClinicalTrials.gov Identifier: NCT00297778 - Recruiting
  Parkinson Disease; Depression
  
• Pravastatin and Protease Inhibitors in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00221754 - Completed
  HIV Infection; Hypercholesterolemia
  
• Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease
  ClinicalTrials.gov Identifier: NCT00529178 - Completed
  Hypercholesterolemia
  
• Pravastatin for Hyperlipidaemia in HIV.
  ClinicalTrials.gov Identifier: NCT00227500 - Completed
  HIV Infections; Lipid Metabolism; Glucose Metabolism; Metabolic Abnormality; Lipodystrophy; Cardiovascular Disease
  
• Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
  ClinicalTrials.gov Identifier: NCT00382460 - Completed
  Actue Coronary Syndromes
  
• Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00107523 - Active, not recruiting
  adult acute myeloid leukemia
  
• Prayer as a Possible Adjuvant Treatment for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00519545 - Recruiting
  Breast Neoplasms
  
• Prazosin Alcohol Dependence IVR Study
  ClinicalTrials.gov Identifier: NCT00167687 - Active, not recruiting
  Alcoholism
  
• Prazosin and Combat Trauma PTSD (PACT)
  ClinicalTrials.gov Identifier: NCT00532493 - Not yet recruiting
  PTSD; Combat Trauma; Trauma-Related Nightmares; Sleep Disturbance
  
• Prazosin for ETOH or Cocaine Craving
  ClinicalTrials.gov Identifier: NCT00240227 - Recruiting
  Cocaine Dependence; Alcoholism
  
• Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00183430 - Recruiting
  Post-Traumatic Stress Disorder; Sleep Initiation and Maintenance Disorders
  
• Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance
  ClinicalTrials.gov Identifier: NCT00108420 - Completed
  Stress Disorder, Post-Traumatic
  
• Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study
  ClinicalTrials.gov Identifier: NCT00175682 - Recruiting
  Autonomic Dysreflexia
  
• Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
  ClinicalTrials.gov Identifier: NCT00240201 - Recruiting
  Stress Disorders, Post-Traumatic; Sleep Disorders
  
• Prazosin Vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
  ClinicalTrials.gov Identifier: NCT00261729 - Recruiting
  Stress Disorders, Post-Traumatic; Sleep Disorders
  
• PRCT: Comparing Two Procedures for Ulno-Carpal Abutment Syndrome.
  ClinicalTrials.gov Identifier: NCT00564980 - Recruiting
  Joint Disease
  
• Pre- and Post-Operative FOLFOX and Cetuximab for Patients With Colorectal Cancer With Liver Involvement
  ClinicalTrials.gov Identifier: NCT00537823 - Recruiting
  Colorectal Cancer; Metastases
  
• Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00444041 - Recruiting
  Metastatic Colorectal Cancer
  
• Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research
  ClinicalTrials.gov Identifier: NCT00250887 - Completed
  Recurrent Glioblastoma
  
• Pre-Clinical Models in Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00250783 - Active, not recruiting
  Endometrial Neoplasms; Uterine Neoplasms
  
• PRE-COG Validation to Predict the Risk of Hospitalization of Discharged Patients With Schizophrenia in the Short Term.
  ClinicalTrials.gov Identifier: NCT00358852 - Recruiting
  Schizoaffective Disorder; Schizophrenia
  
• Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain
  ClinicalTrials.gov Identifier: NCT00149253 - Completed
  a Single-Dose of Etoricoxib; Post-Operative Morphine Consumption; total pain relief over 8 hr(TOPAR8); Post Transabdominal Hysterectomy
  
• Pre-Emptive Sciatic Bloc to Prevent Lower Limb Phantom Pain
  ClinicalTrials.gov Identifier: NCT00528463 - Recruiting
  Phantom Limb Pain
  
• Pre-Emptive Treatment of Severe Nausea and Vomiting of Pregnancy.
  ClinicalTrials.gov Identifier: NCT00293644 - Recruiting
  Hyperemesis Gravidarum; Pregnancy
  
• Pre-ESRD Syndrome in High Risk African Americans
  ClinicalTrials.gov Identifier: NCT00224939 - Terminated
  Blood Pressure
  
• Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
  ClinicalTrials.gov Identifier: NCT00557245 - Not yet recruiting
  HIV-1 Infections; HIV Infections
  
• Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected
  ClinicalTrials.gov Identifier: NCT00218699 - Active, not recruiting
  HIV Infections
  
• Pre-Hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
  ClinicalTrials.gov Identifier: NCT00178620 - Recruiting
  Heart Disease; Myocardial Infarction; Acute Myocardial Infarction
  
• Pre-Hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg
  ClinicalTrials.gov Identifier: NCT00237731 - Recruiting
  Severe, Acute Pain in a Pre-Hospital Setting
  
• Pre-op Rectal ChemoRad +/- Cetuximab
  ClinicalTrials.gov Identifier: NCT00527111 - Recruiting
  Rectal Cancer
  
• Pre-Operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
  ClinicalTrials.gov Identifier: NCT00480389 - Recruiting
  Renal Cell Carcinoma; Metastatic Disease
  
• Pre-Operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00160875 - Active, not recruiting
  Esophageal Cancer
  
• Pre-Operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00230451 - Completed
  Esophageal Cancer
  
• Pre-Operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-Operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-Operatively)(POCOB)EORTC 10902)
  ClinicalTrials.gov Identifier: NCT00544505 - Active, not recruiting
  Breast Cancer
  
• Pre-Operative ECX in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00220103 - Recruiting
  Oesophageal Adenocarcinoma
  
• Pre-Operative Evaluation of Kidney & Pancreas Transplant Patients
  ClinicalTrials.gov Identifier: NCT00580437 - Recruiting
  Kidney Transplantation; Pancreas Transplantation
  
• Pre-operative IL13-PE38QQR in Patients with Recurrent or Progressive Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00041587 - Active, not recruiting
  Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Mixed Oligoastrocytoma
  
• Pre-Operative Rehabilitation Exercise Program for Total Knee Arthroplasty
  ClinicalTrials.gov Identifier: NCT00493142 - Not yet recruiting
  Osteoarthritis; Rheumatoid Arthritis
  
• Pre-Surgical Qigong Therapy for Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00495209 - Recruiting
  Breast Cancer
  
• Pre-Transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00297310 - Completed
  Kidney Transplantation; Transplantation
  
• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
  Hepatitis C
  
• Pre-Treatment Positron Emission Topography (PET) Scanning for Increasing Success in Antidepressant Treatment
  ClinicalTrials.gov Identifier: NCT00456014 - Recruiting
  Depression
  
• Preanalgesic Effect of Gabapentin in Total Knee Repair
  ClinicalTrials.gov Identifier: NCT00279487 - Recruiting
  Pain
  
• PreAsthmaControl (PAC)
  ClinicalTrials.gov Identifier: NCT00234390 - Completed
  Asthma
  
• Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese Adults
  ClinicalTrials.gov Identifier: NCT00522353 - Completed
  Obesity
  
• Precancerous Myeloid Cells in Chinese Factory Workers Exposed or Not Exposed to Formaldehyde
  ClinicalTrials.gov Identifier: NCT00516763 - Not yet recruiting
  Health Status Unknown
  
• Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion
  ClinicalTrials.gov Identifier: NCT00538616 - Not yet recruiting
  Brain Injury; Intracranial Pressure
  
• PRECISION : Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen
  ClinicalTrials.gov Identifier: NCT00346216 - Recruiting
  Osteoarthritis; Arthritis, Rheumatoid
  
• Precision of the Magnetocardiographer for Data Aquision and Analysis.
  ClinicalTrials.gov Identifier: NCT00170014 - Recruiting
  Myocardial Ischemia
  
• Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
  ClinicalTrials.gov Identifier: NCT00457587 - Recruiting
  Adrenocortical Carcinoma; Cushing's Syndrome
  
• PreCoCa - "Prehospital Cooling With Cool-Caps"
  ClinicalTrials.gov Identifier: NCT00398671 - Active, not recruiting
  Heart Arrest
  
• Precursors of CVD Risk Factors--Project Heartbeat
  ClinicalTrials.gov Identifier: NCT00005478 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia; Hypertension
  
• Predicom, Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
  ClinicalTrials.gov Identifier: NCT00230763 - Recruiting
  Glaucoma
  
• PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR)
  ClinicalTrials.gov Identifier: NCT00237133 - Recruiting
  Locally Advanced Breast Cancer
  
• PREDICT: Eplerenone in Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure
  ClinicalTrials.gov Identifier: NCT00293150 - Recruiting
  Diastolic Heart Failure
  
• Predicting Alcoholics’ Treatment Responses to a Selective Serotonin Re-Uptake Inhibitor (SSRI)
  ClinicalTrials.gov Identifier: NCT00249405 - Recruiting
  Alcoholism; Alcohol Abuse
  
• Predicting Complications in Women With Toxaemia
  ClinicalTrials.gov Identifier: NCT00175526 - Recruiting
  Toxaemia
  
• Predicting Insulin Resistance in American Indian Youth
  ClinicalTrials.gov Identifier: NCT00498030 - Recruiting
  Insulin Resistance; Stress, Psychological
  
• Predicting Patients' Response to Spinal Manipulation
  ClinicalTrials.gov Identifier: NCT00285649 - Active, not recruiting
  Low Back Pain
  
• Predicting Physical Activity Change: an Epidemiologic Study
  ClinicalTrials.gov Identifier: NCT00005219 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00537173 - Recruiting
  Breast Cancer
  
• Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
  ClinicalTrials.gov Identifier: NCT00359372 - Completed
  Heart Failure; Left Ventricular Dysfunction
  
• Predicting Risk of Cancer in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00431756 - Recruiting
  Barrett Esophagus; Esophageal Neoplasm; Gastroesophageal Reflux
  
• Predicting Success With Hearing Aids
  ClinicalTrials.gov Identifier: NCT00371449 - Not yet recruiting
  Hearing Loss; Presbycusis
  
• Predicting the Response to Montelukast by Genetic Variation in Asthmatics
  ClinicalTrials.gov Identifier: NCT00116324 - Completed
  Asthma
  
• Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines
  ClinicalTrials.gov Identifier: NCT00001210 - Completed
  HIV Infections; Healthy
  
• Prediction of Acute Rejection in Renal Transplant
  ClinicalTrials.gov Identifier: NCT00205257 - Active, not recruiting
  Kidney Transplant
  
• Prediction of Childhood Epilepsy Outcome in Bangladesh
  ClinicalTrials.gov Identifier: NCT00381537 - Completed
  Epilepsy
  
• Prediction of CK-MB Release During Otherwise Successful Stenting Procedure
  ClinicalTrials.gov Identifier: NCT00489242 - Completed
  Diabetes Mellitus
  
• Prediction of Drug Interactions With CYP2C9 Substrates
  ClinicalTrials.gov Identifier: NCT00226538 - Completed
  Healthy Volunteers
  
• Prediction of Extubation Success by the Patient
  ClinicalTrials.gov Identifier: NCT00448565 - Recruiting
  Mechanical Ventialtion; Respiratory Failure; Extubation
  
• Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
  ClinicalTrials.gov Identifier: NCT00466336 - Recruiting
  Chronic Hepatitis C; Hepatic Fibrosis; Cirrhosis
  
• Prediction of Medication Compliance
  ClinicalTrials.gov Identifier: NCT00148187 - Recruiting
  Kidney transplant
  
• Prediction of NODAT After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00442988 - Completed
  Renal Transplantation
  
• Prediction of Ovarian Response
  ClinicalTrials.gov Identifier: NCT00557687 - Recruiting
  In Vitro Fertilization
  
• Prediction of Postoperative Pain by an Electrical Pain Stimulus
  ClinicalTrials.gov Identifier: NCT00374504 - Completed
  Cesarean Section
  
• Prediction of Quality of Life in Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005420 - Completed
  Cardiovascular Diseases; Cerebrovascular Accident; Hypertension; Depression; Heart Diseases
  
• Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile
  ClinicalTrials.gov Identifier: NCT00272389 - Not yet recruiting
  Hepatitis C Virus Chronic Infection
  
• Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study
  ClinicalTrials.gov Identifier: NCT00466271 - Recruiting
  Chronic Hepatitis C; Hepatic Fibrosis
  
• Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
  ClinicalTrials.gov Identifier: NCT00551798 - Recruiting
  Hodgkin's Disease; Malignant Lymphomas High Grade; Chemoresistance
  
• Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00571090 - Recruiting
  Thyroid Nodule
  
• Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index
  ClinicalTrials.gov Identifier: NCT00366197 - Recruiting
  Rapid Shallow Breathing
  
• Predictive and Protective Factors in the Cause of Diabetes - A Study in Twins
  ClinicalTrials.gov Identifier: NCT00339781 - Active, not recruiting
  Diabetes; Type 1 Diabetes
  
• Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
  ClinicalTrials.gov Identifier: NCT00500227 - Recruiting
  Acromegaly
  
• Predictive Markers in GHD and TS Children Treated With SAIZEN®
  ClinicalTrials.gov Identifier: NCT00256126 - Active, not recruiting
  Growth Hormone Deficiency
  
• Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
  ClinicalTrials.gov Identifier: NCT00481429 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• Predictive Medicine Research
  ClinicalTrials.gov Identifier: NCT00384761 - Recruiting
  Atherolsclerosis, Endothelial Dysfunction
  
• Predictive Medicine Research. (PRE MED)
  ClinicalTrials.gov Identifier: NCT00336570 - Recruiting
  Cardiovascular Diseases
  
• Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications
  ClinicalTrials.gov Identifier: NCT00560768 - Not yet recruiting
  Sudden Cardiac Death
  
• Predictive Value for Stroke
  ClinicalTrials.gov Identifier: NCT00451529 - Recruiting
  Carotid Artery Stenosis
  
• Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment.
  ClinicalTrials.gov Identifier: NCT00156585 - Recruiting
  cerebral metastases
  
• Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
  ClinicalTrials.gov Identifier: NCT00522639 - Recruiting
  Lung Cancer; SCLC; NSCLC
  
• Predictive Values of Serotonergic Alterations for Outcome - 2
  ClinicalTrials.gov Identifier: NCT00000313 - Terminated
  Cocaine-Related Disorders
  
• Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
  ClinicalTrials.gov Identifier: NCT00258999 - Completed
  Atherosclerosis
  
• Predictor of Advanced Subclinical Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00245284 - Completed
  Coronary Artery Disease
  
• Predictors and Intervention for Noncompliance
  ClinicalTrials.gov Identifier: NCT00148174 - Recruiting
  Kidney transplant
  
• Predictors for Pulmonary Valve Replacement
  ClinicalTrials.gov Identifier: NCT00489788 - Not yet recruiting
  Congenital Disorders
  
• Predictors for Response to Dose-Dense Docetaxel and Epirubicin Breast Cancer
  ClinicalTrials.gov Identifier: NCT00496795 - Not yet recruiting
  Primary Breast Cancer
  
• Predictors of Cardiovascular Disease in the Elderly
  ClinicalTrials.gov Identifier: NCT00005460 - Completed
  Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Cerebrovascular Accident; Coronary Disease; Hypertension
  
• Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
  ClinicalTrials.gov Identifier: NCT00496210 - Recruiting
  Autism; Asperger's Syndrome; Rett's Disorder
  
• Predictors of Cognitive Decline in Normal Aging
  ClinicalTrials.gov Identifier: NCT00094939 - Recruiting
  Alzheimer Disease; Dementia
  
• Predictors of Constipation in Healthy Children
  ClinicalTrials.gov Identifier: NCT00398021 - Recruiting
  Constipation
  
• Predictors of Driving Performance and Successful Mobility - Rehabilitation in Patients with Medical Eye Condition
  ClinicalTrials.gov Identifier: NCT00013377 - Completed
  Low Vision
  
• Predictors of Drug Hypersensitivity in HIV Infected Subjects
  ClinicalTrials.gov Identifier: NCT00168220 - Recruiting
  HIV Infections; Hypersensitivity
  
• Predictors of Hospital-Based Care in Asthma
  ClinicalTrials.gov Identifier: NCT00005484 - Completed
  Asthma; Lung Diseases
  
• Predictors of Lymphedema Following Breast Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00202046 - Recruiting
  Breast Cancer; Lymphedema
  
• Predictors of Perioperative Cardiac Morbidity
  ClinicalTrials.gov Identifier: NCT00005197 - Completed
  Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Myocardial Infarction; Ventricular Arrhythmia; Coronary Disease
  
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
  ClinicalTrials.gov Identifier: NCT00198068 - Recruiting
  Systemic Lupus Erythematosus; Antiphospholipid Syndrome
  
• Predictors of Recurrent Stroke in the PROGRESS Study
  ClinicalTrials.gov Identifier: NCT00049894 - Completed
  Cardiovascular Diseases; Cerebrovascular Accident; Cerebrovascular Disorders; Hypertension
  
• Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
  ClinicalTrials.gov Identifier: NCT00086567 - Recruiting
  
  
• Predictors of Response to Biventricular Pacing in Heart Failure
  ClinicalTrials.gov Identifier: NCT00156390 - Recruiting
  Heart Failure, Wide QRS complex
  
• Predictors of Response to Cognitive Remediation in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00333970 - Recruiting
  Schizophrenia
  
• Predictors of the Response to Etanercept and Adalimumab in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00234234 - Recruiting
  Rheumatoid Arthritis
  
• Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
  ClinicalTrials.gov Identifier: NCT00501007 - Recruiting
  Tobacco Dependence
  
• Prednisolone in Active Ankylosing Spondylitis (AS)
  ClinicalTrials.gov Identifier: NCT00244166 - Recruiting
  Ankylosing Spondylitis
  
• Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
  ClinicalTrials.gov Identifier: NCT00135122 - Recruiting
  headache, migraine, analgesics, tension type headache
  
• Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00379730 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00275106 - Recruiting
  Lymphoma
  
• Prednisolone Pharmacokinetics in the Presence and Absence of Ritonavir After Oral Prednisone Administration to Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00072644 - Active, not recruiting
  Healthy
  
• Prednisolone vs. Ciclosporine in Severe Atopic Eczema
  ClinicalTrials.gov Identifier: NCT00445081 - Recruiting
  Atopic Dermatitis
  
• Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Prednisone for Decompensated Congestive Heart Failure
  ClinicalTrials.gov Identifier: NCT00369044 - Suspended
  Heart Failure, Congestive
  
• Prednisone Treatment for Vestibular Neuronitis
  ClinicalTrials.gov Identifier: NCT00271791 - Completed
  Vestibular Diseases; Vestibular Neuronitis
  
• Prednisone TRT Study
  ClinicalTrials.gov Identifier: NCT00146640 - Completed
  Rheumatoid Arthritis
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy
  ClinicalTrials.gov Identifier: NCT00561106 - Completed
  Bell´s Palsy
  
• Preemptive Analgesia for Abdominal Hysterectomy
  ClinicalTrials.gov Identifier: NCT00121498 - Completed
  Pain
  
• Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures
  ClinicalTrials.gov Identifier: NCT00254631 - Recruiting
  Fractures
  
• Preemptive Local Anesthesia in Vaginal Surgery
  ClinicalTrials.gov Identifier: NCT00318292 - Recruiting
  Pain, Postoperative
  
• PREFER (Pacemaker Remote Follow-Up Evaluation and Review)
  ClinicalTrials.gov Identifier: NCT00294645 - Active, not recruiting
  Bradycardia; Arrhythmia
  
• PreFER Managed Ventricular Pacing (MVP) For Elective Replacement
  ClinicalTrials.gov Identifier: NCT00293241 - Recruiting
  Cardiovascular Diseases
  
• Preference and Vegetarian Diet in Weight Loss Treatment
  ClinicalTrials.gov Identifier: NCT00330629 - Completed
  Obesity; Overweight
  
• Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (etanercept) Auto-Injector versus Enbrel® Pre-Filled Syringes
  ClinicalTrials.gov Identifier: NCT00094341 - Completed
  Rheumatoid Arthritis
  
• Preference of Tegaserod Vs. PEG 3350 in Patients With Constipation
  ClinicalTrials.gov Identifier: NCT00171522 - Completed
  Constipation
  
• Preference Study With Elderly Patients Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00170690 - Recruiting
  Ovarian Cancer
  
• Preferred Treatment of Type 1.5 Diabetes
  ClinicalTrials.gov Identifier: NCT00194896 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Pregabalin Epilepsy Add-On Trial
  ClinicalTrials.gov Identifier: NCT00141258 - Completed
  Partial seizure with or without secondary generalization
  
• Pregabalin for Abdominal Pain From Adhesions
  ClinicalTrials.gov Identifier: NCT00310765 - Recruiting
  Abdominal Pain; Surgical Adhesions
  
• Pregabalin in Partial Seizures (PREPS): An Open-Label, Multicenter Add on Therapy Trial.
  ClinicalTrials.gov Identifier: NCT00407797 - Recruiting
  Partial Epilepsy
  
• Pregabalin in Partial Seizures Extension Study.
  ClinicalTrials.gov Identifier: NCT00143130 - Recruiting
  Seizures
  
• Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
  ClinicalTrials.gov Identifier: NCT00141427 - Completed
  Seizures
  
• Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00159679 - Completed
  Diabetic Neuropathies
  
• Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
  ClinicalTrials.gov Identifier: NCT00413010 - Recruiting
  General Anxiety Disorder
  
• Pregabalin Open-Label Extension Trial in Patients with Partial Seizures
  ClinicalTrials.gov Identifier: NCT00143143 - Completed
  Epilepsies, Partial; Epilepsy, Complex Partial
  
• Pregabalin Peripheral Neuropathic Pain Study
  ClinicalTrials.gov Identifier: NCT00141219 - Recruiting
  Diabetic Diabetic Neuropathies; Neuralgia
  
• Pregabalin Treatment of Peripheral Neuropathic Pain Associated With Post-Herpetic, (HIV,Chemotherapy) Diabetic Induced.
  ClinicalTrials.gov Identifier: NCT00407511 - Recruiting
  Diabetic Neuropathic Pain; Neuralgia, Post-Herpetic; HIV Related Peripheral Neuropathic Pain; Chemotherapy Induced Peripheral Neuropathic Pain
  
• Pregabalin Versus Levetiracetam in Partial Seizures.
  ClinicalTrials.gov Identifier: NCT00537238 - Recruiting
  Epilepsy; Epilepsies, Partial
  
• Pregabalin Vs Placebo in Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00143156 - Completed
  Diabetic Neuropathy
  
• Pregnancy Exposure Registry for AVONEX
  ClinicalTrials.gov Identifier: NCT00168714 - Recruiting
  Pregnancy; Prenatal Exposure Delayed Effects; Multiple Sclerosis
  
• Pregnancy Exposure Registry for Tysabri
  ClinicalTrials.gov Identifier: NCT00472992 - Recruiting
  Pregnancy; Prenatal Exposure Delayed Effects; Multiple Sclerosis
  
• Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles
  ClinicalTrials.gov Identifier: NCT00485537 - Completed
  Infertility
  
• Pregnenolone in the Management of Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00174889 - Completed
  Schizophrenia
  
• Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse
  ClinicalTrials.gov Identifier: NCT00223197 - Completed
  Bipolar Disorder; Major Depressive Disorder; Substance Abuse
  
• Preheating of Femur Component in Hybrid Total Hip Arthroplasty
  ClinicalTrials.gov Identifier: NCT00319085 - Active, not recruiting
  Osteoarthritis, Hip
  
• Prehospital CPAP vs. Usual Care for Acute Respiratory Failure
  ClinicalTrials.gov Identifier: NCT00405314 - Completed
  Respiratory Insufficiency; Hypoxia
  
• Prehospital Screening to Prevent Injury and Illness
  ClinicalTrials.gov Identifier: NCT00382655 - Completed
  All Conditions
  
• Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
  ClinicalTrials.gov Identifier: NCT00414869 - Terminated
  Portal Hypertension
  
• Preliminary Efficacy of Recombinant Factor VIIa (NovoSeven NiaStase) in Subjects with Brain Contusions
  ClinicalTrials.gov Identifier: NCT00123591 - Completed
  Contusion
  
• Preliminary Human Trial of NPI-028
  ClinicalTrials.gov Identifier: NCT00010907 - Terminated
  Alcoholism
  
• Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
  ClinicalTrials.gov Identifier: NCT00403598 - Not yet recruiting
  Osteoporosis; Osteitis Deformans; Parathyroid Diseases
  
• Preliminary Study of Endometrial Hyperplasia-Groundwork for a Study to Define Precursors of Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00339651 - Active, not recruiting
  Endometrial Hyperplasia; Endometrial Carcinoma
  
• Preliminary Study of Mycograb and Docetaxel in Advance Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217815 - Completed
  Cancer of the breast.
  
• Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
  ClinicalTrials.gov Identifier: NCT00076375 - Completed
  Atopic Dermatitis; Eczema
  
• Preliminary Study of Safety and Efficacy of Policosanol
  ClinicalTrials.gov Identifier: NCT00312923 - Recruiting
  HIV-Related Dyslipidemia; HIV Infections
  
• Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation
  ClinicalTrials.gov Identifier: NCT00050128 - Completed
  Cerebrovascular Accident
  
• Preliminary Testing of New Treatment for Chronic Leg Wounds
  ClinicalTrials.gov Identifier: NCT00000431 - Recruiting
  Varicose Ulcer
  
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
  ClinicalTrials.gov Identifier: NCT00332202 - Recruiting
  Non Hodgkin Lymphoma
  
• Premature Birth and its Sequelae in Women
  ClinicalTrials.gov Identifier: NCT00005376 - Completed
  Bronchopulmonary Dysplasia; Lung Diseases
  
• Premature Coronary Artery Disease in Women - Risk Factors and Prognosis
  ClinicalTrials.gov Identifier: NCT00544739 - Recruiting
  Coronary Atherosclerosis
  
• Premature Coronary Atherosclerosis in Scleroderma, a Case Control Study
  ClinicalTrials.gov Identifier: NCT00372398 - Recruiting
  Scleroderma
  
• Premature Infants in Need of Transfusion (PINT)
  ClinicalTrials.gov Identifier: NCT00182390 - Completed
  Anemia of Prematurity
  
• Premedication to Reduce Discomfort With Screening Mammography
  ClinicalTrials.gov Identifier: NCT00382083 - Completed
  Breast Pain
  
• Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-Blind, Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00563069 - Recruiting
  Cystoscopy
  
• PREMIER: Lifestyle Interventions for Blood Pressure Control
  ClinicalTrials.gov Identifier: NCT00000616 - Completed
  Heart Diseases; Hypertension
  
• Premium Migraine Trial
  ClinicalTrials.gov Identifier: NCT00355056 - Recruiting
  Migraine Headaches
  
• Prenatal and Postnatal Studies
  ClinicalTrials.gov Identifier: NCT00028145 - Active, not recruiting
  HIV Infections; Pregnancy Complications, Infectious
  
• Prenatal Multi-Micronutrient Supplementation and Pregnancy Outcome
  ClinicalTrials.gov Identifier: NCT00168688 - Active, not recruiting
  Nutrition; Micronutrients; Pregnancy; Birth Weight
  
• Prenatal Nutrition and Adult Disease
  ClinicalTrials.gov Identifier: NCT00024583 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent; Insulin Resistance; Obesity; Hypertension
  
• Prenatal PCB Exposure
  ClinicalTrials.gov Identifier: NCT00012428 - Active, not recruiting
  Maternal Exposure
  
• Prenatal Pelvic Floor Prevention
  ClinicalTrials.gov Identifier: NCT00551551 - Not yet recruiting
  Urinary Incontinence; Anal Incontinence; Pelvic Pain; Genital Prolapse; Quality of Life
  
• Prenatal Screening For Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00070850 - Completed
  Smith-Lemli-Opitz Syndrome; Pregnancy
  
• Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS)
  ClinicalTrials.gov Identifier: NCT00065897 - Completed
  Pregnancy
  
• Preop Chemoradiation Resectable Pancreas
  ClinicalTrials.gov Identifier: NCT00336648 - Active, not recruiting
  Pancreatic Neoplasms
  
• Preop Conformal Radiotherapy - Prostate
  ClinicalTrials.gov Identifier: NCT00252447 - Active, not recruiting
  Prostatic Neoplasm
  
• Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
  ClinicalTrials.gov Identifier: NCT00500188 - Recruiting
  Gastrointestinal Stromal Tumors
  
• Preoperative Anxiety in Pediatric Reconstructive Burn Patients: The Role of Virtual Reality Hypnosis
  ClinicalTrials.gov Identifier: NCT00569647 - Completed
  Anxiety
  
• Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study
  ClinicalTrials.gov Identifier: NCT00330772 - Recruiting
  Coronary Artery Disease; Coronary Artery Bypass Grafting
  
• Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography
  ClinicalTrials.gov Identifier: NCT00300547 - Not yet recruiting
  Obstructing Colorectal Cancer
  
• Preoperative Assessment of Colon Tumor
  ClinicalTrials.gov Identifier: NCT00114829 - Recruiting
  Colorectal Cancer; Colorectal Tumor
  
• Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
  ClinicalTrials.gov Identifier: NCT00392392 - Recruiting
  Breast Cancer
  
• Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
  ClinicalTrials.gov Identifier: NCT00525785 - Recruiting
  Stomach Cancer; Gastric Cancer
  
• Preoperative Chemoradiation With Capecitabine and Cetuximab
  ClinicalTrials.gov Identifier: NCT00297128 - Recruiting
  Rectal Cancer
  
• Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00506623 - Active, not recruiting
  Rectal Neoplasm; Neoadjuvant Therapy
  
• Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00506844 - Active, not recruiting
  Rectal Neoplasms; Neoadjuvant Treatment
  
• Preoperative Chemotherapy vs. Preoperative Concurrent Chemoradiotherapy in N2 Positive IIIA NSCLC
  ClinicalTrials.gov Identifier: NCT00452803 - Recruiting
  Lung Cancer
  
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00580333 - Recruiting
  Breast Cancer
  
• Preoperative Cisplatin in Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
  Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
  
• Preoperative Combined Radiation and Chemotherapy - Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00232453 - Completed
  Rectal Neoplasms
  
• Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00297141 - Completed
  Rectal Cancer
  
• Preoperative Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00546156 - Recruiting
  Breast Cancer
  
• Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
  ClinicalTrials.gov Identifier: NCT00544232 - Active, not recruiting
  Breast Cancer
  
• Preoperative Estetrol in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00464516 - Not yet recruiting
  Breast Cancer
  
• Preoperative Hepatic Arterial Infusion Chemotherapy
  ClinicalTrials.gov Identifier: NCT00522509 - Active, not recruiting
  Colorectal Liver Metastases
  
• Preoperative Herceptin and Navelbine for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148681 - Active, not recruiting
  Breast Cancer; Stage II breast cancer; Stage III breast cancer
  
• Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148668 - Recruiting
  Breast Cancer; HER-2 Positive Breast Cancer; Early stage Breast Cancer
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Preoperative NSAID to Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00473980 - Completed
  Colorectal Cancer
  
• Preoperative Octreotide Treatment of Acromegaly
  ClinicalTrials.gov Identifier: NCT00521300 - Active, not recruiting
  Acromegaly
  
• Preoperative Octreotide Treatment of Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00241033 - Active, not recruiting
  Patients With Acromegaly
  
• Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193310 - Active, not recruiting
  Lung Cancer
  
• Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery
  ClinicalTrials.gov Identifier: NCT00503334 - Recruiting
  Enteral Nutrition
  
• Preoperative Preparation for Children
  ClinicalTrials.gov Identifier: NCT00205244 - Recruiting
  Elective Surgery; Anxiety
  
• Preoperative Prevention and Early Rehabilitation for Patients Undergoing Elective Spine Surgery
  ClinicalTrials.gov Identifier: NCT00459966 - Completed
  Spine Surgery
  
• Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00038181 - Terminated
  Prostate Cancer
  
• Preoperative Thalidomide With Radiation Therapy for Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy, Doxorubicin, Ifosfamide, and Dacarbazine for Patients with High or Intermediate Grade Primary Soft Tissue Sarcom
  ClinicalTrials.gov Identifier: NCT00089544 - Active, not recruiting
  stage I adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; recurrent adult soft tissue sarcoma
  
• Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193427 - Active, not recruiting
  Lung Cancer
  
• Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
  ClinicalTrials.gov Identifier: NCT00193128 - Recruiting
  Esophagus Cancer
  
• Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00335231 - Suspended
  Endophthalmitis
  
• Preoperative Treatment of Breast Cancer with Two Different Sequential Treatment Regimens
  ClinicalTrials.gov Identifier: NCT00149214 - Active, not recruiting
  Breast Neoplasms
  
• Preoperative Treatment of Patients With High Risk Thymoma
  ClinicalTrials.gov Identifier: NCT00387868 - Recruiting
  Thymoma
  
• Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III NSCLC
  ClinicalTrials.gov Identifier: NCT00176137 - Completed
  Non-Small Cell Lung Cancer
  
• Preoxygenation Using NIV in Hypoxemic Patients
  ClinicalTrials.gov Identifier: NCT00472160 - Not yet recruiting
  Critically Ill Patients; Hypoxemic
  
• PREPARE - Primary Prevention Parameters Evaluation
  ClinicalTrials.gov Identifier: NCT00279279 - Completed
  Tachycardia, Ventricular; Implantable Cardioverter Defibrillator (ICD); Fibrillation, Ventricular; Syncope
  
• Preparing the Personal Physician for Practice (P4)
  ClinicalTrials.gov Identifier: NCT00504517 - Recruiting
  Healthy
  
• PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption
  ClinicalTrials.gov Identifier: NCT00457158 - Recruiting
  Pulmonary Embolism; Venous Thrombosis
  
• Preprocedural Fasting and Nitrous Oxide -Oxygen Inhalation Analgesia for Dental Treatment of Children
  ClinicalTrials.gov Identifier: NCT00263289 - Not yet recruiting
  Vomiting
  
• Prepubertal Children with Growth Failure Associated with Primary IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125164 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency
  
• Prepulse Inhibition of Startle in Cocaine Dependence - 7
  ClinicalTrials.gov Identifier: NCT00015249 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Preschool Based Obesity Prevention Effectiveness Trial
  ClinicalTrials.gov Identifier: NCT00241878 - Not yet recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
  ClinicalTrials.gov Identifier: NCT00414921 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Prescription Methods Assessment Project (PMAP)
  ClinicalTrials.gov Identifier: NCT00393653 - Active, not recruiting
  Osteoarthritis; Gastroesophageal Reflux Disease
  
• Prescription Opioid Abuse and Pain - 1
  ClinicalTrials.gov Identifier: NCT00158184 - Recruiting
  Opioid-Related Disorders; Substance-Related Disorders; alcohol & drug use
  
• Prescription Opioid Addiction Treatment Study (POATS)
  ClinicalTrials.gov Identifier: NCT00316277 - Recruiting
  Opiate Dependence; Substance-Related Disorders; Opioid-Related Disorders
  
• Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
  ClinicalTrials.gov Identifier: NCT00517101 - Not yet recruiting
  Psoriatic Arthritis; Ankylosing Spondylitis; Undifferentiated Spondyloarthropathy
  
• Presentation of Lumbar Disc and Reduction of Symptoms
  ClinicalTrials.gov Identifier: NCT00440856 - Not yet recruiting
  Radiculopathy
  
• Preservation of Beta-Cell Function in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00232583 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix
  ClinicalTrials.gov Identifier: NCT00204997 - Recruiting
  - Squamous Cell Carcinoma of the Cervix
  
• Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00574405 - Recruiting
  Diabetes Mellitus
  
• Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy
  ClinicalTrials.gov Identifier: NCT00378014 - Recruiting
  Liver Transplantation
  
• Preserving Function Among Disability Applicants
  ClinicalTrials.gov Identifier: NCT00530985 - Recruiting
  Disability
  
• Preserving Function in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00429286 - Recruiting
  Breast Cancer
  
• Pressure support ventilation during CF exacerbations
  ClinicalTrials.gov Identifier: NCT00008775 - Suspended
  Cystic Fibrosis
  
• Pressure Ulcer Assessment via Telemedicine
  ClinicalTrials.gov Identifier: NCT00012597 - Completed
  Pressure Ulcers
  
• Pressure Ulcer Formation Prevention in Paraplegics Using Computer and Sensory Substitution Via the Tongue.
  ClinicalTrials.gov Identifier: NCT00429013 - Recruiting
  Paraplegia
  
• Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00404209 - Recruiting
  Retinal Detachment
  
• Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy
  ClinicalTrials.gov Identifier: NCT00343759 - Recruiting
  Breast Cancer
  
• Preterm Fetal Growth Restriction and Developmental Care
  ClinicalTrials.gov Identifier: NCT00166660 - Recruiting
  Preterm Birth
  
• Preterm Infants' Weight Gain Following Massage Therapy
  ClinicalTrials.gov Identifier: NCT00029198 - Recruiting
  Premature Birth
  
• Prevacid vs Lifestyle Modifications for the Treatment of LPR
  ClinicalTrials.gov Identifier: NCT00274339 - Recruiting
  Laryngopharyngeal Reflux
  
• Prevalence & Progression of Subclinical Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00006503 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Coronary Arteriosclerosis; Carotid Artery Diseases; Menopause
  
• Prevalence and Clinical Spectrum of the 22q11 Deletion
  ClinicalTrials.gov Identifier: NCT00267397 - Terminated
  Congenital Disorders
  
• Prevalence and Correlates of Childhood Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00005560 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes
  
• Prevalence and Metabolic Consequences of Relative Growth Hormone Deficiency in Abdominal Obesity
  ClinicalTrials.gov Identifier: NCT00562796 - Recruiting
  Obesity; Growth Hormone
  
• Prevalence and Profiles of Sports Injury in Taiwanese Adolescent Baseball Players
  ClinicalTrials.gov Identifier: NCT00174031 - Recruiting
  Sports Injury
  
• Prevalence and Risk of Cataracts in Granulocyte Donors
  ClinicalTrials.gov Identifier: NCT00042627 - Completed
  Apheresis
  
• Prevalence and Treatment of Anemia in Rehabilitation Patients
  ClinicalTrials.gov Identifier: NCT00511901 - Suspended
  Anemia
  
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00164138 - Active, not recruiting
  Cystic Fibrosis; Chronic Obstructive Pulmonary Disease (COPD)
  
• Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic
  ClinicalTrials.gov Identifier: NCT00340769 - Completed
  Zinc Fingers Proteins
  
• Prevalence of Ambivalence Regarding Prenatal Testing
  ClinicalTrials.gov Identifier: NCT00342069 - Completed
  Pregnancy
  
• Prevalence of Asymptomatic Ventricular Dysfunction
  ClinicalTrials.gov Identifier: NCT00005534 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive; Heart Failure
  
• Prevalence of carbohydrate intolerance in lean and obese children
  ClinicalTrials.gov Identifier: NCT00000112 - Recruiting
  Obesity; Glucose Intolerance; Diabetes; Acanthosis Nigricans
  
• Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
  ClinicalTrials.gov Identifier: NCT00453700 - Recruiting
  Chagas Disease
  
• Prevalence of Chronic KIdney Disease in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00383968 - Recruiting
  Hypertension; Chronic Kidney Disease
  
• Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00266474 - Completed
  Cystic Fibrosis; Sinusitis
  
• Prevalence of COPD: First Epidemiological Data From a Large Region of Turkey
  ClinicalTrials.gov Identifier: NCT00388232 - Completed
  COPD Prevalance
  
• Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00222378 - Recruiting
  Crohn's Disease; Ulcerative Colitis
  
• Prevalence of Delirium in Patients Undergoing Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00242151 - Recruiting
  Heart Disease
  
• Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
  ClinicalTrials.gov Identifier: NCT00478829 - Completed
  Adult
  
• Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
  ClinicalTrials.gov Identifier: NCT00224276 - Completed
  Schizophrenia; Bipolar Disorder; Diabetes Mellitus
  
• Prevalence of Endometrial Abnormalities In Obese Women
  ClinicalTrials.gov Identifier: NCT00500591 - Recruiting
  Obesity
  
• Prevalence of Endometriosis in a Well Defined Group of Infertile Women
  ClinicalTrials.gov Identifier: NCT00464139 - Completed
  Endometriosis; Infertility
  
• Prevalence of Hepatitis C Virus Infection in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00037076 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, China
  ClinicalTrials.gov Identifier: NCT00278499 - Active, not recruiting
  HIV Infections; Sexually Transmitted Diseases
  
• Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa
  ClinicalTrials.gov Identifier: NCT00096681 - Active, not recruiting
  HIV Infections; Tuberculosis
  
• Prevalence of Hypogonadism in Male Cancer Patients
  ClinicalTrials.gov Identifier: NCT00472940 - Recruiting
  Cancer; Hypogonadism
  
• Prevalence of Lactose Intolerance Following Stem Cell Transplantation.
  ClinicalTrials.gov Identifier: NCT00247806 - Not yet recruiting
  Lactose Intolerance
  
• Prevalence of Lower Urinary Tract Symptoms in Women With Gynecologic Malignancy Planning to Undergo Surgical Management
  ClinicalTrials.gov Identifier: NCT00580697 - Enrolling by invitation
  Lower Urinary Tract Symptoms; Gynecologic Malignancy
  
• Prevalence of Lymphoma in IBD
  ClinicalTrials.gov Identifier: NCT00577538 - Active, not recruiting
  Lymphoma; Inflammatory Bowel Disease
  
• Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00298844 - Recruiting
  Type 2 Diabetes Mellitus
  
• Prevalence of MODIC Changes in Subjects With and Without Low Back Pain
  ClinicalTrials.gov Identifier: NCT00479063 - Not yet recruiting
  Low Back Pain
  
• Prevalence of Nocturnal Hypoglycemia in Children on a TID Insulin Regimen Using CGMS
  ClinicalTrials.gov Identifier: NCT00542334 - Not yet recruiting
  Nocturnal Hypoglycemia; Type 1 Diabetes
  
• Prevalence of Ocular Surface Disease in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00382122 - Completed
  Glaucoma
  
• Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs
  ClinicalTrials.gov Identifier: NCT00386880 - Active, not recruiting
  Migraine
  
• Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00153621 - Recruiting
  Chronic Kidney Failure; AIDS-Associated Nephropathy
  
• Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
  ClinicalTrials.gov Identifier: NCT00365911 - Recruiting
  Healthy
  
• Prevalence of RHD, Pyoderma and Scabies in Children in Fiji
  ClinicalTrials.gov Identifier: NCT00284843 - Active, not recruiting
  Streptococcus Group A
  
• Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus
  ClinicalTrials.gov Identifier: NCT00381771 - Recruiting
  Globus Pharyngeus
  
• Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
  ClinicalTrials.gov Identifier: NCT00529230 - Completed
  Advanced Cancer
  
• Prevalence of Sleep Apnea in Women
  ClinicalTrials.gov Identifier: NCT00005381 - Completed
  Lung Diseases; Sleep Apnea Syndromes
  
• Prevalence of Sleep Disordered Breathing in Children
  ClinicalTrials.gov Identifier: NCT00022789 - Recruiting
  Lung Diseases; Sleep Apnea Syndromes
  
• Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
  ClinicalTrials.gov Identifier: NCT00282191 - Recruiting
  Mental Retardation; Spasticity
  
• Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
  ClinicalTrials.gov Identifier: NCT00569504 - Not yet recruiting
  Metabolic Syndrome; Schizophrenia
  
• Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an Update
  ClinicalTrials.gov Identifier: NCT00399347 - Active, not recruiting
  Diabetes Mellitus
  
• Prevalence Study of Sleep Apnea in Women With Preeclampsia
  ClinicalTrials.gov Identifier: NCT00259688 - Recruiting
  Preeclampsia
  
• Prevalence, Etiology and Therapy of Micturition Disorders of Children with a Mental and/or Motoric Disability
  ClinicalTrials.gov Identifier: NCT00148005 - Completed
  Micturition disorder
  
• Prevalence, Natural History, Prognosis Factor, Quality of Life, Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France
  ClinicalTrials.gov Identifier: NCT00481338 - Recruiting
  Hip Osteoarthritis; Knee Osteoarthritis
  
• PREvent First Episode Relapse (PREFER)
  ClinicalTrials.gov Identifier: NCT00220714 - Recruiting
  Schizophrenia: A Severe Emotional Disorder of Psychotic Depth Characteristically Marked by Delusions, Hallucinations, and Social Withdrawal.
  
• Prevent Inability To Control Urination
  ClinicalTrials.gov Identifier: NCT00075114 - Recruiting
  Urinary Incontinence
  
• PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing
  ClinicalTrials.gov Identifier: NCT00409916 - Recruiting
  Heart Failure, Congestive
  
• Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy
  ClinicalTrials.gov Identifier: NCT00522756 - Recruiting
  Kidney Failure, Acute
  
• Preventing Adverse Drug Events with PatientSite
  ClinicalTrials.gov Identifier: NCT00140504 - Active, not recruiting
  Preventive health; Primary care; Adverse drug event
  
• Preventing Alcohol Exposed Pregnancies (AEPs)
  ClinicalTrials.gov Identifier: NCT00219336 - Recruiting
  Alcohol Consumption; Contraception; Fetal Alcohol Syndrome
  
• Preventing Anxiety Disorders in Youth
  ClinicalTrials.gov Identifier: NCT00073619 - Recruiting
  Anxiety Disorders
  
• Preventing Behavior Problems in Children with ADHD
  ClinicalTrials.gov Identifier: NCT00057668 - Active, not recruiting
  Attention Deficit Disorder with Hyperactivity; Attention Deficit and Disruptive Behavior Disorders
  
• Preventing Child Abuse in Infants
  ClinicalTrials.gov Identifier: NCT00000382 - Active, not recruiting
  Child Abuse
  
• Preventing Chronic Whiplash Pain
  ClinicalTrials.gov Identifier: NCT00021476 - Active, not recruiting
  Whiplash Injuries
  
• Preventing Cognitive Decline with Alternative Therapies
  ClinicalTrials.gov Identifier: NCT00010920 - Completed
  Dementia; Memory Disorders
  
• Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
  ClinicalTrials.gov Identifier: NCT00513825 - Recruiting
  Contrast Induced Nephropathy
  
• Preventing Cytomegalovirus (CMV) Organ Damage with Valganciclovir in People with HIV
  ClinicalTrials.gov Identifier: NCT00006145 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Preventing Depression in Early Adolescents: A Test of Adolescent and Parent Intervention Components
  ClinicalTrials.gov Identifier: NCT00360451 - Active, not recruiting
  Depression; Anxiety
  
• Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
  ClinicalTrials.gov Identifier: NCT00218556 - Recruiting
  Depressive Disorder, Major; Hepatitis C
  
• Preventing Depression in Patients with Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00042211 - Active, not recruiting
  Depression; Macular Degeneration
  
• Preventing Depression Recurrence in Diabetes
  ClinicalTrials.gov Identifier: NCT00374426 - Completed
  Major Depression; Diabetes
  
• Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy
  ClinicalTrials.gov Identifier: NCT00183560 - Recruiting
  Depression
  
• Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00494715 - Recruiting
  Diabetes
  
• Preventing Frequent Sinus Infections in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00000752 - Terminated
  HIV Infections; Sinusitis
  
• Preventing Harm From Alcohol Use in Older Adults
  ClinicalTrials.gov Identifier: NCT00379093 - Recruiting
  Alcohol-Related Disorders; Alcohol-Drug Interactions
  
• Preventing Lack of Iodine During Pregnancy
  ClinicalTrials.gov Identifier: NCT00379535 - Recruiting
  Pregnancy
  
• Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach
  ClinicalTrials.gov Identifier: NCT00110292 - Active, not recruiting
  Developmental Disabilities; Language Development Disorders
  
• Preventing Loss of Weight, Fat Free Mass and Activities of Daily Living
  ClinicalTrials.gov Identifier: NCT00373971 - Completed
  Hip Fracture; Arthrosis
  
• Preventing Malaria During Pregnancy in Epidemic-Prone Areas.
  ClinicalTrials.gov Identifier: NCT00142207 - Active, not recruiting
  Malaria, Falciparum
  
• Preventing Microalbuminuria in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00503152 - Recruiting
  Diabetes
  
• Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations
  ClinicalTrials.gov Identifier: NCT00302900 - Recruiting
  Syncope, Vasovagal
  
• Preventing Osteoporosis in Adolescent Girls
  ClinicalTrials.gov Identifier: NCT00069173 - Recruiting
  Osteoporosis
  
• Preventing Overweight in USAF Personnel: Minimal Contact Program
  ClinicalTrials.gov Identifier: NCT00417599 - Active, not recruiting
  Overweight; Obesity
  
• Preventing Overweight Using Novel Dietary Strategies (Pounds Lost)
  ClinicalTrials.gov Identifier: NCT00072995 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Preventing Pneumonia and Other Respiratory Problems in Persons With Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00448045 - Recruiting
  Spinal Cord Injury
  
• Preventing Post-Stroke Depression
  ClinicalTrials.gov Identifier: NCT00071643 - Recruiting
  Depression; Cerebrovascular Accident
  
• Preventing Postpartum Hemorrhage Using a Tibetan Traditional Medicine
  ClinicalTrials.gov Identifier: NCT00147420 - Completed
  Hemorrhage
  
• Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study
  ClinicalTrials.gov Identifier: NCT00360581 - Recruiting
  Smoking Cessation
  
• Preventing Pressure Ulcers in Veterans with Spinal Cord Injury (SCI)
  ClinicalTrials.gov Identifier: NCT00105859 - Terminated
  Spinal Cord Injury; Pressure Ulcers
  
• Preventing Problem Behavior Among Middle School Students
  ClinicalTrials.gov Identifier: NCT00062959 - Completed
  Substance Use Disorders; Health Promotion
  
• Preventing Problems in Children's Social Behavior
  ClinicalTrials.gov Identifier: NCT00006446 - Completed
  Behavior Disorders
  
• PREventing Progression of Adipose Tissue Redistribution
  ClinicalTrials.gov Identifier: NCT00389194 - Recruiting
  HIV Infections
  
• Preventing Recurrent Stroke in Minority Populations
  ClinicalTrials.gov Identifier: NCT00211731 - Completed
  Stroke; Transient Ischemic Attack
  
• Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib
  ClinicalTrials.gov Identifier: NCT00365313 - Completed
  Arthritis; Bleeding Ulcer
  
• Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
  ClinicalTrials.gov Identifier: NCT00330863 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Preventing Sexual Transmission of HIV With Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00074581 - Completed
  HIV Infections; HIV Seronegativity
  
• Preventing Staphylococcal (Staph) Infection
  ClinicalTrials.gov Identifier: NCT00108160 - Recruiting
  Staphylococcal Infections
  
• Preventing Substance Use and Risky Behavior Among Rural African American Youth
  ClinicalTrials.gov Identifier: NCT00535704 - Not yet recruiting
  Risky Sexual Behavior
  
• Preventing the Recurrence of Depression with Drugs and Psychotherapy
  ClinicalTrials.gov Identifier: NCT00057577 - Active, not recruiting
  Depression
  
• Preventing the Return of Depression in Elderly Patients
  ClinicalTrials.gov Identifier: NCT00000377 - Completed
  Depression
  
• Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
  ClinicalTrials.gov Identifier: NCT0006752